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Abstract 
 
  It is well established that mixed microbial communities contain organisms which 
have not been studied by conventional culture-based methods. In the human oral cavity 
this number is estimated at around 50%. Commensal bacteria develop and maintain an 
intimate relationship with human cells without triggering proinflammatory mechanisms 
and this study aims to explore this by searching for bacterial proteins which facilitate 
binding to the human tongue dorsum and wider oral cavity.  
  Metagenomic DNA from the human tongue dorsum of 9 volunteers was extracted 
and  a  phage  display  library  created,  to  our  knowledge  the  first  to  incorporate 
metagenomic DNA. Phage display is an elegant molecular technique involving fusion of 
fragmented DNA to a phagemid coat protein, such that inserted DNA is encoded by the 
phage and displayed on the phage surface. The affinity selection technique panning, then 
exploited the natural affinity and specificity of the fusion proteins to identify bacterial 
binding proteins using, in this case, three ligands: IgA, Fibronectin and BSA. IgA is of 
special  interest  to  this  group  as  it  interacts  with  bacterial  proteins  and  is  poised  to 
respond to bacterial numbers in human secretions such as saliva. Proteins from panning 
were analysed in silico, however, the majority were discarded due to the presence of stop 
codons  in  the  protein  sequences.  Remaining  phagemid  displaying  fusion  proteins  of 
interest were  assessed  for  function  and  binding assays carried out  to confirm binding 
specificity.  
  Due to the biased nature of phage display library production, a 16S rRNA gene 
analysis  was  also  carried  out  in  order  to  assess  metagenomic  DNA  diversity  prior  to 
library construction. Because phage display was used successfully by colleagues with the 
genomes of single organisms, it was believed that including metagenomic DNA in a phage 
display library would cast a wide net over the tongue dorsum allowing capture of many 
more binding proteins occurring in this environment from a wide range of bacteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 12 
 
Acknowledgements 
There are many that I should thank and acknowledge but none are more important to me than 
my family. Their faith in me to succeed has always been an inspiration and any achievements I 
have made is owed as much to their unwavering support as it is to any contribution of mine. 
Mum, Dad, Craig, Grans and Deys, for everything, Thank You! 
Several people are worthy of thanks for helping me  manoeuvre through the sleep-depriving 
waters of my PhD. Professor John Ward is, without doubt, the best supervisor I could have 
asked for. Honest and kind, intelligent without condescension, he is the gold standard by which 
all other supervisors should be judged. Professor Brian Henderson has always been full of 
(umpty-tumpty) ideas and encouragement for this project, which he believed in from the start. 
Thanks also to everyone who gave me money: BBSRC, Wellcome, SfAM, SGM, UCL. 
Emma  Stanley  became  a  valuable  ally  and  a  true  friend,  and  I  am  glad  we  took  every 
opportunity to put the world to rights. Kathrin Schulze-Schweifing brought brightness into our 
lab, and my appreciation goes to her for sharing the pain that is phage display with me. Steph 
Hunter is the sensible voice of guidance, and that encouragement will not be forgotten. 
Without the following people, I would be a more miserable, deluded and cynical version of 
myself: Martin (Jackie!) Cowie, my best friend and security blanket for 10 long years. Jenny 
Ritchie became Jenny Marr during the final stretch of my PhD, and is my oldest and dearest 
friend. Mag Murphy, my partner in crime in Edinburgh, is an angel in every sense of the word. 
Charlotte Hamilton: HWU class of 2004!!!  All of my colleagues from UCL, some of whom 
made  me laugh  every day, sometimes at them but mostly  with them, notably:  Will Bryant 
(guilty of numerous Dad jokes), Steven Branston, Lewis Dartnell and Michael Hanley. 
 
 
Planet Earth 
Planet Earth, my home, my place 
A capricious anomaly in the sea of space 
In my veins I’ve felt the mystery 
Of corridors of time, books of history 
Life songs of ages throbbing in my blood 
I’ve danced the rhythm of the tide and flood 
Your misty clouds, your electric storm 
Were turbulent tempests in my own form 
I’ve licked the salt, the bitter, the sweet 
Of every encounter, of passion, of heat 
Your riotous colour, your fragrance, your taste 
Have thrilled my senses beyond all haste 
In your beauty I’ve known the how 
Of timeless bliss, this moment of now.  
MJJ, 1958 - 2009  
 
Ladies and Gentlemen, I am now locked up in a handcuff that has taken a 
British mechanic five years to make. I do not know whether I am going to 
get out of it or not, but I can assure you I am going to do my best. 
-  Harry Houdini, London Hippodrome 
Saint Patrick’s Day, 1904.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
___________________________________ 
Chapter 1 
Introduction 
___________________________________ 
 
 
 
 
 
 
 
 Chapter 1: Introduction 
 
14 
 
General Introduction 
  The natural cycle of life and death, growth and multiplication by organisms great and 
small, is relentlessly shaped by microbial metabolic activity and physiological diversity, which 
has remained largely unexplored for many years. The first use of the microscope by Antonie 
van Leeuwenhoek almost 400 years ago prompted the realisation that a whole world of unseen 
organisms existed unexplored. The notion that more bacteria are present in a sample than the 
number  appearing  on  culture  plates  is  known  today  as  the  ‘great  plate  count  anomaly’ 
(Handelsman,  2004)  and  alluded  to  a  large  microbial  diversity  long  before  molecular 
investigations  became  commonplace.  However,  in  the  19
th  century,  pure-culture  techniques 
underpinned the interrogation of single bacteria and attempts to classify different organisms 
was based on specific nutritional requirements. 
  In  1884,  Danish  bacteriologist  Christian  Gram  developed  a  method  which 
distinguished the two major bacterial classes based on the physical and chemical properties of 
their cell wall. The Gram stain is now a common, and often the first, bacteriological technique 
used when rapid identification of bacterial infections is needed. Some bacterial cell walls are 
resistant to the decolorisation by acids used in the Gram stain, for example Mycobacteria spp., 
and these are called acid-fast bacteria, classified in 1938 (Gordon & Hagan, 1938). 
  However intriguing the microbiological world appeared to certain scientists, the view 
that large animals were of paramount importance was reinforced by evolutionary biologists 
when, in 1969, Whittaker developed a ‘Five Kingdoms’ evolutionary view of life, including 
animals, plants, fungi, protists and bacteria. This representation heavily insinuated what most 
people believed, that life on Earth was dominated by eukaryotes. A revolution in the study of 
microbial  diversity  came  in  the  1970’s,  which  turned  bacterial  evolution  and  the  existing 
variety therein, upside down. Genetic information and taxonomy complement each other in the 
identification  of  living  organisms,  where  taxonomic  information  is  not  robust  enough  as  a 
standalone  resource  (Chu  et  al,  2006).  Carl  Woeses’  pioneering  16S  rRNA  sequence  and 
analysis  study  (1987)  containing  representative  sequences  from  all  known  phylogenetic 
domains  facilitated  the  construction  of  a  sequence-based  phylogenetic  tree,  illustrating 
relationships between previously unlinked organisms. Three domains exist in the current Tree 
of Life: Eukarya (eukaryotes), Bacteria and Archaea (Figure 1). This pictorial representation of 
evolutionary biology highlights that all previous research to record and  describe biological 
species and relationships, had been directed at a tiny portion of microbial species (Pace, 1997). 
Now of course, ribosomal RNA (rRNA) genes are commonly used as ‘DNA barcodes’, and 
PCR  amplification  and  analysis  of  this  small  subunit  gene  is  commonly  used  to  quantify 
species diversity. 
 Chapter 1: Introduction 
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Figure  1  Phylogeny  of  the  Living  World.    This  universal  phylogenetic  tree  is  derived  from 
comparative sequencing of 16S rRNA. The evolutionary distance between two groups of organisms 
is proportional to the cumulative distance between the end of the branch and the node that joins 
the two groups. Data obtained from the Ribosomal Database Project (Madigan et al, 2003). 
 
  The interaction of bacterial communities associated with a human host can have direct 
implications for health (Jones & Marchesi, 2007). Public awareness of the beneficial properties 
of bacteria has increased in recent years, but so too has the implication of pathogenic bacteria 
in disease and the apparent rise of antibiotic resistant bacteria incessantly captures the public 
imagination.  The  acknowledgement  of  the  potential  consequence  of  large  scale  antibiotic 
resistance has triggered a surge in research interest and funding to find novel treatment options 
for bacterial disease. Some research interest has also focussed on bacterial proteomics  – or 
reverse genomics (Brotz-Osterhelt et al., 2005) - for the production of novel antibiotics for use 
in  pharmaceuticals  (Yoneyama  &  Katsumata,  2006).  Primarily,  public  perception  and 
understanding  of  micro-organisms  is  basic,  but  undeniably  tarnished,  governed  by  fears  of 
infectious disease, antibiotic resistance and ‘superbugs’: views reinforced to a degree by tabloid 
ignorance  and  scare-mongering.  Indeed,  the  rich  diversity  of  bacteria  is  only  partially 
understood, but now it is vital to gain functional information on bacterial proteins and how they 
interact with human factors.  
  Given the scale of human bacterial cargo this project aims to discover more about the 
methods  by  which  bacteria,  in  particular  the  commensal  microbiota  of  the  human  tongue 
dorsum, adhere to human surfaces. The human oral cavity supports a huge number of bacterial 
Bacteria  Archaea  Eukarya Chapter 1: Introduction 
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passengers with very few ill effects, and it is of enormous interest to the scientific community 
to discover how this is possible. 
 
Friendly bacteria 
  Most micro-organisms not only co-exist in a co-operative symbiosis with mammals 
and  other  bacteria,  but  through  their  natural  metabolic  pathways,  enable  the  persistence  of 
eukaryotic life as we know it, by encoding essential metabolic functions that humans have not 
evolved  for  themselves  (Ley  et  al.,  2008).  Molecular  studies  of  microbial  populations  at 
specific sites in the human body have highlighted the beneficial effect these communities can 
invoke.  A  major  site  of  interest  is  the  human  gastro-intestinal  tract  (GI),  and  comparisons 
between  germfree  and  conventional  animal  models  have  clearly  shown  the  gut  microbial 
community to have considerable influence on host biochemistry, physiology, immunology and 
low-level  resistance  to  gut  infections  (Gordon  &  Pesti,  1971;  Walter,  2008),  possibly  by 
counteracting the adhesion mechanisms used (Collado et al., 2008).  
  The  beneficial  effects  of  indigenous  microbiota  are  no  longer  disputed  however 
clarification is still needed regarding the methods by which bacteria and host survive together 
without more persistent infections. For example, the presence of certain bacterial components is 
known to trigger particular medical conditions, such as Inflammatory Bowel Disease (IBD). 
IBD causes misery and discomfort for thousands of people, and a study by Lodes et al, in 2004 
set out to identify the bacterial antigens responsible for the pathogenic nature of IBD; found to 
be flagellins. Determining the individual factors responsible for such immune responses may 
illuminate the reasons why bacteria are mostly tolerated on human cells and tissues. 
 
Bacterial Colonization 
  Microbes  do  not  sit  passively  on  host  surfaces.  Micro-organisms  interact  with 
mammalian hosts in a number of ways, most of which are still poorly understood. Three types 
of  host-bacteria  and  inter-bacteria  interaction  are  recognised  in  mammals.  The  first  is 
mutualism – where both members of the association benefit from the others’ presence. The 
second is commensalism – where one member benefits, but the other is unaffected. The third is 
parasitism –  where  one  member benefits at the  expense  of the  other (Wilson, 2005a). The 
predominant  form  of  symbiosis  between  micro-organisms  and  their  warm-blooded  hosts 
appears to be mutualism, and in most literature these are referred to as the normal microbiota – 
or commensals.  
  Bacterial colonization of mucosal surfaces is thought to require the evasion of local 
host immune responses (Kilian, 2003), although it is conceivable that the host mediates its Chapter 1: Introduction 
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reaction  if the bacteria are beneficial, and  facilitates specific adherence  mechanisms  which 
initiate bacterial attachment to a human cell. Attachment is a priority for organisms who benefit 
from  staying  in  a  specific  location.  This  adherence  procedure  is  enabled  by  bacterial  cell-
surface binding proteins, many of which are known  and characterised as adhesins; proteins 
which  recognise  and  bind  specific  receptors  on  human  cells  (Azzazy  &  Highsmith,  2002). 
Commensal and pathogenic bacteria all express adhesive abilities, and suitable locations will 
always  be  efficiently  colonised,  ultimately  reaching  a  healthy  and  dynamic  equilibrium,  or 
climax  community.  Several  studies  have  implied  that  the  commensal  microbiota  act  as  a 
protective barrier to invading pathogens; providing competition for space and nutrients and 
limiting pathogen growth and multiplication (Madigan et al., 2003). The niche-specificity of 
bacteria,  in  association  with  their  ability  to  breach  mucosal  barriers  and  invade  a  host, 
distinguishes pathogenic from commensal organisms (Wizemann et al., 1999). Some bacterial 
diseases are associated with the commensal microbiota, but these are thought to result from a 
failure of normal immune regulatory mechanisms rather than aggressive behaviour on the part 
of the bacteria themselves (Wade, 2002). 
 
Microbial communities 
The mixed microbial communities which populate oral surfaces can contain between 
34 and 72 species per person (Aas et al., 2005) and this assortment of species often leads to 
biofilm development (Figure 2). Growth of any biofilm is in stages, as each bacteria engages in 
signalling and/or metabolic interactions with those around it (Egland et al., 2004), culminating 
in a dynamic 3D structure of cooperative microorganisms (Kara et al., 2007). This process 
probably takes around 8 hours on the tooth surface, but could be less on the tongue dorsum 
since the biofilm would probably never be entirely removed.  
  Metabolic  collaboration  is  widespread  between  species  during  the  development  of 
stable and resilient biofilm communities. Various species of Streptococcus are first to colonise 
oral  surfaces,  and  the  colonization  of  the  tooth  surface  is  particularly  well  understood 
(Kolenbrander  et  al.,  2002).  Primary  colonizers  use  surface  bound  receptors  of  adsorbed 
salivary proteins, meanwhile catabolising carbohydrates to produce shorter chain organic acids. 
Veillonella  species  routinely  accompany  streptococcal  colonisation,  probably  due  to  their 
dependence on Streptococci to catabolise sugars so the Veillonellae can ferment the resulting 
organic  acids  (Palmer  et  al.,  2006).  This  kind  of  interaction  provides  the  basis  for  such 
cooperative symbioses. 
Inter-bacterial  binding,  or  coaggregation  (Rickard  et  al.,  2003),  promotes  bacterial 
accumulation on surfaces that have already been colonised, a trait common to Veillonella sp.. 
Bacteria which join a biofilm community in the later stages of development can act as bridging  Chapter 1: Introduction 
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Figure  2  Biofilm  development  a)  primary  colonisers  of  the  tongue  surface  might  include 
Streptococcal  species,  which  attach  through  specific  or  non-specific  interactions  with  the 
components of the organic conditioning film, b) multiplication of the primary colonisers leads to 
the  formation  of  microcolonies,  the  increased  output  of  which  changes  the  environmental 
conditions of the early biofilm,  c) secondary colonisers attach to the primary colonisers by the 
specific process of coadherence of either single cells, coaggregates (interspecies binding which has 
occurred separate from the biofilm environment) or groups of cells,  d) coadhered cells become 
part of the larger multispecies biofilm community and the biofilm is said to be mature. Adapted 
from Rickard et al., 2003. 
 
 
species,  and  may  be  able  to  form  interactions  with  many  different  kinds  of  bacteria.  The 
biofilm grows in size and complexity until it is mature or parts of it are dispersed by natural or 
mechanical means.  
On  the  tooth  surface,  Fusobacterium  nucleatum  is  such  a  bridging  organism, 
coaggregating  with  a  wide  range  of  oral  bacteria,  causing  it  to  be  known  as  a  secondary 
coloniser and linking it with the development of periodontal disease. The work of Edwards, 
(2007) found that coaggregation of Streptococcus cristatus to Fusobacterium nucleatum not 
only promotes the survival of S. cristatus in saliva, but enables its carriage into host cells as a 
passenger when bound to F. nucleatum (Edwards et al., 2006). Thus, it is clear that adhesion is 
being used as a survival mechanism in the oral environment. 
Being part of a biofilm has many advantages for bacteria. Biofilms concentrate/trap 
food and metabolic by-products as substrates for microbial growth (Kierek-Pearson & Karatan, 
2005).  Biofilms  are  less  susceptible  to  antimicrobial  agents  and  are  structurally  and 
Substratum 
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b) Chapter 1: Introduction 
 
19 
 
functionally organised by countless antagonistic and synergistic microbial interactions. More 
subtle cell-signalling can lead to coordinated gene expression in the community. As a result, a 
multispecies biofilm can possess a combined metabolic activity and efficiency that is greater 
than  a  single  species  population.  Other  advantages  include  gene  transfer,  enhanced 
pathogenicity and an increased host range (Marsh, 2005). 
 
Oral cavity, saliva and tongue dorsum  
  In humans, the  oral cavity  is  generally agreed to be home to around 750 transient 
bacterial species (Jenkinson & Lamont, 2005). Huge disparity in the commensal microbiota 
occurs between individuals, resulting from general heterogeneity within the human population 
such as diet and oral health, and in the various anatomic features of the oral cavity such as gaps 
between the teeth, salivary flow rate and depth of tongue crypts, all of which may influence the 
survival of certain microbes over others (Roldan et al., 2003; Paster et al., 2006). With a mean 
surface  area  of  215cm
2  (Collins  &  Dawes,  1987),  teeth,  keratinized  and  non-keratinized 
surfaces make up about 20%, 30% and 50% of the oral cavity respectively (Mager et al., 2003). 
The presence of keratin on the filiform papillae of the tongue dorsum (Dresselhuis et al., 2008) 
provides  a  tough  impermeable  barrier.  Studies  which  focus  on  the  tongue  microbiota 
specifically (Kazor et al., 2003; Riggio et al., 2008) are rare in comparison to those on dental 
plaque and associated diseases, such as periodontitis and gingivitis (Vitorino et al., 2006). The 
precise role of the tongue microbiota with regards to human health and disease is not clear – 
leaving a gap in the knowledge in this particular area.  
  Local  physiochemical  conditions  in  the  human  oral  cavity  are  conducive  to  rapid 
bacterial  proliferation.  The  ubiquity  of  saliva  has  many  positive  functions  such  as  diluting 
carbohydrates which, when metabolised by bacteria, produce acids promoting the development 
of periodontal disease (Marcotte & Lavoie, 1998). Saliva also promotes the flow of nutrients 
around  the  oral  cavity  and  the  component  lysozyme  causes  aggregation  and  removal  of 
unattached microbes (Wilson, 2005c). 
Additionally,  salivary  components  act  as  ligands  for  bacterial  adhesion  (Table  1). 
These  components,  particularly  Fibronectin  and  other  extracellular  membrane  (ECM) 
constituents, have been major sources of bacterial binding proteins (MSCRAMMs) over the 
last few years (Weiss et al., 2000; Christie et al., 2002; Goo et al., 2006; Mullen et al., 2007; 
Edwards et al., 2007). Salivary amylase binds the oral bacteria S. gordonii, S. mitis and S. 
oralis (Helmerhorst & Oppenheim, 2007), which may promote or prevent adherence within the 
oral cavity. Secreted  IgA (S-IgA), the  main immunoglobulin found  in saliva, enhances the 
antimicrobial activity of other salivary components, such as lactoferrin (sequesters iron in the 
environment), agglutinin (mediates bacterial aggregation and adherence) and mucins  Chapter 1: Introduction 
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Component  Range of concentration in saliva(µg/ml) 
Albumin  25 
Fibronectin  0.2 – 2 
IgG  15 - 30 
Lactoferrin  0.4 – 7 
Proline rich Proteins  0 – 180 
Secreted IgA  5 - 58 
 
Table 1  Salivary Components. Adapted from Scannapieco, F.A., 1994. 
 
 
(protective role), all of which assist in managing the bacterial load present (Marcotte & Lavoie, 
1998).  The  presence  of  S-IgA  limits  the  adherence  of  bacteria  to  surfaces  by  producing 
antibodies against the offending bacterium, such as oral streptococci (Vudhichamnong et al., 
1982), Candida albicans (Williams & Gibbons, 1972) and the fimbriae  of  members  of the 
Enterobacteriacae (Tratmont et al., 1980). It does this by disrupting the stereochemical and 
non-specific interactions required by bacteria to bind to a surface, resulting in a reduction in the 
number of possible adhesive interactions. Additionally, S-IgA agglutinates bacteria, promoting 
clearance  from  the  oral  cavity  (Liljemark  et  al.,  1979).  The  complex  structure  of  the 
hydrophobic tongue dorsum and the nature of salivary components mean that saliva-protein 
emulsions are readily adsorbed (Dresselhuis et al., 2008). Secreted IgA bound to the bacterial 
surface  can  enhance  clearance  from  the  oral  cavity  or  adherence  to  oral  surfaces  or  other 
bacteria (Scannapieco et al., 1989). 
  The tongue dorsum offers a far different environment for bacterial life than the hard, 
non-shedding  surfaces  of  the  teeth  (Mager  et  al.,  2003).  The  papillary  structure  of  the 
keratinized tongue dorsum (du Toit, 2003) has an extended surface area due to the presence of 
deep  crypts  and  grooves  between  the  filiform  papillae  (Figure  3).  This  irregular  surface 
facilitates the accumulation of saliva, other bacteria and particles of food where unregulated 
bacterial  growth leads to the  development  of anaerobic  microhabitats (Roldan et al., 2003; 
Wilson,  2005c).  The  individual  filiform  papillae  are  covered  in  a  layer  of  interdigitating 
epithelial cells in various stages of exfoliation. The anterior surface of each papilla is covered 
in micro-organisms, which can be found between epithelial cells up to four layers down (Brady 
et al, 1975), where bacteria may then come into contact with FN in the ECM. A build up of 
bacterial by-products commonly leads to halitosis (bad breath), and the tongue surface is the 
principal source of oral malodour, the target of many recent studies (Haraszthy et al., 2007;  Chapter 1: Introduction 
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Figure 3  Diagrams of the Human Tongue Dorsum.   A & B both depict the highly papillated 
structure of the tongue dorsum, where the presence of deep furrows produces a highly convoluted 
and therefore increased surface area, perfect for bacterial proliferation. Diagram A is a schematic 
illustration of the proposed bacterial load on this surface, with anaerobic microbes proliferating at 
the bottom of the deep crypts. Diagram B is a histological slice of a murine tongue dorsum, stained 
with haematoxylin and eosin, which clearly shows the dark epithelium covering the papilla and the 
taste buds (arrows).  
   
Riggio et al., 2008). The general anaerobic tendency of microbes living on the tongue dorsum 
is  due  in  part  to  the  development  of  thick  biofilms.  Biofilm  progression  results  in  the 
development  of  a  wide  range  of  redox  potentials  as  it  matures  and  becomes  denser.  More 
bacteria become bound to those in the vicinity – a process known as coaggregation – resulting 
in  the  maturation  of  a  dense  microbial  mat.  During  this  process  the  biofilm  becomes 
increasingly  anaerobic  as  microbial  activity  utilises  trapped  oxygen  and  the  increasing 
thickness  of  the  biofilm  reduces  the  ability  of  oxygen  to  permeate  it  (Marcotte  &  Lavoie, 
1998).  
 
Host cell biology 
  Clearly, bacterial adhesion is a complex process and in order to unravel the interactive 
strings mediating bacterial adhesion to host tissues a thorough knowledge of the cell and tissue 
biology  of  the  target  is  essential  (Ofek  et  al,  2003b).  The  constituents  of  mammalian  cell 
membranes are varied and complex (Table 2), however all membranes share universal features: 
(i)  membrane  lipids  are  organised  in  a  planar  bilayer  configuration,  consisting  of 
glycerolphospholipids, sphingolipids and sterols in a fluid state (ii) the bilayer contains integral 
proteins including glycolipids, glycoproteins and proteoglycans (iii) a combination of weak 
interactions,  hydrogen  bonding  and  hydrophobic  affinities  bind  other  proteins  and 
glycoproteins to the membrane surface, these are known as peripheral components, and (iv) the 
presence of a mucous blanket or cell coat comprising carbohydrate rich materials on the surface 
of epithelial cells  provides protection to the cells and interaction opportunities with bacterial 
adhesins. 
 
A
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B
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Membrane 
Constituent 
Characteristics 
Integral Proteins   
Integrins  Glycosylated, membrane spanning heterodimers, >20 identified, bind 
to basolateral surfaces of  epithelial cells and the basal lamina. Also 
bind  to  ECM  components  and  act  as  receptors  for  a  number  of 
pathogens 
Proteoglycans 
 
Heparan sulfate proteoglycan family contains 5 classes, syndecan and 
glypican are the main components. Some are transmembrane and some 
ECM  components,  but  all  bind  a  variety  of  bacteria,  viruses  and 
parasites including Streptococcus spp.  
Cadherins  E,  P  and  N-cadherin  are  most  widely  expressed  and  all  contain  a 
single  transmembrane  domain,  a  large  extracellular  domain  and  a 
cytoplasmic domain that interacts with the cytoskeleton. 
Glycocalyx  Complex  and  highly  glycosylated,  it  is  comprised  of  integral 
glycoproteins, proteoglycans and glycolipids, as well as a coat of non-
secreted mucins anchored in the cell membrane. The high density and 
diversity of saccharides provides multiple receptors for lectin-bearing 
bacteria. 
Peripheral Proteins   
ECM – Collagens  Three  types,  I,  II  and  III,  exist  of  the  most  abundant  proteins  in 
animals. Consist of a helical arrangement of α chains, polymerized in 
a staggered manner. 
ECM – Fibronectins  Ubiquitous  adhesive  glycoproteins  composed  of  type  I,  II  and  III 
repeats  which  bind  to  various  receptors  such  as  collagen, 
proteoglycans and bacteria. 
ECM – Laminins  Basement membrane adhesive glycoproteins which bind to collagen, 
heparin sulfate and integrins. Interacts with E. coli and viridans and 
group A streptococci. 
ECM – Vitronectin  Part of the complement system, this glycoprotein binds to collagen 
and heparin and is a receptor for group A streptococci. 
Cell Coat  Consisting of a layer of glycoprotein, it often includes mucins, which 
inhibit or promote bacterial adhesion to host mucous membranes. It is 
the first point of contact for bacteria colonising host tissues. 
 
Table 2  Human Cell Membrane Constituents 
 
 
  The first point of contact for a bacterium on a mammalian tissue is most likely to be the 
epithelial (skin) cells or those of the gastrointestinal (GI) tract. Epithelial cells are keratinised, 
the fibrous nature of which provides a tough, impermeable barrier. Structural cells of this type 
exist on the tongue dorsum and the skin (Figure 4) because they provide protection against 
physical  damage  as  well  as  bacterial  colonization.  This  epithelium  has  three  basic 
characteristics:  (i)  the  cell  layer  has  a  free  apical  surface  where  the  superficial  cells  are 
keratinised and coated with a thick mucous layer; (ii) contiguous cells are joined by junctional  Chapter 1: Introduction 
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Figure 4  Stratified Epithelia. Stratified epithelia commonly have up to 20 layers of cells. The basal 
lamina consists of collagen, laminin, proteoglycans, fibronectin and other ECM components. Cells 
are joined by junctional complexes and the apical cell layer is not only protected by keratin, but 
also by a thin mucous blanket.  
 
 
complexes and (iii) the cell layer is attached basally to an extracellular matrix specialisation 
termed the basal lamina. Epithelia such as the tongue dorsum are known as ‘stratified’, having 
up  to  20  layers  of  cells.  Only  the  basal  layer  is  attached  to  the  basal  lamina.  Below  the 
basement membranes (basal side) is the lamina propria, containing the connective tissues, of 
which  fibronectin  and  collagen  interact  to  form  a  structurally  sound  extracellular  protein 
network – the extracellular matrix (ECM) (Geiger et al., 2001). This network contains a range 
of cell types, such as macrophages and fibroblasts, as well as neural and vascular constituents. 
  ECM macromolecules, which also include vitronectin and laminin, can underlie the 
epithelia at a considerable distance from the cell surface. However, they do come into contact 
with  membrane  receptors  in  many  instances,  making  them  a  point  of  contact  for  adhering 
microbes (Ofek et al., 2003b). Bacteria commonly encode and use fibronectin binding proteins 
(Fnbp’s) to facilitate binding to human cells (Jonsson et al., 1991; Joh et al., 1998).    
 
Bacterial architecture 
  When  extracting  mixed  microbial  DNA  directly  from  a  sample,  the  cell  wall 
heterogeneity of the microbes contained within must be considered. A common feature of both 
Gram  positive  (Figure  5)  and  Gram  negative  (Figure  6)  bacteria  is  the  peptidoglycan-
containing  network  which  gives  shape  to  the  bacterial  cell  and  absorbs  trauma.  In  Gram 
basal lamina 
basal cells 
apical cells 
mucus layer Chapter 1: Introduction 
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positive bacteria the peptidoglycan layer is 20-40 nm thick in order to withstand the high (20-
25 atm) osmotic pressure inside the Gram positive cell (Koch et al., 1982), in comparison to the 
5-10 nm layer in Gram negatives. Although peptidoglycan is heterogeneous, it does not appear 
to function as a ligand for bacteria-bacteria adhesion, instead providing a support for adhesin 
presentation and stabilization (Nikaido et al., 1996).  
 
 
Figure 5  Gram positive cell wall containing teichoic acid and a thick (20-40 nm) peptidoglycan 
membrane needed to withstand the osmotic pressure within the cell. Cell wall anchored proteins, 
transmembrane  proteins,  surface  proteins  and  glycolipids  are  all  involved  in  binding.  (LTA= 
Lipoteicoic Acid). 
 
 
 
 
Figure 6  Gram negative cell wall is made up  of LPS and protein and contains thin layers of 
peptidoglycan. The outer layer of the cell wall contains porins for specific types of molecule. Gram 
negative bacteria bind using fimbriae, outer membrane proteins (OMP), glycolipids (LPS) and 
other unknown surface structures. 
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  Gram  positives  also  contain  teichoic  acid,  where  Gram  negatives  have  an  outer 
membrane (OM) covering the thin peptidoglycan layer which also contains lipopolysaccharide 
(LPS), fimbria, porins and type III secretion systems (Ofek et al., 2003c). The means by which 
adhesins are anchored to the bacterial cell surface are different for Gram-positive and Gram-
negative  bacteria.  In  Gram-positives  cell-wall  anchored  proteins,  transmembrane  proteins, 
surface proteins (lipotechoic acid) and glycolipids (internalin) are all involved in initiating or 
maintaining the binding process. In Gram-negative bacteria this role is carried out by fimbriae, 
outer  membrane  proteins  (OMP),  glycolipids  (LPS)  and  other  unknown  surface  structures 
(Ofek  et  al.,  2003c).  It  is  important  to  understand  architectural  differences  between  Gram 
positive  and  Gram  negative  bacteria  during  metagenomic  analyses  as  DNA  extraction 
techniques can result in unequal or non-lysis of certain species, lending a bias to subsequent 
libraries produced from the material (Hattori & Taylor, 2009). 
 
Adhesins 
  The expression of bacterial binding proteins requires complex processes moderated by 
coordinated mechanisms, which differ for each adhesin and between bacterial species (Ofek et 
al., 2003c). One example is the binding proteins of Staphylococcus aureus, one of the many 
virulence factors this organism encodes. Some are expressed throughout the growth cycle, like 
Clumping Factor A (ClfA), whereas most are only expressed during the early exponential and 
mid exponential growth phases, when cell density is low (Lowy, 1998). Fibronectin binding 
proteins (FnBP’s) are also examples and include FnBPA (Signas et al., 1989), FnBPB (Jonsson 
et al., 1991) and protein A (Heinrichs et al., 1996). As growth progresses and bacterial cell 
density increases, the expression of adhesins is downregulated. 
  Of the various types of bacterial binding proteins, all must be presented or anchored to 
the bacterial cell surface in some way before colonisation can occur. Some binding structures 
and components are common between Gram positive and Gram negative bacteria, but again, 
the stage  of  growth and  even the  growth  media used can  have  a drastic  effect on proteins 
expressed at any time (Ofek et al., 2003c).  
 
Bacteria-host interactions 
  In order for a bacterium to attach itself anywhere, an energy barrier must be overcome 
– regardless of the mechanism of adhesion (Ofek et al., 2003a). Both bacteria and adhesive 
substrata on human cells are negatively charged and these repulsive forces are overcome by 
hydrophobic  determinants,  leading  to  weak,  reversible  adhesion.  These  non-specific 
interactions are  mediated by surface proteins such as LTA (G+ve) and type  IV pili (G-ve) Chapter 1: Introduction 
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(Ofek et al., 2003a). Because repulsive forces increase in proportion to the diameter of the 
approaching particles (Ofek et al., 2003a), fimbriae or other small bacterial components are an 
effective way of overcoming the barrier. Maximum repulsion between the adhering substrata 
occurs at 50 nm, and at 2 nm complementary binding relations such as lectins, hydrophobic or 
electrostatic interactions come into play. The stabilizing effect of hydrophobic sites solidifies 
the connection by maintaining stereospecific interactions (Ofek et al., 2003c).  
The  second  stage  of  bacterial  adhesion  involves  stereospecific  interactions  with 
complementary receptors on host surfaces through ionic interactions, hydrogen bonding and/or 
hydrophobic  effects.  For  example,  in  Group  A  Streptococci,  hydrophobic  lipotechtoic  acid 
(LTA) mediates initial binding to fibronectin, but the second step is mediated by fibronectin 
binding protein (FBP), which brings the bacterium through the repulsion barrier set up by the 
respective negative charges, thus increasing binding strength (Ofek et al., 2003a).  
Any binding event involves a complex cascade of molecular interactions between the 
ligand  and  receptor  molecules.  A  successful  binding  event  between  bacteria  and  host  can 
initiate complex signal transduction cascades in the host which may (i) activate innate host 
defences, (ii) initiate changes to host cellular processes which facilitate bacterial colonization, 
or  (iii)  exaggerate  microbial  pathogenicity  by  activation  of  gene  expression  within  the 
bacterium (Soto & Hultgren, 1999). Although binding events are ubiquitous, the process is still 
not explicitly understood. What is known however is that adherence to host structures such as 
the ECM by microbes is a key factor in determining virulence and can lead to the progression 
of infectious disease (Fine et al, 2005). 
 
Types of binding interaction 
Known proteins involved in adhesion are highly conserved (Abraham et al., 1988), and 
the lack of variation is thought to be due to analogous host receptors (Wizemann et al., 1999). 
Due to the ubiquity of bacterial binding, it is likely that uncharacterised binding proteins are 
commonly used for colonisation, and taking a metagenomic approach provides an opportunity 
to identify some of them. 
Attachment  of  a  bacterial  cell  to  a  ligand  is  mediated  by  three  main  categories  of 
adhesive  interaction,  of  which  bacterial  lectins  are  the  most  common  type  among  Gram 
negative and Gram positive bacteria (Wizemann et al., 1999). Lectins can be bound to the 
bacterium or to the mucosa being colonized. In Gram negative bacteria, lectins incorporate 
fimbriae, pili and other outer membrane (OM) components; and in Gram positives lectins are 
found  in  the  peptidoglycan  matrix.  Lectins  are  classified  by  sugar  specificity  and  the 
carbohydrate  structure  of  an  individual  lectin  is  incredibly  difficult  to  study  as  the  sugar 
specificity includes both the primary sugar specificity and fine sugar specificity. An example of Chapter 1: Introduction 
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lectin binding is given by Ruhl et al., 1996, where interactions between bacterial lectins and 
various carbohydrate side chains of IgA were detected in species such as E. coli, S. gordonii 
and  A.  naeslundii.  One  of  the  best  understood  mechanisms  of  bacterial  adherence  is  that 
mediated by cell surface pili or fimbriae, and much is known about them (Wizemann et al., 
1999; Skerker & Berg, 2001). 
Human cell membranes have specific molecules associated with them (Table 3), which 
can function as ligands for commensal bacterial colonization (Kazor et al., 2003). These are 
usually proteins, glycoproteins and polysaccharides (Kolenbrander, 1993), and these protein-
protein  interactions  include  binding  of  Extracellular  Matrix  (ECM)  components  such  as 
fibronectin,  collagen,  vitronectin  (Patti  et  al.,  1994) and  laminin  (Fine  et  al., 2005)  to  the 
Fibronectin Binding Proteins (FnBP’s) of bacteria. For example, the adhesins FimA and SsaB 
have affinity for salivary glycoprotein on the tooth surface and use this attraction to colonize 
the oral cavity (Schennings et al., 1993). 
 
Type of membrane 
component 
Cell type  Adhesin  Bacterium 
Glycolipids  Uroepithelial cells  P fimbriae  E. coli 
Glycoproteins:       
    - Integrins  M cells, enterocytes  IpaB, IpaC  Shigella 
    - Heparan sulphate,      
       proteoglycans 
Epithelial cell  Opa proteins  N. gonorrhoeae 
    - E-cadherin  M cells, enterocytes  Internalin A  L. monocytogenes 
Glycolipoprotein  Mast cells  Type 1 fimbriae  E. coli 
 
Table 3 Human membrane components and associated adhesins.  
 
 
Hydrophobins are the third and least well characterised category of known adhesive 
interactions, but are the most common way for bacteria to overcome initial repulsive forces 
between components. Hydrophobins are not really bonds, but a tendency for apolar molecules 
to associate with other apolar molecules rather than water. Hydrophobins include any surface 
component  which  promotes  hydrophobicity  and  adhesion  to  surfaces,  some  such  as 
streptococcal or staphylococcal proteins are covalently bound to the cell wall (Csh A) where 
others are part of the outer membrane like lipids or fimbriae (Doyle et al., 2000). 
Clearly, bacteria have access to plethora of routes for gaining a foothold in the human 
body, but microbes do  not sit passively on human surfaces ignored by the human  immune Chapter 1: Introduction 
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system, but are recognised by the innate immune system and can induce localized adaptive 
responses without eliciting destructive inflammation (Lu et al., 2006).  
 
Innate microbial recognition  
It is currently accepted that part of the interaction between host and microbial cells is 
mediated  through  the  intercellular  signalling  proteins  cytokines  which  mediate  bacterial 
homeostasis.  These  molecules  interact  locally  with  bacteria  or  their  released  products  and 
become  amplified,  signalling  microbial  presence  (Henderson  et  al.  1996).  However, 
commensal and pathogenic bacteria can produce molecules which induce both pro- and anti- 
inflammatory cytokines thus allowing microbes to exert more control over the host response 
than previously thought (Henderson et al., 1996). Clearly, the innate immune system recognises 
the presence of bacteria but what remains unclear is to what extent this is occurring and how – 
or if – the immune system recognises and copes with commensal and pathogenic organisms 
differently. Similarly, do bacteria recognise when a host immune system is depressed and use 
this chance to invade? 
It  appears  that  pathogens  are  treated  differently  by  the  host.  Both  commensal  and 
pathogenic  organisms  express  Micro-organism  Associated  Molecular  Patterns  (MAMP’s) 
which are recognised by host pattern recognition receptors (PRR’s), but the proinflammatory 
response is limited  only to pathogens, so avoiding  excessive and  detrimental  inflammatory 
responses (Sirard et al., 2006). Commensals avoid  initiating an immune response by  either 
down-regulating the host response themselves or by altering MAMP expression or structure to 
avoid detection. 
Bacteria are also equipped to take advantage of opportunities provided by the host with 
many microbes expressing binding proteins which mediate adhesion to specific areas, like the 
ECM.  Microbial  Surface  Components  Recognising  Adhesive  Matrix  Molecules 
(MSCRAMMS) are molecules on the microbial cell surface which recognise, with high affinity 
and  specificity,  an  ECM  ligand  such  as  collagen,  laminin,  FN and  fibrinogen  (Patti  et  al., 
1994). The host can mediate bacterial attack by upregulating genes with defense functions such 
as SPLUNC1 from humans and rodents, which is closely related to LPS binding protein (LBP), 
known to enhance proinflammatory signals in response to bacterial LPS. More interestingly 
this group (LeClair et al., 2004) located a related but novel protein splunc5, unique to rodents, 
which is expressed solely on the tongue epithelium, suggesting that its placement has been 
adapted to meet specific needs of the innate immune system (LeClair et al, 2004). 
There is clearly enormous diversity in the mechanisms used by bacteria to bind and 
communicate  with  host  cells  and  tissues.  By  choosing  two  panning  ligands  expressed Chapter 1: Introduction 
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commonly in the oral cavity it was anticipated that, over the course of this project, some of 
these complex interactions might be identified and deciphered in more detail. 
 
 
Bacterial Research 
  Microbiology  research  now  depends  less  heavily  on  the  maintenance  of  individual 
bacteria  in  pure  culture,  as  it  is  now  realised  that  very  few  micro-organisms  exist  in  pure 
culture in nature, instead thriving as broad, multifaceted communities in select niches (Lu et al., 
2006).  
  In humans, bacterial cells outnumber human cells by a factor of 10 (Wilson, 2005b) – 
and encode at least 100 times as many genes as the host genome (Jones & Marchesi, 2007). 
Prokaryotes  clearly  demonstrate  such  metabolic  and  physiological  diversity  that  they  can 
successfully populate any environment (Handelsman, 2004; Steele & Streit, 2005). The human 
body contains a huge diversity of unique colonization sites however the  complex nature of 
host-bacteria signalling, host immune molecules and the range of local conditions, means that 
these constant interactions are still poorly understood.  
  The  development  of  polymicrobial  communities  in  humans  has  stimulated  intense 
debate regarding their function, and the reaction of the host immune system in response to 
multiple bacteria, all pumping out extracellular products. This area of research is receiving a 
great deal of attention however the complexity of these interspecies interactions is making clear 
answers a challenge to find. Understanding the mechanisms by which a host is able to survey 
and discriminate between commensal and pathogenic bacteria, is crucial to a more complete 
appreciation of the host-microbe relationship (Lu et al., 2006), and  therefore new insight into 
pathogenic mechanisms.  
  Calling bacteria culturable or unculturable refers to the ability of bacteria to be cultured 
in the laboratory. Unculturable bacteria are those which are known to be present, for example 
through  direct  counts  under  a  microscope,  but  which  do  not  grow  on  conventional  culture 
media  under  standard  conditions  (Wade,  2002).  Current  arguments  on  this  subject  are 
extensive,  mainly falling  into two categories, those  who see ‘unculturable’ as  inappropriate 
terminology (Rappe & Giovannoni, 2003; Stevenson et al., 2004; Cowan et al., 2005) debating 
instead  that,  with  more  detailed  information  on  bacterial  growth/substrate  requirements, 
suitable culture conditions will be found (Hugenholz & Pace, 1996). Others note that media for 
bacterial growth can now be supplemented in virtually endless combinations, and that culture-
based  research  will  continue  to  result  in  only  a  cultivable  fraction  of  a  community  being 
expressed, rather than the cultivable fraction (Ritz, 2007).  Chapter 1: Introduction 
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  A significant proportion of known organisms are associated with human health and 
disease,  and  it  is  prudent  to  suppose  that  a  proportion  of  non-culturables  will  also  be 
attributable to disease involvement (Aas et al, 2005). Therefore the most up to date skills and 
knowledge should be used to assess the prospective variety and resources contained within.  
  Years of focus on pure culture enrichment of micro-organisms on selective media has 
resulted  in  the  generation  of  a  vast  quantity  of  functional  information  concerning  certain 
organisms. It is popularly quoted that less than 1% of all bacteria are cultivable using known 
techniques (Torsvik et al., 1990a; Amann et al., 1995; Pace, 1997), but this number is probably 
an underestimate (Prosser & Embley, 2002). Actually, the number of cultivable bacteria differs 
depending  on  the  environmental  niche.  Soils  are  said  to  contain  around  0.1%  cultivable 
bacteria, seas are less cultivable with 0.01%, probably because much of it is inaccessible. More 
familiar sites, such as the oral cavity are quoted as between 50% (Paster et al, 2001; Jenkinson 
& Lamont, 2005) and 60% (Kolenbrander et al., 2002) culturable. 
  There are several explanations for the general reluctance of bacteria to be maintained in 
pure culture. Commonly, microbes depend on the provision of additional factors for growth and 
replication, such as the by-products  of bacterial fermentation. The absence of a mixture  of 
bacteria may be inhibitory to others (Tringe et al., 2005). Culture media, which often contains 
artificial  substrates,  is  regularly  used  to  cultivate  micro-organisms  from  a  sample  in  the 
laboratory. This media may be toxic and, in its homogeneity, may be lacking in some unknown 
factor(s) required for growth. Furthermore, the production of inhibitory substances by more 
dominant bacteria in a mixed culture may also affect the growth of others (Wade, 2006). 
Cells in the unculturable majority may be either i. species which are already known and 
characterised, but for whom standard culture conditions are not suitable or ii. unknown species 
which  require  further  development  of  a  suitable  culture  method/media  (Handelsman  et  al., 
1998). An example of i. are ammonia oxidising bacteria from terrestrial and aquatic nitrifers, 
challenging to purify  due to  incredibly slow growth and a low  yield  when cultured  in the 
laboratory (Prosser & Embley, 2002). However difficult it may be, reaching pure culture status 
is still a desirable and fundamental objective in order to determine physical characteristics and 
to confirm the  existence  of an  individual  organism  and  its viability  within an  environment 
(Torsvik  et  al.,  1990a).  Pure  culture  techniques  complement  molecular  approaches  as  both 
disciplines  contribute  crucial  pieces  of  the  microbial  genomic  jigsaw.  Culture-independent 
methods  have  become  more  widely  used  and  have  contributed  greatly  to  the  information 
available  in  public  sequence  data  banks.  Assessing  the  DNA  contained  within  an  entire 
microbial community is now possible by undertaking a metagenomic analysis. By extracting 
the entire complement of microbial genes in a mixed community, an opportunity is presented to 
interrogate all microbial genomes present without suffering the potential losses of a cultivation-
based approach (Nichols, 2007). Chapter 1: Introduction 
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 Many metagenomic-based analyses have been carried out over the last 10 years, in a 
variety of environments including sea water (Wexler et al., 2005; Venter et al., 2004; Rusch et 
al., 2007; Yooseph et al., 2007; Kennedy et al., 2007; D’Costa et al., 2007; Wijffels, 2008), 
marine sponges (Daniel, 2004), microalgae (Ellis et al., 2003) and drinking water (Schmeisser 
et al., 2003). A great deal of attention has been paid to soil metagenomes since the likelihood of 
identifying uncultured and previously unknown microbes is high, and the environment is a rich 
source of new antibiotics and biotechnologically important enzymes (Torsvik et al., 1990b; 
Gillespie et al., 2002; Joseph et al., 2003; Liles et al, 2003; Lee et al., 2004; Ginolhac et al., 
2004; Voget et al., 2003; Gabor et al.,2004; Fierer et al., 2007; Hong et al., 2007).  
Closer to home, in particular the oral cavity (Paster et al., 2001; Munson et al., 2002; 
Mager et al., 2003; az-Torres et al., 2003; Roldan et al., 2003; Aas et al., 2005; Jenkinson & 
Lamont,  2005;  Paster  et  al.,  2006;  Spencer  et  al.,  2007,  Riggio  et  al.,  2008)  and  the  gut 
(Backhed et al., 2004; Gill et al., 2006; Turnbaugh et al., 2006; Kurokawa et al., 2007) have 
been extensively studied, in the hope of finding a cure or cause for some bacterial diseases such 
as Crones’ disease (Peterson et al., 2008) and periodontal disease (Kaplan et al., 2009). More 
unusual mixed bacterial communities have also been studied to gain insights into how they 
operate, such as an acid mine biofilm (Tyson et al., 2004), termite guts (Warnecke et al., 2007), 
bovine rumen (Ferrer et al., 2005), human faeces (Brietbart et al., 2003), honey bee colonies 
(Cox-Foster et al., 2007) and the  Uranian  deep sea hypersaline anoxic basin (Ferrer  et al., 
2005). 
 
Metagenomics for Community Analysis 
  The  overwhelming  complexity  with  which  microbial  systems  operate  in  natural 
ecosystems,  and  the  limitations  posed  by  traditional  culture-dependent  analysis  of  micro-
organisms, has forced the rapid development of new technologies which circumvent the need 
for bacterial culture. Metagenomics is one such approach and entails the functional and DNA 
analysis  of  all  genomes  present  in  an  environmental  sample  (Handelsman  et  al.,  1998).  In 
theory,  a  metagenomic  library  is  representative  of  all  genes  present  in  a  mixed  microbial 
sample,  however  this  depends  of  course  on  the  robustness  of  DNA  extraction  and  cloning 
methodologies used (Steele & Streit, 2005). 
  Ribosomal RNA (rRNA) is a structural molecule common to all micro-organisms, so 
there  is  no  codon  usage  divergence.  It  is  extremely  valuable  for  rapid  investigation  of  the 
microbial constituents in an environmental sample using the Polymerase Chain Reaction (PCR) 
(Pace,  1997).  The  study  of  microbial  diversity  based  on  16S  rRNA  studies  –  termed 
phylogenetics – is based on analysis of the highly conserved 16S rRNA gene, which accounts 
for only 0.05% of the microbial genome (Steele & Streit, 2005). The synthesis of ‘universal’ Chapter 1: Introduction 
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PCR primers amplifies rRNA genes from the DNA of all organisms present in a sample and, 
when followed by cloning and sequencing, can generate a huge quantity of environmental data 
regarding sample diversity (Streit & Schmitz, 2004). A phylotype is defined, in 16S rRNA 
terms, as clones which have > 98.5% identity. Those with < 98.5% similarity to previously 
defined clones are considered to represent a new species (Paster et al., 2006). Care must be 
taken  however  since  high  levels  of  16S  rRNA  gene  sequence  similarity  between  strains 
belonging to the same genus do not automatically indicate membership of the same species 
(Yassin  et  al.,  1996).  Clearly,  prokaryotic  physiological  and  metabolic  diversity  cannot  be 
assessed in its entirety using 16S rRNA gene analysis alone (Steele & Streit, 2005), and it is 
recommended for use in conjunction with other investigations, for example shotgun (randomly 
fragmented) libraries involving cloning of sample DNA into a suitable vector, and screening of 
clones for conserved genes by hybridization or multiplex PCR. Expression of specific traits can 
also be sought, such as enzyme activity or antibiotic production (Kang et al., 2009) or the 
shotgun library can be randomly sequenced.  
  The main problem with interrogating entire microbial communities is the volume of 
sequence data which must be generated in order to gain a representative view of the sample 
(Steele & Streit, 2005). As an example of this, the first major attempt at a ‘whole community’ 
sequencing effort was initiated and funded by Craig Venter (Venter et al., 2004). The group 
obtained samples of seawater from the Sargasso Sea in the Bermuda Triangle, known for its 
low nutrient levels, and sequenced as much DNA as possible. They sequenced 1.045 billion 
base  pairs  and  found  1800  genomic  species,  148  belonging  to  new  bacterial  phylotypes. 
Overall, the group recovered 1.2 million new genes. One of the interesting findings of this 
research was the detection of 782 new rhodopsin-like photoreceptors and the discovery that 
they  can be attributed to a  wide range  of bacteria including the CFB  group (Cytophaga – 
Flavobacterium – Bacteroides group). The phylogenetic identification of all species present in 
the samples is far from complete (Handelsman, 2004) and the vast quantity of data generated in 
this  project  will  take  many  years  to  fully  assess,  but  will  provide  a  valuable  insight  into 
prokaryotic species and functional diversity in the Sargasso Sea. 
  An exciting potential of metagenomics is that it allows community-wide assessment of 
metabolic and biogeochemical function, but large scale sequencing efforts such as the Sargasso 
Sea – and the generation of sequence data en masse – entail years of annotation and analysis 
before  the  input  becomes  applicable  for  functional  comparisons.  A  good  example  of  a 
‘complete’ habitat analysis is Tysons’ work on the biofilm community of the Richmond Mine 
(Tyson et al., 2004). The extreme environmental conditions present in the mine means that the 
community structure here is basic, consisting of 3 bacterial species and one archaeal species. 
The bacteria form a pink floating biofilm on the surface of the mine water, which has a pH of 
between 0 and 1 and a constant temperature of 42°C. High levels of Fe, Zn, Cu and As in the Chapter 1: Introduction 
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mine water, results in domination of this small community by extremely specialised species 
able  to  cope  with  these  harsh  conditions  including  Leptospirillum,  Sulfobacillus  and 
Acidomicrobium, whose genetic analysis reveal a multitude of genes centred on maintaining a 
non-toxic intracellular environment (Handelsman, 2004).  
  Tysons’ basic community lent itself to complete DNA cloning and sequence analysis, 
leading to closure of the bacterial genomes dominating that niche. As a result, Tyson’s work 
matched the bacterial phylotypes to functional roles within the biofilm community structure, 
facilitating  deduction  of  interactive  trends  utilised  to  optimise  survival.  This  comparison 
highlights that less complex communities are conducive to genome closure and therefore gene 
function assignment, as their simple nature presents fewer assembly puzzles (Nichols, 2007). 
  A  major  benefit  of  enormous  metagenomic  studies  like  Venters’  is  the  rapid 
development  of  new  software  which  simplifies  cataloguing,  storage  and  processing  of  the 
extraordinary volume of data generated. Perhaps more importantly, these advances enable data 
evaluation and assessment  of complex communities  at the system level (Schmeisser  et al., 
2007). As sequencing capacity has increased however, the capacity to annotate this information 
has not. Between 2004 and January 2007, over 2 billion base pairs were deposited in databases 
of major metagenomic projects, eclipsing the entire 764 Mb of previously sequenced genomes, 
but until the ORF’s are annotated with biological functions to provide context the information 
is not particularly useful (Harrington et al., 2007). 
 
Constructing a Metagenomic Library 
Cultivating  bacteria  gives  microbial  ecologists  a  context  in  which  to  investigate 
theoretical  molecular  findings,  and  provides  more  direct  access  to  environmental  genomes 
(Nichols, 2007). However meticulously formulated, culture conditions can never completely 
replicate the dynamic heterogeneity of a natural environment and so using cultivability studies 
and metagenomics as complementary techniques  will allow contextualisation of phenotypic, 
taxonomic and genomic information from a particular habitat (Ritz, 2007). 
  There  are  several  stages  involved  in  metagenomic  library  construction  (Figure  7). 
Sample collection, including adequate treatment and storage is followed by whole community 
DNA extraction. Extraction approaches differ depending on the analysis method to be used at 
the next stage. For example, if constructing a large fragment library, care must be taken to 
minimise  shear  damage  during  extraction.  Following  extraction,  DNA  fragmentation  is 
normally by sonication or restriction digest to the appropriate size for further analysis. At this 
stage,  it  is  common  to  clone  fragments  into  a  variety  of  vectors  including  pUC18/19, and 
conduct  initial  analysis  by  shotgun  cloning  and  sequencing.  Vectors  designed  for  large 
fragment propagation can also be used such as BAC (Bacterial Artificial Chromosome) and Chapter 1: Introduction 
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fosmids. Plating onto selective media allows selection of DNA fragments containing certain 
traits, e.g. protease activity, antibiotic resistance and  lipase activity (Rhee et al., 2005). As 
depicted  in  Figure  7,  these  are  all  options  for  locating  interesting  genes  which  display  a 
searchable phenotype. 
 
  
 
Figure 7  Construction of a Metagenomic Library.  Metagenomic libraries allow the isolation of all 
genetic information present in an environmental sample. This can be analysed using a range of 
techniques, but completely circumvents the need for bacterial culture, resulting in the potential 
capture of unknown bacteria. 
 
In specific human environment projects like this one, it is important to understand how 
novel proteins could interact with the host. In order to study bacteria-host interactions at the 
molecular  (protein-ligand)  level,  the  molecular  technique  Phage  Display  will  be  employed, 
along with the affinity selection stage Biopanning.  
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  Rather than undertaking a major sequencing and assembly project, the aim of this study 
is to use functional  genomic tools to  identify a few protein  candidates for sequencing and 
characterisation, which demonstrate binding to human ligands. Exploiting naturally occurring 
protein-ligand interactions in an efficient screening process can result in the identification of 
those with highest affinity and specificity (Jacobsson et al., 1997). One of the first genetic tools 
leading  to  the  full  realisation  of  the  value  of  protein-ligand  interactions  was  pioneered  by 
George Smith in 1985 and is called Phage Display (Smith, 1985). 
Phage display is used for many purposes. As a natural selection procedure it is useful 
for generating targets for drug discovery (Benhar, 2001; Trepel et al., 2002; Gnanasekar et al., 
2004), epitope  mapping (Matthews et al., 2002) and for screening antibodies (Prinz et al., 
2004). Antibodies were one of the first proteins to be displayed on a phage surface (McCafferty 
et al., 1990), and the isolation of monoclonal antibodies has been one of the most successful 
applications of phage display to date (Hoogenboom et al., 1998). 
  This project utilises filamentous bacteriophage (Figure 8) for the display of bacterial 
proteins, but all phage carry intrinsic commercial value in their own right. Commonly quoted as 
the most abundant biological entity on the planet, bacteriophages are estimated to total 10
31 
virus particles (Brussow & Hendrix, 2002). Due to the bacteria-killing activity of some phage, 
and to the diminishing power of antibiotics to treat disease,  phage therapy is becoming big 
business (Alisky et al., 1998; Miedzybrodzki et al., 2007; Capparelli et al., 2007) and several 
important studies have been carried out on the possibility of developing phage as an alternative 
to antibiotics (Weber-Dabrowska et al., 2000; Wagenaar et al., 2005).  
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Figure 8 Structure of filamentous phage showing all coat proteins, their location on the phage 
and all genes (adapted from Mullen et al., 2006). Figures in brackets signify the number of copies 
of each structural protein on the phage surface. Chapter 1: Introduction 
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Bacteriophage are used for phage display due to their natural ability to infect bacterial 
cells, and because they can incorporate foreign DNA into their circular genome and transport 
them  into  a  bacterial  cell  during  infection  (Smith  &  Petrenko,  1997).  Filamentous  phage 
display allows assembly in, and secretion from, an infected bacterium without compromising 
the  host  cell  membrane  (Mullen  et  al.,  2006).  Escherichia  coli  cells  infected  with  such 
bacteriophage become a factory for phage production, as the host machinery is commandeered 
to generate phage virions. 
 
Phage life cycle 
  The life cycle of M13 filamentous phage has been described in particular detail (Figure 
9). Coat protein pIII initiates the infection process by binding to the F pilus of E. coli. Pilus 
retraction brings the phage into intimate contact with the bacterial membrane where pIII binds 
to TolA, an E. coli membrane protein (Reichmann & Holliger, 1997). Upon contact, the phage 
transfers its single stranded (ss) genome into the host cell and the coat proteins insert into the 
bacterial outer membrane (Nakamura et al, 2003). The phage genome is immediately converted 
by bacterial enzymes to double stranded (ds) DNA to create the replicative form (RF). The RF 
replicates using the method of rolling circle replication where the build up of single strand (ss) 
binding protein pV sequesters the  displaced strand  leading to the production of plus-strand 
copies  of  phage  DNA  coated  by  pV,  preventing  conversion  to  dsDNA.  Structural  proteins 
pVIII, pVII, pXI, pVI and pIII spontaneously insert into the inner membrane of the bacterium 
as  they  are  synthesised  and  viral  particles  are  assembled  from  the  pV-coated  ss  genomes. 
During assembly, pV is removed from the ssDNA and the phage coated in pVIII, then pVII and 
pIX (Kehoe & Kay, 2005). The virion is extruded from the bacterial cell through a membrane 
pore and pIII and pVI are added to the end at this stage. Infected E. coli cells can grow and 
divide indefinitely, albeit at half the rate of uninfected bacteria (Kehoe & Kay, 2005). 
Phage display involves the expression of proteins on the surface of filamentous phage 
by splicing foreign inserts into the genome (Azzazy & Highsmith, 2002). Phage display differs 
from conventional expression systems in that the foreign DNA is spliced into the gene for a 
major coat protein (Figure 10), resulting in the fusion of the foreign amino acids of the insert to 
the endogenous amino acids of the coat protein. This insert is then replicated along with the E. 
coli host and expressed as a protein - displayed - on the phage surface. By inserting potential 
peptide-encoding  sequences  into  the  cloning  site,  a  peptide  library  is  produced,  containing 
several billion protein sequences encoded from heterologous foreign insert DNA. 
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Figure 9 M13 life cycle. A) a bacteriophage approaches an E. coli cell and attaches to its F’ pili 
using coat protein pIII and by retracting the pilus, the bacteriophage is brought into close contact 
with  the  bacterium.  The  TolQRA  (3  protein)  complex  participates  in  channel  formation 
(Reichmann & Holliger, 1997), where the phage ss genome is brought into the cell, and the phage 
coat  proteins  are  inserted  into  the  membrane.  B)  Conversion  of  the  ss  phage  genome  by  the 
bacterium results in the ds replicative form in C). D) Replication of the RF is by the rolling circle 
method,  leading  to  E)  plus-strand  copies  of  phage  DNA  which  are coated  with  pV  to  prevent 
conversion to dsDNA. At this stage, there will be a build up of structural phage proteins in the 
bacterial  membrane  and  viral  particles  are  assembled  as  they  pass  into  the  membrane.  F) 
Following addition of the phage coat proteins, the assembled phage is extruded from the bacterial 
cell through a membrane pore. 
 
 
Resulting  libraries  are  subsequently  screened  to  purify  specific  phage-encoded 
sequences using affinity selection between protein and ligand (Azzazy & Highsmith, 2002) – a 
process known as biopanning. Clearly, the success of a phage display and panning experiment 
is dependent on the quality, size and range of the initial library (Sidhu, 2001). 
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Figure 10 Phagemid Displaying Fusion Peptides on Gene VIII.  The red block in the phagemid 
genome  depicts  inserted  foreign  DNA,  which  is  then  translated  by  the  host  machinery  and 
expressed as a fusion protein (red circle) on the surface of the converted phage coat protein. 
 
 
Phage display application 
  The power of phage display lies in its ability to (i) maintain a physical link between the 
displayed protein and the DNA sequence encoding it, i.e., between phenotype and genotype 
(Figure 10) (Christensen et al., 2001), and (ii) functionally screen huge libraries containing 
billions of unique peptides and proteins (Russel, 2007a) for specific traits.  
Filamentous  phage  fd,  f1  and  M13  are  used  for  phage  display.  They  are  almost 
identical in structure and biology (Smith & Petrenko, 1997; Marvin et al., 2006), 1µm in length 
and around 10nm wide, with a protein coat encasing the ss DNA genome of 11 genes (Sidhu, 
2001). They are specific for bacteria carrying F-pili (such as E. coli) and are known as Ff phage 
(F- specific filamentous) (Marvin et al., 2006). Of the 11 genes, depicted in Figure 11, 5 code 
for coat proteins – one (p8) is the major coat protein and the other 4 are minor coat proteins 
(p3, p6, p7 and p9).  
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Figure 11  Filamentous Phage f1 (M13/fd) genes and gene products. Gene VIII encodes the major 
coat  protein,  the  protein  used  for  display  in  this  project.  Gene  II  encodes  p2  which  initiates 
replication  by  host  proteins.  P10  is  required  for  the  switch  to  ssDNA  accumulation.  Gene  V 
encodes the ssDNA binding protein p5. Genes VII and IX encode two small proteins that are first 
to exit the cell during assembly. Gene VIII encodes the major coat protein p8, and genes III and VI 
encode p3 and p6, located at the end of the virion. These proteins are responsible for termination 
of  assembly,  virion  release  and  infection.  Gene  I  encodes  p1  and  p11  which  are  essential 
cytoplasmic  membrane  proteins.  Gene  IV  encodes  p4,  a  multimeric  outer  membrane  protein 
channel through which the phage exits the bacterium (Russel, 2007a). 
 
 
All 5 confer structural stability and two in particular are used for phage display – p3 
and p8. Gene III encodes protein 3 (p3) and is present in 3-5 copies per phage. The function of 
p3 is host cell recognition and infection, and it is the largest of the coat proteins at 406 aa 
(Sidhu, 2001). Gene VIII, which encodes protein 8 (p8) is present in ~2700 copies per phage 
(Smith & Petrenko, 1997) and is 50 aa in size. P8 molecules are arranged in a repeating helical 
array, with exposed N termini on the surface and the C termini concealed at the core (Sidhu, 
2001). Because each phage particle contains several thousand p8 molecules, fused peptides are 
displayed  in  a  polyvalent  format  (Russel,  2007a), resulting  in  polyvalent  display  of  fusion 
proteins.  The  remaining  genes  encode  proteins  required  for  viral  replication  and  assembly 
(Sidhu, 2001). Phage do not accept peptides longer than 6 amino acids so for display of larger 
peptides phagemid vectors are used (Figure 12). Phagemid are hybrids of phage and plasmid 
vectors  (Mullen  et  al.,  2006),  and  contain  a  modified  version  of  gene  VIII  which,  upon 
infection with a helper phage, hybrid capsids containing the fusion protein are assembled and 
dispersed in an otherwise wild-type capsid (Cesareni, 1992). Phagemid do not contain an active 
phage  double  stranded  origin  of  replication  and  lack  all  of  the  genes  required  to  make  a 
complete phage. Helper phage infection is therefore required following replication in E. coli as 
a double-stranded plasmid, which deliver a native copy of all other proteins required for  
II/X  V  VII  IX  VIII  III  VI  I/XI  IV 
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Figure 12  pG8H6 Phagemid.  pG8H6 (2.6kb) contains a His-tag inserted between the PelB leader 
sequence and the MCS. It introduces a ribosomal slippage, so down-regulating the fusion peptide. 
This enhances progeny phage production as E. coli viability deteriorates when too many fusion 
peptides are waiting in the membrane for assembly.  
 
 
replication and packaging (Russel et al., 1986), avoiding phage instability as a result of the 
expression  of  overly  large  proteins  in  fusion  to  every  copy  of  gene  VIII  (Sidhu,  2001). 
  Phagemid  often  incorporate  specific  features  which  make  them  valuable  for  phage 
display technology such poly-His tags for ease of expression. Many phagemid use the lacZ 
promoter to drive expression of the coat protein fusion. To display the gene VIII product, the 
lacZ promoters’ catabolic repressor (glucose) is simply removed, which allows generation of 
the fusion product and polyvalent phage particles (Hoogenboom et al., 1998). 
 
Affinity selection – Biopanning 
  Once phage display library construction is complete, the natural specificity and affinity 
of fusion proteins displayed in the library can be exploited to search for genes or fragments of 
interest.  Panning  (Figure  13)  is  an  affinity  purification  technique  which  involves 
immobilization of a ligand on tubes or plates, then phage library incubation with the target long 
enough to allow the formation of protein-ligand bonds (Smith & Scott, 1993). The minority of 
phage  whose  displayed  peptides  bind  to  the  target  are  retained  while  the  non-  specifically 
bound phage are removed by three vigorous washing steps. The hugely enriched bound phage 
are eluted and, still  infective, are propagated by infecting log phase  E. coli. This infection 
produces a hugely amplified eluate which feeds directly into the next round of selection. The 
first  round  of  panning  normally  contains  proteins  with  a  range  of  binding  affinities,  and 
therefore a range of binding proteins with varying degrees of specificity. Three to six rounds of 
panning are recommended for optimum enrichment of clones which bind tightly to the target  Chapter 1: Introduction 
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Figure 13 Panning Process. (1) Grow phage library, (2) Purify phage, (3) Incubate in tube with 
immobilised antigen or ligand, (4) Remove unbound or weakly bound phage by washing, (5) Elute 
bound phage, infect host bacteria and grow colonies, (6) Pick colonies and analyse the selected 
DNA/protein using public databases and in silico tools. 
 
 
protein (Smith & Petrenko, 1997), theoretically resulting in a phage pool dominated by one or 
more specific binders. This has been the case with previous phage display studies which have 
made  libraries from pure  culture DNA  (Jacobsson  & Frykberg, 1996; Mullen  et al., 2007) 
however,  incorporating  metagenomic  DNA  in  phage  display  libraries  could  lead  to  rapid 
identification of many more binding proteins. As yet, there are no studies which have used 
metagenomics and phage display in tandem.   
  Specific binding phage from panning are analysed  individually (Smith & Petrenko, 
1997), most commonly by sequencing the insert following  excision  from the phagemid. In 
silico  analysis  of  the  encoded  DNA  and  amino  acid  sequences  can  lead  to  a  tentative 
identification of the bound peptide, its function and the bacteria it originated from based on 
homology to public sequence databases such as the Genbank database (Benson et al., 2008), 
part of NCBI (National Centre for Biotechnology Information: www.ncbi.nlm.nih.gov). 
1. 
2. 
3. 
4. 
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Panning ligand – IgA 
  Mucosal  surfaces  like  the  oral  cavity  produce  secretions  containing  high  levels  of 
immunoglobulins (Ig) which protect from bacterial attack. The predominant adaptive immune 
factor in secretions is secreted IgA (S-IgA), which is produced in daily quantities which far 
exceed the  combined production  of all other Ig  isotypes  (Kilian, 2003; Woof & Mestecky, 
2005). As the most concentrated immunoglobulin in the oral cavity, IgA is not bound to any 
surface but functions as a bacterial receptor (Ahl & Reinholdt, 1991) and protective component 
of relevant surfaces and tissues.  
IgA  is  locally  produced  by  plasma  cells,  plentifully  located  in  the  mucosal 
subepithelium  (Brandtzaeg & Johansen, 2005) and  is actively transported to the surface by 
selective receptor-mediated transepithelial transport (Woof & Mestecky, 2005). IgA is highly 
heterogeneous in  external secretions and  exists as monomers (mIgA) and polymers (pIgA), 
which are made up of dimers and tetramers of mIgA linked by small polypeptides called J 
chains. 50-90% of pIgA is associated with the secretory component (SC), an extracellular part 
of the Ig receptor, linked to the Fc portion of the molecule (Woof & Mestecky, 2005). The most 
important  distinguishing  feature  of  S-IgA  (Figure  14)  is  the  presence  of  the  associated 
glycoprotein SC, bound by J chain, which is not only the receptor for transepithelial transport 
of polymeric S-IgA to mucosal secretions, but increases S-IgA stability and protects it from 
proteolysis (Bruce et al., 1989).  
 
 
 
 
Figure 14 Schematic representations of monomeric IgA and S-IgA. S-IgA is a double-Y shaped 
molecule of 2 monomers joined at the Fc region. Heavy chains are shown in blue, light chains in 
green, J chain in yellow, SC in red. For clarity, carbohydrates have not been included. Adapted 
from Woof & Mestecky (2005). 
 
 
 
mIgA  S-IgA Chapter 1: Introduction 
 
43 
 
  Polymeric IgA with J chain bound by SC at the cell surface is internalized into vesicles 
and transported through the cell. Following vesicle fusion with the cell membrane, the complex 
is  released  as  S-IgA  with  the  SC  component  remaining  bound  and  intact  (Bruce  et  al., 
1989).IgA dimers contain multiple antigen binding sites - four for IgA dimers, and eight for 
IgA tetramers - and inhibit bacterial adherence to epithelia by imparting a negatively charged 
coating,  repelling  them  from  prime  colonisation  surfaces  (Woof  &  Mestecky,  2005). 
Additionally, S-IgA mediates protection from bacterial disease by direct killing, agglutination, 
inhibition  of  invasion,  inhibiting  microbial  adherence  and  opsonisation  for  uptake  by 
phagocytes (Bruce et al., 1989). pIgA and S-IgA are also extremely adept at neutralising the 
activity of viruses, enzymes and toxins through epitope binding which they may do alone or in 
concert with  other host  defence  mechanisms (Ahl & Reinholdt, 1991; Russel & Mestecky, 
2002).  
S.  pneumoniae  expresses  surface  proteins  that  bind  S-IgA  through  the  secretory 
component (Hammerschmidt et al, 1997). This surface protein (SpsA) of S. pneumoniae that 
binds  to  SC  is  expressed  by  2/3  of  strains  and  conserved  between  different  serotypes 
(Hammerschmidt et al, 1997). Other bacteria, notably Streptococcus pyogenes, bind the Fc part 
of human IgA as part of their virulence capacity using the IgA binding proteins Arp4 and Sir22 
(Johnsson et al, 1994 & 1999).  
Although  in  general,  immunoglobulins  are  resistant  to  bacterial  degradation,  some 
pathogenic microbes produce proteases that cleave IgA molecules in the hinge region, thus 
removing their protective effect (Ahl & Reinholdt, 1991). Of the two IgA subclasses present in 
the oral cavity, IgA1 is far more commonly produced than IgA2, at between 70 - 95%. The 
addition of a 13aa stretch at the hinge region of IgA1 confers added flexibility to the molecule 
but  also  makes  it  more  susceptible  to  IgA1  proteases  from  the  commensal  Gram  positive 
bacteria of the oral cavity (Kilian., 2003). The resistance of IgA to degradation indicates how 
important immunoglobulins are in maintaining the homeostasis of the oral cavity (Dumas et al, 
1987). Secretory IgA coats gut microbiota in healthy individuals and mucosal IgA has been 
shown to bind commensal bacteria specifically suggesting that the commensal flora drives the 
secretory IgA system (Pickard et al., 2004). Since binding events are so common, IgA a clear 
choice for inclusion in panning experiments.  
 
Panning ligand - Fibronectin   
  Fibronectin  is  a  ~450  kDa  modular  glycoprotein  involved  in  extracellular  matrix 
(ECM) interactions as well as cell adhesion, migration, growth and differentiation, and found 
on  the  surface  of  mammalian  cells  (Pankov  &  Yamada,  2002)  (Figure  15).  It  is  a  well 
characterised constituent of the tongue basement membrane zone (Couchman et al, 1979), and  Chapter 1: Introduction 
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Figure  15  Schematic  representation  of  Fibronectin  molecule.  From:  Fibronectin  at  a  Glance, 
Pankov & Yamada (2002). The image here is cellular FN although FN is also found in plasma. 
Type I modules are ~40 amino acids long, type II are ~60 amino acids long and type III ~90 amino 
acids long. Type I and II contain 2 disulphide bonds each, where type III contains none (Pankov & 
Yamada,  2002).  The  main  binding  activity  is  in  the  N-terminal  end,  consisting  of  five  type  I 
molecules (Joh et al., 1998).  
 
 
 
although arising from a single gene, can appear in up to 20 variants which are generated by 
including or excluding some of the Type I, II or III repeats.  
  FN plays a crucial role in the insoluble extracellular matrix (ECM), where it acts as a 
ligand for integrin receptors – linking the ECM with the intracellular cytoskeleton - and many 
other biologically active molecules including heparin, collagen and fibrin. FN matrix assembly 
– or fibrillogenesis – is the process of creating and depositing FN fibrils into the ECM. Fibrils 
are aggregates of FN, where the molecule self-associates in line with binding sites along its 
length. FN is one of the largest multi-domain proteins to have been studied in great detail. As 
such it is well known to serve as a ligand for bacterial adhesion. 
  Many bacteria use FN to gain a foothold onto human cells and tissues. In particular, 
streptococci  and  staphylococci  encode  fibronectin  binding  proteins,  often  in  a  specific  N-
terminal 30 kDa region of the FN molecule (Williams et al., 2002), and a large body of work 
exists on FNBP’s (Mitchell, 2008; Mullen et al, 2008). In particular, FNBPA and FNBPB of S. 
aureus are known to mediate adherence to endothelial and epithelial cells, which suggests their 
importance as virulence factors (Peacock et al., 1999; Dziewanowska et al., 1999). 
  In a general sense, bacterial ECM binding proteins are termed MSCRAMMS (Patti et 
al., 1994) and FN binding proteins share structural similarity to  other cell  wall proteins of 
Gram positive bacteria (Joh, 1999). FN can also act as a bridge between bacterial binding 
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proteins and other, less accessible, host cell components such as integrins (Dziewanowska et 
al., 2000), bound by FN as part of the ECM.  
FN binding has been associated with the propensity to establish colonisation of host 
tissues, and this highly multivalent binding is mediated by several high affinity binding sites 
(Schwarz-Linek et al, 2003; Meenan et al, 2007). It is becoming apparent that the majority of 
bacteria which colonise mammals express FNBP’s (Schwartz-Linek et al., 2004), the majority 
of which bind to the N terminus of the FNI modules 1 to 5 (Schwartz-Linek et al., 2006). Many 
staphylococci and streptococci express FN binding proteins (Joh et al., 1998), notably the 100 
kDa FNBPA (Signas et al., 1989) and FNBPB (Jonsson et al., 1991) of S. aureus which are 
similar in structure to other FNBP’s, and which facilitate mechanically resistant colonisation of 
host tissues (Mitchell, 2008). The FNBP’s of S. aureus and S. pyogenes all contain the cell wall 
anchoring  motif  LPX[T,S,A]G  and  a  short  positively  charged  C-terminal  intracellular  tail 
(Schwarz-Linek et al., 2006). 
Although less information is available on FNBP’s of Gram negative bacteria, what is 
known  is that they  demonstrate structural and  functional resemblances to the  known Gram 
positive FNBP’s of S. aureus and S. pyogenes (Raibaud et al., 2006). BBK32 from Borrelia 
burgdorferi, the causative agent of Lyme disease was the first example of such a protein. In 
contrast,  Mullen  et  al.,  (2008)  identified  a  novel  FNBP  in  the  Gram  negative  bacteria  P. 
multocida, the gene (PM1665) has homologous proteins in all other sequenced members of the 
Pasteurellaceae. The group found that PM1665 did not bind to the N terminal 30 kDa or 45 
kDa fragments many other FNBP’s bind, but instead bound to the 120-kDa central cell binding 
segment  which  mediates active adhesion  of FN to cell surface integrins. The nature  of the 
binding site suggests a novel mechanism of binding action.  
  Undoubtedly, far more is known about FN-binding proteins than IgA binding proteins, 
but the tendency of oral bacteria like Streptococcus sp. to bind to FN extends the likelihood that 
the phage  display  library in this project will lead to the identification of  more FN binding 
proteins. 
 
Aim of this project 
  This project had two main aims: 
1.  To investigate the use of metagenomic DNA in a phage display library 
2.  To test the hypothesis that an enormous variety of binding events are taking place on 
the human tongue and that they can be investigated further with this combination of 
molecular tools. 
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Media, Solutions and Strains 
(a) Media 
All media was prepared and sterilized by autoclaving at 121ºC and 15 p.s.i. for 20 min unless 
otherwise stated. 
 
Growth Media  Broth  Agar Plates 
Nutrient Broth (Oxoid)  13g/L
  + 4g agarose 
Nutrient Broth No. 2 (Oxoid)  25g/L  + 4g agarose 
Luria-Bertani   10g Tryptone, 10g Yeast Extract 
(Difco), 5g Sodium Chloride, 1mg/ml 
Sodium Hydroxide (BDH) 
n/a 
NB2 + 4% Glucose   25g/L
  NB2 + 4g Glucose (BDH)  + 4g agarose 
DNase Agar (Oxoid)  39g/L  n/a 
 
Table 1 Growth media 
 
Ampicillin-containing media 
A stock solution of 100 milligrams per mililitre ampicillin (Sigma, St. Louis, MO, USA) was 
made up in distilled water, filter sterilized and stored at -20ºC. It was added to autoclaved 
nutrient  agar  (<50°C)  to  a  concentration  of  100µg/ml  and  poured  into  9cm  Petri  dishes 
(Western Laboratory, Hampshire, England). 
 
(b) Solutions 
This is a note of general solutions and mixtures used during the course of this project.  All 
solutions were prepared and sterilized by autoclaving at 121°C, 15 p.s.i. for 20 min unless 
otherwise stated. 
 
Loading buffer for agarose gels 
Four grams of sucrose (BDH, Poole, England) was added to a sterile universal tube (20ml). 
Two millilitres of 0.5M EDTA and 1ml bromophenol blue (BPB, 1.5mg/ml) were added and 
the solution  was  made up to 10ml  with sterile  distilled  water. The  loading buffer  was not 
sterilized. 
 
 λPst agarose gel ladder 
One hundred micrograms (µg) of bacteriophage λ DNA (New England Biolabs, Hertfordshire, 
London, UK) was digested fully with the restriction enzyme PstI (New England Biolabs). After 
3 hours incubation at 37ºC, digestion was verified as complete by testing an aliquot on an Chapter 2: Materials & Methods 
 
  48 
agarose gel. When complete, 450 µl of Loading Buffer was added. The ladder was stored at -
20ºC until required. The ladder produced clear fragments between 5 kb and 200 bp (Appendix 
2) and was included with every DNA gel for uniform comparison. 
 
40% (w/v) PEG (polyethylene glycol)/2.5M NaCl 
2.5M NaCl was prepared by measuring 73.55 grams NaCl (BDH, Poole, England) into a 1L 
Duran bottle and adding distilled water up to 1L. The solution was sterilised by autoclaving. 
160g PEG 8000 (Sigma, St Louis, MO, USA) was added to a fresh 400ml Duran bottle and 
2.5M NaCl was added up to 400ml. This solution was stirred on a heated magnetic stirrer for 2 
hours, or until the PEG was completely dissolved. 
 
Sodium carbonate buffer 
Two  starting  solutions  were  required  to  make  this  buffer.  100mM  Sodium  Carbonate 
(Bicarbonate) buffer was prepared by adding 1.682g Sodium Carbonate (BDH, Poole, England) 
to  200  ml  distilled  water.  100  mM  Sodium  Carbonate  anhydrous  was  prepared  by  adding 
2.138g  Sodium  Carbonate  anhydrous  (BDH,  Poole,  England)  to  200  ml  distilled  water.  A 
volume  of 4  ml Sodium Carbonate anhydrous  was added to 46  ml Sodium Carbonate in a 
sterile Duran bottle to make 100 mM Sodium Carbonate Buffer, pH 9.4. 
 
Phosphate buffered saline (PBS) and PBS-T (PBS + 0.05% Tween 20) 
PBS, used for panning, was prepared by making a solution of 137 mM NaCl, 2.7 mM KCl 
(BDH, Poole, England), 10 mM Na2HPO4 and 2 mM KH2PO4 in a 1L Duran bottle. PBS-T (pH 
7.4) was prepared by adding 500µl Tween20 (Sigma, St Louis, MO, USA) to 1L PBS after 
autoclaving. 
 
10% (w/v) CTAB solution 
In  order  to  make  up  this  solution  for  DNA  extraction,  five  grams  of  CTAB  powder 
(Hexadecyltrimethyl ammonium bromide) (Sigma, St Louis, MO, USA) was added to 50ml 
0.7M NaCl solution and autoclaved. 
 
TE buffer with RNase 
For this DNA extraction solution, a final concentration of 10 mM EDTA solution and 100 mM 
Tris-HCl (pH 8.2) was in 1L of distilled water. Forty millilitres of TE buffer was poured into a 
50 ml Falcon and 50 µl (10mg/ml) RNaseA (Fermentas, Hanover, MD, USA) added before 
use. This solution was prepared when required and the excess was not stored. 
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TE + 20% (v/v) glycerol 
This phage eluate recovery solution contained a final volume of 10 mM EDTA solution and 
100  mM  Tris-HCl  (pH  8.2)  in  800  ml  distilled  water.  Glycerol  was  added  to  1L  and  the 
solution autoclaved. 
 
BCIP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium) 
This  colour  change  agent  used  in  antibody  screening  experiments  was  prepared  by  adding 
separately, to water, 50 mg/ml BCIP and 10 mg/ml NBT. When ready to use, 33 µl BCIP and 
330 µl NBT were added to substrate buffer.  
 
(c) Strains, Bacteriophage and Vectors: source, preparation and storage 
All bacterial strains and bacteriophage used are given in Table 2. All phagemid vectors and 
general cloning vectors used are given in Table 3. 
 
Strain/Isolate  Genotype 
(Source) 
Escherichia coli TG1  [K12;Δ(lac-proAB)supE  thi  hsdD5/F’  (traD36 
proA+proB+lacIg lacZΔM15)]
 1 
Escherichia coli JM107  endA1,  glnV44,  thi-1,  gyrA96,  hsdR17  (RK-mK
+)λ
-, 
supE44, relA1, λ, Δ(lac-proAB), [F’, traD36, proAB
+ 
lacI
q, ZΔM15] 
2 
Escherichia coli DH5α  F
- endA1, glnV44, thi-1, recA1, relA1, gyrA96, deoR, 
nupG,  θ80dlacZΔM15  Δ(lacZYA-argF)  U169,  hsdR17 
(rK-mK
+), λ- 
2 
 
1.  Eastman Dental Institute, Grays Inn Road, London, WC1X 8LD 
2.  University College London, Gower Street, London, WC1E 6BT. 
 
Table 2 Names and Sources of Bacterial Strains 
 
 
Preparation of glycerol stocks  
  From agar plates: 25% glycerol (v/v) was prepared by adding 50ml Glycerol (BDH, 
Poole, England) to 150ml distilled water and autoclaving. Four millilitres of the 25% glycerol 
solution was dispensed onto a fresh overnight agar plate and the bacteria were suspended into 
solution by lightly scraping the surface of the plate with an inoculating loop. The suspension 
was removed from the plate by pipetting and dispensed into a sterile 5ml Falcon tube (Falcon, 
Becton Dickinson Labware Europe, France). The suspension was stored at -20ºC. Chapter 2: Materials & Methods 
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  From  liquid  culture:  50%  glycerol  (v/v)  was  prepared  by  adding  100ml  Glycerol 
(BDH) to 100ml distilled water and autoclaving. Two millilitres of 50% glycerol solution was 
dispensed into a 5ml tube (Falcon) and 2ml of a fresh liquid bacterial culture was added to it. 
The suspension was mixed thoroughly before storage at -20ºC. 
 
 
Vector  Source 
pG8SAET phagemid  Gene VIII fusion vector, E. coli origin, MCS (SnaBI), E-tag 
(for enrichment of clones with an ORF), Amp
r 1 
pG8H6 phagemid  Gene VIII fusion vector, E. coli origin, lacZ, PelB leader 
sequence, His-tag, MCS (SmaI), Amp
r 1 
pUC 19 cloning vector  pBR322 based cloning vector, pMB1 origin, MCS (nt 397-
454 inverted), lacZα, Amp
r 
2 
 
Table 3 Names and Sources of Bacterial and Phagemid Vectors Used. 1.  Eastman Dental Institute, 
Grays Inn Road, London, WC1X 8LD. 2.  New England Biolabs, Hertfordshire, England, UK. 
 
 
Phagemid vector isolation 
  Phagemid  were  isolated  using  the  Qiagen  Midiprep  Kit  (West  Sussex,  England) 
according to manufacturers’ instructions. Briefly, 50 ml LB broth in a 500 ml conical flask was 
inoculated with one colony of pG8SAET or pG8H6 from a fresh overnight colony grown at 
37ºC and 200 rpm in NB2 broth plus 100 µg/ml ampicillin. The culture was centrifuged at 
2,500 x g for 15 min, the supernatant discarded and the pellet resuspended in 250 µl Buffer P1 
containing  RNase.  Buffer  P2  (NaOH/SDS)  250  µl,  was  added  to  lyse  the  bacteria  under 
alkaline conditions which denatures chromosomal and plasmid DNA. Buffer N3 (acetic acid) 
350 µl, was added to neutralise the lysate and allow rapid renaturation of the plasmid DNA, in 
addition to creating a high salt environment. This eases plasmid DNA binding to the extraction 
column membrane and allows precipitation of denatured proteins, chromosomal DNA, cellular 
debris and SDS, but not precipitation of the plasmid DNA. Samples were left in the syringe for 
10 min for precipitation and syringed into an equilibrated Midi column which was left to empty 
by gravity flow. Buffer QC (Isopropanol) 10ml, was used to wash the column and the DNA 
was eluted with Buffer QF, 5ml, both allowed to travel through the column by gravity flow. 
The eluted DNA was precipitated by mixing with isopropanol at room temperature (22ºC) and 
filtering through a QIAprecipitator into a waste bottle. The DNA trapped in the precipitator was 
washed  with  70%  (v/v)  ethanol  and  eluted  using  1  ml  Buffer  TE  and  a  syringe.  The Chapter 2: Materials & Methods 
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concentration  of  vector DNA following the procedure  was determined using a Nanodrop™ 
(ND-1000 Spectrophotometer) and found on average to be between 100 – 200 ng/µl. 
 
Phagemid vector digestion and dephosphorylation 
  The phagemid DNA extracted from the Midiprep Kit (Qiagen) was sufficiently pure for 
immediate  digestion  by  restriction  enzymes  following  extraction.  Therefore,  aliquots  of 
pG8SAET  or  pG8H6  DNA  were  digested  using  the  restriction  enzymes  SnaBI  and  SmaI 
respectively  (both  New  England  Biolabs).  pG8SAET  required  3  hours  digestion  at  37ºC 
whereas pG8H6 digestion by SmaI required incubation at 25°C for 3 hours. Complete digestion 
was verified by testing a 10 µl aliquot of digested vector against an aliquot of undigested vector 
on  an  agarose  gel.  Once  verified,  the  restriction  enzyme  was  inactivated  by  heating  in  a 
Thermomixer™ (Microcentrifuge, Hamburg, Germany) at 80ºC for 20 min. In order to prevent 
recircularisation of the  vector it was necessary to  dephosphorylate it. To do this, Antarctic 
Phosphatase Buffer (New England Biolabs) was added to an aliquot of vector after digest, to a 
concentration of no less than 10%, this is due to Antarctic Phosphatases’ requirement for Zn
2+. 
Antarctic Phosphatase (NEB) was added to 3U per reaction (1U/µl). The sample was incubated 
for  30  min  at  37ºC,  and  heat  treating  at  65ºC  for  5  min  denatured  the  enzyme.  Further 
purification was not needed. 
 
(d) Bacterial DNA Sampling, Extraction and Preparation 
Tongue scraping protocol 
  Volunteers from the research group were asked to provide tongue scraping samples 
provided that they had not taken antibiotics for 6 months previous to sampling. Each volunteer 
was given a sample sheet with sampling instructions (see Appendix 1), 12 universal tubes each 
containing 10 ml sterile Dulbecco’s PBS (Sigma), a pack of sterile tissues (VWR, Spartanburg, 
SC, USA) and a toothbrush (Boots, UK). Sampling instructions  were, briefly, swab excess 
saliva from the tongue dorsum using a sterile tissue, gently so as not to remove loosely attached 
micro-organisms. Brush the tongue dorsum with the toothbrush as vigorously as is comfortable 
for one minute, dislodging bacteria from the toothbrush periodically by shaking in an aliquot of 
sterile PBS. The sample was frozen immediately at -20ºC until needed for further processing, 
and the toothbrush was stored at  -20ºC until next use.  
 
 
Sample storage in isopropanol  
  According to Torsvik et al, 1990, the yield of DNA from an environmental sample can 
be increased by storing the sample in isopropanol before extraction. This principle was used by 
Torsvik on soil bacteria although the mechanism by which it works is not clear. Therefore, tests 
were carried out in the current study on tongue bacterial samples. Briefly, 12 tongue scraping Chapter 2: Materials & Methods 
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samples  were  thawed  and  centrifuged  at  2,500  x g for  10  min  at  4ºC  and  the  supernatant 
removed. Five  millilitres  of  isopropanol (VWR)  was added to  each sample and the pellets 
resuspended and left at -20ºC for 1 to 7 days. Aliquots were removed and the DNA extracted 
after each 24 hour period to check the optimum duration for isopropanol treatment. Following 
the isopropanol testing, all remaining bacterial samples were stored in isopropanol for 7 days 
before DNA removal using the CTAB extraction method (Bailey, 1995). 
 
DNA extraction by CTAB method 
  Each  5  ml  tongue  scraping  sample  was  dispensed  into  four  1.5ml  Microcentrifuge 
tubes  (Trefflab,  Degersheim,  Switzerland),  centrifuged  for  1  minute  at  8,000  x  g  and  the 
supernatant removed. Pellets  were resuspended  in 500µl fresh lysis buffer, prepared before 
each extraction (20µg/ml Proteinase K (New England Biolabs) in 0.5% SDS (w/v) (BDH)), and 
maintained at 55ºC for 30 min, with gentle shaking at 10 min intervals throughout. 100 µl of 
prewarmed  NaCl  (5M)  and  80  µl  CTAB  solution  (10%)  were  added  and  the  temperature 
increased to 65ºC for a further 10 min. Addition of 680 µl isoamyl alcohol:chloroform (1:24) 
(Sigma) and subsequent shaking formed an emulsion which, when centrifuged for 10 min at 
8,000 x g, separated into 3 distinct layers. The top aqueous layer was removed to a clean sterile 
microcentrifuge tube and 360 µl isopropanol added which precipitated the DNA during storage 
at 4ºC overnight. After centrifugation at for 10 min, and removal of excess isopropanol, DNA 
pellets were washed by adding 300 µl 70% (v/v) ethanol and centrifuged for a further 10 min at 
8,000 x g. After removal of excess ethanol, the pellets were allowed to air dry and the pellet 
resuspended overnight in 50 µl TE buffer containing RNase at room temperature. At this stage, 
the average concentration of DNA recovered was around 1000 ng/µl by Nanodrop™ (ND-1000 
Spectrophotometer). All samples were extracted separately, and stored as individual volunteer 
samples  at  -20ºC.  Genomic  DNA  fragment  size  was  determined  using  Pulsed  Field  Gel 
Electrophoresis  (PFGE)  (Gene  Navigator  Pulsed  Field  System,  Pharmacia,  LKB)  using  a 
MidRange II PFG Marker and a Low Range PFG Marker (both NEB) and was shown to be 
between 15 and 40 kb. 
 
Ethanol Precipitation 
  Ethanol  precipitation  was  used  to  concentrate  DNA  samples  following  enzymatic 
treatments. Briefly,  one tenth reaction  mixture  volume  in 5M NaCl  was added and  mixed, 
followed  by  two  volumes  of  absolute  ethanol  (BDH).  After  1  hour  precipitation  at  -20ºC, 
samples were centrifuged at 8,000 x g for 10 min and supernatant gently removed. Samples 
were washed with 200 µl 70% ethanol, centrifuged again and the supernatant discarded. After 
air drying completely, the DNA was resuspended in 50 µl EB or sterile distilled water if needed 
for sequencing. 
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(e) Phage Display Library Production 
DNA fragmentation and repair 
  Before fragmentation of total metagenomic DNA, 50 µl was removed from each of the 
nine individual DNA samples and combined in a 1.5 ml microcentrifuge tube for processing. 
  Total DNA was either fragmented using a sonicator or by partial restriction digest. 
Both approaches are described here. For sonication, 450 µl of bacterial DNA was fragmented 
using an MSE Soniprep 150 at 14 amplitude microns, in a 1.5 µl microcentrifuge tube. In order 
to get an initial idea of the time required for suitable fragment generation from sonication, the 
full aliquot was sonicated for 10 seconds, then a small volume removed to a separate labelled 
tube, the remainder sonicated for another 5 seconds and another small volume removed, and so 
on, until the last 50-75 µl had been sonicated for 30 seconds. An aliquot of each sample was 
tested on an agarose gel against λPst ladder and the optimum sonication time confirmed as 15-
18 seconds for a 450 µl sample volume. After sonication, exposure to shearing forces results in 
DNA fragments with overhanging ends. These must be repaired in order to optimise ligation 
into the blunt end vector. This was carried out using dNTP’s (10mM) and DNA polymerase 
(~18U) (both New England Biolabs), which were added to an aliquot of fragmented DNA and 
incubated at 37ºC for 30 min. DNA polymerase was inactivated by heating to 65ºC for 10 min. 
  For  restriction  digest,  bacterial  DNA  was  fragmented  using  blunt  end  restriction 
enzymes RsaI, AluI and HaeIII (both New England Biolabs). Ten µl of each enzyme was added 
to  450  µl  of  DNA,  along  with  buffer  4  (New  England  Biolabs),  the  solution  mixed  and 
incubated  at  37ºC.  Initially,  to  determine  the  optimum  time  for  digestion,  aliquots  were 
removed after every 10 min of digestion following an initial incubation of 20 min, and tested 
on an agarose gel. The optimum digestion time was found to be 20 min for 450 µl of sample. 
The enzymes were inactivated by heating in a Thermomixer at 80ºC for 20 min. 
 
DNA visualisation using agarose gels 
  Tris Borate Electrophoresis Buffer (TBE 1X) was made up using pre-measured sachets, 
according to manufacturers’ instructions. To prepare one gel, 100 ml of 1 X TBE Buffer was 
mixed with 1 gram of high grade agarose (Invitrogen) and microwaved for 2 min, shaking 
every 10 seconds after the solution reached boiling temperature. After heating, 5 µl ethidium 
bromide (EtBr, Fisher, Leicester, England) was added and stirred, the agarose was poured onto 
a  glass  slide  sealed  with  autoclave  tape,  a  20  well  comb  fitted,  and  the  gel  left  at  room 
temperature to set. All agarose gels were run at 150 V for 2.5 – 3 hours. DNA bands were 
subsequently  visualised using the Gene  genius Bio imaging system and Genesnap software 
(version 6.05) from Syngene. 
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Ligation and purification 
  Ligations between blunt ended vector and inserts require a high concentration of insert 
DNA compared to vector. Ligations were set up in 10µl volumes using a 3-fold concentration 
excess of insert to vector, determined by Nanodrop™. Before adding T4 DNA ligase and ligase 
buffer  (both  New  England  Biolabs),  a  few  microlitres  of  the  insert-vector  mixture  were 
removed as a control, then the ligations incubated at room temperature (22ºC) for 2 hours or at 
4°C overnight. After incubation an aliquot was removed and added to 10µl Loading Buffer, 
which was run alongside the control aliquot on an agarose gel to test the ligation efficiency.  
  In  a  successful  ligation,  removal  of  salt  and  other  impurities  is  necessary  prior  to 
electroporation. The PCR Cleanup Kit from Qiagen  is recommended for this by Jacobsson 
(2003), and was carried out according to manufacturers’ instructions. Purified DNA was stored 
at -20ºC until further use. 
 
Preparation of electrocompetent cells 
  Before beginning, 4L shake flasks were autoclaved with distilled water, and the water 
discarded before preparing LB. Care is taken when preparing electrocompetent cells (ECC) 
because  traces  of  detergents  or  chemicals  notably  reduce  electroporation  efficiencies.  An 
overnight  culture  of  Escherichia  coli  was  grown  from  an  overnight  colony,  and  200  µl 
dispensed  into  one  or  two  4L  shake  flasks  containing  1L  sterile  NB2  broth.  Growth  took 
several hours at 37ºC with  vigorous shaking (300 rpm)  and was checked regularly using a 
handheld spectrophotometer (Biorad) and growth stopped once cells reached OD 0.7 or 0.8. 
The flasks were chilled for 30 min on ice, and the cells retained at 4ºC for the remainder of the 
protocol.  The  cells  were  centrifuged  in  sterile  chilled  Sorvall  bottles  in  a  Sorvall 
Ultracentrifuge RC6+ using an SLA-1500 rotor at 3,000 x g at 4ºC for 10 min. The supernatant 
was discarded and the cells washed by gently resuspending the pellet in sterile distilled water 
(sdH2O).  This  centrifugation  -  washing  step  was  repeated  a  further  3  times,  resulting  in  a 
reduction in the ionic strength of the cell suspension. The pellet was resuspended in 40 ml of 
ice cold, sterile 10% (v/v) glycerol and centrifuged in 40 ml Sorvall tubes using an SS-34 rotor 
at 3,000 x g for 15 min. Each pellet was resuspended in 2.5 ml ice cold, sterile 10% glycerol 
and dispensed into 1.5ml precooled microcentrifuge tubes in 50 µl aliquots. The cells were 
stored immediately at -80ºC until further use. 
 
Preparation of chemically competent cells 
  A 5 ml overnight culture of Escherichia coli TG1 was added to 20 ml NB2 with 20 
mM MgCl2 in a 50 ml Falcon tube (Becton Dickinson Labware Europe, France) and left to 
grow for 60 min at 37ºC with shaking (200 rpm). The cells were retrieved by centrifugation in a 
bench-top  centrifuge  (Microcentrifuge)  at  2,500  x  g  for  10  min  at  4ºC.  The  pellet  was 
maintained on ice and resuspended in 2ml ice-cold sterile 75mM CaCl2 15% glycerol. Aliquots Chapter 2: Materials & Methods 
 
  55 
of  200  µl  were  dispensed  into  pre-chilled  1.5ml  microcentrifuge  tubes  and  either  used 
immediately or stored at -80ºC until required. 
 
Electroporation 
  Electroporations were carried out to maximise the efficiency at which phagemid with 
inserts  were  taken  up  into  E.  coli.  The  ligation  mixture  was  added  to  the  ECC  and 
electroporated using a Biorad Micropulser at 2,400 volts. Immediately following application of 
the electric current, the cells were placed into 10 ml prewarmed (37ºC) NB2 and allowed to 
grow at 37ºC, with shaking at 200 rpm, for 2 – 2.5 hours. Aliquots (100 µl) of 10
0, 10
-1 and 10
-2 
dilutions  were  then  plated  onto  prewarmed  NB2  +  Ampicillin  plates  and  grown  at  37ºC 
overnight. The 10 ml cultures were refrigerated at 4ºC until the library was checked for inserts 
by counting the numbers of ampicillin resistant colonies.  
 
Chemical transformation 
  An aliquot (2 µl) of ligation was added to each tube of cells, mixed and left on ice for 
30-45  min.  The  ligations  were  heat-shocked  at  42ºC  for  45  seconds  in  a  Thermomixer 
(Microcentrifuge) and returned to ice for a further 4 min, before adding each aliquot to 5 ml 
pre-warmed NB2. After growth for 2 hours at 37ºC with shaking (200 rpm), aliquots of 100 µl 
were plated onto pre-warmed (37ºC) NB2 + Ampicillin plates and control plates of NB2 only, 
and grown overnight at 37ºC. Transformation frequency was determined the following day by 
counting Ampicillin resistant colonies. 
 
Plasmid extraction (Miniprep) 
  In order to test the insert frequency of each library, between 20 and 40 colonies were 
picked from the plates, inoculated separately into 4 ml NB2 and grown overnight, at 200 rpm 
and 37ºC. The DNA was extracted using the Qiagen Miniprep Kit to produce suitable purity 
plasmid  DNA  for  subsequent  digest  and  sequencing.  Briefly,  the  overnight  cultures  were 
dispensed into 1.5 ml Microcentrifuges and centrifuged at 8,000 x g for 1 minute. The pellet 
was re-suspended in 250 µl buffer P1 containing RNase A, followed by the addition of 250 µl 
buffer P2 (NaOH/SDS) for lysing bacteria under alkaline conditions which denatures plasmid 
DNA. The lysate was neutralised by adding 350 µl of buffer N3. Samples were centrifuged for 
10 min at 8,000 x g and the supernatant transferred to a QIAprep spin column. Samples were 
centrifuged for 1 min at 8,000 x g and the flow through discarded. Discarding flow through at 
every stage, 500 µl buffer PB was added to bind DNA to the membrane and centrifuged for one 
minute, and then the DNA was washed with 750 µl buffer PE and centrifuged twice to remove 
residual ethanol. To elute DNA from the QIAprep spin column, 100 µl EB buffer or sterile 
distilled water (SDW) was added and the columns left to stand for 1 min. The column was 
centrifuged for 1 min at 8,000 x g to elute DNA from the column membrane. Chapter 2: Materials & Methods 
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  Phagemid were then digested with restriction enzymes (NcoI and EcoRI were used for 
pG8SAET, and PstI and XhoI were used for pG8H6) to release the insert, and the sample was 
gel electrophoresed to check for a visual representation of insert frequency.  
 
(f) Phagemid library conversion 
  All cells from successful transformations were combined (If cells had previously been 
in storage at 4ºC, they were resuscitated by growing at 37ºC with shaking (200 rpm) for 1 hour 
before combining). The pooled cells were decanted into 50ml Falcon tubes and centrifuged in a 
chilled rotor (4ºC) at 2,500 x g for 10 min before resuspension in 10 ml sterile NB2. After 
resuspension, all cells were combined and helper phage R408 (Promega, Southampton, UK) 
added to a multiplicity of infection (MOI) of 20. After static incubation at 37ºC for 30 min to 
allow phage attachment, the infection was added to 100 ml sterile NB2 in a 1L flask containing 
100  µg/ml  Ampicillin,  and  grown  overnight  at  37ºC,  200  rpm.  Cells  were  separated  by 
centrifugation in a Sorvall Ultracentrifuge RC6+ using SLA-1500 rotor at 10,000 x g for 15 
min, 4ºC, and the supernatant decanted into sterile Sorvall bottles containing 40% PEG/2.5M 
NaCl. After precipitation at 4ºC overnight, phage were removed by high speed centrifugation in 
40  ml  Sorvall  bottles  in  an  SS-34  rotor  at  15,000  x  g  for  20  min,  4ºC,  and  the  pellet 
resuspended in 1 ml TE Glycerol. The tubes were rinsed with a further 1 ml TE Glycerol, and 
this  additional  volume  added  to  the  first.  A  20  µl  aliquot  of  the  library  was  removed  for 
enumeration and the rest stored at -80ºC until required for Panning. 
 
Enumeration of recombinants 
  Ten microlitres (µl) of 10
0  to 10
-8 phage dilutions in 20 mM Tris HCl were added to 
200  µl  of  log  phase  E.  coli  TG1  and  left  to  attach  statically  at  37ºC  for  30  min.  After 
incubation,  100  µl  of  each  infection  was  plated  onto  NB2  plates  containing  100  µg/ml 
ampicillin and grown overnight at 37ºC. After 16-24 hours growth, colonies were counted and 
the titre calculated. 
 
(g) Biopanning 
  All centrifugation steps in the Biopanning protocol were carried out using a Sorvall 
Ultracentrifuge RC6+ (Beckmann). The rotors and centrifugation speeds are specified at each 
stage. 
  The ligands IgA, FN and BSA (all from Sigma) were diluted into 2.4 ml 100 mM 
sodium carbonate buffer (pH 9.4) and added to a Nunc Immuno Tube (Gibco), then sealed with 
Parafilm™ and rolled overnight at room temperature (22ºC). The tubes were washed with 3 
changes of PBS-T (PBS + 0.05% Tween 20) by adding 4 ml PBS-T, sealing tube with Parafilm 
and  rolling  at  room  temperature  for  10  min.  Blocking  free  binding  sites  on  the  tubes  was 
carried out by adding 4 ml PBS-T + 2% BSA and rolling for 2 hours at room temperature. Chapter 2: Materials & Methods 
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Tubes were washed 4 times with PBS-T as described, and 2 ml titred phage display library 
added. After rolling for 2 hours, excess phage was decanted and retained at 4ºC for use against 
a different ligand, and the tubes were washed with 6 changes of PBS-T. Bound phage were 
eluted by adding 1 ml elution buffer (Glycine/HCl pH 2.2) and rolling for 10 min at room 
temperature. After removal to 500 µl 1M Tris.HCl (pH 7.5) to neutralise the acid, 20 µl eluate 
was enumerated. The remaining eluted phage (all, or an aliquot, depending on the titre) were 
added to 5-8 ml log phase E. coli TG1 in NB2 + 2% glucose, and left to attach statically for 60 
min at 37ºC. After attachment, the cells were grown at 37ºC for a further 60 min, then helper 
phage R408 was added to an MOI of 20, and left to attach statically at 37ºC for 30 min. The 
infection  was  inoculated  into  190  ml  NB2  containing  100  µg/ml  ampicillin  and  grown 
overnight at 37ºC, 200 rpm. Cells were recovered by centrifugation using an SLA-1500 rotor at 
7,ooo x g at 4ºC for 20 min. Supernatant was decanted into a sterile Sorvall bottle containing 
40% PEG/2.5M NaCl and left at 4ºC overnight to precipitate the phage. Phage were recovered 
by centrifugation using an SS-34 rotor at 15,000 x g at 4ºC for 20 min, and resuspended in 500 
µl PBS. The recovered phage were enumerated then used to begin the second round of panning 
(starting at the beginning) to further amplify the binding protein sequences.  
  For enumeration of phage titre the same protocol was used as detailed for phagemid 
library conversion with the exception of using NB2 plates containing 4% Glucose and 100 
µg/ml ampicillin. 
 
(h) Sequencing 
  All  DNA  was  sent  to  the  Wolfson  Institute  for  Biomedical  Research  (WIBR)  for 
sequencing  in  15  µl  aliquots  per  reaction  at  a  concentration  of  100  ng/µl.  See 
www.ucl.ac.uk/wibr/services/dna 
 
Primers 
  Primers  used  in  sequencing  reactions  for  both  phagemid  vectors,  TOPO_TA  (16S 
analysis) and pUC19 are shown in Table 4. Custom primers were supplied to WIBR at 2-
5pmoles/µl,  allowing  6µl  per  reaction.  All  primers  were  ordered  from  Operon  (Operon 
Biotechnologies GmbH, Cologne, Germany). 
 
Vector  Forward  Reverse 
pG8SAET  5’-AGGTACATTACTTATATCTGG-3’  5’-CCGCTTTTGCGGGATCGTCAC-‘3 
pG8H6  5’-TTGCCTACGGCAGCCGCTGAA-3’  5’-TGCGGCCCCATTCAGATCCTC-3 
TOPO TA  5’–AGAGTTTGATCMTGGCTCAG-3’   5’- TACCTTGTTACGACTT -3’ 
pUC19  5' - GTTTTCCCAGTCACGAC - 3'  5' -GGAAACAGCTATGACCATG- 3' 
 
Table 4 List of Primers for Sequencing Chapter 2: Materials & Methods 
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Analysis in silico  
  Sequencing results were returned in text format and  as .ab1 files, viewed using Vector 
NTI software (Invitrogen). Text sequences from forward reaction were pasted into a new word 
document  and  the  signal  sequence  deleted  (from  CCCC  of  the  SmaI  cloning  site).  The 
remaining  sequence  was  pasted  into  CLUSTALW’s  multiple  sequence  alignment  program 
(http://align.genome.jp/) along with the end sequence, which begins GGG from the other end of 
the SmaI cloning site. If the sequence  did  not  extend as far as the c-Myc tag, the reverse 
sequence was entered (reverse complement) into CLUSTALW and the c-Myc tag located from 
that end. At the c-Myc end, the vector sequence was highlighted from GGG to GAAT then the 
remaining vector deleted. The entire sequence and up to GAC of the vector was copied (so that 
the amino acids VQVD appear when in frame), and pasted into either BCM search launcher in 
EXPASY tools (www.expasy.ch/tools/) or another program which allows 6 frame translation of 
DNA sequences, such as http://molbiol.ru/eng/scripts/01_13.html.  
  With the reading frames translated, +1, +2 and +3 were checked for the amino acids 
VQVD at the c-Myc end, giving the reading frame in which the protein is translated. The amino 
acid sequence was pasted into a new word document, so that for each insert sequence both a 
Word file containing the trimmed DNA sequence of the insert, and a Word file containing the 
translated amino acid sequence was generated. Both the amino acid and DNA sequences were 
used to search for homology to other DNA or proteins using the Basic Local Alignment Search 
Tool  (BLAST)  algorithm,  provided  free  online  by  the  National  Centre  for  Biotechnology 
Information (NCBI), found at http://www.ncbi.nlm.nih.gov/blast/. The two main searches used 
were blastp (protein-protein) and tblastx (translated query vs. translated database). 
 
(i) Antibody Screening 
Isolation of phage supernatant 
  Three  hundred  colonies  from  3
rd  round  panning  eluate  titre  plates  were  transferred 
individually into 3ml NB2, infected with helper phage R408, then grown overnight at 37°C 
with  shaking.  Phage  supernatant  was  recovered  by  centrifugation  at  2,500  x  g  in  an 
Microcentrifuge  benchtop  centrifuge  for  5  min.  Phage  supernatant  was  removed  from  the 
bacterial  pellet  and  transferred  into  sterile  microcentrifuge  tubes,  then  stored  at  4°C  until 
needed.  Bacterial  pellets  were  stored  at  -20°C  until  needed  for  analysis  of  the  insert  by 
miniprep. 
 
Antibody screening against anti Poly-His  
  Five microlitres of each phage supernatant was spotted onto nitrocellulose paper and 
allowed to dry at room temperature. The nitrocellulose strips were immersed in 20 ml 5% (w/v) 
skimmed milk powder in Tris Buffered Saline (TBS) and blocked with gentle agitation for 60 
min, after which time they were washed with three rinses of TTBS (TBS plus 0.05% Tween-20 Chapter 2: Materials & Methods 
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v/v), 5 min per wash. After washing, the filters were immersed in 20 ml Anti Poly-His (diluted 
1:2000 in TBS), and incubated with gentle agitation for 60-120 min. Following a further three 
washes in TTBS, 5 min per wash, the filter was treated with BCIP/NBT substrate solution for 
10 min at room temperature, or until colour development occurred. 
 
Antibody screening against anti c-Myc and alkaline phosphatase conjugate 
  5µl of each phage supernatant was spotted onto nitrocellulose paper and allowed to dry 
at room  temperature.  The  nitrocellulose  strips  were  immersed  in  20  ml  5%  skimmed  milk 
powder in Tris Buffered Saline (TBS) and blocked with gentle agitation for 60 min, after which 
time they were washed with three rinses of TTBS (TBS plus 0.05% Tween-20), 5 min per 
wash. After washing, the filters were immersed in 10 ml c-Myc (diluted 1:5000 in TBS), and 
incubated with gentle agitation for 60-120 min. Following a further three washes in TTBS, 5 
min per wash, the filter was incubated with the secondary antibody, IgG Alkaline Phosphatase 
Conjugate (diluted 1:30,000), and incubated for a further 60 min with gentle agitation. After 3 
standard washes in TTBS, the filter was treated with BCIP/NBT substrate solution for 10 min 
at room temperature, or until a colour change was observed. 
 
(j) SDS-PAGE and Western Blotting 
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis of Proteins 
  Proteins were resolved using SDS-PAGE. SDS solubilises proteins and coats them in a 
negative charge, resulting in electrophoretic mobility being based purely on size. Samples were 
prepared for SDS-PAGE analysis by adding 10 µl of 2X SDS gel loading buffer (50 mM Tris 
Cl [pH 6.8], 100 mM dithiothreitol, 2% w/v SDS, 0.1% BPB), 10% glycerol) to a  10 µl sample 
and boiling for 5 min at 95°C. Gels were made fresh on the day of the experiment and consisted 
of a resolving gel containing up to 18 % acrylamide for resolving proteins between 6 and 50 
kDa (1.5M Tris pH 8.8, 10% SDS, 10% ammonium persulphate, 8 µl TEMED). The addition 
of 10 % ammonium persulphate (APS) and Tetramethylethylenediamine (TEMED) catalysed 
the polymerisation of the gels. The resolving gel mixture was cast by pipetting into the space 
between the glass plates. A layer of ddH2O was carefully placed on top to avoid curving of the 
gel  surface.  Once  polymerisation  was  complete,  the  water  layer  was  removed  and  any 
unpolymerized acrylamide was washed away.  A stacking gel containing 5 % acrylamide was 
cast on top with a comb added to form loading wells (contents as in resolving gel except Tris 
used in 1M of pH6.8). Following polymerisation of the stacking gel, the comb was removed 
and  wells  were  washed  with  tris-glycine  running  buffer  to  remove  any  unpolymerised 
acrylamide.  The gel apparatus was assembled according to the manufacturer’s instructions and 
Tris-glycine electrophoresis buffer (25 mM Tris Base, 250 mM Glycine, 0.1% SDS) added to 
the top and bottom reservoirs. Following the addition of 15µl of each sample (heated at 100°C 
for 3 min), and a broad range protein marker (2-212 kDa, NEB), empty wells were filled with 1 Chapter 2: Materials & Methods 
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x SDS gel-loading buffer. SDS-PAGE was performed using Biorad Mini-PROTEAN 3 system 
and a continuous voltage of 8 V/cm was applied to the gel for 40 min, or until BPB reached the 
bottom of the resolving gel. The gel was then carefully removed and stained. 
  To stain, the  gel  was  immersed in 5  volumes  of Coomassie Brilliant Blue  (Severn 
Biotech Ltd, UK) and slowly agitated on a rocking platform for 4 hours at room temperature. 
Excess stain was then removed from the gel by soaking in destain (500 ml methanol; 400 ml 
dH20;  100  ml  glacial  acetic  acid),  on  a  rocking  platform  for  at  least  4  hours  at  room 
temperature. Destain solution was changed whenever necessary during this period. Gel staining 
with  Coomassie  did  not  successfully  highlight  protein  bands,  either  due  to  the  stain  being 
insufficiently sensitive or because of an over-vigorous destain step. Sypro Ruby Red (Biorad, 
USA) was subsequently tried as it is more sensitive, and this involved staining overnight on a 
rocking platform. Stained gels were photographed using Gene genius Bio imaging system and 
Genesnap software (version 6.05) from Syngene. 
 
(k) pET Vector Expression 
Individual primer design 
  In order to amplify DNA from the final 18 clones, individual primers were required 
since each insert had a unique reading frame and were designed to include NdeI and EcoRI 
restriction sites to enable seamless cloning into pET. The individual primers are detailed in 
Table 5. 
 
Individual clone amplification 
  Polymerase Chain Reaction (PCR) was carried out to amplify insert sequences from 
phagemid vector for individual study. PCR was performed in 0.5µl Microcentrifuge tubes in a 
total reaction volume of 50  l.  Reactions comprised 1  l template DNA, 2  l of 5  M each 
oligonucleotide primer and 45  l PCR supermix (Invitrogen, UK). Reactions were prepared on 
ice. The PCR was performed for 30 cycles of 95 C, 5 min (1st cycle only) 95 C, 30 s; 54 - 
68 C, 30 s; 70 C, 60 seconds; 70 C, 5 min (last cycle only), using a Techne TC-512 gradient 
thermal cycler. The PCR product was quality and size checked using 1% (w/v) agarose gel 
electrophoresis.  
 
TOPO TA cloning 
  Ten microlitres of each PCR product were cloned into the TA cloning vector pCR4-
TOPO (Invitrogen, UK) according to the manufacturer’s instructions. The ligation mixture was 
transformed  into  JM  107  chemically  competent  Escherichia  coli.  Transconjugants  were 
detected  on  LB  agar  supplemented  with  50  µg  /  ml  kanamycin.  Successful  clones  were 
harvested by Qiagen miniprep, the inserts excised using restriction enzymes NdeI and XhoI and Chapter 2: Materials & Methods 
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the digests run on a 0.8% agarose gel. Inserts were clearly present as distinct bands and were 
recovered using Qiagen Gel Extraction Kit according to manufacturers instructions. 
 
Universal Primer  5’ – CCG TTT GAT CTC GAG GTC GAC C – 3’ 
Clone Number  Individual Primer 
1  5’ – CAT ATG CCG CTG TTG GTG CTC CTG G – 3’ 
2  5’ – CAT ATG CCG CTC TAT CGC AGG GAA TG – 3’ 
11  5’ – CAT ATG CTA AAT CTT TTG GAA CTG AAA GC – 3’ 
16  5’ – CAT ATG CAA CGT CAC GCT ATA GAA CTA G – 3’ 
17  5’ – CAT ATG TAT ATT ATT TCT GCT AGC CTC TAT G – 3’ 
19  5’ – CAT ATG AAA TCC TGG AAC TTC CAG GAC G – 3’ 
20  5’ – CAT ATG CTG GGC GTG GAG AAC CTG TAC G – 3’ 
22  5’ – CAT ATG GCA GAG GCA GGA CAT ATC GAG G – 3’ 
27  5’ – CAT ATG GAG GGA ACT CCT CCA GAA AAT AG – 3’ 
36  5’ – CAT ATG CTT ATT TTT CTT TTG GGA TTA G – 3’ 
39  5’ – CAT ATG GTG ATG GCT GTT CAC CGC ATG – 3’ 
42  5’ – CAT ATG CTT TAT CTC ATG ACT GCA AAA TC – 3’ 
44  5’ – CAT ATG CCG CAC ACG GTG TCA GCG TCC G – 3’ 
52  5’ – CAT ATG ATC GGT ATC GTT AAA GGG GGG – 3’ 
58  5’ – CAT ATG TCA ACT TTA ATG ATA GGT ATG GAA A – 3’ 
59  5’ – CAT ATG CTT ATT TTA GGT AGA ATA AAC TAT – 3’ 
60  5’ – CAT ATG GTG ATT CTT GGC TTG ATT TTC TTT – 3’ 
 
 
Table 5 Primers for pET vector expression 
 
 
pET Vector Expression 
  Inserts from gel extraction were ligated into pET21 vector pET21b, pre-digested with 
NdeI and XhoI, using T4 DNA ligase (NEB). No successful ligations were ever made so pET 
vector expression was not taken further. 
 
(l) Adhesion assays 
  In order to test the binding specificity of each individual fusion protein for the panning 
ligand that first identified it, individual populations of pure phage were required. To do this, 1 
µl of phagemid containing the insert of interest was transformed into E. coli.  Helper phage 
R408 was added to an MOI of 20 and the infection inoculated into 190 ml NB2 containing 100 Chapter 2: Materials & Methods 
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µg/ml ampicillin and grown overnight at 37ºC, 200 rpm. Cells were removed by centrifugation 
using an SLA-1500 rotor at 7,000 x g at 4ºC for 20 min. Phage supernatant was decanted into a 
sterile Sorvall bottle containing 40% PEG/2.5M NaCl and left at 4ºC overnight to precipitate. 
Phage were recovered by centrifugation using an SS-34 rotor at 15,000 x g at 4ºC for 20 min, 
and resuspended in 500 µl TB containing 20% glycerol. Recovered phage were enumerated 
using  the  same  protocol  as  used  for  phagemid  library  conversion  and  panning  eluate 
renumeration, using dilutions of phage supernatant to infect 100 µl of log phase E. coli. 
  Nunc  Immunoplates  coated  with  100  µl  0.1  mg/ml  ligand  were  incubated  at  4°C 
overnight. Following removal of the ligand, wells were thoroughly washed with 200 µl PBS 
(x5) and 200 µl PBS-T (x5) to remove all unbound ligand.  One hundred microlitres of the 
previously amplified and recovered phage population at 1 x 10
9 were added to each well and 
left to bind to the immobilized ligand for 90 min. Following excess phage removal, the washing 
steps were repeated; 200 µl PBS (x5) and 200 µl PBS-T (x5) to remove all unbound phage. 
Bound phage were eluted in 100 µl elution buffer (glycine/HCl pH 2.2) and neutralised with 50 
µl Tris.HCl (pH 7.5). Dilutions  of  eluted phage  were used to infect  log phase  E. coli and 
enumerated as previously described. Higher titres were expected where fusion proteins showed 
stronger binding affinity to the panning ligands which led to their initial identification. 
 
(m) 16S rRNA Gene Diversity Analysis 
16S rRNA Gene Amplification 
  Polymerase Chain Reaction (PCR) was carried out using universal primers 27f-CM (5’ 
– AGA GTT TGA TCM TGG CTC AG – 3’) and 1492r (5’ – TAC CTT GTT ACG ACT T – 
3’). PCR was performed in 0.5µl Microcentrifuge tubes in a total reaction volume of 50  l.  
Reactions comprised 1  l template DNA, 2  l of 5  M each oligonucleotide primer and 45  l 
PCR supermix. All reactions were prepared on ice. 
  The PCR was performed in the initial analysis for 30 cycles of 95 C, 5 min (1st cycle 
only) 95 C, 45 s; 46 -54 C, 60 s; 72 C, 1.5 min; 72 C 15 min (last cycle only), using a Techne 
TC-512 gradient thermal cycler. The positive control samples contained all the PCR reagents 
together with Escherichia coli DNA. The PCR product was quality and size checked using 1% 
(w/v) agarose gel electrophoresis. In the full 16S analysis, the PCR was performed using the 
same settings but annealing at 46 C and for 10 cycles only. 
 
Cloning of 16S rRNA gene amplified DNA 
  Ten microlitres of each PCR product was cloned into the TA cloning vector pCR4-
TOPO (Invitrogen, UK) according to the manufacturer’s instructions. Two microlitres of the 
ligation  mixture  was  transformed  into  TOP  10  chemically  competent  Escherichia  coli. 
Transconjugants  were  detected  on  multiple  LB  agar  plates  supplemented  with  100  µg/ml Chapter 2: Materials & Methods 
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Ampicillin, 10 mM IPTG and 40 µg/ml X-Gal. Following overnight growth at 37 C, 380 white 
colonies were selected, plasmid miniprepped (Qiagen) and 20 µl dispensed into 96-well plates 
at  a  concentration  of  5  µM  for  sequencing  at  the  Comparative  Genomics  Centre,  part  of 
University College London. 
Purified  PCR-amplified  16S  rRNA  fragments  were  sequenced  using  the  Big  Dye® 
Terminator  v3.1  Cycle  Sequencing  Kit  (Applied  Biosystems)  using  a  3730xl  Capillary 
sequencer, also manufactured by Applied Biosystems. The universal M13 forward (5’– GTT 
TTC CCA GTC ACG AC –3’) and reverse (5’– GGA AAC AGC TAT GAC CAT –3’) primers 
were used. Each reaction (well) contained 10 µl volume, made up of 2 µl DNA, 0.5 µl Big Dye 
reagent, 2 µl of 5X buffer supplied with the kit, 0.32 µl of 5 µM primer, and the rest made up 
with water. The cycle sequencing program was 95 °C for 60s (1
st cycle only), then 25 cycles of 
denaturation at 95 °C for 10s; annealing at 50 °C for 5s and extension at 60 °C for 4 min. 
 
16S rRNA data analysis 
  Once sequenced, the 16S forward and reverse files containing ~900 bp of sequence, 
were  aligned  using  BioEdit  Sequence  Alignment  Editor  v7.0.9  in  FASTA  format.  The 
sequences  were then aligned using the Greengenes  database (DeSantis  et al., 2006a) using 
NAST  (Nearest  Alignment  Space  Termination)  (Desantis  et  al., 2006b),  which  outputs  the 
MSA (Multiple Sequence Alignment) in the standard format of 7682 characters per sequence, 
allowing similar loci to be located in similar positions in subsequent batches. In this analysis, 4 
out of 380 sequences did not meet the match requirements, being either less than the minimum 
length of 1250 bp, or sharing less than 75% identity to the template sequence. These sequences 
were removed from further analysis. 
  Due to the presence of genomic data from different origins containing the conserved 
16S rRNA gene, amplification by PCR is known to introduce hybrid  molecules  which  can 
distort the results of a diversity analysis (Liesack  et al., 1991). The percentage of chimeric 
sequences  in this 16S rRNA  gene analysis  was checked using the  greengenes Bellerophon 
(version 3) server (Huber  et al., 2004). In other studies (Kazor et al., 2003; Aas et al., 2005) 
the number of chimeric sequences was between 1 and 15%. This analysis located 42 chimeric 
sequences (11%), which were below the 97% threshold BLAST similarity and less than 1250 
bp match to the Core Set of sequences. The species identification of chimeric sequences was 
not obtained and these 42 were removed from further study.  
  Using  the  NAST  aligned  sequences,  minus  chimeras,  the  remaining  333  sequences 
were classified using the Simrank interface which finds similarity between query and database 
in terms of the number of unique 7-mer count present in either query or database. Sequence 
diversion  from  near-neighbours  was  calculated  using  the  DNAML  option  of  DNADIST 
(PHYLIP package). The The reference sequences used for classification were  non-chimeric Chapter 2: Materials & Methods 
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(divergence  ratio  <1.10)  and  taxonomic  analysis  was  conducted  using  the  RDP  taxonomic 
nomenclature.  
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Introduction 
  The ligands IgA and Fibronectin (FN) are important components of the human 
cellular  or  immune  system  and  as  such  are  known  to  associate  with  the  commensal 
bacterial  cargo.  The  aim  of  this  project  was  to  investigate  novel  binding  mechanisms 
through  the  combination  of  metagenomics  and  phage  display.  Taking  a  metagenomic 
approach  allowed  the  extraction  of  all  genomic  material  in  the  samples,  and  the 
production  of  a  phage  display  library  containing  representative  sequences  from 
(theoretically) all bacteria present. This chapter details the steps from DNA extraction to 
phage display library production. 
 
DNA sampling and concentrations 
  Nine volunteers were asked to provide scrapings from the tongue dorsum for this study. 
The volunteer data sheet is shown in Appendix 1. All samples were collected in 5 ml of PBS 
after vigorous brushing with a sterile toothbrush.  
  Previous studies mention that resuspending a mixed microbial sample in isopropanol 
may increase the DNA concentration upon extraction (Torsvik et al, 1990). The method used 
by Torsvik in 1990 to achieve this increase was not described explicitly in the publication; 
therefore isopropanol treatment of tongue samples was tested over varying amounts of time to 
assess  the  increase  in  DNA  concentration  (Figure  1).  Briefly,  a  fresh  5  ml  tongue-scrape 
sample in PBS from one of the 9 volunteers was centrifuged and the pellet resuspended in 5 ml 
isopropanol and stored at -20°C for between 1 and 6 days. Following this treatment, DNA was 
extracted using the CTAB protocol and DNA concentration measured by Nanodrop™ 
All Nanodrop™ readings were taken in triplicate as the instrument does not provide a 
completely  accurate  value.  Further,  it  was  realised  that  the  DNA  concentration  between 
samples would vary depending on the number of bacterial cells in the sample from day to day, 
and in order to minimise this effect, samples from one volunteer were used exclusively and 
vortexed just before use. The mechanism by which isopropanol increases DNA concentration 
prior to extraction is unclear, however these data clearly demonstrate that an increase did occur. 
We hypothesised that isopropanol was either penetrating the bacterial cells therefore disrupting 
DNA/protein interactions, or that it was removing lipid contamination similar to the method 
discussed by Stadler & Hales, 2002. Whatever the mechanism, following this experiment all 
subsequent DNA samples were stored in isopropanol for 7 days, as detailed in Chapter 2, page 
51. 
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DNA concentration following treatment with or without isopropanol
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Figure 1 DNA concentration following treatment with and without isopropanol. Blue line signifies 
the DNA concentration with no prior isopropanol treatment, which did not change over 6 days. 
Pink line illustrates the increase in DNA concentration over 6 days.  
 
  Following DNA extraction from all samples using the CTAB protocol, 200 µl from 
samples  1  -  9  were  combined  and  the  metagenomic  DNA  concentration  determined  by 
Nanodrop™ to be in the region of 1000 ng/µl.  This pooled DNA was used to construct a 
phagemid library, and a pictorial overview of this is shown in Figure 2. 
 
 
 
 
Figure 2 Production of a phage display library. Following sample extraction, genomic DNA was 
fragmented and ligated into the phagemid vector pG8H6. Successful ligations were transformed 
into  E.  coli  cells  and  converted  to  a  phage  display  library,  which  was  stored  at  -80°C  for 
subsequent panning. 
Amp
r 
  C
0
1
E 
  M13 
1G 
Signal 
seq. 
H-
ta
g 
Gene 
VIII 
Insert DNA 
  Sap
I 
EcoR
I 
Nco
I 
SnaB
I 
3395b
p 
DNA extraction  sample  fragment DNA  ligate to phagemid 
E. coli TG1 
electroporate  conversion 
helper phage 
phage display library Chapter 3: Constructing a Phage Display Library 
 
68 
 
DNA fragmentation 
  Metagenomic DNA was fragmented by two different methods to identify the optimal 
method for library production; sonication, the traditional method of fragmenting metagenomic 
DNA; and partial restriction digest using three blunt-end restriction enzymes.   
  Sonication of metagenomic DNA was carried out as described in Chapter 2, page 53. 
Briefly, DNA was fragmented for 5, 10 and 15 seconds, blunt-ended using dNTPs and DNA 
polymerase, and the fragments visualised using 1% (w/v) agarose gel electrophoresis (Figure 
3). Phage display is commonly used with DNA fragments between 400 bp – 1 kb; therefore the 
optimum  sonication  time  from  this  gel  is  clearly  15  seconds  as  most  of  the  larger  DNA 
fragments at this time point are around 1 kb.  
 
 
 
Figure 3 Sonication of DNA sample in 5 second intervals. (1) λPst marker with corresponding sizes, 
(2) 1 µl of unfragmented DNA sample at 1000 ng/µl, (3) DNA after 5 second sonication, (4) DNA 
after 10 second sonication, (5) DNA after 15 second sonication. 
 
  DNA fragmentation by partial digestion was carried out as described in Chapter 2, page 
53. Briefly, three blunt-end producing restriction enzymes (HaeII, AluI and RsaI) were added to 
metagenomic DNA for the purpose of partial digest. Each enzyme digests different DNA bases, 
some of which occur more frequently than others in an attempt to make the fragmentation as 
random as possible. Aliquots were removed every 10 minutes from the 20 minute time point 
onwards (Figure 4). 
  There appears to be no real difference in fragment size range, except that the largest 
fragments at each time point decrease in size as incubation time increases. For this project, 
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fragments between 500 bp and 1 kb were thought able to contain enough of a bacterial gene, 
such that binding affinity for a ligand would be retained, facilitating detection during panning 
and for further downstream processing. Fragments  of 500 – 1500 bp were achieved by 20 
minutes, therefore 20 minutes incubation was used for future restriction digests.  
 
 
 
 
Figure  4  DNA  fragmentation  by  partial  digestion  with  AluI,  RsaI  and  HaeIII    (1)  λPst  DNA 
marker, (2) 1 µl of untreated DNA at 1000 ng/µl, (3) DNA after 20 minutes restriction digest, (4) 
after 30 minutes digestion, (5) after 40 minutes digestion, (6) after 50 minutes digestion, (7) after 60 
minutes digestion, (8) after 70 minutes digestion, (9) after 80 minutes digestion, and (10) λPst DNA 
marker. 
 
Determination of optimum ligation conditions 
  Phagemid vector (pG8H6) DNA, extracted using the Qiagen MidiPrep Kit, described 
in Chapter 2, page 50, was linearized with restriction enzyme SmaI and dephosphorylated to 
prevent self-ligation. Using sonicated and partially digested metagenomic DNA, different ratios 
of insert and vector concentration (in ng/µl, from Nanodrop™) were tested to determine the 
optimum insert: vector ratio in 10 µl ligation volumes. Briefly, a variety of ligations were set 
up  using  insert  and  phagemid  vector  pG8H6  DNA  diluted  to  equal  concentrations.  Two 
microlitres of each ligation reaction was then transformed into electrocompetent E. coli cells 
and grown in 3 ml of NB2 broth. Following 2 hours growth, 100 µl from each culture was 
plated  on  NB2  agar  plates  containing  100  µg/ml  ampicillin  and  the  number  of  colonies 
following 16-24 hours incubation was counted (Table 1). 
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      Insert (µl) 
    1  2  3 
Vector (µl) 
 
1  81  389  1306 
2  103  436  1123 
3  96  237  563 
 
Table 1 Number of colonies for ligations with various insert: vector ratios 
 
  Given that both ratios  of two or three parts insert to  one part vector produced the 
greatest number of colonies on ampicillin agar plates, a 3:1 insert to vector ratio was used in all 
subsequent ligations. 
  Ligations  were  prepared  in  a  20  µl  volume.  Before  adding  T4  ligase,  2-3  µl  was 
removed  for comparison  on an agarose  gel (shown  in  lane 2,  Figure 5A).  After overnight 
incubation, the ligation success was visualised using 1% agarose gel electrophoresis. Ligation 
reactions where the vector joined more successfully with DNA fragments occurred more often 
when using DNA fragmented with blunt-end restriction enzymes (Figure 5B).  
 
                
 
Figure 5 Ligation reactions A and B. Figure A; (1) λPst DNA marker, (2) control: vector band 
pG8H6 and smear of metagenomic DNA prior to ligation, (3) ligation reaction following overnight 
incubation;  vector  band  has  disappeared  illustrating  ligation  to  the  metagenomic  DNA  and 
resulting in an overall increase in fragment size. Figure B; (4) λPst DNA ladder. Ligation reactions 
containing pG8H6 phagemid vector and (5) sonicated DNA, and (6) DNA fragmented by 3 blunt-
end restriction enzymes. 
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These ligations also resulted in higher numbers of transformants in the subsequent library, and 
to those transformants containing a higher percentage of metagenomic DNA inserts (data not 
shown). This may be due to the extra step required when using sonicated DNA, prior to ligation 
into a blunt-end vector. After sonication, exposure to shearing forces results in DNA fragments 
with  overhanging  ends  which  must  be  repaired  (with  dNTP’s  and  DNA  polymerase)  to 
optimise ligation into the blunt-end vector. The efficiency of ligation really relies on a high 
degree of end repair however the efficiency of this step is only substantiated by successful 
ligation  reactions.  Using  blunt-end  producing  restriction  enzymes  bypassed  this  repair  step 
completely,  meaning  that  all  DNA  fragments  were  blunt-ended  and  therefore  able  to 
successfully ligate into the phagemid vector. 
 
Transformation 
  Prior to electrochemical transformation, ligation reactions were purified of excess salt 
using the Qiagen PCR Cleanup Kit. Chemical transformations were used in the initial stages of 
phagemid  library  production,  but  were  substituted  for  electrochemical  transformation  when 
testing was over. While testing and optimising phagemid library production electrocompetent 
E. coli cells (EEC) were made in the laboratory to minimise costs. However, the efficiency of 
homemade electrocompetent cells can vary from batch to batch and because the highest quality 
library was required for phagemid conversion, 10 aliquots of electrocompetent  E. coli cells 
(EEC) from Invitrogen were used to produce the final library. 
  In order to get the highest number of transformants in the phagemid library in the early 
stages, different ligation volumes were tested in 50 µl aliquots of EEC. As shown in Table 2, 
increasing the  ligation  volume from 1 µl to 2 µl resulted  in an  increase in the  number  of 
transformants  per  millilitre  from  660  to  1490,  an  increase  which  did  not  continue  with 
additional ligation mixture. When transforming the final phagemid library 2 µl of ligation was 
used in each 50 µl aliquot of ECC.  
 
  Ligation volume (µl) in 50µl of ECC 
Volume plated out (µl)  1  1.5  2  2.5 
100µl  66  84  149  145 
Transformants/ml  660  840  1490  1450 
 
Table 2  Electroporation transformation frequency. 
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Insert frequency and size following transformation 
  Although  the  phagemid  vector  had  been  treated  with  phosphatase  to  reduce 
recircularisation, and because the efficiency of E. coli to take up plasmids is not 100%, it was 
necessary  to  check  the  insert  frequency  before  converting  the  phagemid  library  to  phage 
display. Briefly, 40 individual colonies from ampicillin agar plates were grown overnight in 3 
ml NB2, then the plasmids isolated by plasmid miniprep. Ten microlitre aliquots of plasmid 
DNA  were  digested  with  restriction  enzymes  NcoI  and  XhoI  to  release  the  insert,  and  the 
digested DNA electrophoresed through a 1% agarose gel. Figure 6 clearly shows the phagemid 
library containing a range of inserts between 350 bp and 800 bp in size.  
 
 
     
 
Figure 6 Phagemid vector pG8H6 containing metagenomic DNA inserts. (1) λPst DNA marker, (a) 
DNA samples after splicing with restriction enzymes NcoI and XhoI, clearly showing inserts, (b) 
DNA samples before restriction digest.  
   
  A metagenomic DNA insert must be present in the phagemid genome in order that 
(upon  conversion)  phage  coat  protein  8  displays  a  fusion  protein.  A  high  frequency  of 
metagenomic DNA inserts at this stage was necessary to achieve a high diversity of fusion 
proteins following conversion. It was thought that more than 80% phagemid containing inserts 
would generate a library of adequate complexity for panning. Prior to conversion, this library 
contained inserts in 93% of the phagemid tested. 
  Having  established  the  complexity  of  the  phagemid  library,  it  was  important  to 
pinpoint the origin of that DNA, since a phagemid library containing more human DNA than 
bacterial would be of limited interest for this project. To do this, 40 colonies from a phagemid 
library spread on ampicillin agar plates were plasmid-extracted and sequenced and the results 
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analysed by  BLAST search. From 40  colonies, five  contained  human DNA  (12%) and the 
remainder contained bacterial DNA of mixed homology to the database (data not shown). It is 
prudent to mention here that none of the inserts tested were identical, which means that the use 
of restriction enzymes to fragment metagenomic DNA produces fewer than one clone in 40 that 
is repeated.  
 
Conversion of phagemid to phage display 
  Initially,  test  phagemid  libraries  were  converted  to  phage  display  to  optimise  the 
process before converting the final library. Briefly, cells from successful transformations were 
combined, centrifuged and resuspended in sterile NB2 broth. Helper phage R408 were added to 
an MOI of 20 and incubated statically at 37°C, then incubated overnight with shaking in 100 ml 
NB2 broth containing ampicillin. Following centrifugation to remove E. coli cells, the phage 
supernatant was PEG precipitated overnight then recovered by high speed centrifugation.  
  Because it was important to maintain large inserts for downstream expression, the sizes 
of  50  were  checked  following  conversion  by  excising  inserts  from  miniprep  DNA  using 
restriction enzymes NcoI and XhoI, and visualised using 1% (w/v) agarose gel electrophoresis. 
Metagenomic DNA insert sizes are shown in Figure 7 before and after library conversion. 
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Figure 7 Library insert size before and after conversion.  The converted library (maroon bars) 
generally contains smaller inserts than the phagemid library prior to conversion (lilac bars). Chapter 3: Constructing a Phage Display Library 
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  Prior to conversion, the test library contained 93% inserts (37/40) at an average of 685 
bp in size, and contained 7 x 10
4 transformants (theoretically 6.5 x 10
4 inserts) so was suitable 
for  conversion  to  a  phage  display  library.  Following  conversion,  the  number  of  inserts 
remained stable at 38/40 however, the average insert size decreased from 685 bp to 567 bp.  
  Insert  frequency  did  not  drop  following  conversion,  perhaps  indicating  that  either 
phage  are  better  at  expressing  smaller  inserts,  or  smaller  phagemid  package  more  quickly 
resulting in more being made per cell, and this numerical dominance means they are seen more 
often when analysing individual colonies. 
 
PEG precipitation  
  The protocol for conversion described in Chapter 2, page 56 is a revised version of the 
original which was used for the test conversions, and contains a TE glycerol stage which was 
later removed. The purpose of this stage in the protocol was as a mid-way point in reducing the 
total volume of PEG precipitated supernatant from 100 ml to 50 ml, before final recovery in 1 
ml,  however  it  was  felt  that  phage  were  being  lost  between  these  points.  This  conversion 
process was tested throughout to monitor phagemid losses at each stage (Table 3).  
  The titre  of the practice  library was 1.8 x 10
6  CFU. Stage 2  involved centrifuging 
resuspended phage in 50 ml TE glycerol only to centrifuge and resuspend again in 1 ml. The 
titre of Stage 2 supernatant was low at 5.2 x 10
4 which meant that phage losses were not high 
enough to impact the final library size, however it was decided that this intermediate step was 
not required to concentrate the phage library so it was removed in all subsequent conversions. 
 
Additional rinse 
  Following conversion of the test library, it was eluted in 1 ml TE glycerol. A phage 
display library should be at least 1 x 10
10 CFU/ml for panning (Mullen et al, 2006) so it was 
important that the phage display library titre was as high as possible before amplification.   
 
Stage  1  2  3 
Titre (total)  5 x 10
7  3 x 10
6  4.85 x 10
7 
 
Table 3 Titres of 3 stages during PEG precipitation to account for phage losses. Stage 1 is the titre 
of the whole 100 ml of raw supernatant following bacterial cell removal. Stage 2 is the titre of 
phagemid present in the rinse stage to gauge phage losses, and stage 3 is the final library following 
concentration to 1 ml, without the addition of the rinse.   Chapter 3: Constructing a Phage Display Library 
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However,  due  to  the  viscosity  of  PEG  it  was  difficult  to  get  all  the  elution  out  in  1  ml. 
Therefore, an additional 1 ml rinse of TE glycerol was added following removal of the first 1 
ml, to check how many phage remained in the centrifuge tube after one rinse. In the test library 
the first 1 ml titre was 5 x 10
7 and the 1 ml rinse titre was 3 x 10
6. Clearly, the additional rinse 
did recover a significant number of phage so it was decided to keep the additional rinse of 1 ml 
in every subsequent phagemid conversion.  
 
Final Library Considerations 
  The quality of electrocompetent cells used to transform ligated DNA is perhaps the 
most important factor in producing large libraries according to Woiwode et al., 2003. For this 
project, 10 aliquots of Invitrogen TG1 electrocompetent cells were bought to produce the final 
phagemid library before converting to phage, using the optimised conversion process. Before 
conversion, optimal ligation volume was tested in duplicate transformations with 1 µl, 1.5 µl 
and 2 µl (Table 4). 
 
  Ligation volume (µl) in 50µl of electrocompetent cells 
  1µl  1.5µl  2µl 
Transformants/ml  6.2 x 10
4  6.7 x 10
4  7 x 10
4 
   
Table 4  Electroporation efficiency using Invitrogen electrocompetent cells. Results shown are the 
number of transformants per millilitre, where each transformation was grown in 5 ml NB2.  
 
  The number of transformants per millilitre increases from an average of 6.7 x 10
4 to 7 x 
10
4 as ligation volume is increased from 1.5 µl to 2 µl, whereas between 1 µl and 1.5 µl the 
number of transformants per ml increased from 6.2 x 10
4 to 6.7 x 10
4, a greater increase in 
transformants without a large increase in the ligation volume required. For this reason, 1.5 µl of 
ligation was used in each transformation, which were then incubated in 5 ml nutrient broth and 
plated  onto selective  media to check the  number  of transformants in the  library.  The final 
phagemid library of 50 ml contained 3.5 x 10
6 transformants which, at 93% insert frequency, 
meant the library contained 3.25 x 10
6 inserts. Multiplying the average insert size following 
conversion (567 bp) by the theoretical number of inserts in the library (3.25 x 10
6) means that 
the phage display library could contain in the region of 1,842 Mb of DNA (1.8 Gb). If the 
average bacterial genome is ~5 Mb in size, that would imply that the phage display library 
could contain in the region of 369 average genomes, providing good coverage of the human Chapter 3: Constructing a Phage Display Library 
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tongue microbiota, thought to contain between 12 and 27 genomes per person (Kazor et al., 
2003). 
   Other  groups  have  produced  phage  display  libraries  with  the  fragmented  genomic 
DNA  of  individual  bacteria, ranging  from  9.2  x  10
6  transformants  (Jacobsson  &  Frykberg, 
1995) to 9 x 10
7 (Williams et al, 2002). This phagemid library was felt to be comparable in 
number to previous studies so it was converted to phage. Following phage recovery by high 
speed centrifugation, two rinses of 1 ml TE glycerol ensured near total recovery of the phage 
display library at a final titre of 1.7 x 10
11 CFU. This titre is comparable with that of Jacobsson 
& Frykberg who, in their 1995 and 1996 papers, achieved library titres of 2.6 x 10
10 and 2 x 
10
10 respectively. 
 
Discussion 
  Metagenomics  involves  the  extraction,  cloning  and  analysis  of  the  entire  genetic 
complement  of  a  mixed  microbial  habitat  which  can  be  used  for  diversity  analysis,  or 
functional  assessments  of  microbial  life  within  that  environment.  Making  sure  the  DNA 
containing this diversity remains complete and unbiased throughout library construction is a 
difficult task, and as such every method for the assessment of metagenomic library diversity 
has inherent drawbacks. 
Previous  metagenomic  studies  have  enlisted  a  variety  of  methods  for  interrogating 
microbial samples. Stable Isotope Probing (SIP) (Radajewski et al, 2003) is particularly useful 
for  accessing  metabolically  active  organisms;  however  this  method  can  be  limited  by 
incomplete labelling. DNA microarrays allow high-throughput robotic screening for the target 
of multiple gene products (Wu et al, 2001) and, although this began as an expensive option, as 
it becomes more heavily used it is becoming cheaper and therefore more accessible. Shotgun 
sequencing of 16S rRNA, used in a landmark paper by Tyson et al in 2004, allowed complete 
sequence  closure  of  a  simple  bacterial  community.  Shotgun  sequencing  was  also  used  to 
sequence  viruses  by  Brietbart  et  al,  2003.  Pyrosequencing,  a  next-generation  sequencing 
technology,  was  developed  by  Margulies  et  al  in  2005  as a  high-throughput  alternative  to 
capillary sequencing  which uses  emulsion PCR to amplify  individual DNA strands coating 
hundreds of thousands of beads. The individual beads are separated onto individual fibre optic 
strands and sequenced,  each 7  hour  run giving around 100 Mb of sequence  data in 250bp 
chunks per sample (Mardis et al, 2007). This technology was used by Cox-Foster, D.L. (2007) 
in a study of honey bee colony collapse disorder, and is now becoming a more convenient 
method of bulk sequencing of environmental metagenomes (Margulies et al, 2005). 
Subtractive  cloning,  PCR,  fluorescent  in  situ  hybridization  (Harmsen  et  al,  2002), 
terminal  restriction  fragment  length  polymorphism  (T-RFLP)  (Nagashima  et  al,  2003), Chapter 3: Constructing a Phage Display Library 
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membrane assays (Matsuki et al, 2002), cosmid (Courtois et al, 2003) and fosmid libraries 
(Nesbo et al, 2005) are all alternative methods of interrogating bacterial samples, however none 
of  these  alternatives  present  the  opportunity  to  functionally  screen  the  (partially  unknown) 
proteome in the same way as phage display does. Although the process of arriving at a phage 
display library suitable for panning took around 2 years, the information contained within it, 
and its functional screening capacity, may shed more light on the binding proteins of tongue 
bacteria and the variety of interactions going on in this area. 
 
DNA Extraction Method 
  When extracting metagenomic DNA it is important to maintain two factors as much as 
possible: sample diversity and DNA concentration. Options to increase the amount of DNA in 
the samples, for  example sample cultivation  in saliva (Foster & Kolenbrander, 2004) were 
unsuitable  for  this  project  since  this  could  alter  and  reduce  sample  diversity  as  culturable 
bacteria thrive at the expense of others (Schmeisser et al, 2007). Daniel, 2005, agreed that 
enrichment steps like this can have a negative impact on sample diversity but could be useful 
when  particularly  high  quality  DNA  is  needed  or  when  carrying  out  SIP  analysis  on 
metabolically active community members.    
  Various methods exist for DNA extraction from an environmental sample and although 
it generally produces DNA of high quality and purity, the CTAB protocol was chosen since it 
was rapid and had been used previously to successfully extract high quality metagnomic DNA. 
CTAB is a direct method of extraction, known to introduce less bias than indirect methods, 
such as those involving prior cultivation or cell separation (Courtois et al, 2003; Kauffmann, 
2004).  
  When  isolating  DNA  from  environmental  samples  for  metagenomic  studies, 
Schmeisser et al (2007) pinpointed 3 issues which should be taken into account: 
1. DNA should come from the broadest host range possible and must represent the original 
microbial  community.  To  achieve  this  in  this  project,  samples  from  9  volunteers  were 
combined to create a more diverse library than using individual samples. 
2. Unintentional mechanical shearing of genomic DNA should be avoided as much as possible; 
although this has more serious implications for large fragment library construction rather than 
phage display library construction. 
3. DNA should be free from contamination which could interfere with downstream processing 
such as restriction, ligation and transformation. One of the main benefits of using the CTAB 
protocol was that it produced high concentration, high purity DNA which was ready for use 
immediately (Bailey, 1995). Chapter 3: Constructing a Phage Display Library 
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  Clearly, the eventual success of metagenomic library production and screening depends 
on  a  combination  of  factors:  sample  diversity  and  composition;  collection,  extraction  and 
storage of the sample; the host and vector systems used for cloning and expression; and the 
screening strategy itself (Daniels, 2005). To get the highest concentration of DNA possible 
from the tongue bacterial samples, cells were resuspended in isopropanol and stored at -20°C 
for one week which increased the DNA concentration of the final extracted DNA. Although 
isopropanol treatment was used by Torsvik (1990), the exact mechanism by which isopropanol 
treatment increases DNA concentration is not entirely clear. It is possible that the solvent acts 
to disrupt the cell membrane, lysing the cells and then separating lipids and nucleic acids for 
subsequent  purification.  With  environments  such  as  soil,  DNA  extraction  techniques  must 
avoid  concentrating  matrix  compounds  from  the  soil  itself  (Daniels,  2005)  so  isopropanol 
treatment may not be appropriate for all environmental samples. In the oral cavity, one of the 
main issues is human DNA contamination which, if not removed before DNA extraction from 
the  environmental  sample,  would  continue  to  appear  in  the  phagemid  and  phage  display 
libraries. In order to try to reduce the presence of human DNA prior to DNA extraction, a crude 
method of repeatedly freeze-thawing the samples disrupted the delicate osmotic balance of the 
human cells, exposing the DNA to bacterial DNases prior to their own lysis. This ‘freeze-thaw’ 
method was chosen over an alternative but tricky cell-separation, which would have removed 
human cells but also, potentially, the bacterial cells associated with them, potentially resulting 
in a reduction in sample diversity. Human DNA concentration following the freeze-thaw cycle 
method  was  checked  by  end-sequencing  40  shotgun  clones,  which  identified  <10%  human 
DNA (results not shown). This number is low enough to merit library construction with this 
DNA, and it was not thought necessary to extract DNA from samples which had not been 
through the freeze-thaw cycles.  
Ultimately, diversity of a metagenomic DNA sample depends on the bacterial makeup 
of the original sample. The CTAB protocol was chosen without knowing whether this method 
was equally suitable for the various organisms present on the tongue surface (Archaea, G+ve 
and G-ve bacteria). It is likely that this method has resulted in unequal lysis of cells, which is 
probably unavoidable given the variety of bacterial cell wall architecture. Some microbes, such 
as Mycoplasma spp., have very delicate cell walls which are likely to lyse in the early stages of 
extraction.  Gram  positive  bacterial  cells  like  Arthrobacter  and  Rhodococcus  can  also  be 
inefficiently  lysed  as  their  cell  wall  architecture  makes  them  more  resistant  to  lysis 
(Kauffmann, 2004). Rapid cell lysis may have resulted in the release of DNase which could 
damage  other  DNA  in  the  sample,  and  also  the  early  release  of  genomic  DNA  may  have 
resulted in excessive mechanical shearing as the protocol progressed. Taking these points into 
consideration, extracting metagenomic DNA is clearly likely to introduce bias towards bacterial 
cells that are in the middle of the lysis spectrum. It is important to realise that from sampling, Chapter 3: Constructing a Phage Display Library 
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each processing stage will make the library less representative of the original environment. This 
does not mean that it has less value only that care must be taken when drawing conclusions 
about it. 
 
Library Construction 
   Prior to conversion to phage, the phagemid library contained 3.5 x 10
6 transformants, 
where 93% of those phagemid contained metagenomic DNA. This meant that the library had a 
complexity  (number  of  inserts)  of  3.25  x  10
6  and,  given  an  average  insert  size  following 
conversion  of  567bp,  that  it  could  potentially  hold  1,842  Mb  of  DNA.  Given  an  average 
bacterial genome size of 5Mb (between 0.6 – 10Mb), the phagemid library could represent 369 
whole bacterial  genomes. However, the presence  of  insert DNA  in the phagemid  does  not 
guarantee that a recombinant protein will be displayed on the phage surface. It is estimated that 
only 1 in 18 phage will contain an insert that is in the correct orientation and in-frame with the 
promoter and gene VIII and therefore display a recombinant protein (Jacobsson et al, 2003), 
which leaves a theoretical 20.5 (369/18)  genomes represented by the phage display library 
after conversion. Because the extracted metagenomic DNA contains several unknowns, such as 
the number of species and the abundance of each species within the sample, it would be almost 
impossible to tell what representation of the metagenome was present in the library.  
  Vector  choice  is  extremely  important  in  phage  display.  Previously,  the  minor  coat 
protein III has been used for monovalent display (1 – 5 fusion proteins); however occasionally, 
because  there  are  only  5  copies  of  the  protein  per  phage,  and  overexpression  is  tightly 
controlled, phagemid would contain no fusion proteins at all (Jacobsson & Frykberg, 1995). 
Fusion to the major coat protein 8 facilitates multivalent display – fusions on more than one of 
the ~3000 copies of p8 – which allows identification of a wider range of proteins including 
those with lower affinity to the ligand but, due to the polyvalency of display, higher avidity. 
This avidity effect allows identification of a wider range of proteins than protein III display and 
should result in a wide variety of interesting bacterial binding proteins.  
  Choosing the correct bacterial host can also have an effect on the resulting library. E. 
coli, the microbiologist’s equivalent of a white mouse, has limited capabilities when it comes to 
expressing  environmental  libraries.  E.  coli  continues  to  carry  out  endogenous  activities, 
potentially  diverting  resources  away  from  the  production  of  expression  compounds,  for 
example antibiotic resistance. Some bacterial inserts in the library will never be expressed in E. 
coli, as is thought to be the case with Actinomycete and other high G+C genes (Strohl, 1992), 
the promoters for which E. coli does not recognise (Kauffmann, 2004). Bacterial hosts which 
have the inherent ability to express the gene clusters needed for small molecule manufacture 
have since been developed. Martinez et al (2004) has extended the range of bacterial hosts to Chapter 3: Constructing a Phage Display Library 
 
80 
 
include  the  Actinomycete  Streptomyces  lividans,  known  for  its  expression  of  heterologous 
polyketides (Kieser et al, 2000), and Pseudomonas  putida, a soil organism  which not  only 
produces  a  wide  range  of  secondary  metabolites,  but  which  has  now  been  developed  for 
straightforward genetic manipulation. The Martinez group found that increasing the range of 
vectors  and  host  strains  facilitated  high  throughput  screening,  therefore  increasing  the 
likelihood of capturing the numerous and diverse natural products contained within.  
  Not only is protein expression dependant on the bacterial host used, but it also depends 
whether the sequence and folding characteristics of the encoded protein are compatible with 
transport  through  the  bacterial  inner  membrane  and  display  on  the  phage  surface.  Often, 
cytosolic proteins are incompatible  with this translocation process, impairing  cDNA library 
display (Slootweg, 2006). Lytic phage display, in the case of T7 phage applications, bypasses 
this completely since the phage are released from the bacterium by bacterial lysis instead of 
relying  on  the  secretory  mechanism  (Slootweg,  2006).  DNA  fragments  encoding  external 
membrane proteins could be more readily expressed on the phage surface over intracellular 
proteins, which do not normally exist in an oxidising environment such as that on the outside of 
a cell.  Although this  is a true bias, it  works  in  favour of this project as bacterial proteins 
involved in binding events with human tissue or immune components are likely to be externally 
distributed as cell-surface molecules/ extracellular proteins, and could therefore be stable on the 
phage surface. 
 
  Phage  display  is  an  extremely  flexible  molecular  tool  which  allows  functional 
screening for virtually any trait one might wish to search for. The combination of phage display 
with  metagenomics  to  seek  out  binding  proteins  is  a  novel  approach  although  functional 
analysis  using  phage  display  libraries  of  individual  bacteria  was  previously  successful  and 
resulted  in  the  identification  of  4  genes  encoding  potential  adhesins,  none  of  which  were 
previously proposed to code for adhesins (Mullen et al, 2007).  
  The major strengths of phage display are the creation of large libraries, the level of 
control  over  binding  conditions,  the  link  between  phenotype  and  genotype  to  establish 
interactions, and the variety of freedom regarding the screening agent from various proteins to 
whole cells (Slootweg, 2006). It has been in use for over 20 years and the following chapters 
detail results from the unique combination of metagenomics and phage display. 
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Introduction 
  Using phage display, the natural specificity and affinity of fusion proteins on the 
phage  surface  can  be  exploited  by  screening  against  ligands  (in  this  study;  IgA, 
fibronectin  (FN)  and  BSA)  to  identify  protein-protein  interactions.  Genes  or  coding 
fragments can  then  be  identified by sequencing. The  procedure of  affinity selection is 
called bio-panning (panning) and was used in an attempt to locate a range of bacterial 
binding  proteins  that  may  be  involved  in  facilitating  bacterial  binding  to  the  human 
tongue dorsum and oral cavity. The panning process is depicted in Figure 1, which shows 
a phage display library containing a range of fusion proteins (coat protein 3 depicted for 
clarity). 
 
 
Figure 1 Panning process. (a) phage displaying various fusion proteins (green and red ellipsoids 
and  spheres)  are  added  to  immuno  tubes  containing  immobilized  ligand.  (b)  phage  displaying 
fusion  proteins  with  affinity  adhere  to  the  ligand  and  are  retained,  while  (c)  non-binders  are 
washed off. (d) these specific phage are eluted and amplified before being added to the next round 
of panning. 
 
a. 
b. 
d. 
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Panning Procedure 
  The procedure for panning a phage display library is described in Chapter 2, page 56 
and Figure 2 provides a pictorial overview of the panning arrangement used in this project. 
Briefly, tubes were coated overnight with 0.5 mg of the ligands IgA, FN or BSA in PBS. Tubes 
were subsequently blocked with BSA for 2 hours and washed extensively with PBS-T (PBS 
containing 0.05% Tween20) then PBS. The 1.7 x 10
11  phage  display  library constructed  in 
Chapter 3 was diluted to 1 x 10
10 CFU/ml and 2 ml added to each tube, which were incubated at 
either  22°C  or  37°C  for  2  hours.  Unbound  phage  were  removed  and  the  tubes  washed 
extensively with PBS-T then PBS as before. Bound phage were eluted in 1ml glycine buffer 
(pH 2.1) and neutralised with 0.5ml Tris-HCl (pH 8.0). Bound phage were enumerated upon 
elution by E. coli infection and then amplified for use in the second round of panning.  
 
 
 
Figure 2  Schematic representation of the panning of a phage display library at 2 temperatures. 
Each of the four panning experiments used BSA as a control, and both the IgA and Fibronectin 
experiments were carried out at 22°C and 37°C to determine whether a wider range of proteins 
might be more easily identified at a temperature closer to that of the original environment. 
 
 
  To amplify the phage for the next round of panning, eluted phage were added to log 
phase F` containing E. coli cells and grown for 1 hour. Superinfections with helper phage R408 
at an MOI of 20 were then grown overnight in 200 ml NB2 containing ampicillin. Phage were 
recovered by PEG precipitation and pellets resuspended in 2 ml TE glycerol. Three rounds of 
panning were used, each with an elution stage and an amplification stage, apart from the third 
round where the eluate was analysed directly without amplification. The titres from each stage 
are shown in Figure 3. 
IgA     BSA        IgA      BSA         FN     BSA            FN     BSA 
     22ºC                    37ºC                                    22ºC                    37ºC 
Phage display library (10
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Figure 3 Numbers of bound phage following 3 rounds of panning. Phage were enumerated by 
infecting log phase E. coli TG1 then counting colonies present on ampicillin selective agar.  
 
Previously, Mullen et al, 2007 reported that libraries containing fragmented DNA from 
a single bacterial species showed clear enrichment for specific clones by an increase in phage 
titre from round 1 to 3. In the Mullen report, only half of the panning experiments showed 
enrichment, however, none of the panning experiments from this thesis, depicted in Figure 3, 
show this enrichment. This could be because metagenomic DNA is so diverse that enrichment 
for one specific clone would require more than 3 panning rounds and as such, demonstrates a 
wide variety of proteins which show binding affinity for the ligands used.  
 
Panning results 
(a) IgA 
  Two millilitres of
 phage display library (2 x 10
10 CFU total), was panned against IgA 
with a BSA control, at 22°C and 37°C (Figure 3). Following the first round of panning, a total 
of 2.7 x 10
6 phage particles bound to IgA tubes at both temperatures, whereas a slightly lower 
number of 1 x 10
6 phage particles bound to BSA at both temperatures. Upon amplification, an 
increase of at least three logs was produced of each phage population for the next round of 
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panning. In the second round of panning, 2 x 10
11 and 1.8 x 10
10 phage particles bound to IgA 
at 22°C and 37°C respectively. For the BSA tubes, 4 x 10
9 and 1 x 10
11 phage particles bound 
at 22°C and 37°C respectively. Upon amplification of the second round eluate, a small increase 
was observed in phage present. In the third round of panning, 4.12 x 10
10 phage particles bound 
to  IgA  at  both  temperatures  which,  taken  with  the  round  1  binding  numbers,  gives  the 
impression that no temperature based enrichment is taking place for IgA binding proteins. In 
the BSA tubes, 2.2 x 10
6 and 3.64 x 10
10 phage particles bound at 22°C and 37°C respectively, 
which show a consistent high number of phage binding at 37°C in contrast to 22°C. This could 
be indicative of an increase in efficiency in domain folding. 
 
(b) Fibronectin 
  Two millilitres of
 phage display library, containing 2 x 10
10 CFU, was panned against 
Fibronectin (FN) with a BSA control, at 22°C and 37°C (Figure 3). Following the first round of 
panning, a total of 2.4 x 10
9 and 2.1 x 10
9 phage particles bound to FN at 22°C and 37°C 
respectively. In the BSA tubes, 5.8 x 10
9 and 4.1 x 10
9 phage particles bound at 22°C and 37°C 
respectively. These phage particles are showing an extremely high affinity for FN after only 
one round of panning. This result is understandable because FN is a known ligand for many 
different bacterial binding proteins (Joh et al., 1998; Schwarz-Linek et al., 2004) whereas no 
such comparable body of work exists for IgA binding proteins. Alternatively the high amounts 
of phagemid seen binding at the early rounds could include non-specifically bound phagemid 
particles. Due to the already high titre of the eluate, amplification added only one log to each 
phage population. In the second round of panning, both ligands at both temperatures bound 
phage in low (10
9) numbers. There is a possibility that many of the binding phage from the first 
round had low affinity for the ligand and were replaced in the second round by fewer, more 
strongly binding phage, or those with more fusion proteins on the surface, contributing to the 
avidity effect. Due to the low titres from the second round eluate, amplification added one log 
to both BSA phage populations and two logs to FN populations. In the third round of panning, 
2.4 x 10
9 and 5.2 x 10
8 phage particles bound to FN at 22°C and 37°C respectively. In the BSA 
tubes, 1.3 x 10
11 and 1.8 x 10
8 phage particles bound at 22°C and 37°C respectively, which is 
the opposite result to that in round 1 of the FN panning experiments, and the BSA results 
within the IgA experiments.  
 
Bioinformatic Screening of Fusion Proteins 
  Two hundred colonies from the 3rd round panning eluates were individually analysed 
by excising the insert and sequencing it. Vector bases were trimmed in silico from both ends of 
the raw sequence files, leaving the insert sequence and the first four amino acids of the vector - Chapter 4: Panning & Antibody Screening 
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VQVD. It was important to determine the amino acid sequence of the final protein product 
picked up by the panning experiments to begin to piece together potential roles for the bacterial 
proteins binding to human ligands. Because each sequence could have been ligated into the 
vector in any reading frame, and in the forward or reverse orientation, and because the insert 
sequence should remain in the same frame all the way through, the VQVD sequence acted as 
an identifier of the correct reading frame when the insert sequences were translated into all 6 
frames  (Figure  4).  Proteins  which  appeared  to  remain  in  frame  from  start  to  finish  were 
retained for closer analysis and all others were discarded.     
 
 
 
Figure 4 pG8H6 phagemid sequence showing the poly-His and c-Myc tags. Inserts are spliced into 
the SmaI site shown in yellow and the amino acids VQVD, below the yellow text, were used for in 
silico frame selection.  Chapter 4: Panning & Antibody Screening 
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  This analysis was supposed to show that the panning eluate contained a selection of 
binding proteins from which individuals could be analysed in more detail. One hundred clones 
each from the IgA and FN panning eluates were sequenced and a summary of findings are 
shown in Table 1. 
  Many  of  the  amino  acid  sequences  ending  in  VQVD  contained  one  or  more  stop 
codons in all 3 forward reading frames, meaning that these inserts would not form a continuous 
protein and should therefore not appear on the phagemid surface. These clones should not have 
displayed any binding capacity above that of the phagemid alone. An effort was made to ensure 
the stop codons were not simply sequencing artefacts by resequencing following PCR cleanup 
using the Qiagen PCR Cleanup Kit. Although some stop codons were expected, the very high 
number in some clones in all 3 forward reading frames was not; especially since the phagemid 
vector pG8H6 contains a poly-His tag which is designed to allow frameshifting into the correct 
frame. 
 
  IgA  FN 
Number of clones sequenced  100  100 
Number of good quality sequences  31  78 
Number of clones with/without stop codons  24/7  72/6 
 
 
Table  1  Initial  sequence  analysis  of  panning  experiments.  One  hundred  clones  were  initially 
sequenced from each ligand, however many of the reactions encountered secondary structure and 
were not able to provide sequence data. On translation to amino acids using the VQVD sequence of 
the vector as a guide, it was clear that a huge number of clones contained between one and 20 stop 
codons in the insert sequence, and should not result in fusion proteins on the phage surface. The 
clones without stop codons were taken from this experiment and added to those from antibody 
screening. 
 
Because  this  initial  analysis  (Figure  5,  arrow  to  ‘initial  sequence  analysis’)  only 
identified 13 proteins suitable for individual protein analysis and expression, it was decided to 
analyse a much larger number of clones from the panning eluate using a different method. 
Antibody screening was introduced as a rapid screening step to identify and eliminate from 
further analysis those clones which did not express both the poly-His and c-Myc tags, and 
therefore a legitimate fusion protein. One hundred clones from each ligand IgA, FN and BSA 
were screened; 300 in total (shown on Figure 5, arrow to ‘antibody screening’). It was thought 
that a larger number of clones (300 as opposed to 200 in the initial analysis) as well as the rapid 
elimination of ‘decoys’ by antibody screening, would facilitate identification of many more 
legitimate proteins that could be studied in more detail. Chapter 4: Panning & Antibody Screening 
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Antibody Screening  
  Antibody screening analysis of 300 clones for the presence of the c-Myc and poly-His 
tags was carried out as described in Chapter 2, page 58. Briefly, each of the 300 individual 
phagemid were transformed into E. coli, converted to phage, and then superinfected with helper 
phage  and  the  phage  containing  protein  fusions  recovered  by  PEG  precipitation.  These 
supernatants were spotted individually on nitrocellulose and screened separately for the c-Myc 
tag and the poly-His tail, present at either end of the insert (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
   
Four outcomes were possible following this screening process:  
(i) A positive result for both tags (desired outcome) 
(ii) Positive poly-His, negative c-Myc 
IgA     BSA        IgA      BSA         FN     BSA            FN     BSA 
     22ºC                    37ºC                                    22ºC                    37ºC 
Phage display library (10
11) 
3 rounds of panning 
Eluates stored at -80°C 
Initial sequence analysis  Antibody screening 
Further sequence analysis 
Figure  5  Schematic  representation  of  steps  taken  following  antibody  screening.  Following  3 
rounds of panning an initial sequence analysis was carried out. During this analysis, most of the 
clones contained stop codons so this line of enquiry was taken no further. Another small aliquot 
was taken from the panning eluate and used to analyse 300 clones through antibody screening, 
looking specifically to eliminate those clones which did not express the c-Myc and poly-His tags. Chapter 4: Panning & Antibody Screening 
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(iii) Negative c-Myc, positive poly-His 
(iv) A negative result for both tags. 
   
  The presence  of the tag combined  with the  BCIP/NBT (5-bromo-4-chloro-3-indolyl 
phosphate/nitro blue tetrazolium) substrate solution gave a colour change denoting tag presence 
(Figure 6, Figure 7 and Figure 8). If an individual clone showed a positive result for both tags, 
it was retained for further study. Similarly, any showing a negative result for both tags were not 
studied further. A positive result for c-Myc was important because it implied that translation of 
the inserted protein continued into the vector in the correct frame. However, it was conceded 
that a sufficiently large inserted protein may – by its size or folding domains - have blocked the 
tag, preventing detection by antibody screening as the c- Myc tag was closest to the phagemid 
coat  protein  and  sandwiched  between  the  inserted  peptide/protein  and  the  coat  protein. 
Therefore, with one or two exceptions, recombinants with a negative result for c-Myc were 
excluded from further study. However, recombinants with a negative result for the poly-His tag 
were not immediately disregarded because it was considered possible that the inserted DNA 
sequence could contain an internal Shine-Dalgarno sequence, promoter and signal sequence, 
meaning the poly-His tag would not be present on the phagemid even if it did carry a fusion 
protein. Therefore, although most of the recombinants analysed did contain poly-His, those 
which  did  not,  but  which  tested  positive  for  c-Myc,  were  also  taken  to  the  next  level  of 
screening. This selection process reduced the number of recombinants in analysis from 300 to 
221. 
 
Antibody screening colour change results   
(a) IgA 
 (a) 37°C        
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(b) 22°C 
 
 
Figure 6 (a) and (b). Antibody screening results from phage display library panned against IgA. 
 
 
 
(b) Fibronectin                                                                                  
(a)  37°C  
              
 
 
(b) 22°C  
 
 
Figure 7 (a) and (b). Antibody screening results from phage display library panned against FN. 
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(c)  BSA  
(a)  37°C  
          
 
 
(b) 22°C  
        
 
Figure 8 (a) and (b). Antibody screening results from phage display library panned against BSA.  
 
From  Figure  6,  Figure  7  and  Figure  8  there  is  clear  disparity  in  tag  presence 
depending on the ligand used for panning. IgA binding clones had the lowest tag presence of 
the three ligands, followed by FN, with BSA displaying the highest number of tags, almost 
100%. This could be because of the size of the fusion proteins; in the BSA panning experiment 
they were generally much smaller than those in either the IgA or FN experiments and smaller 
proteins tended to contain fewer stop codons in the protein sequence in at least one frame (see 
Appendix 3, 4 & 5) so would have been more likely to express both tags with the fusion.  
  Recombinants containing tags  were sequenced resulting  in the  elimination  of some 
clones,  including  those  containing  no  insert  (10)  and  –  from  BLASTn  searches  –  those 
containing human DNA (33). Unfortunately, there were also 34 instances where the presence of 
secondary structure meant that the sequencing reaction itself was unsuccessful and, following 
previous futile attempts to make these reactions work, these 34 clones were also discarded. This 
left 144 recombinants for the next level of analysis (BSA=66, FN=50, IgA=28).  Chapter 4: Panning & Antibody Screening 
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The following level of screening involved a more detailed in silico examination of each 
cloned insert. Again, each insert was translated to the reading frame ending in the amino acid 
sequence VQVD, which signifies the changeover from insert back into the amino acids of the 
vector. Because all clones not displaying the poly-His and c-Myc tags had been removed from 
further  study,  the  remaining  clones  should  have  been  free  of  stop  codons  and  able  to  be 
displayed on the phage surface. Unfortunately, a large number of the remaining 144 clones (69) 
testing positive for tags still contained multiple stop codons in all 3 frames (Table 2). 
  Occasionally, two fragments of metagenomic DNA would ligate to each other, prior to 
insertion in the phagemid vector, which was easily spotted from BLAST searches where the 
pictorial representation of the DNA sequence being compared clearly contained two different 
coloured sequences, and matches to completely different proteins. These clones were left aside. 
Additionally,  as  a  final  vetting  process,  some  proteins  were  considered  too  short  for  the 
subsequent  individual  analysis,  i.e.,  those  less  than  50  amino  acids  in  length,  were  also 
removed. This final step removed 55 clones, leaving 17. The 13 clones which came from the 
initial analysis were included (see Table 1), plus an additional 3 clones from a previous lab 
project, which brought the total to 33 clones.  
  From these 33 clones, a shortlist of 18 was made for further analysis in order of insert 
size and interest value. Insert size was the crucial deciding factor in which of the 33 clones to 
include in the shortlist because, in order to carry out the intended binding studies with the 
individual proteins, the  fusion protein should be  of  a sufficient size to retain some folding 
ability or domain structure. Ranking in terms of ‘interest value’ was based on BLAST results 
where proteins or sequences with no known homology to the database, or with homology to a 
hypothetical protein, were classed as potentially more interesting since they could be novel 
proteins.  These 18 clones are described in more detail in Chapter 5.  
 
 
 
 
 
 
 
 
 
 
 
Table 2 Antibody screening experiment results. As illustrated in column (a) 100 clones from each panning experiment were analysed by antibody screening for the 
presence of the poly-His and c-Myc tags. (b) shows the results of the antibody screening experiment, with some clones showing a positive result for both tags and some for 
c-Myc  only.  The  remaining  221  clones  were  sequenced  (c),  where  ‘no  sequence  data’  means  that  either  the  clone  had  no  insert  or  the  sequencing  reaction  was 
unsuccessful. Column (d) shows the results following in silico translation into the correct reading frame (containing VQVD entering the vector), where clones containing 
stop codons in all 3 forward frames were removed from further study. In addition, clones containing less than 50 amino acids were also removed, leaving 17 clones for 
individual analysis. 
 
  (a)  (b) Tag presence    (c) sequence data  (d) Following translation   
   
Clones 
analysed 
 
Both 
 
c-Myc 
only 
 
Remaining 
clones 
No 
sequence 
data 
 
Human 
DNA 
Number of 
clones 
containing 
stop codons 
Clones 
containing 
< 50 amino 
acids 
 
Remaining 
clones 
IgA  100  15  31  46  16  2  20  5  3 
FN  100  35  40  75  10  19  28  10  8 
BSA  100  98  2  100  21  12  21  40  6 
Overall  300  148  73  221  47  33  69  55  17 Chapter 4: Panning & Antibody Screening 
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Discussion 
Panning considerations   
  There are many considerations when panning a phage display library which have the 
potential to affect the outcome: 
1.  Choice of ligands: One of the main aims of this project was  to locate binding proteins 
responsible for interactions between bacteria and the human tongue dorsum, so the choice 
of FN and IgA are supportive of this goal as they are known to interact with bacteria in the 
oral cavity. FN especially is known to interact with a plethora of bacteria in its role as a 
part of the ECM. It was anticipated that studying the binding interactions of IgA against a 
range of bacterial proteins would unearth some previously unseen communication between 
the two, which would be interesting since far fewer IgA binding bacterial proteins have 
been  identified  than  FN.  Because  the  oral  cavity  contains  many  host-derived  proteins 
(Table  1,  Introduction  page  31),  a  wide  variety  of  ligands  could  have  been  used  for 
panning, and could still be used in future to pan the existing library. 
2.  Number of panning rounds: Typically 3 rounds are used with libraries produced from the 
genomes  of  distinct  bacterial  phylotypes  (Mullen  et  al.,  2007).  However,  because 
metagenomic  DNA  was  used  in  this  project  and  resulted  in  a  wide  variety  of  binding 
proteins, even after 3 panning rounds, panning for more than 3 rounds may have only acted 
to narrow the range of proteins to those with highest affinity to the ligands. Additional 
rounds of panning were not added however, since more rounds could have resulted in the 
loss of bacterial proteins with lower expression levels or of those with a lower affinity to 
the ligand, but still novel or intriguing to study. Phage enrichment described by Mullen 
(2007) and previously discussed in this chapter refers to enrichment of a particular phage 
containing a particular fusion protein, however it seems unlikely that enrichment of a single 
fusion protein would occur from a metagenomic library using only 3 panning rounds. 
3.  Frameshifting: Commonly,  inserts identified through panning are  not in frame  with the 
pG8H6 vector sequence (Jacobsson et al., 1995; Jacobsson & Frykberg, 1996; Carcamo et 
al., 1998). It appears there is a selection for inserts out of frame (usually frame +1 or -1) 
and ribosomal slippage corrects the frameshift during translation. It was for this reason the 
pG8H6  vector  was  constructed  with  the  poly-His  tag  in  front  of  the  insert  sequence 
(Jacobsson and Frykberg, 1996) and a stretch of 5 adenosines in the c-Myc tag, which 
should have resulted in fusions in frame. However, by selecting an out-of-frame fusion, the 
phage  display  system  can  mediate  fusion  protein  expression  levels  by  frameshifting  to 
downregulate expression. This means that expression does not always remain high enough 
for display at the phage surface (Jacobsson et al., 2003) meaning the expression levels of 
some proteins are too low to enable binding or detection (Jacobsson & Frykberg, 1998). Chapter 4: Panning & Antibody Screening 
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This is why it is common to see a high titre of bound phage following the first round of 
panning, and a lower titre in the second round; the system has introduced a frameshift to 
allow the production of viable phage which may have reduced expression levels such that 
these fusion proteins are no longer affinity-selectable (Jacobsson & Frykberg, 1996). 
4.  Using two panning temperatures: Incubations and washes are normally carried out at 22°C 
as cooler temperatures could prevent dissociation of the bound phage (Woiwode et al., 
2003). The hypothesis was that using a panning temperature closer to that of the human 
body would identify a range of proteins which are normally produced at that temperature. It 
was hoped that two distinct groups of binding proteins would be found, with perhaps more 
identified  closer to body temperature than 22°C. This may still be a useful  experiment 
when  panning  a  library  produced  from  a  single  species,  however,  no  distinction  was 
observed in the bound proteins between the two panning temperatures in this project. This 
is probably due to the diversity of the library and also that the number of clones picked out 
for analysis was too small to provide sufficient data for conjecture on content of the entire 
library.  
5.  Valency of display: This point relates to the number of times the fusion protein appears on 
the phage surface and  is important because of its  impact on the ability to  discriminate 
binding  proteins  with  varying  affinity  for  the  ligand.  Polyvalent  display  allows  the 
expression of multiple fusion proteins on coat protein 8 which, along with high affinity 
proteins (strength of a single bond), allows weaker binding clones to be identified where 
polyvalency  causes  a  strong  interaction  (high  avidity  –  combined  strength  of  multiple 
bonds). In contrast, phage display using phage coat protein 3 allows between 1 - 5 fusions 
per phagemid, so selection is based purely on affinity and is mainly used in studies where 
only the tightest binding variants are required (Russell et al, 2004). Currently, it is not 
known how  many fusions appear per phage  or how  much that number  differs between 
phage populations or within the same phage population. 
Of the 5 points above, choice of ligand is the principal factor in dictating the binding 
proteins recovered from the panning process. Both FN and IgA are known to interact with 
bacteria by binding to them or being bound by them. They are very different ligands in terms of 
structure,  size  and  purpose,  and  it  was  hoped  that  this  variety  of  function  would  facilitate 
identification of a range of binding proteins.  
As well as using BSA as blocking agent in the FN and IgA panning experiments, BSA 
was used as a control for checking protein binding between panning experiments. However, the 
tertiary  structure  of  BSA  is  similar  to  Human  Serum  Albumin  (HSA)  (Geisow  &  Beaven, 
1977) and, because many bacterial proteins bound to it, panning against BSA acted less like a 
control  and  more  like  a  separate  panning  experiment.  In  plasma,  HSA  is  one  of  the  most Chapter 4: Panning & Antibody Screening 
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dominant proteins, along with immunoglobulins (Ig) (Johansson et al., 2001), and this has led 
to the isolation of proteins that specifically bind albumin by several bacterial phylotypes such 
as Streptococcus pyogenes (Frick et al., 1994). The use of BSA in panning is discussed in more 
detail in Chapter 8.  
 
Antibody screening  
  Antibody screening was used to rapidly eliminate phagemid displaying fusion proteins 
which contained stop codons and therefore were not in frame with the vector. The resulting 
fusion proteins should therefore have been uninterrupted with a true binding affinity which 
could be studied further in individual analyses. Ending up with 17 clones out of 300 analysed 
fits with Jacobssons’ statement that only 1 in 18 clones will be in the correct orientation and in 
frame however, the presence of both tags on a clone clearly was not indicative of a legitimate 
binding protein. Out of the 148 clones displaying both tags, many seemed not to contain a 
legitimate ORF at all, even though they had been enriched through 3 rounds of panning and 
displayed the tag indicating fusion to protein 8. Looking back at Table 1, at the very first 
analysis  of  the  panning  eluate,  13  clones  satisfied  all  the  requirements  shown  in  Table  2. 
Following  at  least  6  weeks  of  phage  supernatant  precipitation  and  antibody  screening,  17 
additional clones met the same requirements.  
Aside  from  identifying  potential  positive  clones  for  individual  analysis,  antibody 
screening could also indicate how efficient the phage are at producing fusion proteins, a more 
intense  colour  meaning  more  tags,  i.e.  more  protein.  It  was  decided  to  use  5  µl  of  phage 
supernatant  for  the  antibody  screening  experiment;  however  this  volume  would  not  have 
contained equal numbers of phage particles, or the same number of fusion proteins per phage 
since these features depend on the phage population. It is difficult to quantify the amount of 
fusion protein produced by a phage simply by making an objective decision based on a colour 
change. This is made more difficult by the potential of each individual phage particle to display 
a different number of fusion proteins (increased avidity), which depend on how well the fusion 
becomes incorporated into the phage coat and its behaviour on the phage surface. 
  Frameshifting is frequently mentioned as an issue by other groups using phage display 
(Carcamo et al., 1998; Jacobsson et al., 2003), and the enduring presence of stop codons in the 
coding sequence was very common in this project. In many instances, the DNA sequences of 
the peptide encoding genes alone were sufficient to draw some conclusions regarding the types 
of organisms in the sample. However, this project intended to use some individual proteins for 
expression and eliminating those containing stop codons left few clones with which to take the 
planned individual analysis forward. Chapter 4: Panning & Antibody Screening 
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In order to still be present following 3 rounds of panning, the clones containing stop 
codons  must  have  had  some  binding  capacity  and,  until  sequencing,  they  appeared  to  be 
legitimate binding proteins. Much time was wasted during the analysis of these clones in order 
to reach a sufficient amount to take forward to pET vector expression. 
From the antibody screening data (Figure 6, Figure 7 and Figure 8) it is quite clear 
that  most  of  the  BSA-binding  clones  should  express  both  tags,  where  FN-binding  clones 
contain fewer and IgA-binding clones contain fewer again. Diminishing tag presence may be 
due to the insert size where, as in the BSA-binding clones, smaller fusion proteins facilitate 
expression  and  display  of  both  tags  in  concert,  which  could  be  due  to  smaller  proteins 
containing fewer stop codons. Larger proteins like those more commonly found binding to FN 
or IgA, with bulky folding domains could block the tag, negating detection.  
In  Table  2, the  17  successful  clones  resulting  from  antibody  screening  are  clearly 
outnumbered compared to the 55 clones which were smaller than 50 amino acids (column d). 
As expected, the phagemid system preferentially expresses proteins which are smaller than 50 
amino acids, and because the largest proteins were the priority of this study it is likely that 
some interesting small proteins have been completely bypassed. In particular, some FN binding 
proteins are known to share a similar repeated modular architecture to the FN molecule, and 
some of these repeated domains are around 40 – 50 amino acids in size. Binding proteins like 
these could be among the 55 small proteins found. 
Because there is no power over which fragments are cloned into the phagemid vector 
during metagenomic library construction, there were probably millions of ‘decoy’ sequences in 
the wrong frame and containing multiple stop codons present in the library prior to panning. 
Gene 8 was used for fusion in this project because the polyvalent aspect of display should have 
resulted  in  selection  of  weaker  binding  interactions  (high  avidity)  as  well  as  strong  (high 
affinity).  There  is  a  possibility  that  it  resulted  in  many  non-specific  interactions  being 
mistakenly analysed through  high avidity  clones. Individual proteins are  discussed  in  more 
detail in Chapter 5. 
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Introduction 
  As described in Chapter 4, antibody screening and in silico analysis of a selection 
of recombinant  clones,  affinity purified through 3 rounds of panning,  led to the  final 
shortlisting of 18 proteins. These 18 clones resulted in the translation of novel/interesting 
proteins that bacteria may use to facilitate binding to the human tongue dorsum. This 
chapter  looks  at  the  final  18  in  more  detail,  and  discusses  plans  for  their  analysis 
according to size and ‘interest value’, i.e. if the insert coded for a previously unidentified 
protein. Larger inserts, likely to contain more of the gene of interest, were thought likely 
to retain folding and binding properties similar to the full length protein, and these were 
prioritised in the list (Table 1).  
  One of the targets of this project was to express one or more of these 18 proteins 
using  the  pET  vector  expression  system.  Successful  expression  was  to  be  followed  by 
periplasmic  extraction,  and  then  individual  assessment  to  check  binding  affinity  for 
panning ligands, along with other traits. With 18 potential proteins and the likelihood of a 
huge  time  investment,  clones  were  taken  forward  in  order,  the  largest  and  most 
interesting  first.  This  chapter  describes  the  18  shortlisted  clones  in  more  detail  and 
outlines the pET expression studies and the subsequent  adhesion assays which became 
necessary following continuous pET expression failure. 
 
Final 18 Clones      
  A list of 18 clones identified from panning a metagenomic phage display library was 
compiled in order of priority, based on apparent interest and the size of the protein product. 
This list is shown in Table 1. The 18 shortlisted proteins were found to contain homology to 
some interesting proteins in the NCBI BLAST database, regardless of the species level match. 
Certain putative proteins were more interesting than others, for example number 36 shows very 
low  identity  (52%)  to  an  outer  membrane  transport  protein,  or  number  42  shows  some 
homology  to  a  pili  biogenesis  protein.  These  are  exactly  the  types  of  proteins  that  were 
expected from the phage display/panning process; likely to be oriented on the bacterial cell 
surface where they could potentially act as receptors for human cells or salivary components. 
  Certain types of bacteria and adhesins were expected to result from this metagenomic 
analysis  of  the  tongue  surface.  Due  to  the  high  concentration  of  S-IgA  in  the  oral  cavity 
(Scannapieco et al., 1994), organisms encoding IgA proteases, common colonisers of human 
mucus  membranes,  would  certainly  be  expected.  These  include  Prevotella  sp.,  several 
Neisseria sp., and some Streptococcus sp., including pneumoniae, sanguinis, oralis and mitis, 
all  commonly  found  in  the  oral  cavity  (Kilian,  2003)  and  present  in  this  study.   
 
Clone 
Number 
Binding 
Ligand 
Tag 
presence 
 
tBLASTx result 
 
Protein sequence 
36  BSA  BOTH  A. pleuropneumoniae OM receptor protein  
(Fe transport) E=7e-21, id=45/85 (52%) 
LIFLLGLDAPLTDIWKIGNNISTGFRNPTASEMYFSFEHPAGNWIPN
PDLKAEQALNQSIYIQAEHLLGSFGLTFYHTRYKNLLTEQESTYKK
RNPYYNAYSASYGQQGVQVD 
59  IgA  n/a
1  F. nucleatum chloride channel protein 
E=2e-46, id= 99/100 (99%) 
LILGRINYNNWFFELLAKFFAGVLGIGAGLSLGREGPSVQLGSYVG
YGASKILKTDTVERNYLLTSGSSAGLSGAFGAPLAGVMFSIEEIHK
YLSGKLLI 
1  IgA  BOTH  A. odontolyticus hypothetical protein  
E=1e-29, id= 62/62 (100%) 
PLLVLLVDPIVSGGNASEADAGHEIAARVWRVGSDLTAGVDVPAP
GTQVGLAPEIACGHCAPCTSGRSNVCANMRLFGTGVDG 
39  IgA  n/a
2  G. kaustophilus twitching motility protein 
Expect = 0.001, Id = 17/27 (62%) 
 
VMAVHRMISLFPGEQQEEIRSQISQVLRAVICQRLLRWNKKFITIRD
ILLNTHAVANLIRTRKEPQIISIQETQLPMKTLEMGVQVD 
42  IgA  n/a
2  N. meningitides FtsK DNA translocase 
E=1e-16, id=48/85 (56%) 
LYLMTAKSSKTQTKKRASTKPAAKPTTRKSAKTQTQADNKVSQR
LKAAKELQKNEEKKARPEHVVNLINDALWLFGLVITIYLGVQVD 
58  IgA  n/a
1  S. usitatus radical SAM domain protein 
E=3e-14, id=35/97 (36%) 
STLMIGMETDTVESIRQIPDIIEEIGVDVPRYNILTPYPGTPFYEQLK
AENRLLTRDWYYYDTETVVFQPKNMSPATLQEEFYKLWQDTFTY
KRIFK 
44  FN  n/a
2  Rothia sp. Aspartate/ornithine binding domain 
E=1e-13, id=32/39 (82%) 
PHTVSASADNNALMTCWSRERIKSGDAWDNASPSRPPESDSGWRC
ASSVKSNDASIVRVRCSSARLVESSTSSNTLSRK 
52  FN  n/a
2  A. metalliredigens IM component 
E=2e-09, id=29/74 (39%)   
IGIVKGGLAGFSTPSIDRWLSRLIDLVLGFPNMVIAIAFIGIMGPSITN
VIISLCITKWAEYALITRGLVVVEKVFYRH Chapter 5: Individual Protein Analysis 
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22  FN  BOTH  N. meningitides hypothetical protein 
E=4e-10, id=39/72 (54%) 
AEAGHIEAAFQLAGCLFENHENEQDLAIAVEYLKQAARAGHPYAR
YNLLQLQENNGAEVETLISAYQELAEEGLVP 
30  BSA  BOTH  A. odontolyticus hypothetical protein 
E=0.012, id=18/29 (65%) 
ERRRMAEYLASPQGYDHVMHVVRARFMAGNYYDLCAGVCRDFA
NTVGNFNIDRGVADGHWTRPTRRRRHGIGLGLGVQVD 
60  IgA  n/a
1  S. mutans putative ABC transporter  VILGLIFFLDTRLGQAYIATGDNSDMAKSFGINTDRMELMGLVISN
GIIALSGALMAQQE GYADASRGIGVIV 
17  FN  c-myc  C.  botulinum  PstC,  ABC-type  phosphate  transport 
system. E=2e-08, id= 33/63 (52%) 
YIISASLYVSLLSLIWALPLGIGTSVGLSLGVSPRIRQFCLSTIDMIAG
IPSVIVGFIGLAVVVP 
19  FN  BOTH  A. odontolyticus hypothetical protein 
E=4e-27, id= 55/63 (87%) 
KSWNFQDAGIGMAAINAYHSHPEVALARGFTPCEENNWARTFHP
YAPLVAGKRVAIIGHFPFAGVQVD 
20  FN  BOTH  A. odontolyticus hypothetical protein 
E=3e-22, id= 50/53 (94%) 
LGVENLYEAANTPLIGFLNNAIRAKELFFRDRDYIVDAGEILIVDEH
TGRVLP 
27  BSA  BOTH  No similarity  EGTPPENRDGTCRVLVLPRVQPPAGRLHGRQWLHEGRRGFFLGVR
VSEKARTRKATR 
2  IgA  BOTH  P. gingivalis glycogen synthase 
E=4e-10, 
RSIAGNDKELYTYMDAYDGDQMARELGVEAKHEVEKLAAHKAR
TVMPAALPVIASAPAGVQVD 
16  FN  c-myc  H. influenzae PP-loop superfamily ATPase 
E=1e-18, id= 47/57 (82%) 
QRHAIELEKARWIAKDLGVKQTLIDTSVIKSITHNALMDANADIEQ
KDGELPNTFVD 
11  FN  BOTH  B. fragilis Fe-S-cluster redox enzyme 
E=1e-08, id= 28/51 (54%) 
LNLLELKAVAKEFGMPAFTGGQMAKWLYIQHVTTIDEMTNISKNN
REKLKA 
Table 1 Table of 18 clones identified from panning experiments against the ligands IgA, Fibronectin or BSA, following 3 rounds of affinity selection. Alongside the clone 
number is information regarding the panning ligand where affinity was shown and the presence or absence of the Poly-His or c-Myc tags. Data from tBLASTx searches are 
shown and the resulting protein product as identified from the search database. BLAST searches are accurate as of 25
th June 2009. 
1 No tag data is available for these clones because they resulted from a parallel project to the present thesis, supervised by the author, and have been included in this study. 
2 No tag data is available for these clones as they resulted from panning experiments carried out prior to antibody screening. 
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In general, IgA binding proteins of streptococci belong to the M protein family, and 
are dimeric coiled-coil molecules that can bind more than one Ig at a time. IgA binding proteins 
bind to various parts of S-IgA, but some bind to the Fc part of human IgA and are particularly 
expressed by pathogenic bacteria, mostly G+ves. Although not all IgA binding proteins are 
related, some regions have been identified that bind to IgA including the Sir22 binding protein 
(Johnsson et al., 1999) and Arp4 (Johnsson  et al., 1994), which both contain a 29 residue 
binding region. None of the putative IgA binding proteins identified from this study included 
this binding region. IgA proteases cleave IgA1 at the hinge region leaving the Fab fragments 
free to be bound by other bacteria, commonly seen in plaque bacteria, which enables them to 
evade the host immune response. Several Streptococcus sp. express surface proteins which bind 
IgA molecules in an antibody-independent manner, i.e., through the secretory component (SC) 
(Kilian, 2003), for example the protein SpsA of S. pneumoniae that binds SC is expressed by 
2/3 of strains and is conserved between serotypes (Hammerschmidt et al., 1997). None of the 
proteins  identified  from  the  IgA  panning  eluate  showed  any  homology  through  the  NCBI 
database to IgA binding proteins. The Fc part of human IgA also binds commonly to Group A 
Streptococci, and the IgA binding proteins which facilitate interaction are members of the M-
protein family (Johnsson et al., 1999).  
  The oral colonising streptococci are well known for their adhesion properties to the 
extracellular matrix (ECM) and in particular fibronectin (FN), a major component of the tongue 
dorsum which is also present in soluble form in saliva. FN-binding proteins from the shortlisted 
18  proteins  would  also  be  expected  to  share  similar  characteristics  to  known  FN-binding 
proteins. The best-characterized FN-binding proteins from streptococci and staphylococci share 
a similar mosaic architecture (similar, in fact, to FN), the ligand-binding domain consisting of 
tandem repeats of a 45 amino acid long unit which binds to the 29-kDa N-terminal region of 
FN (Joh et al., 1999). In fact, a recently described adhesin of Campylobacter jejuni, named 
fibronectin-like protein A contains fibronectin type III domains (Flanagan et al., 2009).These 
cell surface proteins possess an N-terminal signal peptide for sec-dependent secretion and an 
LPXTG  C-terminal  motif  for  covalent  anchorage  to  cell-wall  peptidoglycan  (Navarre  & 
Schneewind,  1999).  Of  the  8  putative  FN  binding  proteins  identified  from  this  study,  all 
contained an N-terminal signal peptide according to the SignalP search tool from expasy tools 
(www.expasy.ch/tools/).  None  however,  contained  the  LPXTG  C-terminal  motif  within  the 
length of the protein sequence, which is probably because the full length gene was cut short by 
the phage display library construction process. Again, none of the proteins investigated from 
the  FN  panning  eluate  showed  any  homology  to  known  FN  binding  proteins,  however,  as 
previously mentioned, phage display does not operate without bias and, for whatever reason, 
either the known FN binding proteins were not represented in the library at all, or were not in 
the small number of clones analysed.  Chapter 5: Individual Protein Analysis 
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  Known albumin binding proteins have been found to express a conserved 45 aa stretch 
within a 52 aa region (Jacobsson  et al., 1997), which is homologous with albumin binding 
modules found in other bacterial cell surface proteins. Again, none of the 18 proteins shortlisted 
from the panning experiments detailed in previous chapters showed any identity to this region.  
 
pET Expression  
  A wide variety of pET vectors are available, all derived from the commonly used E. 
coli cloning vector pBR322. The vector used in this project is pET 21b, a transcription vector 
which expresses target RNA and provides translation signals. The main reason for choosing 
pET  21b  is  because  it  has  an  expanded  multiple  cloning  site  in  all  three  reading  frames, 
allowing the inserts of interest to be cloned in by precise primer design to match the reading 
frame required for expression. 
Before cloning the DNA fragment of interest into pET21b for expression, each insert 
required  PCR amplification,  involving  the  design  of  individual  primers  for  each  of  the  18 
clones.  The  primers  were  designed  to  lift  out  the  insert  from  the  phagemid  vector  pG8H6 
complete with restriction enzyme sites needed for easy cloning and expression into the pET 
vector expression system. Figure 1 illustrates the main features of the pG8H6 phagemid vector 
and how the primers were designed to facilitate cloning into pET. 
PCR amplification was performed in 0.5 µl Eppendorf tubes in a total reaction volume 
of 50  l.  Reactions comprised 1  l template DNA (phagemid containing insert preparation), 2 
l of 5  M each oligonucleotide primer and 45  l PCR supermix. All reactions were prepared 
on ice. The PCR was performed for 30 cycles of 95 C, 5 minutes (1st cycle only) 95 C, 30 s; 
54 - 68 C, 30 s; 70 C, 60 seconds; 70 C, 5 minutes (last cycle only), using a Techne TC-512 
gradient thermal cycler. The PCR product was quality and size checked using 1% agarose gel 
electrophoresis.  All  inserts  were  successfully  PCR  amplified,  with  the  exception  of  clone 
number 58 which, despite several attempts, was not amplified. In the interest of time, clone 58 
was left aside. 
In the following stages, clones were taken forward in more manageable groups of 4. In 
the interest of simplicity, inserts were cloned first into TOPO TA (Invitrogen) with the aim of 
using the introduced NdeI and XhoI sites from PCR amplification to ease cloning into pET21b. 
However, the following problems were  encountered  with  cloning into TOPO:  i. ligation  of 
amplified insert into TOPO TA was not successful, (and this stage was not able to be checked 
on a gel due to the tiny volume of vector present), and/or; ii. transformation of ligation was not 
successful (no colonies present on kanamycin agar plates). If ligation and transformation were 
both successful then TOPO clones containing the insert were grown up individually in nutrientChapter 5: Individual Protein Analysis 
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broth and a high concentration plasmid preparation (Qiagen Plasmid Prep Kit) was digested 
with  restriction  enzymes  NdeI  and  XhoI  before  quality  checking  on  a  1%  agarose  gel  and 
extracting the insert using Qiagen Gel Extraction Kit. Several issues were encountered at this 
stage including; iii. unsuccessful restriction digest (not able to be checked until a 1% agarose 
gel was run); iv. there was not enough insert DNA to set up a ligation following gel extraction. 
 If  the  restriction  digest  was  successful,  and  recovery  from  gel  extraction  gave  an 
adequate concentration of insert to set up ligations, then the insert was cloned into pET21b 
(pre-digested with NdeI and XhoI – another stage which could not be quality checked) and 
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TCAGAAGAGGATCTGAATGGGGCCGCATAGAAGCTTGAGGGTGACGATCCCGCA-- 
HindIIi 
tag 
TTGTTATTACTCGCGGCCCAGCCGGCCATGGCCCAGGTGCAGCTGCAGCACCACCACCACCA 
SfiI                   NcoI  PstI 
PelB leader  P o l y l i n k e r  w I t h 
 L    L     L     L      A     A     Q     P     A      M     A     Q     V     Q     L     Q     H    H     H     H     H    
CCACCCCGGGTGCAGGTCGACCTCGAGATCAAACGGGCGGCCGCAGAACAAAAACTCATC 
SmaI  SalI       XhoI  NotI 
h i s t i d i n e  t a i l  c-myc 
    H        P    
                       V     Q     V     D      L     E      I      K     R     A     A     A     E     Q     K     L       I 
    S     E     E     D     L      N      G     A      A     -      K     L      E     G     D     D     P     A      
Figure 1 Schematic drawing of the phagemid pG8H6 showing main features and sequence of cloning 
site used for primer design. Individual primers were made for each clone at the N terminal end of the 
insert, keeping the protein product in frame once expressed and incorporating an NdeI site. From the 
C- terminal end of the insert, a universal primer was designed which spans the XhoI site, in the same 
frame for cloning into pET21b. Yellow highlighted area is SmaI restriction site used for cloning 
insert sequences. Green highlighted area illustrates the sequence which was used as the universal 
primer incorporating XhoI site. 
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transformed  into  electrocompetent  BL-21  E.  coli  cells.  Problems  at  this  stage  were;  v. 
unsuccessful ligation and/or; vi. unsuccessful transformation. Due to these issues, none of the 
remaining 18 clones were able to be expressed using the pET expression system in this project. 
Apart from the problems mentioned, expression cloning in E. coli gives accessibility to fewer 
proteins than originally thought since many expression signals do not function in this organism 
(Gabor et al., 2004).  
The problems encountered with pET vector expression may turn out to be more easily 
solved than initially thought. Phage display fuses inserted proteins with a structural protein 
which provides support to the fusion protein (protein 8), which may in some cases, enable 
folding of the fusion into its native state. pET vector expression linearises the peptide insert 
into a plasmid with no flexibility, and relys on the proteins ability to fold completely by itself 
upon expression. This may not be a suitable method of expression for small(ish) proteins like 
those in the final 18. An alternative might have been glutathione-S-transferase (GST) fusions, 
another  IPTG-inducible  expression  vector,  because  of  its  large  tag  (26kDa)  and  the  GST-
fusions high affinity for glutathione.  
 
Adhesion assays 
  Due  to  the  persistent  problems  with  pET  expression,  and  the  necessity  of  proving 
binding of at least some of the panning clones to their respective ligands in the time remaining 
for the project,  it  was decided to use adhesion assays, used previously  with phage  display 
libraries constructed from 4 members of the Pasteurellaceae by Mullen at the Eastman Dental 
Institute (Mullen et al., 2007). Mullen used adhesion assays with success against 10 different 
ligands  to  quantify  the  affinity  of  certain  fusion  proteins  for  specific  ligands.  Those 
recombinants with the strongest affinity for a ligand bound in numbers exceeding 25,000 phage 
per well. Those ligands which did not demonstrate affinity bound in numbers of around 100 
bound phage per well. One of the most exciting aspects of adhesion assays is that, as in the 
Mullen  study,  recombinants  can  be  tested  against  similar  ligands  to  determine  binding 
specificity.  For  example,  the  recombinants  identified  from  panning  against  FN  were  tested 
more thoroughly by Mullen against the 30 kDa, 45 kDa and 110 kDa fragments of FN, as well 
as the whole molecule (~440 kDa), and similar molecules such as fibrinogen. Such experiments 
provide a great deal of additional information about fusion proteins which have not yet been 
characterised and could provide useful information in the present study, for example, on the 
high number of recombinants showing affinity to IgA which could also be tested for affinity to 
IgG and other immune factors. 
  The  purpose  of  adhesion  assays  is  that  upon  incubating  a  pure  sample  of  phage 
displaying the fusion proteins of interest with a variety of separate ligands, obvious and strong Chapter 5: Individual Protein Analysis 
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affinity should be shown to one in particular (preferably the ligand identified from the panning 
process). Indeed, the adhesion assay procedure is very similar to that of panning. Briefly, Nunc 
Immunoplates were coated with 100µl 0.1 mg/ml ligand and left to bind overnight. Following 
removal of the ligand and thorough washing a phage population were added (1 x 10
9 per well) 
and left to bind to the immobilized ligand for 90 minutes. Following excess phage removal and 
thorough washing steps, the bound phage – still infective – were eluted and used to infect E. 
coli,  then  equal  volumes  plated  onto  selective  agar.  Counting  colonies  resulting  from  the 
adhesion assays gave an indication of binding affinity to the ligands chosen; in this project IgA, 
FN and BSA. Adhesion assays were carried out as follows: Nunc Maxisorp plates coated with 
immobilized ligand were thoroughly rinsed and 100 µl of 1 x 10
9 recovered phage was added. 
After incubation and rinsing, bound phage were eluted in low pH glycine buffer and diluted for 
adding to log phase E. coli. Infections were incubated for 30 minutes before plating on NB2 
agar  containing  ampicillin  and  bound  phage  per  well  calculated  from  colonies  following 
overnight growth. 
  The adhesion assay process was not as straightforward as initially imagined. Firstly, 
each  clone  population  required  transformation,  conversion  to  phage,  amplification,  PEG 
precipitation  and  recovery  in  order  to  reach  an  adequate  volume  of  fusion  phage  at  high 
concentration. From the list of 18 clones, 30, 39, 44 and 59 were amplified and recovered to 1 x 
10
11 CFU, then diluted to a concentration of 1 x 10
9 CFU required for adhesion assays. Other 
clones 36, 1, 42 and 58 either did not transform well, or were unsuccessful at the conversion 
stage. Additionally, no blocking agent was used in the first or second adhesion assay; under 
normal circumstances BSA would be used, however some interesting clones from the panning 
experiment bound to BSA so it was decided to use it as one of the ligands for study, instead of 
the control it was intended as. The inclusion of a blocking agent is discussed later. 
  In the first adhesion assay all agar plates (showing bound phage per well) showed the 
same number of colonies for all ligands and all dilutions. This was caused by E. coli cells 
which developed ampicillin resistance, which happened in the first adhesion assay and again in 
the second. There seemed to be no obvious explanation for this resistance, since the E. coli 
cells used were isolated from an ampicillin sensitive stock which had been used previously in 
multiple experiments and all aliquots stored at -80°C. 
  Recognising continuity issues but in order to carry out a repeat experiment in the short 
time remaining, strain JM107 (also F’) was swapped for ampicillin sensitive E. coli TG1 cells 
for phagemid infection. At least one clone identified from each panning ligand was tested in the 
adhesion assays alongside the empty phagemid vector pG8H6 as a control. Using the above 
protocol and the 4 phage supernatants 30, 44, 59 and 39, the results are summarised in the 
following figures; Figure 3, Figure 4, Figure 5 and Figure 6, with the control results shown in  Chapter 5: Individual Protein Analysis 
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Figure 2 Adhesion assay results from control experiment. The phagemid pG8H6 with no insert was 
used to test basal binding levels to each ligand; IgA, FN and BSA. For each ligand experiments 
were carried out in triplicate, numbered 1, 2 and 3 on the chart. For ease of comparison, bound 
phage per control well are presented in thousands (main picture) and also in hundreds (in box), 
due to the low control numbers. The number of bound phage per well is calculated from plating 
neat and 10x diluted samples onto NB2 agar + ampicillin. 
 
Figure 2. 
  Figure 2 shows the adhesion assay control results. All the following figures use the 
same scale (bound phage per well in thousands), however because the control results were low, 
it was thought appropriate to also present them on a scale showing bound phage in hundreds. 
From the figure it is clear that basal binding of filamentous phage without fusion proteins is 
very low, although the interaction of phage with the ligand FN was a little above the average. 
Taking an average of these control figures shows basal IgA binding at 320 bound phage per 
well, FN binding at 550 and BSA binding at 160 bound phage per well. These figures were 
averaged because the three experiments showed similar numerical results. This was not the case 
in some of the other adhesion assays discussed over the remainder of this chapter. 
  Figure 3 shows the results of testing the binding levels of clone 30 to the 3 ligands 
used in adhesion assays; IgA, FN and BSA. Because clone 30 was originally identified binding 
to BSA in the panning experiments (Chapter 4), it was expected to bind preferentially to BSA 
in this experiment.  
  From Figure 3, the highest number from the BSA wells (BSA 1) is almost 8 times 
higher than the other 2 wells, which both show a similar binding affinity to each other, slightly 
higher than that of clone 30 for FN. The obvious outlier in this case is BSA1 with almost 9000 
bound phage per well. Disregarding BSA1 for the moment and taking only BSA2 and BSA3  
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Figure 3 Adhesion assay results with clone 30. Binding levels of clone 30 was tested against each 
ligand; IgA, FN and BSA. For each ligand experiments were carried out in triplicate, numbered 1, 
2 and 3 on the chart. The number of bound phage per well is calculated from plating neat and 10x 
diluted samples onto NB2 agar + ampicillin. 
 
 
into consideration, one could say that clone 30 binds better to BSA than to either IgA or FN, 
and that clone 30 clearly binds better than the control which had an average of 160 bound 
phage per well compared to a minimum of 800 in experiment BSA 3. These numbers may not 
prove  that  clone  30  is  a  BSA  binding  protein  but  they  do  strengthen  the  case  for  further 
investigation of this clones specific binding capacity. 
The aberrant numbers of binding clones, such as that seen in BSA1 in Figure 3, could 
be  due  to  the  tendency  of  phage  to  aggregate  in  high  numbers.  Filamentous  phage  are 
extremely long and thin, and these hair-like structures can align closely in a linear fashion, 
groups of which could easily be picked up with a pipette and end up in one of the experimental 
wells. Combined with the sensitive titre method used to detect even low phage numbers, this 
could easily result in some quantitative errors. The structure of FN could also explain why 
filamentous phage appear to ‘stick’ to it. FN has already been discussed in Chapter 1 as a well 
known ligand for bacterial adhesion. This large, multi-domain protein is made up of 29-31 
modules of 3 types of molecules stacked end to end, and is well placed to act as a ligand for all 
sorts of interactions. For this reason, adding these long structures, FN and filamentous phage, 
together, even if binding does not take place there could still be a degree of entrapment evident 
in the experimental numbers, and this is what is believed to be the cause of the elevated control 
numbers to FN. This experiment should be repeated with some minor variations to reduce or 
prevent phage aggregation, which are discussed at the end of this chapter; however there was 
no time to make these amendments within the timeframe of this project.  
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Clone number 44, which contained a putative FN-binding protein (Figure 4), bound in 
similar numbers to IgA (average ~ 450 bound phage per  well) and BSA (average ~ 400). 
Again, there is a very high figure (FN2) in the experimental numbers, although the difference 
between highest and lowest is not as much as noted previously in Figure 3. If the experiment 
FN2 is discounted clone 44 would then appear to bind all 3 ligands in quite similar numbers. 
When compared with control results, clone 44 does not appear to bind FN or BSA any better 
than the control did, but does appear to bind IgA twice as strongly as the empty vector, and this 
potential  binding  affinity  could  be  investigated  further  with  additional  adhesion  assays 
incorporating changes discussed later. 
 
 
Figure 4 Adhesion assay results with clone 44. Binding levels of clone 44 was tested against each 
ligand; IgA, FN and BSA. For each ligand experiments were carried out in triplicate, numbered 1, 
2 and 3 on the chart. The number of bound phage per well is calculated from plating neat and 10x 
diluted samples onto NB2 agar + ampicillin. 
   
  Fusion proteins displayed on the phage surface that do not bind back to the respective 
ligand  in  adhesion  assays  can  be  explained  like  this:  phage  enrichment  takes  place  on  the 
promise that bound phage will remain bound during the washing process of panning prior to 
phage elution. Phage that are specifically bound, but not tightly bound (perhaps through low 
affinity  for  the  ligand,  a  low  expression  level,  or  a low  number  of  fusion  proteins  on  the 
surface) will be removed during the washing steps, leaving phage which may not be bound 
through a specific interaction but which are bound to the ligand through the presence of many 
fusions on the phage surface (avidity effect).  
Clones 39 and 59 were both identified from IgA panning experiments and show very 
high identity to proteins from organisms normally resident in the oral cavity; Veillonella dispar 
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(96%) and  Fusobacterium nucleatum (99%) respectively (Table 2). However, the adhesion 
assays showed that perhaps the binding affinity of clone 39 was not as strong as its recovery 
from the third round of panning suggested (Figure 5).  
 
 
 
Figure 5 Adhesion assay results with clone 39. Binding levels of clone 39 was tested against each 
ligand; IgA, FN and BSA. For each ligand experiments were carried out in triplicate, numbered 1, 
2 and 3 on the chart. The number of bound phage per well is calculated from plating neat and 10x 
diluted samples onto NB2 agar + ampicillin. 
 
  Clone 39 bound to IgA in very similar numbers (average ~ 350 bound phage per well) 
as the control pG8H6 to IgA (average ~ 250), indicating no real binding affinity for IgA at all. 
Although there is an instance of apparently strong binding to FN1, as previously discussed, this 
is more likely to be due to phage aggregation, since the other two FN wells showed consistently 
low binding affinity. BSA and FN (excluding FN1) binding numbers for clone 39 are on a par 
with those in the control experiment so it appears that clone 39 binds no better than the control 
to any of the ligands.  
In contrast, clone 59 (Figure 6) bound to FN, BSA and the control pG8H6 in very 
similar numbers, but importantly, bound in consistently higher numbers to IgA. In order to 
show the binding of clone 59 more clearly, bound phage per well have also been presented on a 
hundred scale. This experiment is interesting because the average bound phage to the FN wells 
is slightly lower than in the control experiment, and bound phage to IgA wells is almost 3 times 
higher than the control results (average of 800 bound phage per well compared to 320). The 
consistency of the results for this experiment also makes them seem more believable as there  
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Figure 6 Adhesion assay results with clone 59. Binding levels of clone 59 was tested against each 
ligand; IgA, FN and BSA. For each ligand experiments were carried out in triplicate, numbered 1, 
2 and 3 on the chart. The number of bound phage per well is the average calculated from neat and 
10x diluted samples onto NB2 agar + ampicillin. 
 
 
are no extreme figures present to skew the results. For these reasons, clone 59 is the most 
reasonable suggestion for closer analysis of binding affinity. A closer analysis of clone 59 was 
carried out using SignalP of expasy tools to search for a signal sequence, and an InterProScan 
search of the protein sequence to identify any conserved topological domains (Figure 7). The 
SignalP program identified a predicted signal peptide (probability 0.991) for cleavage at amino 
acid  residue  9.  The  InterProScan  analysis  located  the  signal  sequence  along  with  one 
transmembrane domain and a chloride channel protein. The InterProScan analysis for all 18 
clones is in Appendix 8. 
 
 
 
 
Figure 7 InterProScan result from analysis of the protein sequence of clone number 59. 
 
 
Even though all the adhesion assays were performed in triplicate, at the same time 
using the same buffers, the presence of outlying experimental numbers did plant seeds of doubt 
that the results could be fully trusted. On the  other hand some affinity clearly  was shown, 
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especially in the cases of clone 30 and clone 59, for the ligands which identified them in the 
panning  experiments,  and  these  clones  could  be  investigated  more  thoroughly  for  binding 
affinity and specificity. Clone 39 would possibly be best left aside as it appears not to show 
affinity to IgA however clone 44 could be tested for affinity to IgA, instead of FN. 
In cases  where there are aberrant numbers  of bound phage per  well, this  could be 
remedied by a variety of approaches. Firstly, fewer phage could be applied to the well; a lower 
phage titre means that there is less opportunity for aggregation, and this alteration alone could 
give more consistent results. Secondly, adding more Tween-20 to the buffer used for phage 
dilution could help to disperse some of the phage aggregates already present and prevent others 
forming. A similar approach is to use a higher concentration of salt in the dilution buffer to 
prevent and disperse phage aggregates.  
The value of using monovalent phage has already been discussed (Chapter 4) as having 
only  one  fusion  protein  on  the  phage  surface  allows  binding  affinity  to  be  separated  from 
avidity; the effect of multiple bonds on binding strength. Although it may not have any effect 
on phage aggregation in solution, monovalent display might help to clarify binding affinities 
for a particular fusion protein for different ligands. In binding clones, such as 59, which show 
clear preference for one ligand, the fusion protein could be excised from the pG8H6 vector and 
used in a gene III vector, which would allow testing of the binding affinity of between 1-5 
fusion proteins. With polyvalent phage display (as with pG8H6), there is no way to tell how 
many  fusion  proteins  each  phage  produces,  or  whether  that  number  varies  within  a  phage 
population,  and  by  how  much.  Another  available  option,  time  permitting  would  be  GST 
fusions,  commonly  used  to  confirm  suspected  interactions  between  a  probe  protein  and 
unknown targets. This approach was used successfully by colleagues at the Eastman Dental 
Institute (Mullen et al., 2008) however there was not enough time to integrate GST fusions into 
this project. 
Although adhesion assays are useful for determining the affinity of fusion proteins for 
a certain ligand, they are less useful for determining binding strength when using phagemid 
where proteins can appear on the phage surface more than once. Using a phage display vector 
which allows protein display in a polyvalent fashion means that direct quantification of binding 
strength cannot be calculated, unlike using gene III for monovalent display which, in reality can 
allow between 1 and 5 fusions, depending on the vector. Because of this uncertainty in the 
number of fusion proteins on a phage and in a phage population, the binding affinity of each 
fusion protein is most effective when compared against ligands, and not against other fusion 
phage populations (Deshayes et al., 2002). That is why one cannot say, for example, that fusion 
protein 59 binds more strongly to IgA than clone 30 because there may be more fusion proteins 
displayed on the surface of clone 59 than clone 30, so the apparent ‘high affinity’ is purely due Chapter 5: Individual Protein Analysis 
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to a higher avidity effect of multiple fusion proteins. Similarly, at first glance of the pictorial 
results clone 44 appears to have very weak binding affinity for any of the ligands but it would 
not be a first choice for further investigation because it bound to the ligands in lower numbers 
than the other clones, because this could be due to fewer fusion proteins presented on the phage 
surface. It would not be first choice for further investigation simply because it did not show a 
clear preference for one ligand over the others.  
 
Individual Proteins 
  Whilst attempting to find out more about the physical properties of the fusion proteins, 
more  research  was  carried  out  on  the  homology  of  these  proteins  to  others  in  the  public 
databases, which are updated on a daily basis. To do this, the BLASTp function of the NCBI 
website  was used,  which  is a protein – protein  homology  database. In addition to  locating 
potential protein functions, it was useful to find homologous sequences in the database to the 
final  18  clones,  as  none  had  shown  any  homology  to  BLASTn,  a  nucleotide  –  nucleotide 
comparison. The results of this analysis are shown in Table 2. 
 
 
Clone 
number 
Size of 
predicted 
protein 
(amino acids) 
 
Residue 
identity 
(%) 
 
 
Positives 
(%) 
 
 
Predicted protein product 
36  105  49/102 
(48%) 
67/102 
(65%) 
Putative OM haemoglobin receptor 
[Neisseria meningitides] 
59  100  99/100 
(99%) 
100/100 
(100%) 
chloride channel protein [Fusobacterium 
nucleatum]; Gene ID:992636 FN 1727 
1  83  62/62 
(100%) 
62/62 
(100%) 
hypothetical protein ACTODO_01254 
[Actinomyces odontolyticus ATCC 17982] 
39  83  81/83 
(97%) 
   82/83 
(98%) 
hypothetical protein VEIDISOL_00956 
[Veillonella dispar ATCC 17748] 
42  84  76/80  
(95%) 
77/80 
(96%) 
hypothetical protein NEISUBOT_00167 
[Neisseria subflava NJ9703] 
58  97  96/97 
(98%) 
96/97 
(98%) 
radical SAM domain-containing protein 
[Fusobacterium sp. 2_1_31] 
44  79  -  -  No similarity to protein database 
52  79  60/64 
(93%) 
62/64 
(96%) 
ABC-type dipeptide/oligopeptide/nickel 
transport system, permease  
component [Veillonella parvula DSM] Chapter 5: Individual Protein Analysis 
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22  76  75/76 
(98%) 
75/76  
(98%) 
Sel1 repeat family protein [Neisseria 
flavescens SK114] 
     30  76  18/29 
(65%) 
24/29 
(82%) 
hypothetical protein ACTODO_00462 
[Actinomyces odontolyticus ATCC 17982] 
60  73  63/73 
(86%) 
69/73 
(94%) 
ABC transporter permease protein 
[Streptococcus gordonii str. Challis] 
GENE ID: 5598624 SGO_0857 
17  65  33/63 
(52%) 
46/63 
(73%) 
phosphate ABC transporter permease 
[Clostridium botulinum B1 str. Okra] 
GENE ID: 6148283 CLD_0364 
19  64  55/63 
(87%) 
59/63 
(93%) 
hypothetical protein ACTODO_00837 
[Actinomyces odontolyticus ATCC 17982] 
20  53  50/53 
(94%) 
52\53 
(98%) 
IISP family type II  secretory pathway 
protein SecA [Actinomyces odontolyticus 
ATCC 17982] 
27  57  -  -  No similarity to protein database 
 
2 
 
59 
 
30/40 
(75%) 
 
34/40 
(85%) 
 
glycosyltransferase family alpha-
glycosyltransferase [Parabacteroides  
distasonis ATCC 8503]; GENE ID: 
5307154 BDI_2004 
16  57  47/57 
(82%) 
52/57 
(91%) 
predicted PP-loop superfamily ATPase 
[Haemophilus influenzae R3021] 
11  51  40/51 
(78%) 
42/51 
(82%) 
hypothetical protein PREVCOP_00536 
[Prevotella copri DSM 18205] 
 
 
Table 2 Predicted protein product of final 18 recombinant clones from panning which showed 
binding affinity to ligands IgA, FN or BSA. This table shows the homology between the proteins in 
the  most  likely  reading  frame  (dictated  by  tBLASTx)  to  those  in  the  protein  database. 
Recombinant  clones  are  in  order  of  priority  for  pET  vector  expression  or  adhesion  assay 
experiments. Search results accurate at 29
th June 2009. 
 
  Table 2 includes 7 clones which contained hypothetical proteins from three of the well 
known oral microflora such as Actinomyces, Veillonella and Prevotella sp. It was thought that, 
through the use of pET vector expression systems and adhesion assays, more information could 
be gained on the specific ability of these proteins to facilitate bacterial binding to the tongue 
dorsum. In particular, three clones (1, 39 & 42) were picked up from panning against IgA, the Chapter 5: Individual Protein Analysis 
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affinity between the tongue bacteria and IgA being of particular interest to this group. The table 
also contains two clones which showed no similarity to the protein database (BLASTp), or the 
nucleotide database (BLASTn). One of these, number 27 (BSA binding), showed no similarity 
at all to tBLASTx (translation into all 6 reading frames), a more stringent checking system, 
where number 44 (FN binding) contained a small region with homology to an aspartate binding 
domain.  
  What is also interesting from the table is the presence of 4 hypothetical proteins, with 
reasonable similarity and identity scores, supposedly from the oral commensal Actinomyces 
odontolyticus.  According  to  Hallberg  et  al  (1998),  A.  odontolyticus  is  the  most  prevalent 
member of the Actinomyces sp. on the tongue surface. The Hallberg group tested the binding of 
A. odontolyticus, and A. naeslundii genospecies 1 and 2 to N-acetyl-[beta]-D-galactosamine 
and acidic proline-rich proteins and found that both genospecies 1 and 2 of A. naeslundii bound 
N-acetyl-[beta]-D-galactosamine  with 100%  efficiency  where A. odontolyticus showed  only 
10% efficiency. Upon binding to acidic proline-rich proteins, A. naeslundii genospecies 1 and 2 
bound with 25% and 100% efficiency respectively, where A. odontolyticus bound with only 
15% efficiency. The group observed that A. odontolyticus bound in 89% of cases to unknown 
structures on the surface of streptococci isolates, highlighting that those organisms which bind 
to buccal and dental mucosa exhibit alternative specificities to those that enable colonisation of 
the  tongue  surface  (Hallberg  et  al.,  1998),  suggesting  that  a  great  variety  of  adhesive 
mechanisms have yet to be discovered in this area, not only to human components. Although 
the fimbrial and host adhesive receptors of A. odontolyticus have not been fully investigated, 
Actinomyces sp. are well known for inter- and intra- generic coaggregations with streptococci, 
and  interactions  with  the  oral  epithelia  in  general  (Gibbons,  1989),  and  therefore  it  is  not 
surprising to see the Actinomyces sp., and mainly A. odontolyticus, present in the current study 
alongside Streptococcus sp.  
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Introduction 
  For many years, much of microbiological diversity could not be accessed due to 
the inability of culture methods to sustain many bacteria. Since 1990, 16S ribosomal RNA 
(rRNA) gene  analysis  has become  the single  most common  method of studying  mixed 
microbial communities, and is often used to complement other molecular techniques such 
as cosmid (Courtois et al., 2003) and fosmid libraries (Nesbo et al., 2005), fluorescent in 
situ  hybridisation  (FISH;  Harmsen  et  al.,  2002)  and  fingerprinting  methods  such  as 
denaturing gradient gel electrophoresis (DGGE; Peterson, 2007) and terminal restriction 
fragment length polymorphisms (T-RFLP; Case et al., 2007); the combination of which 
provides different viewpoints into community structure and function.  
  The inherent bias in using any PCR-based technology is well known, as is the case 
with many other techniques – whether culture based or not. 16S rRNA analysis is used 
principally to differentiate between operational taxonomic units (OTU’s) and usually a 
similarity of 97-98% is deemed sufficient to identify two sequences as belonging to the 
same OTU (Gevers et al., 2005), although even 99% identity can still represent sufficient 
diversity within a species (Case et al., 2007). 
  In  order  to  assess  the  diversity  of  the  human  tongue  dorsum  in  a  manner 
comparable to other studies (Kazor et al., 2003; Aas et al., 2005; Haraszthy et al., 2007; 
Riggio et al., 2008), 16S rRNA phylogenetic analysis was undertaken. In this project, it 
was felt that the phage display library was unlikely to have provided a representative 
view of the level of microbial diversity in the original sample, leading to partiality towards 
certain bacterial phylotypes or bacterial proteins. This chapter details the analysis of 16S 
rRNA genes from the human tongue dorsum and comparisons between the 16S rRNA 
and phage display analyses. 
 
Initial analysis 
  The 16S rRNA was PCR amplified initially using 30 cycles for testing purposes, then 
using 10 cycles for the 16S rRNA used  for the analysis,  described  in Chapter 2, page 62. 
Briefly, 30 cycles were carried out using the twofold degenerate primer 27f-CM (5’– AGA 
GTT TGA TCM TGG CTC AG -3’) and 1492r (5’- TAC CTT GTT ACG ACT T -3’) (Frank et 
al., 2008), and a gradient of annealing temperatures between 46°C and 54°C, based on the 
melting temperature of the primers, and the previous annealing temperature of 48°C used by 
Frank  et  al.,  2008.  The  resulting  PCR  products  were  checked  using  1%  agarose  gel 
electrophoresis. The band showing a clear PCR product of the correct size (roughly 1500 bp) 
with  high  intensity  was  used  for  cloning  using  the  TOPO  TA  cloning  kit,  according  to 
manufacturer’s instructions. Successful colonies were identified using blue/white screening and Chapter 6 – R & D: 16S rRNA Diversity Analysis 
 
118 
 
21 white colonies were sequenced to confirm the presence of the 16S rRNA gene. Sequencing 
was carried out using the primers M13 forward (5’– GTT TTC CCA GTC ACG AC –3’) and 
reverse (5’– GGA AAC AGC TAT GAC CAT –3’) at a concentration of 5 µM. Sequence data 
was searched for homology to the Ribosomal Database Project  sequence collection (Cole et 
al., 2009) and the top match taken as the search result.  
  From the 21 white colonies, 4 were Streptococcus and 4 were Veillonella (2 V. dispar 
and 2 uncultured). Three were identified as Prevotella sp. and 3 as uncultured bacterium from 
unknown  sources.  Two  were  identified  as  Haemophilus,  one  uncultured  and  one  H. 
parainfluenzae, and one each of the genus Neisseria, and Clostridiales, and one each of the 
phylotypes  Fusobacterium  peridonticum,  Rothia  mucilaginosa  and  Bulleidia  moorei.  The 
preliminary results showed the same types of bacteria in similar proportions to previous studies 
carried out on the tongue dorsum (Aas et al., 2005; Kazor et al., 2003) and on the strength of 
this data, the full 16S analysis of 380 clones was carried out. 
 
Full 16S rRNA analysis 
  Following the successful 16S analysis trial, a slight variation of the aforementioned 
PCR reaction was set up using 10 cycles instead of 30, with the aim of retaining as much of the 
original diversity as possible, at the optimum temperature established in the test (49°C). The 
PCR product was tested using 1% agarose gel electrophoresis and then cloned, as before, using 
the  TOPO  TA  cloning  kit,  according  to  manufacturer’s  instructions.  From  the  blue/white 
screening plates, 380 colonies were hand-picked and miniprepped using the Qiagen Plasmid 
Spin  Kit,  and  the  DNA  diluted  to  10  ng/µl  for  16S  rRNA  analysis,  carried  out  at  the 
Comparative  Genomics  Centre,  part  of  University  College  London.  The  primers  used  for 
sequencing were M13 forward and reverse, detailed in the ‘Initial Analysis’ section. Primers 
were synthesized commercially by Eurofins MWG Operon (www.eurofinsdna.com) and were 
based on the primers tested by Frank et al., 2008.  
   
16S rRNA data analysis 
Once  sequenced,  the  16S  forward  and  reverse  files  were  aligned  using  BioEdit 
Sequence  Alignment  Editor  v7.0.9  in  FASTA  format  to  form  the  contiguous  16S  rRNA 
sequence of around 1592 bp. Contigs were then specifically aligned for use in the Greengenes 
database  (DeSantis  et  al.,  2006a)  using  NAST  (Nearest  Alignment  Space  Termination) 
(Desantis  et  al.,  2006b),  which  outputs  the  MSA  (Multiple  Sequence  Alignment)  in  the 
standard format of 7,682 characters per sequence, allowing similar loci to be located in similar 
positions in subsequent batches. During this analysis, 4 out of 380 sequences did not meet the Chapter 6 – R & D: 16S rRNA Diversity Analysis 
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match requirements, being either less than the minimum length of 1250 bp, or sharing less than 
75% identity to the template sequence. These sequences were removed from further analysis. 
  Due to the presence of genomic data from different origins containing the conserved 
16S rRNA gene, amplification by PCR is known to  introduce hybrid  molecules which can 
distort the results of a diversity analysis (Liesack et al., 1991). The percentage of chimeric 
sequences  in  this  16S  rRNA  gene  analysis  was  therefore  checked  using  the  greengenes 
Bellerophon (version 3) server (Huber  et al., 2004). In other studies (Kazor et al., 2003; Aas et 
al., 2005) the number of chimeric sequences was between 1 and 15%. This analysis located 42 
chimeric  sequences  (11%),  which  were  below  the  97%  threshold  BLAST  similarity  and 
contained  fewer  than  1250  matching  base  pairs  to  the  Core  Set  of  sequences.  Species 
identification of chimeric sequences was not obtained and these 42 were removed from further 
study.  
  Using  the  NAST aligned  sequences,  minus  chimeras;  the  remaining  333  sequences 
were classified using the Simrank interface which finds similarity between query and database 
in terms of the number of unique 7-mer count present in either query or database. Sequence 
diversion  from  near-neighbours  was  calculated  using  the  DNAML  option  of  DNADIST 
(PHYLIP  package).  The  reference  sequences  used  for  classification  were  non-chimeric 
(divergence  ratio  <1.10)  and  taxonomic  analysis  was  conducted  using  the  RDP  taxonomic 
nomenclature.  In  the  identification  of  closest  relatives,  all  sequences  were  compared  to 
>100,000 sequences in the RDP database. The similarity cut-off used for species differentiation 
was 98%, and 16 of these clones did not meet this cut-off. Those 16 with a higher level of 
differentiation are shown on the phylogenetic tree by only the clone number (Appendix 6). 
 
16S rRNA gene analysis results  
  From the 333 sequences, the majority (60.4%) were from the phylum Firmicutes. The 
remaining  classification  revealed  19.8%  Bacteroidetes,  12.9%  Proteobacteria,  4.2% 
Actinobacteria, 2.1% Fusobacteria and 0.6% TM7, a novel phylum for which there are no 
cultured  representatives.  The  classification  indicated  26  genera  in  total  and  the  two  most 
abundant,  both  from  the  phylum  Firmicutes,  were  Veillonella  (26.7%)  and  Streptococcus 
OTU’s (24.6%). Although the oral cavity is known to harbour Archaea, most commonly of the 
genus  Methanobrevibacter,  PCR amplification  of  Archaeal  rDNA  requires  specific  primers 
which were not included in this analysis (Lepp et al., 2004). 
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Novel bacteria 
  During this analysis, 15 clones  fell short of the 98% similarity cut-off, and  in this 
situation, these clones were tentatively classed as potentially novel phylotypes. These 16 clones 
are analysed in more detail in Table 1. 
  In all BLAST searches where the top match did not suggest a species name for the 
sequence,  the  second  match  did.  In  clone  9  the  highest  species  homology  was  to  Rothia 
mucilaginosa; clone 60 was most similar to Haemophilus parainfluenzae; clone 233 was most 
similar  to  Prevotella  ‘Oral  Taxon  299’;  and  clone  307  was  most  similar  to  Streptococcus 
parasanguinis. Clone 327 however showed very low homology to an uncultured Veillonella 
species, but this similarity was at least half way down the BLAST ranking table. This discovery 
could make clone 327 of particular interest as perhaps an as yet uncultured Veillonella species, 
or an unknown member of a related species.  
  From the RDP classification, clones number 22, 23 and 70 (in bold typeface) all have 
between 92 – 98% homology to the same uncultured bacterium clone FIU_KM_MD_004, which 
shares  some  similarity  with  an  oral  Prevotella  species.  An  alignment  of  these  3  rRNA 
sequences using clustalw showed that, although showing homology to the same entry in the 
BLAST  database  and  therefore  potentially  from  the  same  organism,  the  sequences  do  not 
completely align. Out of the 1500 base pairs aligned, there are 132 bp (8.8%) which do not 
align between clones 22 and 23, and 134 bp (8.9%) non-alignment between clones 23 and 70, 
whereas clones 22 and 70 appeared more closely related with only a 103 bp non-alignment 
(6.8%). Of course, one can not tell from this information whether or not clones 22, 23 and 70 
belong to the same organism or species but given the positioning of these 3 clones on the 
phylogenetic tree (Appendix 6), it is probable that they all belong to the Prevotella sp. Given 
that  clones  22,  23  and  70  were  sufficiently  different,  they  were  submitted  to  Genbank  as 
separate entries. 
 
 
 
 
 
 
  
 
Clone 
number 
 
Number of bases 
available for BLAST 
 
Matching 
bases 
 
Sequence 
identity (%) 
 
Accession number 
 
Closest species match 
 
Additional information regarding 
environmental origin 
9  1671  1461/1510  96.7  GQ398416  Uncultured bacterium clone A_S_01_77  Healthy Chinese oral cavities 
FJ470589 
22  1611  1428/1505  94.9  GQ398417  Uncultured bacterium clone   Clone from cystic fibrosis patient 
EU670056 
23  1613  1402/1510  92.8  GQ398418  As 22  As 22 
45  1622  1465/1514  96.8  GQ398419  Haemophilus sp. oral clone JM053   
47  1608  1473/1510  97.5  GQ398420  Prevotella salivae strain EPSA11   
60  1629  1464/1522  96.2  GQ398421  Uncultured bacterium clone A_D_01_61   
71  1614  1464/1519  96.4  GQ398423  Uncultured Porphyromonas clone 302E06   
137  1598  1441/1506  95.7  GQ398424  Prevotella sp. oral clone ID019   
189  1647  1484/1538  96.5  GQ398425  Streptococcus sp. F1   
233  1601  1458/1493  97.7  GQ398426  Uncultured bacterium clone P1D1-678  Healthy Chinese oral cavities (as 
clone 9) FJ470432 
273  1640  1472/1553  96.0  GQ398427  Streptococcus parasanguinis   
284  1584  1384/1495  92.6  GQ398428  Uncultured Campylobacter sp. clone 202B08 
(oral) 
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296  1621  1459/1519  96.1  GQ398429  Prevotella ‘Oral Taxon 299’   
307  1642  1478/1545  95.7  GQ398430  Uncultured bacterium clone SJTU_F_10_28  Clones from human tracheal 
aspirates EF511999 
327  1634  1482/1539  96.3  GQ398431  Uncultured bacterium clone Oh_3137A9A  Isolates of Bartonella positive 
fleas EU137432 
 
 
Table 1 Similarity of 15 'novel' phylotypes to public access database.  Clones in bold typeface were thought to be homologues. Clones were submitted to GenBank using 
BankIt (http://www.ncbi.nlm.nih.gov/BankIt/) on 17
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Discussion 
The 16S rRNA gene contains a few fundamental properties which have facilitated its 
use as a conventional molecular marker such as its essential function, ubiquity and conserved 
nature. 16S rRNA analysis was included in this project for several reasons. Firstly, to assess the 
initial diversity of the bacterial metagenomic DNA used to make the phage display library. 
Secondly, it allows the use of that diversity as a benchmark for assessing the diversity of the 
phage display library. Thirdly, it allows a comparison between this and other similar studies on 
the human tongue dorsum. Lastly, it provides some context into the range of bacteria being 
identified by the panning process and allows speculation on phage display limitations. It should 
be noted that this study does not attempt to infer which phylotypes were the most prevalent 
(i.e., present in the most people), as most comparable studies have done. In this project, 16S 
rRNA  analysis  was  simply  carried  out  to  try  to  gauge  microbial  diversity  in  the  tongue 
metagenomic DNA samples used to create the phage display library. The expectation was that a 
representative analysis of the tongue microbiota by 16S rRNA analysis would provide some 
information on the types of bacteria that could be expected in the phage display library, and of 
course, highlight any notable exceptions. 
  The primers used in this study were tested previously by Frank et al., 2008, where the 
27f – 1492r primer set was found to bind commonly to most bacteria. The 27f primer has also 
been commonly used in many previous studies assessing tongue diversity (Kazor et al., 2003; 
Paster et al., 2006, Riggio et al., 2008) and in those which assessed the specificity of certain 
primers to bacteria from different environments (Flanagan et al., 2007). However, different 
primer sets  were used by  Aas  et al., 2005 (D88f and E94r) when assessing  oral  microbial 
diversity, and clearly primer choice will result in some bias in the resulting diversity analysis. 
When attempting to assess true diversity of a sample, it appears that culture dependent and 
independent methods should still be used in concert (Pratten et al., 2003).  
The  bias  towards  certain  species  over  others  in  a  PCR-based  analysis  has  been 
attributed to preferential amplification of low G + C templates (Polz, 1998). This intrinsic bias 
is  reportedly  reduced  by  using  fewer  amplification  cycles  (Suzuki,  2008),  as  any  initial 
inequality in the sample, perhaps resulting from the DNA  extraction  method used,  will be 
increased exponentially as the cycles progress. In order to retain as much of the original sample 
diversity through to the PCR end product, ten cycles were used in the current study as opposed 
to either 30 (Kazor et al., 2003; Aas et al., 2005) or 33 (Riggio et al., 2008). Although the 
increase in preserved diversity is probably not large (Pratten et al., 2003), in this project it has 
resulted in the location of 112 phylotypes from 5 bacterial phyla, with a further 16 phylotypes 
which showed < 98% similarity to the RDP database, and can tentatively be classified as novel. 
In a comparable study carried out by Kazor in 2003, ninety-two phylotypes were identified Chapter 6 – R & D: 16S rRNA Diversity Analysis 
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from 6 bacterial phyla (they classed the Clostridia as a separate phylum), from a sample size of 
11 patients, in comparison to 9 volunteers used in the present thesis. The number of species in 
the present study was 44, not including the additional 16 ‘novel’ clones, which may belong to 
one  or more species. In similar studies, using 30 PCR cycles, the following  numbers were 
observed from the tongue dorsum; 8 patients, 84 species (Haraszthy et al., 2007); 5 patients, 39 
species  (Aas  et  al.,  2005);  32  patients,  78  species  (Riggio  et  al.,  2008).  Of  course,  the 
combination of primer set and number of amplification cycles, plus many other contributing 
factors,  will  cause  some  of  these  variations  in  final  figures.    From  these  numbers,  the 
combination of the 27f-CM – 1492r primer set with a reduced number of 10 PCR cycles has 
allowed the identification of a comparable number of species on the tongue dorsum to that 
found in other studies. 
In the present study the two most common genera, making up just over half of the total 
sample  and  both  from  the  phylum  Firmicutes,  were  Veillonella  (26.7%) and  Streptococcus 
(24.6%). The most common were 13 varieties of uncultured Veillonella, making up 18% of the 
total. This was followed by 18 varieties of uncultured Streptococcus at 12% and 6 uncultured 
Prevotella  at  7%.  The  most  common  species  found  were  Veillonella  dispar  ATCC  17748 
(5.4%), Neisseria mucosa AJ239279 (4.2%), and an uncultured Veillonella Ax3_690 (3.9%). 
All of the isolates found were generally accepted members of the normal human oral cavity. 
Points of differentiation between the present study and others in terms of diversity are 
summarised as follows. In the study conducted by Riggio (2008), 5 – 10 % of clones were 
made up of various Actinomyces sp., where in the present study Actinomyces constituted 0.01% 
of  all  clones.  This  could  be  due  to  the  primer  set  used  by  Riggio  (27f  and  1387r)  which 
potentially recognises Actinomycete 16S rRNA better than the primers used in this thesis. They 
also found that between 7 and 12 % of clones were Lysobacter-type species, not previously 
found in great numbers on the tongue surface, and not present in the current analysis. They also 
found Streptococcus salivarius in 6% of clones and Veillonella dispar in 5.5%, the latter figure 
agreeing  almost  exactly  with  the  present  findings.  The  group  also  identified  9  known 
Streptococcus species, making up 13 - 16 % of total numbers, along with numerous unknown 
Streptococci making up a further 3 – 6 %. The present study identified 5 known Streptococcus 
species  making  up  8%,  but  the  majority  were  unknown  or  uncultured  species,  making  up 
14.7%. The appearance of a higher percentage of unknown/uncultured species may be due to 
reduced stringency of the primers during PCR, or it could be due to the reduced number of 
amplification cycles used,  which  may suggest that the original  environment  contains  many 
more unknown or uncultured species than first thought. The same scenario is true with the 
identified Veillonella: where the Riggio study located 4 known Veillonella species (between 11 
and 14 % of total), and 1.5 % unknown species. In the present study, 3 known species (7.5 %) 
and 13 unknown or uncultured, making up 19.2 %, were identified. The differences in these Chapter 6 – R & D: 16S rRNA Diversity Analysis 
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figures could be real or they  could be  due  to reasons such as errors during sequencing.  A 
similarity cut-off of 98% was used in this study which, in the 1250bp of sequence used for 
classification,  is  only  25  base  pairs,  so  any  sequencing  errors  at  all  could  result  in  the 
appearance  of  higher  sample  diversity  than  was  actually  present.  In  addition,  the  melting 
temperature of the 27f-CM primer used in the present study was 54 °C, and the annealing 
temperature found to give the sharpest band of the correct size was 49 °C. The low annealing 
temperature  in  comparison  to  the  high  primer  melting  temperature  could  result  in  reduced 
specificity,  as  primers  are  known  to  hybridize  to  template  DNA  in  conditions  of  lower 
stringency (Pratten et al., 2003). 
The results of the present study align with those of Kazor (2003), in that only 40% of 
clones were identifiable as known species. This is directly comparable with the present study 
where 37% (122/333) were identified as known species. Although the Kazor study was split 
into  halitosis  and  healthy  samples,  by  far  the  most  common  genus  identified  were  various 
known and unknown Streptococcus species, with no Veillonella presence in the top 4 common 
species in either healthy or halitosis groups. This is where Kazor and the present study differ, as 
Veillonella was the  most abundant species found here  with  over 26% presence. The Kazor 
study may not have picked up Veillonella species with great frequency due to the primers they 
chose, as a similar study by Tanner et al., 2006, also used the same primers as Kazor and did 
not even place Veillonella in the 40 most prevalent species, their study being heavily biased 
toward Streptococcus sp. 
The results described in this thesis are probably more representative of true microbial 
diversity  at  the  tongue  surface  they  are  in  agreement  with  culture  based  and  DNA-DNA 
hybridization studies, such as that of Faveri et al., 2006; Donaldson et al., 2005; and Mager et 
al., 2003, who identified Veillonella sp. as the most prevalent, and Prevotella as the second 
most prevalent. What is important to remember however is that the human oral microbiota 
varies from person to person, and also between geographic locations, depending on diet and 
various other factors. The abundance of one genera or species over another may simply be a 
manifestation of local variation. 
  One study which stands alone from all others in this field is that of Keijser et al., 2008, 
who  identified  19,000  phylotypes  in  the  oral  cavity  as  a  whole,  by  analysing  saliva  and 
supragingival plaque from 71 individuals. This group targeted the 16S hypervariable region 
which is flanked directly by well conserved regions that can be used for PCR amplification. 
Using  high throughput pyrosequencing  which provides reads  of around 100 base pairs, the 
group  generated  almost  200,000  reads  and  allocated  a  new  phylotype  to  each  sequence 
containing a single base discrepancy. A phylotype is defined, in 16S rRNA terms, as clones 
which have > 98.5% identity. Those with < 98.5% similarity to previously defined clones are 
considered to represent a new species (Paster et al., 2006). The Keijser analysis was driven by Chapter 6 – R & D: 16S rRNA Diversity Analysis 
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the hypothesis that even the now-common use of molecular techniques for assessing microbial 
diversity, such as 16S rRNA analysis, was still missing low abundance phylotypes, and set out 
to analyse ‘true’ microbial diversity by analysing thousands of clones. However, the problem is 
that a single base pair discrepancy does not automatically signify a new phylotype or species, 
and it is known that very similar bacteria can have significant differences between 16S rRNA 
sequences. It has been demonstrated previously, that high levels of 16S rRNA gene sequence 
similarity between strains belonging to the same genus do not indicate membership of the same 
species  (Yassin  et  al.,  1996).  Further,  a  single  base  discrepancy  can  easily  be  introduced 
through sequencing errors, leading to a misrepresentation in the studies final numbers. 
  In Table 1, the 16 ‘novel’ clones identified during 16S rRNA analysis are described in 
more detail. In this study so far, 63% of clones were from known genera but unknown species 
and 57% had never been cultured. These figures agree with other studies which have estimated 
the number of uncultured representatives in the oral cavity at between 50% (Paster et al, 2001; 
Jenkinson & Lamont, 2005) and 60% (Kolenbrander et al., 2002). There does not appear to be 
much information on the number of ‘novel’ species found on the tongue surface or oral cavity 
but the number of ‘novel’ species or phylotypes in this study could be as much as 4%. This 
number may seem rather low in comparison to other environments which appear to continually 
identify novel species, however given the amount of research carried out on the oral cavity 
microbiota, perhaps a figure of 4% is reasonable.  
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Introduction 
    Due  to  the  overwhelming  complexity  of  natural  microbial  ecosystems,  and  the 
limitations posed by traditional culture-dependent analysis of micro-organisms, a variety 
of approaches are now routinely used which circumvent the need for bacterial culture. 
Currently, it  is standard practice to  interrogate  a bacterial sample  by sequencing the 
microbial genomes contained within it. The most straightforward way of doing this is to 
create a library of randomly fragmented DNA spliced into a cloning vector.  These so-
called ‘shotgun libraries’ are also useful because they allow the clones to be screened for 
specific  traits,  such  as  enzyme  production,  and  clones  which  show  interesting 
characteristics can then be sequenced. 
    In  2005,  a  BamHI  shotgun  library  was  produced  by  Professor  John  Ward  in  the 
universal cloning vector pUC19, containing the fragmented microbial genomes of organisms 
from the  human tongue.  Upon sequencing the  ends  of 50 clones, they  were used to  query 
tBLASTx  database  for  homologous  sequences.  This  analysis  revealed  that  some  of  the 
recombinants, in particular pQR492 and pQR494, contained DNA fragments worthy of closer 
analysis.  From  the  BLAST  comparison  –  carried  out  in  2005  -  clone  pQR492  showed 
homology  to  a  putative  glycopeptide  synthesis  gene  from  the  predominantly  oral  genus 
Actinobacillus  and  pQR494  showed  homology  to  a  tetracycline  resistance  gene,  a  trait 
commonly found in the oral cavity (az-Torrez et al., 2003). This chapter discusses work which 
was started at the very beginning of the project and picked up at various points during and at 
the  end  of  the  project,  with  the  aim  of  obtaining  full  sequences  of  pQR492  and,  time 
permitting, pQR494.   
 
Investigating pQR492 
  Clone pQR492 contains a ~6kb bacterial DNA fragment, inserted into pUC19 (2.6kb), 
using the BamHI cloning site. Starting with around 700 base pairs (bp) of sequence from the 
initial sequence analysis, the NCBI BLASTn algorithm confirmed that the insert was indeed 
from a bacterial source (by not matching to any part of the human genome, which has been 
sequenced in its entirety), and also noted some homology to a potential glycopeptide synthesis 
gene  using  the  tBLASTx  search  function.  Because  of  this  interesting  potential  function 
pQR492 was chosen for further analysis however the BLAST search carried out in 2005 did not 
produce the same match in a BLAST search carried out in July 2009. At this time, the first and 
last 800 base pairs of pQR492 showed homology to a transcription repair coupling factor and a 
putative membrane protein, and these similarities are discussed in more detail in this chapter. 
    The first stage in analysing pQR492 in more detail was to produce a restriction map of 
the fragment. Briefly, pQR492 was transformed into E. coli Top10 F’ and the plasmid extracted Chapter 7: Additional Work – pQR492 
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using  the  Qiagen  Plasmid  Maxi  Kit  according  to  the  manufacturer’s  instructions,  which 
provided 1  ml  of plasmid DNA. Sequencing returns approximately 800 bp of good quality 
DNA sequence each time, so a basic restriction map was constructed using single and double 
digests (Figure 1), and plasmids where deletions were created then the deleted recombinant 
sequenced. During this process it became clear that most restriction sites were clustering to the 
left side of the insert, leaving big gaps to the right. In order to access sequence at the right side, 
subcloning was introduced at that end only. From Figure 2, three PstI sites are clear, 2 in the 
insert itself, 950 bp apart, and one in the vector just after the end of the insert sequence, so the 
PstI restriction sites were used to separate the 6 kb insert into 3 fragments. To do this, 300 µl of 
plasmid preparation  was  digested using the restriction  enzyme  PstI at 37°C for 3  hours to 
ensure complete digestion, which cut pQR492 into 3 easily identifiable fragments; 950 bp, 3.5 
kb and just over 4kb (Figure 2). The digested plasmid was then run on a 0.8% agarose gel, and 
the 3.5 kb DNA fragment excised and extracted using the Qiagen Gel Extraction Kit, according 
to the manufacturer’s instructions. 
 
Figure 1  pQR492 restriction map. Using single and double digests, and creating deletions within 
the insert with sequencing, this restriction map was compiled. The arrows denote the distance 
between restriction sites at the beginning and the end of the arrow. 
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  Following  extraction,  the  3.5  kb  fragment  was  split  into  3  aliquots  and  digested 
individually using the restriction enzymes HaeIII, AluI and Sau3A, resulting in DNA fragments 
of  around  50  –  100  bp,  which  were  cloned  back  into  pUC19.  Thirty-six  of  the  resulting 
recombinants  were sequenced and the sequences aligned using  multiple alignment software 
(Geneious), by a visiting Nuffield student who produced the resulting alignment ‘match 3’, a 
contiguous alignment of 900 bp to the right of the insert. All of the preceding and subsequent 
analysis  of pQR492  was carried  out by the author.  The situation at this stage  is shown  in 
Figure 3, diagram b,  which illustrates all sequenced parts of the 6  kb  insert to that point. 
Around 700 bp at the start and end of the insert came from the initial exploratory sequencing 
which  checked  whether  the  recombinant  was  worth  studying  further.  ‘Match  2’  was  a 
contiguous sequence of around 1.8 kb from the restriction mapping exercise, placed around the 
left hand side of the 6 kb fragment. ‘Match 3’ was known to be from the right hand side of the 
fragment,  although  where  exactly  was  not  known.  ‘Match  2’  did  not  align  with  the  start 
sequence  or  with ‘match 3’ and ‘match 3’ did  not  align  with the  end sequence. The  non-
alignment was mainly due to a shortage of overall sequencing of the 6 kb fragment, having 
only reached 3850 bp of sequence at this time. At this point it was decided that primer walking 
was the best approach to close the gaps in this sequence. 
  When attempting primer walking for the first time primers were designed from both 
ends of each aligned fragment of DNA. As an example, primers were designed for the left hand 
side of ‘match 2’ coming out towards the start and into the alignment, and also from the right 
hand side of ‘match 2’ out towards ‘match 3’ and into the alignment. However, only the reverse 
complement primers were ever successful. It was supposed that primer binding failure was due 
to errors in the 6 kb insert sequence, leading to the design of ineffectual primers. This approach 
gave the scenario depicted in Figure 3, diagram c which, though the primers produced a further 
2  kb  of  sequence,  still  did  not  allow  alignment  between  the  start,  end,  or  either  ‘match’ 
sequence. Primer walking was continued and the new sequences added together until all DNA 
fragments aligned, leaving the insert size at 6,318 bp, agreed by agarose gel electrophoresis. 
 
 
Figure 2 pQR492 showing PstI sites (black arrows) used for extraction of a 3.5 kb part of the insert 
needed for subcloning. Red block arrow illustrates target DNA sequence for separate analysis.  
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Figure 3 Sequencing of pQR492 insert DNA. a) full 6kb sequence, b) areas of alignment (match 2 
and match 3) along with the start and end sequences (3850bp in total), c) primer walking (blue 
area) added 2080bp (5930bp total), d) further primer walking from the blue sequences (in red) 
added 1796bp (7726bp total). The insert was known from agarose gels to be 6kb in size so the lack 
of alignment was thought to be due to some bad quality sequence at the C terminal end of match 3, 
match 2 and start. 
 
 
In silico analysis 
  With the full sequence of pQR492, the whole 6 kb was used to check homology to 
sequences  held  in  public  databases.  An  NCBI  BLAST  search  using  both  BLASTn  and 
tBLASTx  showed  no  significant  similarity  with  the  full  length  sequence.  Since  the  full 
sequence did not generate any ‘hits’ with tBLASTx, possibly because using the full 6.3 kb 
made any short areas of homology seem insignificant, it was split into 4 blocks of 1575 bp 
which were used separately to query the database. The 4 shorter fragments did match others in 
the database and the results are shown in Table 1. 
  The first quarter of pQR492 shows homology to a different protein than the remaining 
three quarters. One could assume that this was due to the joining of insert fragments during the 
ligation process, prior to cloning into pUC19 – similar to that seen in the phage display library - 
but if this was the case an internal BamHI site would indicate the point of ligation since this 
restriction enzyme was used to make the library. Instead, the general low level homology to the 
organisms  Arthrobacter  sp.  and  Corynebacterium  aurimucosum  could  indicate  that  the 
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Start  Match 3  P1  P1  End  Match 2 
b. 
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fragment in pQR492 is similar to both organisms but is actually neither. The fact that homology 
exists to these two high G+C Gram positive organisms however does indicate that the origin of 
pQR492 is also likely to be a high G+C Gram positive organism.  
 
Insert part  Description of tBLASTx hits 
0 – 1593 bp  Arthrobacter sp. FB24, transcription repair coupling factor, identity 65/97 
(67%), Positives 82/97 (84%), 3e-97, 3-4 large (100aa) matches over the 
query sequence. 
1594 – 3177 bp   Several  very  low  identity  (35%)  short  (50  –  80  aa)  matches  to 
Corynebacterium aurimucosum across this fragment 
3178 – 4751 bp   Several  very  low  identity  (35%)  short  (50  –  80  aa)  matches  to 
Corynebacterium aurimucosum across this fragment 
4752 – 6318 bp     As above but slightly higher identity (60%) fragments of 150 – 250 amino 
acids across the sequence, to Corynebacterium aurimucosum 
 
Table 1 tBLASTx homology of pQR492 using short fragments of the whole 6.3 kb sequence. 
 
 
  Three  of  the  four  fragments  in  Table  1  show  low  levels  of  homology  to 
Corynebacterium aurimucosum, an organism commonly found on the tooth surface (Aas et al., 
2005) and therefore also a likely member of the tongue microbiota. Arthrobacter sp. are more 
commonly  found  in  soil  and  are  also  members  of  the  Actinomycete  branch  of  the  Gram 
positive bacteria. The BLAST searches seemed to suggest that three quarters of the pQR492 
sequence contained a large part, if not all, of an Actinomycete gene. The next stage in this 
analysis was to identify open reading frames in the pQR492 sequence. The open reading frame 
(ORF)  finder  program  from  NCBI  (www.ncbi.nlm.nih.gov/projects/gorf/orfig.cgi)  identified 
potential ORF’s of pQR492, which are shown in Figure 4).    
  ORF’s  coloured  in  red  are  those  which  showed  homology  to  Corynebacterium 
aurimucosum  or  Actinomyces  odontolyticus,  another  high  G+C  organism  similar  to  C. 
aurimucosum also found in the oral cavity. The ORF depicted in yellow is a putative 430 amino 
acid  transcription  repair  coupling  factor  (TRCF)  with  95%  sequence  identity  to  Rothia 
mucilaginosa,  another  high  G+C  Actinomycete.  From  Figure  4,  the  placement  of  the  red 
ORF’s indicated that they may in fact form a single continuous protein. Even single base errors 
during sequence alignment of the pQR492 fragment could be responsible for the appearance of 
the protein as 4 separate ORF’s. Although an effort was made to achieve 3 to 4 times sequence 
coverage of the 6 kb insert, there are one or two instances where short areas may only have 
been sequenced once. In order to identify whether these ORF’s do in fact form a single protein, 
it was important to find their closest homologues in the public databases and use them as a 
basis for comparison. 
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5’ to 3’ Frame 1 
 
 
5’ to 3’ Frame 2 
 
 
5’ to 3’ Frame 3 
 
 
3’ to 5’ Frame 1 
 
 
3’ to 5’ Frame 2 
 
 
3’ to 5’ Frame 3 
 
   
 
                                                    
 
 
 
 
 
  The largest continuous open reading frame is in frame +2 and is 518 amino acids long; 
subsequently referred to as ORF 1. BLASTp identified homology or ORF1 with a putative 
membrane  protein  (cauri_0414)  from  Corynebacterium  aurimucosum  ATCC  700975  with 
143/367  (38%)  identity,  206/367  (56%)  positives,  and  an  expect  value  of  1e-64. 
Corynebacterium aurimucosum is a novel species discovered in 2002 and the family of bacteria 
are known for their appearance in isolates of clinical and veterinary importance (Yassin et al., 
2002). The genus belongs to the Actinomycetes, common in the oral cavity and on mucosal 
surfaces.  
  Frame three on the 5’ to 3’ strand (Figure 4) contains two fragments (in red) with 
similarity to a hypothetical protein from the oral commensal Actinomyces odontolyticus; a 149 
amino acid protein (hereafter called ORF 2) and a 171 amino acid protein (hereafter referred to 
as ORF 3). Although the highest similarity was to A. odontolyticus for these two fragments, the 
second  BLASTp  match  was  again  to  cauri_0414  of  C.  aurimucosum,  indicating  that  the 
Figure 4 Diagram showing ORF’s present in pQR492. Frames are depicted on this diagram with 
all  ORF’s  of  20  amino  acids  or  more,  identified  using  ORF  Finder 
(www.ncbi.nlm.nih.gov/projects/gorf/orfig.cgi).  ORF’s  depicted  in  red  are  those  identified  by 
BLASTp  to  have  homology  to  protein  cauri_0414  from  Corynebacterium  aurimucosum  or 
Actinomyces odontolyticus, which is very similar to C. aurimucosum. The ORF in yellow has 95% 
identity to a transcription repair coupling factor from Rothia mucilaginosa, and the position of 
these ORF’s within 492 creates the possibility that there may be 2 genes in the fragment. 
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fragment captured during cloning may encode some or all of a related protein. At the end of 
frame  1  on  the  5’  to  3’  strand  there  is  another  ORF  with  homology  to  C.  aurimucosum 
(subsequently known as ORF 4). This putative 251 amino acid protein goes right to the end of 
pQR492, with no stop codon before the BamHI site of the pUC19 vector, which means that the 
protein has been cut short by the cloning process. 
  The 4 ORF’s with homology to C. aurimucosum all have various degrees of similarity 
to the putative membrane protein cauri_0414. Taking ORF’s 1 - 4 together gives 1,090 amino 
acids,  very  close  to  the  full  length  cauri_0414  protein  which  is  1,213  amino  acids  long, 
suggesting that not only do ORF’s 1 – 4 belong to the same protein, but that they could align 
with the cauri_0414 gene, the closest homologue. The insert of 6 kb may appear in different 
frames in parts of the sequence where alignments done by hand are incorrect by one or two 
bases,  which  may  not  have  been  obvious  at  the  time  but  which  could  be  manifested  as  a 
frameshift. Because the protein represented by ORF’s 1-4 is shorter than cauri_0414, one could 
presume  that  the  end  of  the  protein  is  missing  where  fragmentation  during  cloning  has 
occurred. Figure 5 outlines the proposed layout of genes contained in pQR492 and indicates 
areas a, b and c which, on the current sequence, lie between ORF’s 1, 2, and 3. Figure 6 
depicts  all  areas  of  pQR492  identity  to  the  BLAST  database  along  with  amino  acid  level 
homology and illustrates the areas of frameshifting between ORF’s. 
  Areas of sequence  outside  of the proposed ORF’s were used  individually to  query 
BLAST for homology to cauri_0414. Box a, a potential promoter region for ORF1 and ORF5, 
had no similarity to the BLAST database and box c showed very low level identity to fragments 
of human and zebrafish DNA. This lack of homology suggests that the gene fragment cloned 
into pQR492 has not yet been characterised. Box b did contain two short regions of homology 
to the C. aurimucosum genome, although not to the cauri_0414 protein itself. Again, these short 
areas of low homology appear to suggest that the fragment contained within pQR492 belongs 
to a similar kind of organism to C. aurimucosum, and is likely to be a high G+C organism. This 
is exactly the type of organism that researchers hope to find when doing a metagenomic, non-
culture based analysis. The low identity to BLAST indicates no record of this particular protein 
in  the  NCBI  databases,  although  its  homology  to  a  membrane  protein  suggests  a  possible 
function. That this exact protein does not exist in the database could indicate that the original 
organism  has  not  yet  been  characterised.  Perhaps  the  organism  has  particular  nutritional 
requirements which prevent it being easily cultured, or it may be present in very low numbers 
in  the  oral  cavity,  making  it  difficult  to  detect  in  some  molecular  based  analyses  which 
recognise abundant organisms more effectively than those in the minority. 
    
 
 
 
 
 
 
 
 
 
 
 
 
492 -1 ASSPVAPPTSPTLSDIGDEIADAISQNELAGAAADELLDADTVLETIEWWSLKAELAQATTQDITRFGSDSMRLQGLDIPAVADAEASTDWAAALFEENTAVLDEARARVREPEVN 
             P  + T +DIGDEIADAISQNELAGAAADELLDADTVLETIEWWSLK ELAQ TTQDITRFGSDSMRLQGLDIPAVADAEASTDWAAALFEENTAVLDEARARVREPEVN 
             PTANVTYTDIGDEIADAISQNELAGAAADELLDADTVLETIEWWSLKDELAQTTTQDITRFGSDSMRLQGLDIPAVADAEASTDWAAALFEENTAVLDEARARVREPEVN 
 
 
492 -1 IIMSGAPLLETLTNMSEILLPTLSEMGEVYIGGAIKELMAAAAPYDAKLRAARSMVEPTILLERCPLLTLETLEEGGSLTRQDAVSFHRMEDLEDGFFELRVPTTATPPFVDIIGG 
       IIMSGAPLLETLTNMSEILLPTLSEMGEVYIGGAIKELM AAAPYDAKLRAARSMVEPTILLERCPLLTLETLEEGGSLTRQDAVSFHRMEDLEDGFFELRVPTTATPPFVDIIGG 
   IIMSGAPLLETLTNMSEILLPTLSEMGEVYIGGAIKELMAAAAPYDAKLRAARSMVEPTILLERCPLLTLETLEEGGSLTRQDAVSFHRMEDLEDGFFELRVPTTATPPFVDIIGG 
 
492 -1 RVAYEGRKAVLDVRSYAADNLGRVVDKFPYEEGRVLHVPELKEIGTVIPQIVARVPAIVVQPRKAAEGTMARLVQLRRGVTSDRPSLREHPLTEWAPFLAIDAAPLYSRLAAALDE 
       RVAYEGRKAVLDVRSYAADNLGRVVDKFPYEEGRVLHVPELKEIGTVIPQIVARVPAIVVQPR   EGTMARLVQLRRGVTSDRPSLREHPLTEWAPFLAIDAAPLYSRLAAALDE 
       RVAYEGRKAVLDVRSYAADNLGRVVDKFPYEEGRVLHVPELKEIGTVIPQIVARVPAIVVQPRSSPEGTMARLVQLRRGVTSDRPSLREHPLTEWAPFLAIDAAPLYSRLAAALDE 
 
 
ORF 1  ORF 5  ORF 2  ORF 3  ORF 4 
430 amino acids, 
transcription repair 
coupling factor 
Id: 214/406 (52%) 
 
518 amino acids, putative 
membrane protein cauri_0414 
Id: 143/367 (38%) 
 
149 amino acids, 
putative membrane 
protein  
Id: 55/151 (36%) 
 
171 amino acids, 
putative membrane 
protein cauri_0414 
Id: 55/100 (55%) 
 
251 amino acids, 
putative membrane 
protein cauri_0414 
Id: 60/206 (29%) 
 
a  b  c 
Figure 5 Outline of the possible gene structure of the genomic DNA fragment cloned into pQR492. Yellow arrow depicts ORF5 which showed homology to the Mfd 
gene of K. rhizophila and the red arrows depict ORF’s 1 – 4, all with homology to C. aurimucosum. Direction of arrows indicates direction of translation. White block 
regions, boxes a, b and c, depict areas between ORF’s, some of which also showed homology to C. aurimucosum. Box (a) could contain an area consisting of two 
promoters to ORF1 and ORF5, however checking for homology with the tBLASTx database did not reveal any similarity to either protein in this 211 amino acid 
region. Box (b) contains 175 amino acids, which contain two short homologous BLAST matches to the C. aurimucosum bacterium already identified from this study, 
and these areas of homology are shown in the sequence alignment in Figure 11 (below). Box (c) also contains 175 amino acids but a BLAST search with this sequence 
reveals homology to human and and zebrafish DNA, rather than bacterial. Chapter 7: Additional Work – pQR492 
 
 
 
  ORF 5 
492 -1 AQRDTPAIILSLAEATTDRVATSIDAILAAHTGAVAGILTRASRETPQASAATRIAAWSSLQNTNLLPHLPAELPQATAKRTTSVPEGSDPTKEQPPQAPPPSSHITPISRHRNPA 
       AQRDTPAIILSL E TT RVA SIDAILAAHTGAVAGILTRASRE P+ASAATRIAAWSSLQNTNLLPHL                                   
 AQRDTPAIILSLVEPTTGRVAASIDAILAAHTGAVAGILTRASREAPKASAATRIAAWSSLQNTNLLPHL 
 
 
 
                                        ORF 1 
492 +2           Promoter           *KRMPIMSARWGAFASLVLLYWRPLTLTINCGFSSALNSPYLSMFLPERRIRKTHMTTTYTNKPAEKRHAHSWSAKKWGAFALAFG 
492 +3           Region             * 
492 -1 DSHIQR*// 159 AMINO ACIDS // * 
 
 
 
492 +2 TAFTAAPLTPTTPASAATGTHDGSSSDKAAASCYEVKQVNPSASSGTYWMLYTPQSGPAQFYCDQETDGGGWVMIGRGREGWTESYNGTGDPNQLHQNPTGPSAFTPVQLPANTV 
               +P  +   A  T DGSS D+AAASC+ +KQ NP A +G+YW L TPQM P +F+CDQE DGGGWVMIGRGREGW     G GD + L      P+ F P QLP  T+ 
               SPAAQDTPAVVTRDGSSPDRAAASCWAIKQDNPDAKNGSYWILLTPQMAPQEFFCDQEMDGGGWVMIGRGREGWDRYPAGQGDISALTSRDRTPADFAPAQLPTKTI 
 
 
 
492 +2 DALLNGIKPQDLPDGMRLHRAHNARGTQWQNVYVQRPQTEQWTWAMSYGQRWGTVKFTGAGI----NRTAHMGRHASEMAPGITTSSVRFFANPNQGYQIGFAYGALVNFGNENP 
       D LL+G    +L +GMR+ RA N  GT+WQ   ++  + E W+WA+S       ++F+        +RT     +A  +  GI  S+ R      + Y+IGF YG     G                
       DGLLSGQHINELDEGMRVVRATNNSGTRWQTADIKPQRMENWSWALS-AEDPALFRFDNGPLWYRADRTDRFMGNAIGLR-GIDISTTR-----ARQYKIGFGYGPWKRVGRALP 
 
 
 
492 +2 DSYIYHKRGSAGYSIPFTQVFLRPKLTQRDLNFSQIGSSSAAS-NRRALPNSYTMPVRWRTSEQTGTGKKNEMNTYVQAITQVGDTVFTGGDFKYVESAGGERVDQSYLAGYNVD 
       DS+IY   G A  ++P+ +++LRP+L+  D  F  I  +        A+ +S++ P +W  +    TG+  E N  VQ A Q  DTVF GG+F   E+A GE + ++ +A   ++ 
       DSEIYLRPGLANADAPFEPIPLRPLLEVTDSAFVSIFSSPTQWGVTGAL-TSRSTPGNWPTGADSFTGSTNEYN--VQAFAQKDDTVFVGGNFTAAENHAGESLPRTAVAAFDAT 
 
 
 
492 +3                                                                                         ORF 1   KGQYV*GVRLLACAARFKLS 
492 +2 SGELVRSFRPTFNGQIKALKALPNNRLALPNNRLALVASSPRVMARRSTTSSPFWTQPARSTARGIFSQRVMRCSSGEDLLVQDGYLYIGVTSPM*     * 
       +GE+ R F    +GQ+KAL  LPN +L +                                                                  *     * 
       TGEVRRDFAVDLDGQVKALLVLPNGKLLI  Chapter 7: Additional Work – pQR492 
 
 
 
                                            ORF 2 
492 +3 NGAVDWNWRPNFNGTVNGITAASDNSTVHAAGYFTELNNQRAFRLAALNGSDASNIRWEWEPSLKLNITDRIVYAFQFDVQDAGSTVWTAGADHLIANYSKNGYGRISTAISKYGG 
       +G  D +W P FNGTV     ++D    +AAGYFT+                                                                          +S  GG 
       DGVPDRSWNPEFNGTVVDTDVSADGGRFYAAGYFTK                                                                          MSSNGG 
 
 
 
492 +3 DWQDLHLSGNTIYGACHCGDVLFEGSTGYHTYWKESKAVHRMRLVAAFDKDSGEVVGEFSPVLKGASGYGVWESFVDSRGNLWVGGDINRS-LGANGEQRTVGFARFAPRDVTAPS 
       DQ +  +G   Y +CHC +  ++ S  + T          ++ V A+D   +G ++GEFSP + G++  G W  F+   G LW GGD   S       Q   GF R+  +D  AP   
       DVQTIASNGEVTYASCHCNENAYQDSYSWPT         RIQWVGAWDAKTGKQLGEFSPYMLGSNNGGGWSLFIAEDGALWAGGDFTGSRTNLTTAQWNGGFVRYPAQDREAPR 
 
 
 
                     ORF 2 
492 +3 TPSNLSV-QRDGSTDKLSWSGVRESGARYQVLRDDRVIATVSGTSYEVEHTDGARYYVRSIDASENFSASTGAAQA*VRLLI*FL*AAAWFGLCRVCGVRVRRRCTRGVCPL 
        P  ++  Q    T  L+W+   ++ A Y+VLRDDRV+AT       V      RY+VR++D + N SA+T  A A* 
       VPDKVTFNQSTAKTVGLTWAEASDA-ASYEVLRDDRVVATSISPRATVPRGGDDRYFVRAVDEAGNRSATTHVAVA* 
 
 
 
 
492 +3 *FWFGPVFPVCYLFAPVAAMMGWDSLRRMGCFRPFR*WAES*SVVFLRCWYDRGNFTDF*RSASYGCVATVGFVREGWGVFIQFPITTLTDSGYRLAVSAVHNASPLPRCLVT 
 
 
                                    
 
                                   ORF 3 
492 +3 MLCLVWGGCCCVNCSFLLCAG*GL*ERQMNFLPFTRGGRAQGAASSASEGSRVASRSGSRALGAAAASFAMVAASLGPIASGAQAADARYYDGSSSERAAASCWEVKQNNPRGKSG 
                                                                                                  DG S+  AAASCWE+KQN+PR ++G 
                                                                                                  DGLSAATAAASCWEIKQNDPRSQNG 
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                                                                                                            ORF 4 
492 +1                                                                                        GTTWQDFKAHRDSSTEWTWTLRSKMFWSN 
492 +2                                                                                  ORF 3 GT+W D+ A R S T WTWT 
492 +3 AYWLYTPAMSAPEQFYCDQETDGGGWVMIGRGRESWTENYYGRGNADQLYKNPT---GFDAVQLSGVTVNALLNGTRPQDSIARER*GTSWPDWGAWRRSGTWWTWT 
       YWL T  M AP QF+CDQ TDGGGWV+IGRGRE W      G+G+ ++L   P     F+ VQ S  TVN LL GT   D      * 
       YWLQTSTMDAPGQFFCDQTTDGGGWVLIGRGREGWETWSQGGQGDQEKLKTRPRTAGDFEVVQASHQTVNGLLGGTSVSD      * 
 
        
 
492 +1 ISVKNTWQYSNRYDYANRGQVAGNIFTHDSDDFRSLNFEEKASQGYKLGFTYGRNAKITWWTETYLMNRPSAYIYRPADDSTTPLVFTQMFLRPKVTQNDLVAKGLHDYGQQGAAA                       
                                                                                                              
                                                                                                                                                          
 
 
492 +1 SNRRALPNSYSEKWKWRTSADTGTGKNGEMNTQVEAITEVGGAVFTGGDFAYVESASGEKVEQAFLAGYEVGTGELRRSFRPKINGQVKSVEALPNGLLAVGGSFDQVNGEYYNG 
                              TG++ E N  V+A  +    VF GG+F   E+A+GE + +  +A ++  TGE+RR F   ++GQVK++  LPNG L +GG F +  GE + G  
                              TGRSTEGNAPVQAFAQKDDTVFVGGNFTAAENATGESLPRTAVAAFDATTGEVRRDFAVDLDGQVKALLVLPNGKLLIGGDFLRAGGEEHRG 
 
        ORF 4 
 
492 +1 FVILVPGPSLN 
        V++ P 
       TVLVDP 
 
 
Figure 6 Sequence alignment of the entire amino acid sequence of pQR492 and all areas of homology to the BLAST database. Top line is the probable full amino acid 
sequence of pQR492. Open reading frames located by the ORF Finder program of NCBI are highlighted in yellow with arrows marking the beginning and end. pUC19 bases 
at the beginning and end of the 492 sequence are shown highlighted in green. Asterisks denote a stop codon and frameshifts are illustrated by the continuation of the amino 
acid sequence on a higher or lower text line, and frame is shown by +1, +2 or +3 at the left hand side of the sequence. The promoter region between ORF’s 1 and 5 contained 
multiple stop codons in all 6 frames, making the true amino acid sequence difficult to identify. Chapter 7: Additional Work – pQR492 
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  Knowing that much of the pQR492 sequence, whether contained within a single ORF 
or not, did share similarity with cauri_0414, and given the similar lengths of the two proteins, a 
clustalw  alignment  was  used  to  identify  exactly  where  the  ORF’s  1  –  4  aligned  on  the 
cauri_0414 gene. To check this, the 4 ORF’s were individually aligned with the full amino acid 
sequence of cauri_0414, shown in Figure 7. 
  Figure 7 illustrates the sequence similarity shared between ORF’s 1, 2, 3 and 4 and 
cauri_0414. ORF’s 3 and 4 share sequence similarity with ORF 1 and the corresponding region 
on the cauri_0414 sequence, which gives the impression that the protein encoded by pQR492 
could fold back on itself and is in fact not related to cauri_0414. As the pQR492 text sequence 
was aligned in a piecemeal fashion over a period of about 3 years, there was a small possibility 
that one or two fragments had been misplaced or repeated in the sequence, which could have 
led to the scenario in Figure 7. To check for overlapping text in the pQR492 sequence a DNA 
dot  blotting  program  (www.vivo.colostate.edu/molkit/dnadot)  was  used,  which  checked  for 
areas of repeated sequence. According to this program there were no such repeated regions in 
the nucleotide sequence of pQR492, meaning that instead of repeated regions due to human 
errors during sequencing or alignment, the nucleotide sequence in the original organism and the 
corresponding protein structure contains repeated domains which are a legitimate part of the 
domain architecture. That there is evidence of repetition in the raw text sequence of pQR492, 
but there is in the protein structure could indicate that, as the organism has evolved, the DNA 
sequence has changed but the protein structure has conserved these repeated domains which 
may serve a functional purpose. The same dot blotting program was used to check if the closest 
homologue to ORF’s 1-4, cauri_0414, contained any regions of repetition similar to that seen in 
pQR492, but none were found. This finding posed an interesting scenario where, instead of 
seeing the expected alignment of ORF’s 1 – 4 from pQR492 along the length of cauri_0414, 
there appeared to be a region of similarity between the first and second half of pQR492, which 
could functionally differentiate it from the cauri_0414 protein. To see if the ORF arrangement 
around cauri_0414 was similar to pQR492, the genes in the immediate vicinity were checked.
    
50aa  420aa 
1 
640aa  760aa 
2 
cauri_0414 (1,213 aa) 
3  4 
Figure 7 Alignment of putative ORF’s from pQR492 with cauri_0414 of C. aurimucosum using 
clustalw multiple sequence alignment program.  Chapter 7: Additional Work – pQR492 
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  According to Genbank the full length of the putative membrane protein cauri_0414 is 
3,639 bp and lies immediately downstream of another putative membrane protein, cauri_0413, 
of 1,587 bp and upstream of a smaller hypothetical protein, cauri_0415, of 567 bp (Figure 8). 
This  section  lies  between  450  and  455  KB  on  a  2.79  Mb  genome.  The  567  bp  protein, 
cauri_0415, does not appear downstream of ORF 1 in pQR492, or indeed anywhere in the 
pQR492 insert sequence. The level of homology between cauri_0414 and ORF 1 is very low 
however, because  of the  general  level  of  homology spread across the pQR492 fragment to 
Corynebacterium  aurimucosum, and  since  pQR492  does  not  contain  the  1,213  amino  acid 
protein cauri_0414, it may contain a similar protein from a related organism. 
 
 
 
Figure 8 Corynebacterium aurimucosum genome fragment showing the location of the 3,639 bp 
cauri _0414 gene, showing the highest homology to ORF 1, the largest in pQR492, at 1,557 bp.      
  
 
  What is clear from this analysis so far is that pQR492 contains a fragment of microbial 
genome showing various (low) degrees of homology to Corynebacterium aurimucosum ATCC 
700975  and  Actinomyces  odontolyticus.  Both  these  organisms  belong  to  the  phylum 
Actinobacteria and share some characteristics. They are both Gram positive rods capable of 
anaerobic metabolism, and are both constituents of the skin flora. These organisms are both 
classed  as  high  G+C  content  with  A.  odontolyticus  having  a  65%  G+C  content  and  C. 
aurimucosum at 60% G+C content. Corynebacterium aurimucosum ATCC 700975 has been 
fully  sequenced  so  the  distinct  lack  of  full  homologous  sections  between  pQR492  and  the 
NCBI  database  could  imply  that  an  unknown  representative  of  the  Corynebacteria  or 
Actinomycetes has been isolated in this case.  
  To find out more about the functional role of domains contained within cauri_0414 and 
the  ORF’s  of  pQR492  the  Pfam  database  was  used,  provided  by  the  Sanger  Institute 
(www.pfam.sanger.ac.uk). The Pfam database is a large collection of protein domain families. 
Each  family  is  represented  by  multiple  sequence  alignments  and  hidden  Markov  models 
(HMMs).  There  are  two  levels  of  quality  to  Pfam  families:  Pfam-A  and  Pfam-B.  Pfam-A 
entries are derived from the underlying sequence database. Pfam-B families are un-annotated 
and of lower quality as they are generated automatically from the non-redundant clusters of the 
latest ADDA release. Although of lower quality, Pfam-B families can be useful for identifying 
functionally conserved regions when no Pfam-A entries are found (Finn et al., 2008). Pfam 
search results were used to compare domains present between cauri_0414 and ORF’s 1 – 4. Chapter 7: Additional Work – pQR492 
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From cauri_0414, five Pfam A entries and 3 Pfam B entries were found, and are illustrated in 
Figure 9.  
 
 
 
Figure 9 Results of Pfam search of gene cauri_0414 of C. aurimucosum. Pfam A results are shown 
above the bar depicting the entire 1,213 amino acid protein of C. aurimucosum, and Pfam B results 
are shown below the bar in regions denoted by the vertical lines.  
 
 
  With this information, ORF’s 1 to 4 of pQR492 were also compared for shared domain 
architecture with cauri_0414 or similar proteins. These results are shown in Figure 10.  
 
 
 
 
Figure 10 Results of Pfam search of ORF’s 1 to 4 of pQR492 for domain architecture similar to 
cauri_0414. ORF’s  are  depicted  by  the  white rectangles  and  vertical  lines illustrate  where  the 
architecture has been identified. All matches are to Pfam A and therefore are depicted above the 
white rectangles. ORF 2 has not been depicted here because it contains no Pfam A or B matches. 
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  Constructing  Pfam  diagrams  helped  to  locate  areas  of  similar  domain  architecture 
between the ORF’s of pQR492 and the nearest BLASTp homologue, cauri_0414, with the aim 
of identifying a potential role of the protein encoded by pQR492. Figures 9 and 10 show clear 
repetition of the fibrinogen beta and gamma chains, C-terminal globular domains, between 75 
and 260 amino acids on cauri_0414, and ORF’s 1 and 3. ORF 4 contains architecture similar to 
the  SLA1  domain  which  is  thought  to  function  as  an  endocytic  adaptor.  The  presence  of 
fibrinogen related domains could, if also present on the surface of neighbouring bacteria, act as 
a focal point for some binding interaction. Clearly, the presence of fibrinogen related domains 
in both pQR492 and cauri_0414 was the source of previous sequence identity, but does this 
mean that these two proteins share a similar function? 
  Because of it’s similarity to cauri_0414, a putative membrane protein, the topology of 
pQR492 was checked to highlight potential membrane spanning domains. This analysis was 
carried  out  using  InterProScan  of  expasy  tools  (/www.ebi.ac.uk/Tools/es/cgi-
bin/iprscan/iprscan.cgi?), which combines  different signature recognition  members  native to 
the InterPro member databases into one resource  (Zdobnov & Apweiler, 2001). Figure 11, 
which represents ORF 1, contains a signal peptide followed by two transmembrane regions, 
and  a  fibronectin/fibrinogen  binding  domain.  The  presence  of  a  signal  peptide  and  a 
transmembrane domain indicates that this protein could be targeted to the membrane in the 
original  organism,  therefore  strengthening  its  position  as  a  potential  membrane  protein  as 
initially indicated from its homology with cauri_0414.  
 
 
 
Figure 11 InterProScan analysis of ORF 1. This diagram illustrates the presence of a signal peptide 
and two transmembrane domains which was not identified in any previous analysis and which 
could  indicate  that  this  protein  is  targeted  and  anchored  to  the  bacterial cell  membrane.  The 
presence of two transmembrane domains could indicate that the protein is either intracellular or 
extracellular.  
 
 
  Regions of pQR492 shared domain architecture with the first half of cauri_0414 in the 
fibronectin/fibrinogen  like  domains,  indicating  a  similar  functional  role  for  both  of  these 
proteins, so the other half of the cauri_0414 protein was checked for topology which could 
confirm or deny further similarity to pQR492. The program InterProScan did not identify any 
further regions of homology to pQR492 other than the fibronectin/fibrinogen domains already 
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the  role  of  cauri_0414  further  from  pQR492.  This  analysis  means  that  so  far,  protein 
cauri_0414 is the closest homologue to ORF’s 1 – 4 of pQR492 and there is no additional 
information available to differentiate them further. 
  It was initially thought that ORF’s 1-4 could be part of the same protein, potentially 
one closely related to cauri_0414, and that sequencing or alignment errors could have resulted 
in the frameshifts present between the ORFs. However, these ORFs could each represent a 
separate gene and if this is the case they should each be preceded by a ribosome binding site 
(RBS). Ribosome binding sites consist of a Shine-Dalgarno (SD) sequence (4 - 9 bases long), 
positioned 3 – 11 bases upstream of the initiation codon, usually ATG (Winnacker, 1987) but 
which  can  also  be  GTC  and  CTG  in  high  G+C  organisms  like  that  partially  cloned  into 
pQR492. Although much is known about RBS’s in E. coli, there were no guarantees that RBS’s 
from the organism pQR492 originated from would follow the same rules. Gene recognition is 
made much more difficult by the interruption of reading frames by frameshifting, which can 
either be biological or caused by sequencing or alignment errors, which was a possibility in this 
case.  The  pQR492  text  sequence  (Appendix  7)  was  checked  by  eye  for  RBS’s  because 
computer programs for this purpose may not recognise the gene recognition features present in 
pQR492, many being based on the gene start sites of E. coli, where the inserted fragment in 
pQR492 probably originated from a high G+C organism. Two potential RBS’s were identified 
upstream of ORF 1 and these are illustrated in Figure 12. 
 
 
 
Figure 12 Potential ribosome binding sites of ORF 1. Potential SD sequences are underlined and 
the potential start codons are shown in bold typeface. The vertical arrow indicates the ORF start 
position as proposed by the ORF Finder program and the horizontal arrow indicates direction of 
translation. 
 
  Although ORF’s can be predicted with some degree of accuracy using current online 
programs, gene start sites are somewhat more difficult for a computer program to pin down. 
Because the pQR492 sequence was a manageable size, the 5 ORF’s were checked for RBS’s by 
hand. The first potential RBS in ORF 1 is the most likely true start site. The SD sequence 
GAAAG is followed 6 bases downstream by the start codon ATG, which also indicates the 
proposed start position of ORF 1, illustrated by the vertical arrow. However, there is a second 
potential RBS 160 bases downstream of the first which is again comprised of the SD sequence 
GAAAG  followed  by  ATG.  The  validity  of  start  site  prediction  can  only  be  tested 
GAAAGCGCCGCATGCCCATCATGTCTGCTAGATGGGGTGCTTTCGCCTCGCTTGTACTGCTTTACTG 
 
GCGACCTCTTACTCTTACTATCAACCCTCCGGTTTTCAGTATTTACTGCGGTTTTTCTAGTGCGCTAA 
 
ATTCACCGTATCTTTCGATGTTTCTTCCGGAACGTCGCATCAGAAAGACGCATATGACAACCACATA 
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experimentally; therefore what is said here is by no means without question, however given the 
predicted ORF start position the first potential RBS appears to be the most probable. 
  Carrying out the same analysis on the nucleotide sequence at the beginning of ORF 2 
again identified two potential RBS’s, illustrated in Figure 13. 
 
 
 
 
Figure 13 Potential ribosome binding sites of ORF 2. Potential SD sequences are underlined and 
the potential start codons are shown in bold typeface. The vertical arrow indicates the ORF start 
position as proposed by the ORF Finder program and the horizontal arrow indicates direction of 
translation. 
 
 
  The first potential RBS of ORF 2 consists of the SD sequence AGGA followed by the 
translational start site CTG 7 bases downstream. Although this potential RBS fits the ‘rules’, 
i.e., the SD sequence (4 - 9 bp) is positioned 3 - 11 bases upstream of the start codon, there is 
another  potential  RBS  further  downstream  which  both  fits  the  rules  and  is  closer  to  the 
proposed ORF start position. This potential RBS, consisting of the SD sequence AAGG , is 
followed  11  bases  downstream  by  the  start  codon  ATG  and,  because  it  is  closest  to  the 
proposed ORF start position (indicated by the vertical arrow), appears the most likely RBS of 
the two illustrated for ORF 2. 
  The  same  analysis  carried  out  on  ORF  3  identified  only  one  potential  RBS  at  the 
proposed ORF start position, illustrated in Figure 14. 
 
 
 
Figure 14 Potential ribosome binding sites of ORF 3. Potential SD sequences are underlined and 
the potential start codons are shown in bold typeface. The vertical arrow indicates the ORF start 
position as proposed by the ORF Finder program and the horizontal arrow indicates direction of 
translation. 
 
 
  With the SD sequence AGGAG followed 6 bases downstream of the translational start 
site ATG, and in the same position as the proposed ORF start site, it appeared that this was the 
only sequence capable of acting as the RBS for ORF 3. 
  Repeating the process for ORF 4 revealed two potential RBS’s, illustrated in Figure 
15. 
AGGTCTCTAGGAGAGACAAATGAATTTTCTTCCGTTCACGCGTGGAGGG 
   
CTGGCAGGATCTGCACCTGAGCGGTAACACCATTTACGGCGCGTGCCACTGCGGTGACGTCCTCTTTGA 
 
GGGTTCTACCGGTTACCACACCTACTGGAAGGAATCGAAGGCGGTTCACCGCATGCGCCTGGTCGCGG 
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Figure 15 Potential ribosome binding sites of ORF 4. Potential SD sequences are underlined and 
the potential start codons are shown in bold typeface. The vertical arrow indicates the ORF start 
position as proposed by the ORF Finder program and the horizontal arrow indicates direction of 
translation. 
 
 
  Although there is only one potential RBS close to the proposed ORF start site (vertical 
arrow), the situation is not as clear cut as that for the other ORF’s. The nearest proposed ORF 
start site is 9 bases upstream of the SD sequence, which is followed 4 or 5 bases (depending on 
whether the SD sequence is GAAGA or GAAG) downstream by the translational start site 
CTG. Although this is probably the most likely RBS for ORF 4, the other one should also be 
considered which begins 38 bases upstream of the proposed ORF start site, consisting of the SD 
sequence AAGG followed by the translational start site GTG 6 bases downstream. Since both 
of these potential RBS’s fit the ‘rules’, the most likely of the two is probably that closest to the 
proposed ORF start site. 
   The RBS analysis showed that each of the 4 ORF’s with similarity to cauri_0414 of C. 
aurimucosum could contain its own RBS and could therefore be individual genes. They could 
also be part of the same operon since they share homology to the same membrane protein, 
cauri_0414.  
 
  Going back now to Figure 4, which showed all the ORF’s identified in pQR492, the  
first ORF in frame 1 (in yellow and now known as ORF 5) in 3’ to 5’ direction  was also 
analysed  in  some  detail.  Because  this  chapter  was  the  last  to  be  written  prior  to  thesis 
submission, an update in the BLAST database on the 5
th August 2009 provided this match to a 
R.  mucilaginosa  transcription  repair  coupling  factor  (TRCF),  where  previously  the  highest 
homology was to the same protein from the organism Kocuria rhizophila at 52% identity. The 
conserved nature of TRCF’s means they are invariable between species, which could imply that 
although ORF 5 shows 95% identity to the R. mucilaginosa TRCF, this does not necessarily 
mean pQR492 contains 6.3 kb of the R. mucilaginosa genome. The entire TRCF gene which 
appeared in the BLAST database on the 4
th August 2009 was 1,249 amino acids in length, far 
longer than ORF 5 at 430 amino acids. To find out what part of the TRCF gene was present in 
pQR492, both TRCF and ORF 5 were aligned using clustalw, illustrated in Figure 16 which 
confirmed that pQR492 contained the first 430 amino acids of the TRCF gene. This meant that 
locating a probable RBS for this gene within the 211 amino acid region between the start of 
ORF 5 and the start of ORF 1 was quite likely. As expected, no stop codon was present before 
the BamHI site of the pUC19 vector, which confirms that the full length version of the gene 
cloned into pQR492 was probably shortened due to fragmentation during the cloning process.  
AAGGCTCACCGTGATTCCAGTACCGAATGGACTTGGACTTTGCGTTCGAAGATGTTCTGGTCAAATA 
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ORF 5  RQIHSDAPNRHRSIPTIHSSPPAQPPQAKTPDSGEPVSTTRKATAQPLEAPLHPLLNTLN 
trcf   ------------------------------------MSTTRKATAQPLEAPLHPLLNTLN 
                                           :*********************** 
ORF 5  QLSSWAAIRTAASAQPTERSARTLIGAVAGRHAALIADISTAVRDTTAEALSLIIAPTDR 
trcf   QLSSWAAIRTAASAKPAERSARTLIGAVAGTHAALIADISAAVRGTTPEVLSLIIAPTDR 
       **************:*:************* *********:***.**.*.********** 
 
ORF 5  QAEDLAAALRSYLPAADIALFPAWETLPHERLSPRSDTVGRRLQVLRAMTGEAAKRPQVV  
trcf   QAEDLAAALRSYLPAADIALFPAWETLPHERLSPRSDTVGRRLQVLRAMTGEPSSRPQVV  
       ****************************************************.:.***** 
 
ORF 5  IAPVRAVIQPIVTGIEKLEPVHLVEGEEYPFKDVVRGLNDAAYSRVDLVAKRGEYAVRGG  
trcf   IAPVRAVIQPIVTGIEKLEPVHLVRGEEYPFKDVVRGLNDAAYSRVDLVAKRGEYAVRGG  
       ************************.*********************************** 
 
ORF 5  IIDVFPPTATTPVRLEFFGDELDEMRHFSVADQRTLSGGEELTELTLLPCRELLITPEVM  
trcf   IIDVFPPTATTPVRLEFFGDELDEMRHFSVADQRTLSGGEELTELTLLPCRELLITPEVM  
       ************************************************************ 
 
ORF 5  SRAARLKADYPAAAAMLEKIAGGIYVEGMESLTPLLIESMNTLTELLPAGSMIINVEPER  
trcf   SRAARLKADYPAAATMFEKIAGGIYVEGMESLTPLLIESMNTLTELLPAGSMIINVEPER  
       **************:*:******************************************* 
 
ORF 5  VRARAEDLVATNEEFLAAAWDTSAEADAVAPIDLGQLRMSDSGFRTIDQTTAQALEAKLS  
trcf   VRARAEDLVATNEEFLAAAWDTSAEADAVAPIDLGQLRMSDSGFRTIDQTTTQALEDKLS  
       ***************************************************:**** *** 
 
ORF 5  WWEITELVTDADLLEDAAAGALENQSIADAIEDGIDSLTPS-------------------  
trcf   WWEITELVTDADLLEDAAAGALENQSIADAIEDGIDTYTVNATPATAFNGSVERMLSQVG  
       ************************************: * .                    
 
ORF 5  ------------------------------------------------------------ 
trcf   DLIQQQWTVLALTNGRGSTDRLIDLFHSGEGAPAVPAARRTSLEADPAGDLEHGIVEVCE  
                                                                             
 
 
 
Figure 16 Clustalw alignment of ORF 5 with transcription repair coupling factor, part of the Mfd 
superfamily  of  helicases.  The  full  length  transcription  repair  coupling  factor  (TRCF)  is  1,249 
amino acids in length (full length not shown on the clustalw alignment) and is illustrated by the red 
arrow  under  the  sequence  alignment.  The  yellow  arrow  illustrates  ORF  5,  contained  within 
pQR492, and therefore depicts how much of the TRCF gene is contained within pQR492. 
 
 
  Because of the  high sequence identity of ORF 5 to the TRCF, it was important to 
identify if these genes (or this gene, if they were one and the same) played a similar functional 
role  in  the  environment.  To  find  this  information,  InterProScan  of  expasy  tools 
(/www.ebi.ac.uk/Tools/es/cgi-bin/iprscan/iprscan.cgi?) was used to try to predict the topology 
of the, albeit, shortened gene captured in ORF 5 (Figure 17). 
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Figure 17 InterProScan analysis of ORF 5. This analysis identified a region containing a P-loop 
containing nucleoside triphosphate hydrolases, a region which is included twice in the full length 
version of the TRCF gene.  
 
 
 
 
Figure 18 InterProScan analysis of the full length TRCF, identified as the closest homologue to 
ORF 5. The P-loop is clearly present in 3 repeated domains of the 230 amino acid conserved region 
of the AAA family of proteins. 
 
  The InterProScan search of ORF 5 identified a phosphate binding loop which are often 
contained in ATP and GTP-binding proteins (Saraste et al., 1990). According to Snider et al., 
(2008) the family of proteins which contain this highly conserved region are called ATPases 
Associated with diverse cellular Activities, or AAA, and they often perform chaperone-like 
functions  that  assist  in  the  assembly,  operation,  or  disassembly  of  protein  complexes.  The 
common conserved module of the AAA proteins is 230 amino acids long, which appears to be 
the part identified on the InterProScan diagram in Figure 17, shown by the thick black line. An 
InterProScan search of the full length TRCF gene showing high identity to ORF 5 located 3 of 
these  highly  conserved  P-loops  in  the  1,249  amino  acid  sequence,  suggesting  that  ORF  5 
contains  the  first  of  these  three  (Figure  18).  From  this  analysis  is  would  seem  likely  that 
pQR492 does contain the first 430 amino acids of a TRCF from a high G+C organism. 
  With confirmation that ORF 5 contained the start of a gene, an investigation could 
begin into possible gene start sites. Potential RBS’s have already been discussed for ORF 1 in 
Figure 12 so what follows is a discussion of the potential RBS’s of ORF 5.  
 
 
 
Figure 19 Potential RBS’s of ORF 5. The top arrow denotes the proposed translational start site by 
the ORF Finder program, and the horizontal arrow denotes direction of translation. 
CCCCAACCAACTCCCACAAGTCCTCACGTCCCCACGAAGCTCCCCGACAC 
 
GTCATCGAAAAGCCCACCACGAGTGCCCAAGAGGACTCAGACCCCAGAA 
   Chapter 7: Additional Work – pQR492 
 
148 
 
  From the diagram, there are three potential RBS’s followed by translational start sites. 
The first potential SD sequence GAAG is followed 13 bases downstream by the alternative 
start codon CTG. Although 13 bases could be considered stretching the rules regarding the 
usual number of bases between a RBS and start codon (usually 3-11), this RBS was included 
because the CTG codon itself was identified by the ORF Finder program to be the start of ORF 
5 (shown by the vertical arrow), which means it could be the true RBS. Further upstream is the 
potential  SD  sequence  GAAAAG  which  is  followed  by  the  start  codon  CTG.  Again,  the 
strength of this sequence as a potential RBS is debatable because there are only three bases 
between the RBS and start codon. The final potential RBS has the SD sequence AGGAGA 
followed by the alternative start codon GTG. Although there are only four bases between the 
proposed RBS (underlined) and the start codon, the RBS could in fact incorporate fewer bases 
than those underlined. For example, canonical guidelines could be met if the RBS consisted of 
any of these base combinations: AGAGG; GAGG; AGAG, which could leave up to 6 bases 
between the RBS and the start codon. There are limitations with all the RBS’s suggested for 
ORF 5 which means it is almost impossible to choose the most  likely without experimental 
confirmation. 
  Although potential RBS’s have been analysed thoroughly for ORF’s 1 - 5, a similar 
analysis of potential promoters would be far more difficult and less accurate. Because promoter 
regions can differ between bacterial phylotypes, and because there was still no confirmation of 
the species level of the organism cloned into pQR492, analysis of potential promoters in box a 
of  Figure  5  was  not  carried  out.  A  study  of  the  high  G+C  organism  Corynebacterium  
glutamicum promoters carried out in 2003 by Patek et al., identified common promoter motifs 
in the -10 and -35 positions which were found to be substantially less conserved than those 
found in E. coli and B.subtilis.  
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Introduction 
  The  present  study  details  the  successful  production  of  the  first  phage  display 
library  to  use  metagenomic  DNA;  previous  phage  display  projects  have  all  used  the 
genomes of single organisms. Combining metagenomics and phage display presents an 
opportunity  to  include  a  multitude  of  bacterial  protein  fragments  with  a  functional 
screening process of elimination. In this project, metagenomics was the ‘broad net’, cast 
to allow detection of a larger proportion of the significant binding events occurring on the 
tongue dorsum than had previously been identified. The incredible molecular instrument 
phage  display  comprises  many  production  stages,  all  with  prospective  hindrances, 
invariably  making  it  a  difficult  technique  to  master.  This  chapter  will  discuss  the 
difficulties and setbacks encountered during the current project, and address methods of 
resolution. 
In general, there are many examples of bacterial proteins binding to host cells, but very 
little data regarding the substrata they have affinity for. The approach taken in this thesis turned 
this around by using the host ligand as the bait for which to ‘fish’ for bacterial proteins that 
interact with them. The  hypothesis  was that tongue  bacteria employ a host  of proteins, far 
beyond those already known, that facilitate binding to the tongue surface and oral cavity, and 
that employing a combination of molecular techniques would help to identify a great deal more 
of them. A variety of proteins from different oral bacteria were successfully identified in this 
study  through  homology  to  the  public  sequence  databases,  and  by  some  functional  data. 
However it may have been possible to achieve greater results by amending and modifying some 
of the decisions made throughout the project. 
Using  metagenomic  DNA to create the phage  display  library is a novel  method  of 
searching a mixed microbial community for binding proteins. But by its diverse nature, the 
DNA may have been the source of issues that were not envisaged at the start of the project. In 
previous phage display publications which use the genomes of single bacteria, typically one or 
two proteins are identified by 3 panning rounds of successful enrichment, the identification of 
one or  more clones containing  overlapping regions  of the same  gene. The  intention in the 
present study was to use this same enrichment process to identify, by the 3
rd panning round, a 
large pool of different genes encoding proteins responsible for bacterial adhesion. This did not 
happen  for  several  reasons.  Firstly,  and  due  to  the  inclusion  of  metagenomic  DNA,  phage 
display library diversity was high which, although this is a positive aspect, did mean that each 
panning round was crowded with an enormous variety of proteins.  Secondly, and in concert 
with the first point, using only 3 rounds of panning did not significantly reduce the large variety 
of proteins identified from the panning process which therefore, and thirdly, resulted in the 
subsequent in silico analysis being insufficient to cover a representative number of clones in the 
library. The resultant diversity of the third round panning eluate could be explained either by 
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specific interactions, the latter being the most likely explanation. In order to find out, further 
experiments, like adhesion assays, on pure preparations of individual clones must be carried out 
to identify how the clone of interest behaves. 
Because of these unforeseen considerations, the range of proteins identified (and still 
awaiting identification) was much wider than expected and more numerous than the group had 
time to investigate. Perhaps this range of binding proteins actually goes some way to proving 
the original hypothesis; that the tongue microbiota do encode an enormous variety of binding 
proteins which facilitate association with the tongue surface and surrounding host proteins. 
 
Phage Display 
The use of the pG8H6 phagemid vector system in this project was based on the success 
of  our  colleagues  at  the  Eastman  Dental  Institute  in  their  discovery  of  several  new  genes 
encoding potential adhesins when using phage display libraries made from single organisms 
(Williams et al., 2002; Mullen et al., 2007). However, the phagemid system has many issues, 
occasionally these are  individual to  each project, but in  many cases they are  not. Because 
genomic DNA is randomly fragmented before cloning into the pG8H6 phagemid vector and 
both must be in frame for expression, ribosomal slippage is often required in either the poly-His 
or c-Myc regions in order to produce the inserted protein in the correct frame with both tags 
and  therefore  the  coat  protein  8.  However  this  slippage  could  be  detrimental  to  protein 
production, an issue noted more than once (Jacobsson & Frykberg, 1995 & 1996; Carcamo et 
al., 1998). Jacobsson and Frykberg are known for their work on phage display vectors and 
found  this  problem  of  frameshifting  was  extremely  common.  In  1996  they  developed  the 
pG8H6 vector, used in this project, with a deliberate ribosomal slippage sequence (poly-His) 
inserted in front of the fusion protein, so that the sequence would frameshift naturally to end up 
fused to the coat protein. Jacobsson found that all of their resulting inserts were out of frame 
with the phagemid vector, either +1 or -1 in all cases, which led them to suggest that the system 
was selecting against clones in the correct frame.  Frameshifting downregulates expression of 
the fusion protein; although  it should remain high  enough for display at the phage surface 
(Jacobsson et al., 2003) although, unfortunately sometimes, this expression level may be too 
low to enable binding or detection (Jacobsson & Frykberg, 1998). For this reason, the group 
went on to design the phagemid vector pG8SAET, which contains an E-Tag in frame with gene 
8. Because the E-tag is out of frame with the signal sequence until a foreign insert is spliced in, 
this restores the reading frame in 1-in-18 clones. Following successful panning, the number of 
clones in the correct frame will then increase leading to, they claimed, almost 100% correct 
clones. The metagenomic DNA in the current project was used in both pG8H6 and pG8SAET, 
however the pG8H6 library came to fruition first and because phage display libraries take so 
long to make, library construction in pG8SAET was discontinued. Chapter 8: Discussion 
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The pG8H6 system has the added limitation that fusions are to the C-terminal end of 
the displayed polypeptide which may impair identification of binding domains located in the 
extreme C-terminal end of the foreign protein. Crameri and Suter (1993) solved this problem 
by creating the phagemid pJuFo that contains gene III fused to the Jun-gene fragment and Fos-
gene after which the foreign DNA is inserted. Thus, through the interaction between Jun and 
Fos, the foreign polypeptide is displayed at the phage surface (Jacobsson et al., 2003). The 
variety of phagemid vectors available demonstrates the flexibility with which phage display can 
be used. Perhaps pG8H6 was not the optimal phagemid to use in the current study, however 
there was no guarantee that others would have performed better. 
The problem  of frameshifting is common  in phagemid libraries, noted by Carcamo 
(1998)  who,  although  using  coat  protein  III  for  display,  noticed  46%  of  clones  contained 
‘unusual  sequences’;  in  other  words  they  contained  either  stop  codons  or  frameshifting, 
resulting in an out-of-frame protein. So-called ‘unusual sequences’ were easier for the Carcamo 
group to spot as the library was constructed from a single synthetic stretch of 145 nucleotides. 
In the same study the group also noted that the frequency of inserts appearing out of frame was 
linked to the ligand used for selection. This appears also to be the case in this project where 
proteins identified from the IgA panning experiment were mostly out of frame and in the BSA 
panning experiment were, with few exceptions, short (around 30 amino acids) and contained 
both tags, and therefore in frame. It would appear on the basis of this evidence that there is a 
selection for inserts which are out of frame, which are then corrected by the inherent ribosomal 
slippage feature of the phagemid vector during the translation process. However in some cases, 
particularly  the  IgA  panning  eluate,  this  slippage  did  not  operate  sufficiently  to  allow 
expression of many of the proteins from the library.  
  The  choice  of  coat  protein  8  for  peptide  display  appeared  straightforward  at  the 
beginning of this study as protein 8 – present in ~2700 copies - allows polyvalent display of 
fusion proteins, therefore opening up the possibility of identifying weaker binding interactions 
as well as strong from the panning process. This was thought to be a useful trait which would 
allow identification of proteins which did not demonstrate strong affinity for the ligands used 
but which may still have been involved in the binding process. However, the likelihood of 
identifying any fusion proteins  with strong affinity  was probably  lowered by  incorporating 
metagenomic DNA  with the  gene 8 phagemid  vector. The reasoning behind this  is that an 
increased variety of recombinant phage going into the panning experiments will have resulted 
in  the  elution  of  an  increased  variety  of  fusion  proteins. Because  the  pool  of  ‘interesting’ 
proteins is now so large, the number of proteins from the panning eluate able to be analysed 
individually  became  a  much  lower  proportion  of  the  entire  eluate  pool.  Some  of  these 
‘interesting’ proteins demonstrated non-specific and weak affinity to the ligand which, because 
of  a  higher  number  of  fusions  on  the  phage  surface,  would  bind  tightly  through  increased Chapter 8: Discussion 
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avidity. Indeed, this did happen with clones 30, 39 and 44, analysed with adhesion assays. It 
appears that the failure of these clones to bind back to the original ligand refuted their binding 
specificity in the first place. Panning works on the premise that non-specific clones are washed 
away,  leaving  those  with  a  specific  binding  interaction.  In  reality  however,  washing  may 
remove  those  clones  which  are  specific,  but  which  are  weakly  bound  due  to  a  reduced 
expression level, or those which have few fusions on the phage surface. These bound but non-
specific ‘decoy’ sequences in this project absorbed a significant time investment in sequencing 
and analysis before finding that they demonstrate very little ligand specific binding, or that the 
inserted DNA sequence contained a frameshift or stop codons. It was estimated by Cesareni 
(1992) that there could be between 100 – 1000 fusions per phage, which means that the ability 
of  a  weakly  binding  fusion  protein  to  appear  as  one  with  strong  affinity,  simply  due  to 
increased  avidity,  is  very  high  (Cesareni,  1992).  However,  there  is  some  disagreement 
regarding the number of fusion proteins appearing on the phage surface, with Clark and March 
stating in 2006 that larger proteins (25 kDa) can be displayed less than once per phage.  
  The Carcamo study also agrees with the Jacobsson work, stating that for some of their 
‘unusual  sequences’,  expression  of  the  inserted  gene  (b-gal)  did  occur,  indicating  that 
successful translation of clones containing frameshifts (either +1 or -1) is not a rare event.  It 
would appear that a similar trend occurred in this study, where out of 253 clones analysed in 
antibody screening experiments (with inserts), 69 (27 %) contained multiple stop codons in 
more than one frame (Chapter 4, Table 2), but apparently still showed preferential binding to 
their respective ligand, which enabled enrichment following 3 rounds of panning. A spot check 
of 20 DNA sequences from the antibody screening experiments showed that around 20% of 
sequences with multiple stop codons in one frame had at least one other frame free of stop 
codons. This means that in these 20% of sequences it is likely that, following the frameshift, 
the  sequence  was  still  capable  of  producing  a  fusion  protein.  Unfortunately,  due  to  time 
constraints, none of these proteins were analysed further. 
  One reason why the presence of these frameshifted sequences was so destructive was 
that they were numerically significant among recombinants analysed individually, contributing 
to the analysis time without resulting in a protein of interest which could be tested further. With 
hindsight, using coat protein 3 for monovalent (1 to 5 fusions) display rather than coat protein 8 
for  polyvalent  display  may  have  facilitated  the  identification  of  the  most  strongly  binding 
proteins. Combining monovalent display (protein 3) with metagenomics, though eliminating 
some of the ‘interesting’ proteins with weaker binding affinity, would probably have resulted in 
fewer  eluted  proteins.  A  gene  III  based  library  would  not  have  solved  the  problems  of 
frameshifting  as  Carcamo  (1998)  described,  and  it  would  still  have  been  subject  to  lower 
expression levels by the phage system therefore potentially missing out more proteins, but it 
would have resulted in fewer overall clones which should all have stronger affinity for their Chapter 8: Discussion 
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respective  ligands.  So  far,  only  500  recombinants  from  the  phage  display  library  (10
11) 
constructed  during  this  project  have  been  explored,  leaving  many  more  potential  binding 
proteins unidentified. 
In  filamentous  phage  display,  phage  particles  are  assembled  in  the  cytoplasmic 
membrane  and  secreted  from  the  infected  host  without  disrupting  the  integrity  of  the  cell 
membrane (Mullen et al., 2006). However, the very basis of this life cycle imposes limitations 
on peptide display, where some proteins assembled to form the hybrid capsid protein may have 
inherent properties which prevent the correct transfer through the lipid bilayer of the E. coli 
inner membrane (Castagnoli et al., 2001). Some fusion proteins, whether in their native  or 
unfolded  state,  may  be  too  bulky  to  make  it  through  the  narrow  pore  for  phage  extrusion 
created by phage proteins 1, 4 and 11. It is also possible that some fusion proteins are toxic to 
the E. coli host and if a reduction in expression level continues to result in toxicity to the cell, 
frameshifting may occur and upon closer analysis, the fusion protein may appear to have no 
continuous ORF (Carcamo et al, 1998), a situation which occurred in this project. Most likely, 
the selection for inserts out of frame is a natural way for the system to optimise the production 
of viable phage with recombinant proteins on the surface.  
Fusion proteins may not make it through the bacterial cell membrane for other reasons. 
High G+C organisms contain promoters which may not be recognised by E. coli and therefore 
these DNA inserts may not be produced in this system. Phage display does not allow the total 
expression  of  a  mixed  bacterial  proteome  on  the  surface  of  filamentous  phage  and,  as 
previously discussed, only 1-in-18 fusions will appear in frame on the phage surface. Proteins 
that are only produced under specific conditions would also be missed along with those that are 
quickly  degraded  and  do  not  accumulate  in  the  cell.  Additionally,  genes  shortened  by 
fragmentation prior to library construction may result in shortened proteins which are no longer 
able to fold in their native conformation. Unfolded proteins, if they make it out of the bacterial 
cell on the phage surface, are less resistant to proteolysis and may therefore never appear in the 
panning eluate.  
Alternative  phage  display  systems  to  filamentous  phage  do  exist,  in  particular 
exploiting the lytic phage, whose life cycle involves lysing the host bacterial cell membrane. In 
the  cases  of,  for  example,  T4  or  T7  phage  display,  these  virulent  phage  assemble  in  the 
cytoplasm and lyse the bacterial membrane, negating the need for secretion through the host 
cell membrane. These systems are being trialled by our group at the moment but they have their 
own complexities and problems associated with them. 
 
Panning 
  One of the errors made during this project was to use BSA as a ‘control’ ligand in 
panning  experiments.  Jacobsson  and  Frykberg  discussed  its  successful  use  in  many Chapter 8: Discussion 
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publications; however they used it in phage display libraries containing pure Staphylococcus 
aureus DNA as they were under the impression that S. aureus did not bind to BSA. In the 
panning experiment in this thesis, the control was in place so that fusion proteins identified 
from the (‘more important’) FN or IgA experiments could be compared with those from the 
BSA experiment, and if any isolates were identified from both FN and BSA, or IgA and BSA, 
they  clearly  demonstrated  no  specific  affinity  to  one  or  the  other.  Although  there  was  no 
problem with this reasoning, the enormous diversity of recombinants in the panning eluate, 
which did not become clear until after the panning process and analysis was completed, meant 
that, in order to find out if a protein of interest also bound to the control, all clones from the 
BSA panning eluate would have to be analysed – a feat certainly not achievable during the time 
span for this project. The additional factor not considered prior to panning was that BSA could 
also be a ligand suited to bacterial interaction, possibly due to its structural similarities to HSA, 
the most abundant protein in human blood plasma known for its ability to bind to hydrophobic 
molecules.  
  There are many successful phage display studies in publication (using the genomes of 
single  bacteria),  all  of  which  identified  at  least  one  bacterial  protein  from  a  variety  of 
overlapping clones from the phage display library, and the same was expected from this project 
with  the  proviso  that  many  more  clones  would  require  analysis.  Because  of  the  small 
proportion of clones analysed from each panning eluate, expecting to find overlapping clones 
was short-sighted at best. This was one of the issues thrown up by the combination of phage 
display and metagenomics which was not expected in the initial stages of the project. From a 2 
ml elution following 3 rounds of panning (at 1 x 10
11 CFU), 10 µl of this eluate, enriched with 
potential bacterial binding proteins, was used to infect E. coli and spread on agar plates. Due to 
the enormous time investment required to analyse the clones, a maximum of 500 was ever 
investigated in sufficient detail to tentatively allocate nomenclature or function. This means 
that a further 9.9 x 10
10 clones remained in the library for analysis, clearly illustrating that the 
analysis performed on the 500 clones provides only the most cursory indication of the potential 
bacterial proteins contained within each panning eluate. It is of course realised that of these 9.9 
x 10
10 clones, only 1 in 18 are in the correct orientation and in frame (5.5 x 10
9). Because of 
this and the labour intensive nature of analysis, it is unlikely that a great deal more progress 
could have been made by analysing more clones in the time allowed for this particular project. 
The panning eluates remain at UCL however, and are a valuable resource for more research 
into the proteins with affinity for FN or IgA. The original library also remains, which could be 
used to pan against other ligands. 
  With the benefit of hindsight, two alterations could have been made to the panning 
experiments which may have enhanced their success. Using any animal protein as a blocking 
agent could throw up unseen problems so perhaps the best solution would have been to use Chapter 8: Discussion 
 
  156 
either a plant derived protein (soy protein) or no blocking agent at all. Blocking binding to 
everything but the ligand of interest may have caused a small reduction in the overall number 
of fusion proteins retrieved from the analysis. Secondly, panning for 4, 5 and perhaps 6 rounds 
may  have  reduced  the  variety  of  fusion  proteins  eluted  from  panning,  providing  a  more 
manageable binding ‘proteome’ for each ligand. Of course, additional rounds of panning would 
also have acted to exclude many other fusion proteins from the analysis, as more numerous 
phage were amplified further, some of these not specific binders at all, but being retained by the 
ligand due to the avidity effect.  
  A plethora of potential panning ligands could have been incorporated in this study, 
which would have provided very different results. This could include other salivary proteins 
(Introduction Table 1), other Immunoglobulins and mucins. Any human components used as 
ligands will further the current knowledge as to how and why bacteria and humans exist in 
synergy. In addition, the option of panning against other bacteria would provide an insight into 
inter-bacterial communication such as that already explored by other groups (Egland et al., 
2004). However, the results of this project do highlight a warning to other investigators; using 
metagenomics and phage display together will provide an enormous amount of material which 
needs to be analysed further. It is advisable to simplify experiments as much as possible, by 
using  only  one  ligand  perhaps,  or  by  only  looking  for  the  strongest  possible  binders  in  a 
population. 
 
 
Antibody screening 
  Antibody  screening  was  carried  out  following  panning  to  rapidly  eliminate  clones 
which did not display in fusion with the screening tags, c-Myc and Poly-His, and therefore the 
coat protein 8. The elimination of clones not in fusion with the tags would therefore avoid mass 
sequencing all 300 recombinant clones and concentrate attention on those which would contain 
inserts expressed in frame with the vector and (theoretically) be displayed on the phage surface. 
  Antibody screening initially seemed to solve many problems as a rapid screening step 
which would accurately pinpoint the 1 in every 18 clones supposedly in the correct orientation 
and in frame with the phagemid vector. Once it was realised that the poly-His tag may not be 
identified in clones where the insert contained an inherent promoter and signal sequence and 
that one or both tags could be blocked by a large insert, antibody screening began to throw up 
more  questions  than  it  answered.  It  became  apparent  after  antibody  screening  that  some 
recombinants containing ORF’s showed a negative result for one or both tags, and that some 
recombinants which showed a positive result for both tags contained multiple stop codons in all 
3 frames, and therefore should not logically have given a positive result. This was particularly 
trying  when,  following  sequencing,  some  ‘positive’  recombinants  did  not  even  contain  an Chapter 8: Discussion 
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insert, so the effort made to get these clones to the sequencing stage was completely in vain. 
The antibody screening results (Chapter 4, Table 2) clearly demonstrated the inherent library 
issues such as frameshifting and stop codons; clones affected by this were already present in 
the phage display library before panning and were seen in the antibody screening results table. 
Because  the  antibody  screening  results  made  no  sense  at  the  time,  all  300  clones  were 
eventually sequenced to try to find a  logical  explanation.  As  mentioned previously, clones 
containing  an  ORF  should  have  provided  a  positive  result  for  both  tags,  although  it  was 
possible that the tags might not appear for the reasons stated above. However, there appeared to 
be no possible explanation for clones containing no insert, or an insert in the ‘wrong’ frame as 
coat protein 8, to provide a positive result for tags on the phage surface.   
  Antibody screening however did bring to light the difference in number and size of 
fusion proteins identified from the BSA panning experiment in comparison to FN and IgA. The 
majority of the BSA eluate recombinants included both tags (Chapter 4, Figure 8 (a) and (b)) 
and were around 30 amino acids in size. Of the 77 proteins identified from panning against 
BSA, most of which were in frame with gene 8 of the vector, 61% started with the bases CCC, 
CCA  or  CCG.  It  could  be  possible  that  frameshifting  in  BSA  binding  proteins  is  more 
successful. This could be because, since most of the proteins binding to BSA were very small, 
that these proteins can cross the E. coli inner membrane more efficiently, and so appear in the 
BSA  panning  eluate  in  higher  numbers.  This  would  also  benefit  them  during  the  multiple 
rounds of amplification during panning. Conversely, fusion phage with binding affinity to the 
ligands IgA or FN may be less common, resulting in more availability for ‘decoy’ phagemid (in 
the wrong frame) to bind to the ligand. 
 
Individual Proteins 
  None of the 18 shortlisted proteins shared any homology to the known albumin, FN or 
IgA binding domains tested. Of course, there are probably scores of bacterial binding proteins 
which do not fit any previously noted canonical binding sequence, for example FBP54 and 
SDH in S. pyogenes and PavA in S. pneumoniae (Christie et al, 2002). One possibility which 
was not accounted for in our studies was the likelihood that some proteins in the phage display 
library  would  not  bind  immobilized  FN/IgA,  only  the  soluble  version,  which  is  a  real 
possibility but probably outside the scope of this projects remit for investigation.  
  Eight of the 18 proteins identified following panning of the phage display library were 
‘hypothetical proteins’ or were unrecognised by public databases (Chapter 5, Table 3). This 
result  fitted  with  the  hypothesis  that  a  variety  of  unknown  bacterial  proteins  are  partially 
responsible for interacting with host ligands. It is possible that some bacterial genes from little-
studied organisms still have no function associated with them. In most metagenomic studies, 
even with closure, around 40% of genes cannot be assigned a function (Nichols 2007). The Chapter 8: Discussion 
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result that almost half of the proteins identified in this study have no known function or do not 
match public databases means that the human tongue dorsum remains a potential source of 
novel bacterial proteins and/or binding  mechanisms.  In Jacobsson and Frykberg (1996) the 
complete  genome  of  S.  aureus  was  panned  against  IgG  and  binding  clones  containing 
overlapping inserts were used to identify the gene responsible for binding as protein A, a well 
known IgG binding ligand. A comprehensive analysis with a clear outcome was not possible 
with the phage display library constructed in this project for many reasons. One reason is that 
metagenomic DNA from the human tongue dorsum is not equally or fully represented in the 
public databases. As a result, many of the proteins which demonstrated binding affinity during 
panning  still  have  no  known  function  assigned  to  them.  For  these  ‘unknown’  proteins, 
functional data was needed.    
  Although not previously discussed, mostly because there were no ‘results’ as such, is 
that protein gels were attempted during this project, with the aim of continuing to Western 
blotting. The protein gels were used initially to try to visualise the fusion phage compared to 
phagemid only, which would have provided information regarding the size of the fusion protein 
and  the  amount  of  protein  each  phagemid  produced,  but  would  not  have  revealed  phage 
numbers, or exactly how many copies of the fusion appeared on the phage surface. The protein 
gels were problematic in that the bands on the gel were not able to be clarified, and no fusion 
proteins could ever be visualised in comparison to the control. This may have been because the 
protein gels were of such low quality, and/or that the staining itself was not clear (using Sypro 
Ruby or Coomassie  Brilliant Blue). It is also possible that the  gel resolution  was not  high 
enough to allow visualisation of the smaller fusion proteins (between 50 and 100 amino acids). 
Although  incrementally  higher  proportions  of  acrylamide  were  used  in  successive  gels  to 
capture the fusion proteins, they were never visualised and it was thought illogical to proceed 
with Western blotting experiments. 
A major part of the latter stages of this project was intended to be taken up by pET 
vector expression. The minimal set of requirements for gene expression includes the presence 
of  a  promoter  for  transcription,  and  a  ribosome  binding  site  (rbs)  in  the  -20  to-  1  region 
upstream of the start codon for initiation of translation. Both sites must be suitable for the 
expression machinery of the bacterial host cell, and this suitability may have been a major 
contributor to the downfall of pET vector expression in this project. Besides these cis -acting 
DNA sequences, the formation of an active protein may also rely on trans factors that need to 
be provided by the host organism such as special transcription factors, inducers, chaperones, 
cofactors, protein-modifying enzymes, or proper secretion machinery. Whether or not essential 
trans factors are present in the host is in most cases difficult or even impossible to predict 
(Gabor et al., 2004). None of the proteins attempted in pET vector expression were successful; 
all failing at different stages, however it was considered unlikely that all of these proteins were Chapter 8: Discussion 
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toxic to the E. coli cell, however  with so  many alternative  issues to  consider, it  would be 
difficult to identify exactly why the proteins did not express. The main reason for the failure of 
pET expression is that there simply was not enough time to optimise the process for each clone 
individually. With 18 potential proteins to express and time running out, priority shifted to an 
attempt to prove specific binding of at least one clone to its panning ligand. 
 
Binding affinity confirmation 
  Adhesion assays in Chapter 5 provided preliminary  data on the binding affinity  of 
recombinant clones to the panning  ligands  which first identified them.  The 8 recombinants 
chosen for antibody screening were taken from the top of the list (Chapter 5, Table 1) as the 
fusion proteins were larger and should theoretically have retained some folding ability over 
smaller  proteins.  However,  due  to  time  constraints,  this  did  mean  that  the  remaining  10 
recombinants  on  the  list  were  not  involved  in  any  further  analysis  to  confirm  binding 
specificity. Only 4 out of the 8 recombinants were tested in binding assays, the other 4 either 
did not transform into E. coli or were unsuccessful at the conversion stage. It seemed unlikely 
that  some  recombinants  would  not  amplify  in  pure  phage  populations  as  they  had  done 
previously during panning, but there did not seem to be an adequate explanation why some 
individual clones did not respond to amplification. In all 4 failed cases, the E. coli host cells did 
not grow following either transformation with the phagemid or conversion to phage.  
  In the binding assay, clone 39 did not show preferential binding for the panning ligand 
which identified it (IgA), apparently showing greater binding affinity for FN. Ostensibly, this 
apparent shift in affinity seems unlikely given the specific nature of protein-ligand interactions. 
The 83 amino acid protein displayed on clone 39 may be showing greater affinity for FN than 
IgA in adhesion assays, but it is possible that, had analysis of more clones from the FN panning 
eluate  taken  place,  clone  39  would  appear  more  often  in  that  population  than  in  the  IgA 
population. It is also possible that clone 39 had a high avidity reaction with IgA, and was 
retained in that population over the FN population. 
  From the 4 binding assays carried out, one clone in particular did indicate that it could 
have  affinity  to  the  ligand  which  identified  it  from  panning.  Clone  59  showed  clear 
reproducible binding affinity to IgA, without any outlying results, making it a promising clone 
for further experiments, potentially testing binding strength. Unfortunately, experiments with 
clones 39, 44 and 30 gave some aberrant results which, because these experiments were the last 
ones carried out prior to thesis writing, left no time to incorporate changes to the method. Even 
without  further  experiments,  there  are  clear  indications  that  fusion  proteins  identified  from 
panning experiments do show preferential binding to the respective ligands. It is worth noting 
the potential reason for phage identified by panning not showing affinity for the original ligand. 
Phage enrichment takes place on the premise that bound phage will remain bound during the Chapter 8: Discussion 
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washing process of panning prior to phage elution. Phage that are specifically bound but not 
tightly bound (perhaps through low affinity or low expression levels) will be removed during 
the washing steps, including those which adhere to the plastic or blocking material, leaving 
phage which may not be specifically bound but which have high affinity through polyvalent 
avidity or other interactions.  
  Other  alternatives  were  available  which  could  have  been  used  to  identify  binding 
specificity such as surface plasmon resonance (SPR) – commonly used to measure adsorption 
of a solute (in this case, our protein of interest) onto a surface coated with the corresponding 
ligand, FN or IgA (Mullen et al, 2008). GST fusions were also an option, previously discussed 
in Chapter 5. Alternatives like this were considered but due to a lack of time only adhesion 
assays were used.  
 
16S rRNA gene analysis 
  The common nature of 16S rRNA gene analysis makes it a valuable comparative tool 
in genomics. 16S rRNA gene analysis was used in the present study to corroborate findings 
from the phage display library regarding bacterial proteins from panning, and to help identify 
any shortcomings in the phage display library such as a reduction in bacterial diversity through 
each stage and into the panning process. However, the phage display process provided a much 
less  comprehensive  analysis  of  bacterial  proteins  than  was  first  imagined;  making  the  16S 
rRNA  gene  analysis  in  this  study  very  important,  in  both  assessing  the  range  of  bacterial 
species  from  the  initial  metagenomic  DNA  sample  and  providing  a  basis  for  comparison 
between the present study and others in the area. Although it did not provide any functional 
information, population inferences regarding species were helpful for tentative agreement on 
the species variety between the whole sample (16S rRNA) and variety following phage display 
and panning. 
  The 16S rRNA gene analysis in the present study (Chapter 6) was comparable with 
most studies carried out on or including the human tongue microbiota, in that most studies have 
varied results, mostly due to employing different extraction methods with a variety of primers 
and  occasionally  changing  the  number  of  PCR  cycles.  The  results  from  this  study  were 
compared closely to research carried  out by Riggio  (2008) and Kazor (2003) in particular, 
which showed differences in the abundance of certain species. The metagenomic DNA used in 
this project consisted mainly of Veillonella (26.7 %) and Streptococcus (24.6 %), both well-
known oral genera, but did not recognise a major contribution of Actinomyces or Lysobacter, 
which the Riggio (2008) study identified as important parts of the tongue microbial community. 
  Leaving aside individual discretions which can occur for many reasons, the 16S rRNA 
analysis provided a reasonable assessment of metagenomic DNA diversity. Results from phage 
display functional analysis and 16S rRNA diversity analysis were then compared.  Chapter 8: Discussion 
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Comparison of 16S and phage display analyses 
 
  In order to try to assess the level of diversity in the phage display library, sequence data 
from each stage of the phage display and panning process were compiled. Sequence data from 
the 500 panning clones analysed were used to infer the diversity of the phage display library 
and  compared  against  the  16S  rRNA  analysis  results  to  identify  points  of  disparity.  For 
example,  a  species  identified  from  16S  rRNA  analysis  as  being  present  in  the  original 
metagenomic library, but which was not seen in the panning analysis of 500 clones could be 
explained in several ways. Perhaps, as in the case of high G+C organisms, promoter regions 
were  not  recognised  by  the  E.  coli  host  and  therefore  these  organisms  (and  their  related 
proteins) were not represented in the phage display library. Alternatively, a bacterial phylotype 
may have been present in very low numbers in the metagenomic DNA, notably those bacteria 
present in  low  numbers in the bacterial community, the 16S rRNA amplification  of  which 
could have resulted in identification in the diversity analysis, but which may have appeared in a 
very low proportion of phage display clones. It is well known that oral bacteria can produce 
biofilms, which form in layers consisting of primary colonisers which bind to the host, and 
secondary/tertiary colonisers which bind to the primary colonisers and some late arrivals. As 
the most abundant genus from 16S rRNA analysis, making up almost 27% of clones sequenced, 
Veillonella sp. was identified surprisingly little from phage display and panning clones, and 
appears only twice in the final 18 clones for further analysis. Veillonella is a Gram negative 
oral  commensal  which  is  normally  found  in  synergistic  association  with  Gram  positive 
Streptococcus  sp.,  where  it  utilizes  the  lactate  produced  by  Streptococcus  for  growth. 
Incidentally,  Streptococcus,  present  at  25%  according  to  16S  rRNA  analysis,  was  also 
identified in lower numbers than expected from sequence data of the 500 clones and appears 
only once in the final 18 clones, surprising since Streptococcus sp. are known to encode many 
FN  binding  proteins.  The  low  presence  of  Veillonella  sp.  in  the  panning  eluate  could  be 
explained by the fact that Veillonella acts as a secondary or tertiary coloniser of the tongue 
surface, and the low appearance of Streptococcus could indicate that these two organisms fill a 
similar ecological role on the tongue dorsum. Although colonisation on the tooth surface is 
known in detail, the same is not known for the tongue, and the species which act as early and 
late colonisers to the tooth surface may not on the tongue. On the tooth, proline rich proteins 
(PRP’s)  and  statherin  coat  enamel  which  are  recognised  by  the  early  colonisers  (mostly 
Streptococci),  which  have the  distinct advantage  of the  expression  of  multiple adhesins for 
receptor recognition (Jenkinson & Lamont, 2005). Even though, on epithelial surfaces, mucin 
and  agglutinins  are  the  substrates  for  bacterial  interaction,  the  multiple  adhesins  of 
Streptococcus sp. should enable them to carry out the same ecological role all over the oral 
cavity.  Chapter 8: Discussion 
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 It was hoped that data from successive panning rounds  would provide  information 
regarding  the  enrichment  of  certain  types  of  proteins  (for  example,  membrane  proteins  or 
transport proteins) as round 1 progressed to round 3. Indeed, in the shortlisted 18 clones there 
are  3  supposed  ABC  transporters,  a  SecA  component  for  protein  transport  and  a  chloride 
channel, as well as several hypothetical proteins which could have the same roles. Interestingly, 
most  of  the  sequence  data  showed  mid  to  low  (30  –  60%)  homology  to  the  NCBI  public 
database using BLASTn and tBLASTx (only 25 - 36% showed any similarity to the BLASTn 
database), which makes it very difficult to identify trends imposed by library construction or 
panning. This information in itself seems unusual. The oral cavity supposedly consists of 50% 
cultured  bacteria, a  high  number  given  the  low  percentage  of  cultured  bacteria  from  other 
environments, so the expectation was that BLAST homology of the panning clones would show 
a clear trend regarding the function of the supposed binding proteins. Given the number of 
hypothetical proteins, this was not possible. 
 The  appearance  of  only  16  ‘novel’  phylotypes  from  a  16S  rRNA  analysis  of  333 
clones (Chapter 6, Table 1), would suggest that much of the bacterial species present in the 
phage display library are indeed from known bacteria, suggesting that perhaps full genome 
sequences are not yet completed or fully annotated, so clones identified during this analysis 
may  not  appear. Further,  it  is  not  impossible  that  certain  genes  used  to  facilitate  bacterial 
binding as yet have no functional data associated with them. Of course, the similarity cut-off 
used for the 16S rRNA analysis in this project was 98% where others have used 97%, and that 
extra 1% may have drastically increased the number of ‘novel’ phylotypes from this analysis. 
  An  additional  comparative  observation  is  that  Actinomyces  sp.,  present  at  0.01% 
according to the 16S rRNA analysis, appeared several times  in the phage  display analysis, 
making up 4 of the shortlisted 18 clones. This increase implies that either Actinomyces sp. are 
present at higher numbers in the metagenomic DNA but are not suitably amplified by PCR, or 
that Actinomyces sp. express proteins with very strong affinity for the ligands FN and IgA. The 
first explanation seems more likely, although this reasoning was contradicted by Riggio, 2008, 
who found 5 – 10% Actinomyces sp. in their metagenomic DNA sample, but as a consequence 
of using different primers. However, the very presence of Actinomyces in the phage display 
library  refutes  the  earlier  comment  that  the  promoters  of  high  G+C  organisms  (like 
Actinomycetes) are not recognised by E. coli hosts, as clearly some of them are.  
  Other, more detailed conclusions are difficult to draw. It was hoped that most panning 
clones would clearly identify bacteria and proteins responsible for binding, allowing sensible 
trends  to  be  noted.  For  example,  in  a  hypothetical  library,  the  oral  bacterium/pathogen 
Fusobacterium nucleatum, identified as a  minor player from 16S  rRNA analysis  would be 
expected to decrease in numbers following panning since it is not normally found binding to 
the tongue dorsum, and is in fact a known periodontal pathogen (Kaplan et al., 2009). Chapter 8: Discussion 
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  From this comparison of molecular techniques using the same source of metagenomic 
DNA  clearly  phage  display  libraries  do  not  incorporate  the  representative  mixed  microbial 
community as fusion proteins. The omission of two key genera, Veillonella and Prevotella, 
from the phage  display  library, but which  were  identified as major players during the 16S 
rRNA diversity analysis, could be attributed to any of the phage display nuances previously 
discussed including vector choice, coat protein used for fusion or choice of host bacterium, or 
could simply be due to the ecological role of the organisms as secondary colonisers, which 
would mean these organisms do not normally adhere to FN or IgA. 
 
pQR492 
  The analysis of a 6 kb bacterial DNA fragment required taking a different analytical 
approach where importance was placed on investigating the role of the genes contained within. 
This analysis was a more complete version of that which could eventually have been carried 
out on the individual proteins identified from panning, and a great deal of information was 
found relating to pQR492, mostly because the inserted fragment was larger than any of the 
panning proteins. The  organism from  which pQR492 originated  was probably a  high  G+C 
bacterium, most likely an Actinomycete given the homology of every BLAST analysis carried 
out on pQR492. The estimation that pQR492 contained 4 ORF’s within the same operon was 
probably correct, given that the 4 ORF’s (1-4) appeared to serve very similar functions and 
shared homology to the same protein, cauri_0414 of C. aurimucosum- although it appeared that 
the protein contained within pQR492 differed in its folding or domain architecture given the 
presence of repeated domains which were not present in cauri_0414. Although gene start site 
prediction is an inexact science, some possibilities were identified for RBS’s for each ORF 1 – 
4.  Whether  pQR492  does  in  fact  contain  a  membrane  protein,  the  supposed  function  of 
cauri_0414,  the  closest  homologue  to  ORFs  1-4  of  pQR492,  is  not  known  however  the 
presence of a signal sequence and two transmembrane domains in ORF 1 suggests that this 
protein may indeed play some role at the cell surface.  
  The  part  of  transcription  repair  coupling  factor  (TRCF)  also  identified  in  pQR492 
contained  a  highly  conserved  AAA  module  (ATPases  associated  with  diverse  cellular 
activities). Although AAA modules have many diverse roles, one of these is in the bacterial 
membrane where proteins of this type are involved in protein degradation and unfolding. The 
analysis on pQR492 taken together suggests that the ORF’s 1 – 5 could all play a role at the 
cell membrane. 
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Future experiments 
Given more time, the following experiments would be a useful continuation of the work set out 
in this thesis: 
From the existing clones identified during this project: 
1)  Continue with binding assays of remaining proteins from panning.  
2)  Attempt pET expression with the most promising binding clones from binding assays. 
If pET expression continues to fail, GST vector expression would be a logical next 
step. 
With the existing phage display library: 
3)  Pan the existing library against FN and IgA again, using a plant-based protein as a 
control 
4)  Pan the existing library using for up to 6 panning rounds 
 
 
 
Conclusions 
  This project brings together several molecular biology techniques including shotgun 
cloning (Chapter 7), 16S rRNA diversity analysis (Chapter 6), metagenomics and phage display 
(Chapter 3) with which to interrogate the microbiota residing on the tongue dorsum. In phage 
display,  combining  diverse  ligands  such  as  IgA  and  Fibronectin  against  a  low  stringency 
selection process was designed to provide as many bacterial binding proteins for individual 
study as possible. The use of a protein 8 based phagemid vector was based on the success of 
colleagues; however the combination of only 1 in 18 clones being in the correct orientation and 
in frame plus the use of metagenomic DNA to make the library, did cause the entire project to 
become rather unfocussed due to the very large number of clones from the panning eluate. The 
gene 8 based system increased target binding avidity through polyvalent display, which, along 
with  the  metagenomic  DNA  inserts,  vastly  increased  the  number  and  variety  of  ‘binding 
clones’. Analysis of these clones became a gargantuan task, and meant that only a fraction of 
the panning eluate was ever studied. The issues encountered could not have been foreseen and 
the analysis which was carried out revealed a wide range of binding proteins which could be 
used  by  bacteria  to  bind  to  the  human  tongue  dorsum  and  interact  with  the  immediate 
environment. 
  The tongue dorsum has previously been included in dental studies due to its tendency 
to harbour periodontal pathogens, and the relationship between their presence on the tongue 
and transmission to other areas of the mouth has fascinated dental researchers. However, the 
tongue dorsum is a fascinating environment on its own, unique in the human body with an 
indigenous microbiota unlike any other area. Fitting with this and other dedicated studies, it is Chapter 8: Discussion 
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an ideal environment to search for bacterial binding proteins due to the importance of bacterial 
adhesion in this area, and the mechanisms the human body uses to try to thwart such adhesion. 
Of course, the conditions under which binding interactions were investigated during this study 
are in no way representative of the conditions under which these interactions would normally 
take place. However, the potential of a huge variety of bacterial proteins to bind human ligands 
has been presented which deserves further investigation.  
  Through  the  panning  of  a  metagenomic  phage  display  library,  several  distinct  and 
interesting proteins have been identified, as well as some ‘hypothetical’ proteins which may 
have novel functions involved in facilitating bacterial binding to the human ligands IgA and 
FN. Much more research into the specific nature of each interaction is needed to shed light into 
the field of bacteria-human interaction. This thesis highlights that there are numerous microbial 
species currently using a variety of proteins of unknown function to interact with humans to 
facilitate binding. The diversity of these interactions has been insinuated through the present 
study and the existence of the phage display libraries will allow far more detailed analysis to be 
carried out on these and other proteins. Furthermore, the combination of phage display and 
metagenomics could provide many other opportunities to identify bacterial proteins responsible 
for interaction.  
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Appendix 1   Sample Sheet for Volunteers                
 
Tongue Metagenomic Study              Dear …………  You are number ….. 
 
Included:  1 x toothbrush  
    1 x 10ml PBS (sterile) 
    1 x pack sterile tissues  
    1 x instruction sheet 
 
Instructions for sampling 
 
1.  Swab  tongue  lightly  with  sterile  tissue,  for  5  seconds  maximum.  Aim  to  remove 
salivary contamination from the tongue surface by blotting lightly, not rubbing. 
 
2.  Dip toothbrush in PBS and brush tongue surface as vigorously as is comfortable for 15 
seconds. Concentrate on the middle of the tongue, where the bacterial mat is thickest. 
 
3.  Use PBS to shake off some of the bacteria and repeat the brushing step a further 3 
times (four x 15 second repeats altogether). 
 
4.  After  last  brush,  shake  the  toothbrush  in  the  PBS  to  dislodge  as  many  bacteria  as 
possible. 
 
5.  After sampling, put the toothbrush back in its plastic wrapper and store at -20ºC. 
 
6.  Try to avoid the toothbrush coming into contact with any other area of your mouth at 
any time during the sampling. 
 
7.  Try not to close your mouth between repeats, as doing so will introduce fresh saliva to 
the tongue surface. 
 
8.  Sample collection should be carried out every Wednesday and Friday for 3 or 4 weeks. 
 
9.  Keep your own toothbrush (put your name on it!) 
 
10. Date samples after collection and leave in Sam’s -20ºC freezer. 
 
 
Points to note: 
 
  The samples you provide will be treated in such a way that will attempt to destroy all 
mammalian cells and DNA within the sample. The bacterial information that remains 
will  be  pooled  and  treated  as  a  whole  metagenomic  library  from  human  tongue 
material, so no individual inferences will be able to be drawn from resulting data. 
 
  It is preferable to leave at least 2 hours between eating and collecting your sample. This 
is due to removal of the bacteria colonising the tongue surface by the movement of 
food and saliva around the mouth. 
 
  If you routinely brush the tongue dorsum as part of your oral hygiene regime, this will 
significantly reduce the volume of bacteria on the tongue surface. On sample collection 
days, please try to avoid brushing your tongue in the morning, if you forget, just leave 
sample collection to as late in the day as possible. 
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Appendix 2  Restriction Map of λPst Ladder 
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  Protein BLAST  tblastx  Tag  ORF 
size 
(aa) 
Amino Acid Sequence 
F1  No similarity  Bacteroides thetaiotaomicron 
valyl-tRNA synthetase   
Expect = 9e-49, Id = 84/152 (55%) 
  157aa  YHFNSLQVSHFNDYTVVSLVVVLTDYVQVELNLWSNVLLIAYGSHTADN
RLNLLNSLDEL*FLLAWCIKFEFVTHDTLVILALIDVLPQLLSNERHEWMQ
HLQE*IEEFKGCFVGELVDWFAIFWLNHLQVPA*EFVPEEAVNSHQSF*NT
IGVQVD 
 
F2  No similarity  Uncultured bacterium  genomic sequence 
Expect = 0.058, Id = 14/26 (53%) 
Cmyc  48aa  FGTSEKGVHNYADVKASACTLSMSTSVSKGFQ*SKSERPSAPGGVQVD 
 
F4  CONSERVED DOMAIN 
Arthrobacter aurescens PtrB 
putative protease II  
Expect= 2e-19 
Arthrobacter aurescens TC1 putative 
protease II oligopeptidase family protein 
Expect = 8e-24 
  186aa  DRRPHVRHAVGRRRRPGRRRKLTRPAGAPAAI**PASLFDTLELGVPTAP
AHPHRHPAAQERGRRRHTPFTNP*LNERGGSMAEQNLTPPVPKKVEHRR
EHHGDVFIDHYEWLRDKESEEVLNYLKAEAEYTEAVTADQQPLRESIFNE
IKGQRVGNREEQPLRDDHGTARRDVQVVAGVQGVQVD 
F5  Phenylalanyl-tRNA synthetase 
beta subunit Magnetospirillum 
Expect=0.58 
Listeria welshimeri serovar  cysS 
(cysteinyl-tRNA synthetase) 
Expect = 6e-10, Id = 22/30 (73%) 
polyH  102aa  PASTSASPPQPNAPRSCSPPPTVTPPARRAPWLRRASRLIQRQLDYLHEWS
ASIHQKKLKEIRLSEETYDSNLQHLNKTKRSI*TD*RRKSEHVCVRGVQVD 
 
F6  No similarity  Mycobacterium smegmatis alcohol 
dehydrogenase, Expect = 1e-07 
Id = 25/53 (47%) 
BOTH  88aa  RCWCSW*TLLFRVAMHQKLMLATKSPRAYGALEATSPQESTFPLRARRS
DSRPRLPADTAPPARVGALTCARTCAYSERGWMEGVQVD 
 
F9  Porphyromonas gingivalis 
glycogen synthase, putative  
Expect=4e-10 
Porphyromonas gingivalis glycogen 
synthase 
Expect = 2e-12, Id = 31/44 (70%) 
BOTH  63aa  RSIAGNDKELYTYMDAYDGDQMARELGVEAKHEVEKLAAHKARTVMP
AALPVIASAPAGVQVD 
 
F10  Hypothetical protein 
Leishmania braziliensis 
Expect=3.5 
One match only -Bos taurus    
Expect = 3.7, Id = 12/15 (80%), 
Cmyc  23aa  SSTGTRSTTALRRSWKRSGVQVD 
 
F11  Histidine Kinase Burkholderia 
xenovorans Expect=16 
Dinoroseobacter shibae 60 kDa inner 
membrane insertion protein  
Expect = 6.9, Id = 12/16 (75%) 
  19aa  RGRTVRVPCPTEVAGVQVD 
 
F12  No insert         
F13  pyruvate dehydrogenase 
complex Listeria 
monocytogenes (id 9/11 81%), 
Expect=28 
No similarity    16aa  ARTALVASDIPGVQVD 
 
F14  No similarity  Burkholderia mallei  formate    41aa  SS*GVSTPER*SCDLR*PCTPGTEKQEGDVTIRVLVGVQVD IgA Antibody Screening Results 
 
dehydrogenase accessory protein 
Expect = 0.21, Id = 13/22 (59%) 
F15  No similarity  Human clone (e=0.48) from chr 6. id =8/15 
(51%) 
Cmyc  100aa  PCCSHCFLEANFLLWACSLGLA*ASSLF*PILLVSFGPLSWWLLGPMYLTG
WL*KWAVLTMYSLL*RSNGIYKVMKYYYVLVCIQLFLFSWLSSVGVQVD 
F16  hypothetical protein A.  
odontolyticus 
Expect=0.001 
Acidovorax sp. serine O-acetyltransferase. 
Expect = 5.0 
Id = 12/18 (66%) 
Cmyc  21aa  AFETDREPGEDLRSIEGVQVD 
 
F17  No similarity  Streptococcus sanguinis DNA repair protein 
radC. Expect = 0.003 
Id = 18/30 (60%) 
Cmyc  35aa  NFWLLMICSELINSSL*ILRPNSITARSSMGVQVD 
 
F18  No similarity  2 parts showing homology to same 
sequence = Thermobifida fusca 
regulatory protein, MerR  
Expect = 0.004, Id = 15/27 (55%) 
  55aa  LEKALELEDASNPPEVNAFLLAHPLDVEQALHVTIILVATPPLLTMRNPQG
VHVD 
 
F19  No similarity  Veillonella dispar RNA polymerase B 
subunit  (rpoB) gene 
Expect = 8e-150 
Id = 289/293 (98%) 
BOTH  443aa  P**E*CTSRTSKPARSRDKPPGPRADKRRL*VNSANGFVWSMNWDNWEE
PKNSLIAATTGRMLINA*GVIDSIS*IVIRSRTTRSIRVKPIRNWFCNNSPTQR
RRRLPK*SISSV*PAPSIRLSK*EMLAIISSRVTVR*SNGKLQLLQITLDSTPS
LFTM*NSAKPSPSNTWLFATISSCSSPTCTPASRITSPVSGSTIG*ANV*PNIR
*RQPSFLFNL*RPTRAKS*RRASKNKLSNKLRADSTVGGSPGRNFL*ISTNA
SSAD*VVSFSNVRTMRSS*IGKPSSSVLPFQRGQGCFH*YPNLMHVPIL*LV
IYGYGQYEPLRFRSHRFQARSMHNG*ESLWNP**TVTHLIDFLYYSKTP*R
AYHLGYDTHVLHH***CCYQSSSCSRP*ILLDL*CSVFLDHYLPTIYLHKW
CCVCSITIFTFINIILRLT*GVQVD 
 
F20  sodium dependent transporter, 
Expect=3.5 
Human DNA sequence  
Expect = 4e-53 
Id = 81/81 (100%) 
Cmyc  113aa  SPTAAKIKPSAVDTGVAALTGATVAPTALFLFCLPPTSATTMCLWVPPQL
ELAFPSTRAPSFRDTSYSLQTPGLPLDQTTLSRSRGLGSCTSPKFNTFAPPC
PPRSHLGVQVD 
F21  no significant similarity  Burkholderia sp. histidine kinase, Expect = 
0.068, Id = 18/31 (58%),  
Anaeromyxobacter transcriptional regulator, 
TetR family 
Expect = 0.13, Id = 19/38 (50%) 
  46aa  TGRRTRHIAAADQSCRASSFAVAAMIRSARAFEASRLAVIVGVQVD 
 
F22  unnamed protein product 
homo sapiens Expect=3.3 
Candidatus Desulforudis audaxviator, DNA 
polymerase III, Expect = 1e-17, Id = 33/60 
(55%) 
  79aa  PHYEIY*SHSLRSKRASQILHLQWTLRCHY**NLV*RIPVAP*GRILFSYPSH
DALNLLGLPRCWDYRLEPLRLGVQVD 
 
F23  chromosome 14 ORF 93 homo  Streptococcus sanguinis DNA    142aa  RGS*TASRRERRRNPGAAVPRRHRTALPGQPRQPGFCHHARLIFVFLVETIgA Antibody Screening Results 
 
sapiens 
Expect=4e-06 
recombination protein RmuC, 
Expect = 2e-18, Id = 44/45 (97%) 
GFHHVGQAPRSSRRRATPDPARSRGSACVSTPPGRRSSERPRPESLQTYGI
LI*PIPTPC*CHLHSFGC*AF*SQQTRSSRGLIRYLGVQVD 
 
F25  no significant similarity  Clostridium botulinum str. Loch Maree, 
PTS system, fructose family 
Expect = 3e-60  
Id = 55/76 (72%) 
Cmyc  247aa  PRAIRRGARGPSAAFGSGSSETGADICEAKNPATNAPKNPDGVYANTSLF
RLRILGSARIPPTIPTINPGLSAILRPMNPARIGNIILNEILPK*NNTSAYLL*L
GSSGLNELIPQINDIAIRIPPATTNGSILLTPSIRCL*V*RQMLSSPAESSASSS
APS*L*IGALPSKIV*ISSFGLLIPSATFVIIVGRPLKRATSTFLSAATIIPAALS
ISSLVSLFSTPI*PFVSTLTSSPISLGVQVD 
 
F26  polysaccharide biosynthesis 
protein CapD 
Expect=8e-06 
 
Neisseria meningitidis pilin glycosylation 
protein,  
Expect = 2e-133 
Id = 191/276 (69%) 
Matches all over sequence 
Cmyc  305aa  LAHDPACDSDRSSPQTDDPRHHLRCRSVRPPVVGSHQTG*RIFSHCLCR*Q
PKNPTYRHL*PCRPQPQRNPDADQPLRRPQNPAGDSKFYARRTQRHHPPP
RSIQMRSPDHSGHERFSRRQNQRQLIEKNLCGRFARPRPCDTAP*IDECRH
QRQSRDGDRRRRLYRLRTLPSDSQLPSDQTAIV*IVRICPVQHRQRIARNPS
SARQPSRSRTAFGLGSKQRTP*QHHEDLSRRHRLSCCGLQTRPYGRVQHH
RRHSKQRVRHTLLRTGCRRCRRSTFVLISTDKAVRPTNTMGASKRMGVQ
VD 
 
F27  no similarity  Acidobacteria TPR repeat protein, Expect = 
6.7, Id = 13/29 (44%), 
Cmyc  50aa  LFEHLTDF*KCSVSTPPSSEPPPPNLA*EPKN*DIARKV*S*LSLGVQVD 
 
F28  flavodoxin from 
Fusobacterium nucleatum 
Expect=2e-10 
Nocardioides sp 
phospholipid/glycerol acyltransferase 
Expect = 2e-10, Id = 26/49 (53%) 
Cmyc  163aa  PPPEGPGRAVNKAQLNRHVRLHRDAIEARLPKVARRARPLRRDAQREGV
GFANAPCHLVHQARDVLGTLHNPYIALFATAGVPPQMEHAKQSLINAAA
CLPEGVVPVDTFICQGKVDPKVIEMMYKMFPKGHSHGQSADRDARHKQ
AAVHPNEDDFKAGVQVD 
 
F29  no similarity  Clostridium beijerinckii IMP 
dehydrogenase 
Expect = 7e-06, Id = 21/28 (75%) 
Cmyc  33aa  LSIDCEPNMKEIPPSLASATAIVSFDTGVQVD 
 
F30  no similarity  Streptococcus thermophilus LMD-9, 7,8-
dihydro-6-hydroxymethylpterin-
pyrophosphokinase 
Expect = 2e-12, Id = 30/34 (88%) 
Cmyc  51aa  SRGFSWQLSL*GKARFKKSA*FVSPQAAVS*YEDTALTSVSGKSFKGVQV
D 
 
F31  no similarity  Homo sapiens BAC clone RP13-744A23 
from 7,  
Expect = 2.7, Id = 16/46 (34%) 
  104aa  PCSAFMISLASTCLNWLAKSLRTSPRASPVPKRFKKPFNCSTRSLSGTVSS
ALASVFSLALGSSS*VAGASTGTSLADATSSPCRLGISPSNVKPAFIKGVQV
D 
 
F33  CONSERVED DOMAIN  Campylobacter curvus    320aa  PSLMTVILFLGGFQLLTIGILGKYVGKIFMETKKRP*V*IA*IRQVVESCPPEIgA Antibody Screening Results 
 
DraG glycosyl transferase 
Streptococcus gordonii 
Expect=7e-11 
 
phosphomethylpyrimidine kinase 
Expect = 2e-25 
Id = 56/80 (70%) 
KITRACCFSIVNS*FC*RGRFANRVI*RLTDYNGFRL*SRHFIFFYIA*L*AST
P*NQNFKTCCAPLLRDCIKKALLPIR*PCLPAPFPFCSVYF*HCLQVYPHYS
GFCRSGCLSAWR*MRWTVCWHGSSATWVLLNSKSYQEAVESALSVKGS
KNLPVVVSTLAAAYYGLSQIPKDWVNALAGKEEVREIAIEWQMRWLD*E
RNLYRNQFFILYLTKSILLYKRRILKEARLSSRAFLLTNNAVNSLLIFYIGQ
VYKV*DSGVQVD 
 
F35  hypothetical protein 
Expect=4.5 
No similarity    22aa  PALPPDISEPIRGKVNEGVQVD 
 
F36  no similarity  Clostridium perfringens Transketolase 
Expect = 1e-16, Id = 37/43 (86%) 
  48aa  CKHSSFPYLTFFKFSITENGIYTIISIIDFTC*SHTTSCRNPLGVQVD 
 
F37  1 match – hypothetical 
protein, Expect=7.5 
Moorella thermoacetica UDP-N-
acetylmuramoylalanyl-D-glutamate--2,6-
diaminopimela... 
Expect = 1e-87 
Id = 94/196 (47%) but several matches to 
diff parts of seq, some with ID of 68% 
  353aa  PSNVSPRNATNTYPD*IVRVSVDISLNCKLTSPLHVPPVASIISCNVNSAILD
LLKSLSSLFSVIKMNSFIL*NLIIFMTLARNNNNIACFSIMNCMIDCLSTIDN
HLIRCTITKCFFYTYLYILNNLYRIFSARIIGCNINSITIFCCNASHNWAFCSI
TITTATKYDDNAIFFNSLCCF*NIL*TIRCMCIIYNYSKILPFLD*FKSTWYRT
KCFQSRINGFH*NTFL*TSPNGSQCIIHIK*TRSIHRYRITFTIIINSILAHLSRH
MNIGCI*GTIS*CTIRNSWSCRFFNHTMTIRIVNIDYSAFTSFNLIGCTNLFK
HLHLACSSSQRFCGNPNDLASNRKYGVQVD 
F38  phosphate ABC transporter, 
ATPase subunit, Expect=0.6 
Helicobacter pylori type I restriction 
enzyme M protein, Expect = 0.005 
Id = 16/21 (76%) 
Cmyc  26aa  PRVRPVRGLGVSAPEVREAARGVQVD 
 
F40  no similarity  Methylobacterium radiotolerans, RNA-
directed DNA polymerase 
Expect = 1e-18,  Id = 44/87 (50%) 
BOTH  106aa  LFHAA*QASS*P*RSQIYNKERISRT*RRLTFTFSVTIKPVTSCRLPRRCKWV
FSSFSRKP*RSTIAFTCCTSSPCGRRISVSELKVRSSA*RVKVIPCAAGVQVD 
 
F42  No insert 
F45  tartrate dehydratase subunit 
alpha Wolinella succinogenes, 
Expect=2.9 
Streptococcus pneumoniae strain g394 
surface protein PspC (pspC)   
Expect = 9e-10, Id = 24/42 (57%) 
Cmyc  92aa  RIREEVPRPPNPHPTGHHHTRLLQEIPRITNPQPTSNHRTIGHVHAKTVASH
PDAKVATSTTSGCASLTTV*APRSAPL*SVPSGRLGVQVD 
F46  BioW protein Bacillus 
amyloliquefaciens, 
Expect=0.023 
 
B.sphaericus bioXWF operon genes, 
Expect = 5e-56 
Id = 88/170 (51%) 
  245aa  RPLSLPHPHPPRPKKKESGRARGRVFFVRSEIDRESVIEYLEKAPVLVQRRN
NV*VF*RTA*S*NQQS*FADLKRILPSRCSAREAR**RILDDGF**LFRTYL*S
SCHRRGCKRGSTIWYWIRRVSTCVWNISIIYRA*KCISKI*EY*KSSRI*YRL
YG*CRNNFGYCR*EYYYL*RRLKSC*YH*WLSFK*SLYKGV*S*RCRGIKV
PTETSGSRYTKTHRY*WCL*HGWRYCTIR*GVQVD 
 
F48  ABC transporter, ATP-
binding protein Neisseria 
Neisseria meningitidis ABC transporter, 
ATP-binding protein 
Cmyc  39aa  SIFRKMTVEQNIRAILEISMKDKSRIDAELEKLLGVQVD 
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meningitides 
Expect=5e-09 
Expect = 1e-10 
Id = 31/34 (91%) 
 
 
 
F51  cytochrome c biogenesis 
protein, transmembrane 
region, Expect=68 
No similarity    17aa  ALQEHRVGGVLVGVQVD 
 
F54  no similarity  Bifidobacterium adolescentis preprotein 
translocase SecY subunit 
Expect = 1e-04, Id = 15/18 (83%) 
  38aa  LLVIASKRGITTRGSWIIIEA*CTA*FPAQRCLRVQVD 
 
 
 
F57  CHORISMATE BINDING 
isochorismate synthase 
Bacillus cereus 
Expect=2e-06 
Bacillus cereus subsp. cytotoxis 
isochorismate synthase 
Expect = 5e-08 
Id = 21/41 (51-59%) 
  45aa  LTCLDGARAIHPTPAICGAPTEKALDLIRQLESFERRYFGGVQVD 
 
F59  NO INSERT    Cmyc     
F60  GTP-binding protein EngA 
Rhodospirillum, Expect=16 
No similarity  cmyc  20aa  PGLHRLMDA*PHAKWGVQVD 
 
F61  no similarity  Bifidobacterium longum conserved 
hypothetical protein with phosphoesterase 
domain 
Expect = 5e-05 , Id = 23/41 (56%) 
Cmyc  46aa  TLGRESEHVLPRDRVVRAQVLDHAEGARLAVLPGSPEIIDEGVQVD 
 
F63  No insert 
F65  CONSERVED DOMAIN 
murD, UDP-N-
acetylmuramoyl-L-alanyl-D-
glutamate synthetase 
Streptomyces coelicolor 
Expect=2e-23 
Streptomyces coelicolor putative UDP-N-
acetylmuramoylalanine-D-glutamate ligase 
Expect = 2e-27 
Id = 50/93 (53-80%) 
BOTH  102aa  ADHLNWHGSLEAYAADKAKVYANTKLAAIYDLASEAALKMVQEADVRE
GCRAIGLSRAVPEISQFGIVDGAIVDRAFVPLRNKNAQIVAELEDLAHLGV
QVD 
 
F66  hypothetical protein 
Actinomycetes odontolyticus,  
Expect=2e-27 
Listeria monocytogenes CoA-dependent 
propionaldehyde dehydrogenase 
Expect = 2e-22 
Id = 53/71 (74%) 
Cmyc  250aa  SGMSEGEFAATSETARLQYANGFFSGGHDLIIGKRHYVDGATEAHQLAGS
GTLTPEEHEQYTAGVLFVVSSAGFVYAKLSTQFANRVVNIDAYASDEQNK
AALRIKY*N*TLH*IKHQV*KTLLQSVKLVIMV*HYMNYQPMVSSVL*RQV
RIQQKH*YVIPSVCWWPRYR*PGRLHGQWMNPLRW*RLESFEAHHVRHF
AGRRIYVRASQCANVGFVGLAVPSAALLVTRITRCLGAEAGSFSSGVQVD 
 
 
F68  CONSERVED DOMAIN  Fusobacterium nucleatum Outer membrane  Cmyc  201aa  QYLISQGVSSNRIVANGFGSSNPIASNATQEGRQANRRVEVRILPAQ*SQ**IIgA Antibody Screening Results 
 
OmpA Outer membrane 
protein Fusobacterium 
nucleatum, Expect=2e-15 
protein 
Expect = 3e-17, Id = 41/48 (85%) 
IFSKQLSNYLLPLIIVKKIINNNIS*VIYSH**LN*KWLEQ*SRSSLYYYNISNF
SIALFLNSSLNFG*ASCLRPAPPPARAPRSAPRSPPPCASPSSTCWRS*FRWR
FGSSTAPSTRTTPRSWCPS*FPWRRPTLPRTPLRAGVQVD 
F72  no insert 
F73  No insert 
F74  no similarity  Renibacterium salmoninarum aspartyl-
tRNA synthetase 
Expect = 0.009, Id = 17/17 (100%) 
Only 6 hits altogether 
  22aa  PGTRGRSCP*STR*GRSGVQVD 
 
F76  no similarity  Bifidobacterium longum NusB 
antitermination protein 
Expect = 0.042, Id = 14/30 (46%) 
BOTH  39aa  PRLRSRSFRSRSLGEWRTTCAASTP*FRRTPACPGVQVD 
 
F80  no similarity  Acidothermus cellulolyticus transcription 
elongation factor GreA 
Expect = 5e-22, Id = 46/66 (69%) 
BOTH  97aa  PAKEGRQPFRVRRFHHQRGFRQPQRCAAFLRVPGYGSR*GTARCERHGSR
RSRANRLLGEPRRLGEQSQDDAPRRDP*AHLVRETHLVADHLGVQVD 
 
F81  CONSERVED DOMAIN 
RnR_3 anaerobic 
ribonucleoside triphosphate 
reductase Listeria 
monocytogenes  
Expect=4e-21 
Lactobacillus reuteri ribonucleoside-
triphosphate reductase class III catalytic... 
Expect = 9e-18 
Id = 38/73 (52%) 
Cmyc  272aa  PFGKWHPFENQYR*LLAPLTILLLNLDDDLSETNLATCQFLAIVANLLGLFG
GDETKTKENANKDARLFSTFRDLEAGEVSRFYALQRLPERVSGAHVSGDIH
FHDLDYTVPGGMFNCMLVDLPFILSREDFPIGNTRVNRVRSVETATDLIPQI
AAQVSVGHSFLGLTLHLLSLLCCAWGNSLVYPSPSPRREYLEPHSISAYPSS
PHSHFINQGCWAFSHSSHPAREWGFTKLAKQRCYRCYELWYNFQDTRAKT
IDATVDAIKAGVQVD 
F82  no similarity   Chlamydomonas reinhardtii flagellar 
associated protein 
Expect = 1.4, Id = 14/22 (63%) 
3 matches only 
Cmyc  29aa  SDRSWRRAVAPA*ATARGKSPRRKGVQVD 
 
F83  no similarity  Streptococcus gordonii aspartate 
aminotransferase 
Expect = 2e-31, Id = 58/64 (90%) 
Cmyc  69aa  SDRLEIGTNSFPL*TKRP*IS*ARMRTSCSTAQFPMAKSSSRE*IIPVGLDGEL
RTNTLLLSVRGVQVD 
 
F85  no similarity  Porphyromonas gingivalis 
NADH:ubiquinone oxidoreductase, Na 
translocating, A subunit 
Expect = 6e-07, Id = 22/27 (81%) 
polyH  32aa  P*ASRRSLPC**APCG*SAYRPDLRGVGVQVD 
 
F86  no similarity  Human DNA 
Neisseria meningitidis oxidoreductase, 
short-chain dehydrogenase/reductase family 
Expect = 3e-26, Id = 42/57 (73%) 
BOTH  273aa  WRRSSSSPRHPPCSPCSSPEPPDSPGPQRGPTLSSRPLGSGQLGGAATGAAC
REQSQDGDRAGHPFWKCLHFQAGEGRQWVAGSAGPPWLLVILKRKPKRL
LRRLPLLPHRPRASSSGSTPSATPMQG*RAQGRTACTSSPPRPASRVISLRTIS
RHVRASSTRSSTTSRLRTSKPFSSDDCKIYIWPDADYLNQDLIFPNKDILCFSIgA Antibody Screening Results 
 
NVSSFTGAGSSR*TFMPAKVWATGMISMELTFIRAGR**SHKAVSAISCGWI
NSTFS*TSGVQVD 
 
F88  hypothetical protein 
Salmonella enterica 
Expect=5e-11 
Expression vector pHA-SP Expect = 2e-55 
Id = 87/101 (86%) 
  181aa  ANPVTSGCCQWR*VVSYRVGLKTIVTG*GAAVGLNGGFVHTAQLGANDL
HRTEIPTA*AMRKRHPSRREKGGQVSRKRQPPPPPPHEGGSRGKLQNLYNPI
GTMQMWL*QGKKNSRHGGKSY*NMPAQRPFCNSNVLGYVSSAYKSNIITK
ICGYH*KVESDSRLSVMLKYDLSL*GVQVD 
 
F91  hypothetical protein 
Burkholderia, Expect=0.34 
Actinoplanes sp. acarbose (acb) gene 
cluster, Expect = 2.7 
Id = 12/17 (70%) 6 matches only 
  25aa  LLRAAVEKRIRRRKEFVDREGVQVD 
 
F92  no similarity  No similarity  BOTH  32aa  PGPFTTS*L*PSSRIPSPFLSCSLALAGVQVD 
 
F93  no similarity  Rhodococcus sp. 
C4-dicarboxylate transporter 
Expect = 0.18, Id = 14/23 (60%) 
polyH  66aa  RVRMGAPDESDAPIHPPQRGDYGINRETIRSSDQPSSL*PMSLGEIGRARFRL
IVGITHARGVQVD 
F94  ATP-dependent protease La 1 
Bacillus thuringiensis 
Expect=1e-06 
Desulfitobacterium hafniense ATP-
dependent protease La 
Expect = 6e-37 
Id = 66/108 (61%) 
polyH  292aa  PRRCRRSAWR*AGTCVSYPMLIHGRVVPYHRLGLSRL*RMRGTR*PGMGIC
KSSMMPMRCSPSTNLSGSRP*ARSMSPLTPTFDERLMISGTVITPFPPFRQSA
SRILRPFTCDGNIRPIGQRCINPNFDKA*KCINKTI*KNSIP*WCRVNFH*RCIR
RNR**SITAKNRCSWFACYH*KGDETRYVRSSFHAGSN*VHRKS*IRAEHR*
TYTQK*GRPRHPVEIVIRRNSFLCRNEFLFII*IPGGSMNLLEIGIPTVPLRGM
VVYPNIVIHLDIGRDKSIKAVEGVQVD 
 
F96  No insert 
F97  not bacterial   Homo sapiens chromosome 16,  
Expect = 3e-28 
Id = 52/53 (98%) 
  180aa  PEFAFKNHSIAGFLWHHFTSEVLFVCLLIHYLLRILFMPGVVAHACNPSTLE
GHHCYCRCYCRRYCSRHCRYSRCRRCYSRRCHCWNRCRYCSRRCRYSRC
RRSPNSRWARRRASRWG*ASRWARQRTAERRSSRSARAWARCCAPCG*T
RPSTGSRRPAGSRSPASCSRSTRRPGVQVD 
 
F99  OmpA family protein 
Pseudomonas fluorescens 
Expect=11e 
Arthrobacter sp. acetyl-coenzyme A 
synthase 
Expect = 4e-06, Id = 18/25 (72%) 
BOTH  30aa  RNQPCTP*WRQ*ESRNRCGFFHTVRGVQVD 
 
 FN Antibody Screening Results 
  Protein BLAST  tblastx  Tag  ORF 
size (aa) 
Amino Acid Sequence 
1  No similarity  Human DNA sequence Expect=2e-14  polyH  28aa  PMCIRPQCTQNSAQTKGRHPGTHTFPGGVQVD 
 
2  CONSERVED DOMAIN FTCD_N 
Streptococcus gordonii glutamate 
formiminotransferase 
Expect = 4e-07,Id = 26/27 (96%) 
Streptococcus gordonii glutamate 
formiminotransferase  Expect = 3e-
08 
Id = 25/25 (100%) 
Cmyc  26aa  ERINRELGIPIFLYEDAATRPERKNLGVQVD 
 
3  putative p150 [Homo sapiens] 
Expect = 3e-16, Id = 42/61 (68%) 
Human DNA sequence, Expect 2e-
56, Id=100% 
Cmyc    LHIKLNRN*LIKGSERSLQ*KLQNIGEINLTGYKI*KDIPCSWTERINIVKM
VILRKAI*RFNVILIKIPMTFFAEIEKTILKFMWNHKRP*IAKGVQVD 
 
4  No similarity 
 
Thermobifida fusca cobalamin-5'-
phosphate synthase 
Expect = 0.75 Id = 13/20 (65%) 
Cmyc  27aa  LLGIIGLDERLGDGRQGVALGDDLGQGVQVD 
5  hypothetical protein [Bacteroides 
fragilis Expect = 7e-09, Id= 28/51 
(54%) 
Bacteroides fragilis conserved 
hypothetical protein 
Expect = 2e-10, Id = 28/50 (56%) 
BOTH  52aa  LNLLELKAVAKEFGMPAFTGGQMAKWLYIQHVTTIDEMTNISKNNREK
LKAGVQVD 
 
6  No similarity  Burkholderia xenovorans Rhs family 
protein 
Expect = 3e-04, Id = 19/31 (61%) 
BOTH  124aa  PQNRNNVAGCYADSLLHRSIGFAV*TAGARSDRRVHHFSDDREKMIESP
EK*KVCTCRS*AAYIRRLGCYANLITFNF*NIDS**ILLTF*NFRLG*LFL*V
EIFSY*ICCSKDLIHFEEKRQGVQVD 
 
7  Methylocella silvestris outer 
membrane protein assembly 
complex, YaeT protein  
Expect = 28, Id = 12/19 (63%) 
Human DNA sequence ch9  
Expect = 1e-10 
Id = 23/23 (100%) 
Cmyc  24aa  HQAGLGTSDSFSISVAVTESTFKGVQVD 
8  Aspergillus fumigatus DNA 
damage repair protein (Rad9) 
Expect = 0.032, Id = 26/67 (38%) 
1
st half is bacterial Arthrobacter 
aurescens 
phosphoribosylformylglycinamidine 
synthase II 
Expect = 2e-15, Id = 46/54 (85%) 
2
nd half Homo sapiens chromosome 
17, Expect = 2e-48, Id= 85/86 (98%) 
Cmyc  195aa  FKTRCIQCI*AI*GTDKGDECRTFKFTTSTFCSFHQYDNGTHG**IRNNIRY
NGHRRGRHRPRHHLHGRPPDRRHGPAALRRRRPPRHCARRPRRRLRRR
RLRQLPGPFSASAIRQLEVRAVFSSFFHLPFSCAK*CYEGG*MLKVYFFFL
I*KRQLTVNSRQFSKHTLIRDSGYEEESVVGRMWTLESEQLHLGVQVD 
9  No insert 
10  Xanthomonas oryzae  
amidase/aminoacylase/peptidase 
family protein  
Homo sapiens chromosome 5  
Expect = 2e-90, Id = 142/142 (100%) 
BOTH  248aa  LSRWHHHDQ*VFIFYTLLFLRSVCLMNVLSPELSYYNLYTCPSSVYRCVA
*WDLRKAD*AEEMGSSL*LKRRFMRLLVMAAPALLSTLAAGAGSCNEW
RIGNSISGLVRGESRLKKLWIEDETLFQNCPLGSEKGGQSSVNGAVAPLQFN Antibody Screening Results 
Expect = 0.40, Id = 23/91 (25%)  IRCQLVIEIGNGVSESAENEYFSVTRVNLVGSGLLRDQCPQRTELGITIRG
HCTGVTDQFVENRNVAYEVHGQSLAVHIAQVDANLRPDLEHLSISVIEG
VQVD 
 
12  Haemophilus influenzae PittGG 
methionyl-tRNA formyltransferase 
Expect = 4e-30, Id = 62/85 (72%) 
Haemophilus influenzae SUN protein 
Expect = 3e-144, Id = 165/212 (77%) 
polyH  330aa  PISFLQLTDEQGNEQTLKVYAAAVLPHVDKPAGTILSVDKKGIQVATKE
GVLNLLQLQPAGKKPMSVQDFLNGRADWFQVGKVLG*WHFNAKKQK
NRPHFRYALLLLK*FCRF*IKVSLYQCCFQKCNRR*NHRIYLYYRKSPLV
FFAYYLV*KIL*KNY*ISH*RVKPASCTACYWWDCTNYFICVCPLMRLW
MKW*MPQNH*NRIVFVVWLMVYCVASYGNKRIFLL**INIGKRFILNGL*
INSKKLIRIGVKLLRRITKSHQCGCELTNNKIIRKLTRTLLEEQR*QRLNVK
IHMLYV*LNAFCLETAEF*TRFGDSSGSQCSVVGVQVD 
 
13  No similarity  Clostridium tetani oxygen-
independent coproporphyrinogen III 
oxidase 
Expect = 2e-06, Id = 26/41 (63%) 
  66aa  PCRASNAVY*S*L*CFISRF**LFLQFLVDSRKGSSVKTDLPKLIIF*VPYIV
LNSRCNIFGC*MGVQVD 
 
14  transcriptional activator 
Cryptococcus neoformans 
Expect = 4.9, Id = 10/13 (76%) 
No similarity    19aa  PTARFGVRPASMSPSISEGVQVD 
 
15  Pedobacter  3-ketoacyl-(acyl-
carrier-protein) reductase  
Expect = 1.1, Id = 12/14 (85%) 
Homo sapiens chromosome 13 
Expect = 1e-07, Id = 21/21 (100%) 
BOTH  22aa  LAPSLRFAGILKVLSVLELPVGVQVD 
 
16  CONSERVED DOMAIN Yersinia 
mollaretii Pyrrolidone-carboxylate 
peptidase  
Expect = 9e-05, Id = 18/25 (72%) 
Citrobacter koseri hypothetical 
protein 
Expect = 3e-06, Id = 18/25 (72%) 
polyH  103aa  PLRAQFCYRASNFLPFEMCTFMMVRENDRFDQRELSSRLIV*RRCA*RA
AIGEQ*AACGTCSVR*AACGACGVQLRCGGKMKKILVTGFEPFGGEKIN
PAWEGVQVD 
 
17  No similarity  Pseudomonas stutzeri membrane 
protein 
Expect = 0.001, Id = 17/36 (47%) 
Cmyc  39aa  CW*TESIVVAFTRKSHQH*Q*NCTNDRNNTNKHKTARTGVQVD 
 
18  No similarity  (4 matches) Nocardioides sp. 
glycosyl transferase, group 1 
Expect = 1.0, Id = 14/18 (77%) 
cmyc  38aa  PNAAPRRHPSSLGAWAAGVACPAARAPSAGQCADLAGVQVD 
 
19  Streptococcus gordonii str. Challis 
Replication initiation and 
membrane attachment 
protein (DnaB) superfamily  
Streptococcus gordonii Replication 
initiation and membrane attachment 
protein  
Expect = 3e-16, Id = 39/78 (50%) 
BOTH  96aa  PT*SGSSSRSTTPRRWVASYDQGEKQYILAQILNHLNIGFPQLLLAFDRLI
AMGLLDLYEEEVGITIQLHAPLASEEFFSNAVFKRLLEKKIGEKGVQVD 
 FN Antibody Screening Results 
Expect = 1e-14, Id= 40/82 (48%) 
20  No similarity  Corynebacterium glutamicum 
hypothetical protein 
Expect = 1e-04, Id = 18/31 (58%) 
BOTH  34aa  PGFGRVDRGVERAIRTDEDVLADDHRSDVEDGQGVQVD 
 
21  human    Cmyc  156aa  PPSGC*WSPSLALGVLASWPFILSHAALALATLVYLVYAVRVGVPYAFM
LTSFFLVAWVFQSPSRYVIAGIVPIVAIAEVFAYAEGEPLWSGCYLALVGI
FVGMARWRMERSSRERLRRQDAIQRAKAAERARMSTDLHDILGHSLIGI
TMISELGVQVD 
22  CONSERVED DOMAIN PRK 
10263 
No similarity 
Arthrobacter aurescens  
2-isopropylmalate synthase 
Expect = 2e-91, Id = 134/199 (67%) 
Cmyc  271aa  HQCSDQHADWSHQYQPNQC*STQYGTYPNGSADQQQAGTHPRRCSTAS
RWSSRRPQRQYEPEQSLRTQPEHDAANPDRDPASAGTPYRPYRTASSHE
*SPHRYDPGREDQSAGTEPPSKPHPRSYQPQQRYAPEPQSPS**RPGENQR
TR*TPGHHHTANARAPSAGCSTQQSYGYRQYQRNQSADQYPGCTCSG**
E*A*SWNISLPCSIREVEN*GNSTRY*K*VYP*IIS**VN*AS*SSI*ILSSITRY
YRGYFMYI*L*T*IL*GGVQVD 
 
23  Lactobacillus plantarum 
amylopullulanase, collagen – 
lipoprotein repeat 
 Expect = 9e-15, Id = 55/109 (50%) 
Lactobacillus salivarius conserved 
hypothetical protein  
Expect = 1e-11, Id = 33/60 (55%) 
Cmyc  316aa  FSNCSPI*SN*EIS*KTRKTN*KTCC*YSSES*IQLHEEIRRSCVESW*IQLRI
ERQRW*RD*NRKQ*C*R*DQVLSS*IQTWSRRYLYLSCRRSER*RGWS*V
R*DGCYSWSCCDEGR*SINSYFTNA*RY*V*QQGNTANTANTANAANTA
NTANTANAANTANTANTANTANTTNTANTANTINTTNAANTANTANTA
NTANTANTANTTNTANTANTTNTANTTNAANTANTANTGNTANIRKT*
RS*VAKYW*TI*IWSCCTWCCAWSRRSRFGCKTKKT*RLRLR*HQYFDV
EITILALK*RGFARKSKGVQVD 
24    human  BOTH  157aa  HFEPLSVEKTKRMIAFACLGLDSCDPLELELDAKLQFVDGMTTKEIQKTL
VQTAIEKVISKKDDGFGNQVNKMNQDWQFVAARLFLFDLYKEAAITRR
YKAFGYGNFPNLVHMLVEEKKYADFFVTEYTADELQELGDYIKPKRDY
LFNYEGLKLLGVQVD 
 
25  Leishmania braziliensis DNAJ-
domain transmembrane-like protein 
Expect = 0.16, Id = 18/27 (66%) 
No similarity  cmyc  25aa  L**AAAAPARGARTRTAGATSTAGGVQVD 
 
26  CONSERVED DOMAIN COG 
O313 Actinomyces odontolyticus 
hypothetical protein 
(methyltransferase) 
Expect = 4e-21, Id = 51/53 (96%) 
Caulobacter sp. TonB-dependent 
receptor 
Expect = 2e-16, Id = 24/31 (77%) 
BOTH  183aa  AKGGARVVFVSDAGMPTVSDPGFRLARAAIEAGVPLSVLPGPSAPLVAL
ALSGRLTFKAAKVQCYLVAQFAAHKYT*GIPLIPCCIVFIPTRVIHRICTN
WCRRILFTKESPFYTN*ETWRAVVDFIGLTTHIAYPNSSRATFFSRCFSND
INNAAHRIRTI*SRSSAFQHFDTGDRTCWNRGVQVD 
 
27  Clostridium thermocellum  Clostridium thermocellum  Cmyc  183aa  VYKKSGNKDKIIGFYRYLMEKYNLEIRSTIDNFENEDSFIGFVYSDGDGLFN Antibody Screening Results 
hypothetical protein 
Expect = 1e-05, Id = 46/172 (26%) 
hypothetical protein 
Expect = 7e-05, Id = 12/33 (36%) 
GDFFKNIKKVFIAADKRKVPNIEEEYLKFLKSFSAILDEVTKESLAETLNEI
FKGTDSEDPKRWGEFLIVGGDDVCAVFDPTLAIEISVKTQKKFEDTMEA
RMSELSKKFTDSKLEEGICKVKITSSSGVVIGVQVD 
 
28  No similarity  Human DNA synthetic construct 
Expect=0.01 
Cmyc  56aa  PYSLTRLFA*EW*VSTVGSAMPLRSSSSVGSSRRLRRRVFRPIRDSFQAPR
ERHVGVQVD 
 
29  No similarity  Similarity to human DNA and 
Bacillus cereus, same E value?? 
Cmyc  66aa  FLLAIKLKKKSSNSWSAAFGIGVSAIIFVAESTLFVVSVVSATTVLVESAG
STFFLLQLVVRLIIGVQVD 
 
31  Anabaena variabilis Protein of 
unknown function  
Expect = 2.2, Id = 29/84 (34%) 
Only 2 matches 
Porphyromonas gingivalis glutamine 
cyclotransferase-related protein 
Expect = 9e-12, Id = 19/34 (55%) 
Cmyc  191aa  PLPRSTTRTPCPT*PTVTRRLSTASPADSRMLSCPACWTSRRAPTPLSTAE
SATRQPWRRWLRSTPVTCPTSSSWRTAADRTARPART*RTRPTTSGAS*T
DMPSR*NCAPSPPTISRRIPN*GLTAVGKFFA*Y*APNAQESSLF*YPVAQ
VGTPQSSASKQTKSTPTVSFLSACN*RANSSITATPLGVQVD 
 
32  No similarity  Homo sapiens BAC clone  
Expect = 1e-74, Id = 118/118 (100%) 
BOTH  119aa  AENLRVTAVPSGNHL*LKARPQPSVN*EFLCQLFNFQGLLC*NQMSKR*N
GSAVSRKCQ*HTQ*QKETKL*KATWKILTLY*ISPFGFKK*GFVFSWSLFK
LEPFIKGP*NLFIMEMPGVQVD 
 
33  No similarity  Bacteroides thetaiotaomicron beta-
hexosaminidase precursor 
Expect = 1e-39, Id= 62/97 (63%) 
Cmyc  100aa  ITVQEFFHTMGEMAL*LGYIF*VMLLHHLLTIRTSLPCAALCLVSSDVDIL
RREELHYLFQHVLHEGIGGFLTYTEVRLCIRFACT*QLWVGINNLIAMGV
QVD 
 
34  No similarity  Homo sapiens BAC clone RP11-
511H23 from 7,  
Expect = 3e-27, Id = 48/48 (100%) 
Cmyc  47aa  RIRTKE**D*KKYAAFYLISLWITEFHLHT*TILC*IA*ERSSSSNWGVQVD 
35  Homo sapiens ch21 similar to 
seven transmembrane helix 
receptor 
Expect = 5.5, Id = 33/103 (32%) 
Homo sapiens chromosome 21  
beta-site APP-cleaving enzyme 2 
Expect = 0.70, Id = 14/27 (51%) 
Cmyc  184aa  PTCKVRRGSYVEKPHVCREATSLVAFRNTCGFSSIGVLPFGWLVFRFLTS
PPSLHTPHRYEEYNSMTSNLFTRRAMLSGGTLLGLGALLAACGFLILQIIL
RLRFRAHLSAPLSHWFL*ASSSRESCYRSNLGIHDVTLASRVREYCLSRG
ERYVIYDNTSSYSHRFI*RQPP*CVCSID**PGVQVD 
 
36  No similarity  Bifidobacterium adolescentis 
anthranilate synthase component I 
Expect = 4e-62, Id = 112/170 (65%) 
cmyc  174aa  PRRPSRKPCE*RSPDPRPPTGRSNRPRRRTRRAPRARNHR*AGWHEAWA
RPTGCPQGMSQPGHQARQHPRAARPSPWRKCAECERNA*VP*A*RPRPT
RDRRPSTGRFEPGPRA*RAPTAPSGPREARQPGDGPRPNPRREGATLRSD
TS*RGVVQSSRGSRETSQQPQNDRPGVQVD 
 FN Antibody Screening Results 
37  No similarity  Bacteroides vulgatus putative 
GTPase, ThdF family 
Expect = 1e-40, Id = 80/110 (72%) 
Cmyc  111aa  LCQ*SGK*FPVSLLCPQ*HRG*YHEYLKQSLSPHVTSNSRALICPHLSCQ*
WLLALHASVRYLFQTT**APRYARVLFQPTPSTPLYQQTLAPHDRRSRAL
TQVGTSSSRGVQVD 
 
38  No similarity  Human chromosome 4, Expect=3.1  Cmyc  68aa  GAGILLIILLL*PDNIIPAAAPKAILLNEPPVGILGFSLINILLALPVISSKAFC
PISAASSCWSAIGVQVD 
 
39  No similarity  Human DNA  
Expect = 3e-85, Id = 80/82 (97%) 
  139aa  PALLDWGSSPG*YPAECFPTWFHSPHHFQVHQSDVDLVFSHSPIFLGGFA
HFFLFFFL*TSLLASFHSFHLPLLIPFLPVDRIGS*GFCILHVVLEPWFSAPS
APLSTSLYWLF*LYILLNFFQSFQLLCLWFECPPVGVQVD 
 
40  No similarity  Streptomyces griseus subsp. Griseus 
conserved hypothetical protein 
Expect = 0.027, Id = 15/25 (60%) 
  53aa  SSLTVPWSHWSPSWCASSGSPSSGWQDARTPSTRVPPKASLKLSS*PGPA
CEGVQVD 
 
41  Aspergillus fumigatus 
serine/threonine protein kinase,  
Expect = 4.8, Id = 11/15 (73%) 
Streptomyces griseus subsp. griseus 
putative guanosine pentaphosphate 
synthetase 
Expect = 4e-07, Id = 23/25 (92%) 
Cmyc  26aa  PMR*ARTLLASSPSRSPSTRSARSSGVQVD 
 
42  Chlamydomonas reinhardtii 
hypothetical protein 
Expect = 3.5, Id = 15/31 (48%) 
Possible human sequence, E value=3  Cmyc  26aa  PPSHGGDDVCNVPTALSAWHGDAPWGVQVD 
 
43  Neisseria meningitides membrane 
fusion protein / antibiotic resistance 
efflux pump component Expect = 
4e-22, Id = 53/56 (94%) 
Streptococcus pneumoniae cation-
transporting ATPase, E1-E2 family 
Expect = 8e-68, Id= 114/151 (75%) 
Cmyc  226aa  PICHSFEACEFHVPFPLARHLQSLLLSQFALQSHGLLQHYLQ*A*PF*DHV
FSI*Q*LLEHFP*GHPARQLSLLTDHLRIGRQLFLLLSQAIQIVFDNHVE*Q
DHLRVWHSPTRLVYH**SQSHLFHARLGSFPLGKG*FLVQMHDKQ*LEP
RSRRDMLLPCVMLHDQTTAKRSAEAGVKSAQAAIKSAGISLNRSRITAPI
SGFIGQSKVSEGTLLNSGDTTVLGVQVD 
44  No similarity  Solibacter usitatus binding-protein-
dependent transport systems inner 
membrane Expect = 0.079, Id= 17/45 
(37%) 
Cmyc  57aa  R*WCSRSVDVLDLIGVHGGHSLVGAWACCGRAIASGVPLNREGSRRSH
GGALADGWGVQVD 
 
45  Hypothetical protein homo sapiens  
Expect=0.02 
Homo sapiens chromosome 8  
Expect = 5e-61, Id = 94/94 (100%) 
Cmyc  95aa  PV*EMLLL*PTLDLQPVVPPAVVILSWKPSALTISSQVL*EQFSAGALILG
K*CPWNPVLTPRRHLCHHR*GG*RGTLTQGAKAGCQQGS*PSLGVQVD 
 
46  No similarity  Haemophilus influenzae conserved 
hypothetical protein – predicted 
ATPase 
Cmyc  58aa  NVTL*N*KKPVGSPKISA*NKH*LIRPSSNLLPIMP*WMPMQILNKKTVNY
LIPL*MGVQVD 
 FN Antibody Screening Results 
Expect = 7e-23, Id = 47/57 (82%) 
47  Clostridium botulinum phosphate 
uptake ABC transporter, PhoT 
family, permease protein  
Expect = 2e-08, Id= 33/66 (50%) 
Clostridium botulinum phosphate 
uptake ABC transporter, PhoT 
family, permease  
Expect = 9e-12, Id = 33/62 (53%) 
Cmyc  68aa  YIISASLYVSLLSLIWALPLGIGTSVGLSLGVSPRIRQFCLSTIDMIAGIPSVI
VGFIGLAVVVPGVQVD 
 
48  Homo sapiens ring finger protein 
170 Expect = 3e-08, Id = 18/23 
(78%) 
MACACA MULATTA BAC clone 
CH250-327L24 from chromosome 
13, Expect = 8e-09, Id= 23/23 
(100%) 
cmyc  25aa  PGQAQWLTPVILALWKVKAGGSLEGVQVD 
 
49  No similarity  Campylobacter concisus 
transformation system protein 
Expect = 1e-39, Id = 75/88 (85%) 
Cmyc  120aa  LRSWRLD*RILPPLLPKTALIIV*KTNLLGVLGLMPLVIYRQGENLLWKV
KIFSKFLKCKFG*IFIDKKSVHLVL*VDELFDLRVAIEAINFKAL*LSYQRA
WLA*NLRAGFTKCL*RKGVKVD 
 
50  chromodomain helicase DNA 
binding protein 4  
Expect = 0.72, Id = 29/76 (38%) 
Azospirillum brasilense plasmid 90 
Expect = 0.088, Id = 12/28 (42%) 
  167aa  SQSEHQAL*NAKVPKQGTGYSIMSLSPEVRHKPTSLTRISSGDVLRRARR
RVITFIPQNDITLEGHTCLLTFLAARLSLAQHGLLRLSQHLLQFPLLLPPLS
ATTHLLPSSTFPVSPPALRTPSSSPFPRRSTRSSSRLLVAQVAVPTRLLVVP
VLS*PV*SPSRKGVQVD 
 
51  No similarity  Homo sapiens genomic DNA, 
chromosome 4 
Expect = 9e-80, Id = 128/128 (100%) 
BOTH  205aa  SKAQQ*QGCPSQWH*RD*LDCSTCCMPGTPLLQQAKASFPQESDLHSHH
AC*TSGHPTLFLDLPPCD**TTECIPANLDGLFSLP*FSIG*SLIILLFKILHIIL
IVLSFL*AFSNITYKFLRQLILVKGLL*MEMFVSPQNSYIE*SPNP*YGIFGD
RTSNSTTKEAI*G*MHKGEALL*QD*CFIRRDSRELSLSVHTH*GKGVQV
D 
 
52  No similarity  Magnetospirillum magneticum 
Molecular chaperone 
Expect = 0.043, Id = 14/28 (50%) 
 
BOTH  37aa  RS*KRTCRRGSARPRQRPGYPCR*RRPGACS*WCS*GVQVD 
 
53  No similarity  Myxococcus xanthus cell cycle 
protein, FtsW/RodA/SpoVE family 
Expect = 0.002, Id = 18/32 (56%) 
BOTH  75aa  RRGPSFRPASTSYPSPASSPSSSTGSRRCLTRPASGPG*PTR*RAGPRRRSR
TRSQPAGSRSSPARLCTRWRFRGVQVD 
 
54  Actinomyces odontolyticus 
hypothetical protein 
Expect = 4e-27, Id = 55/63 (87%) 
Moorella thermoacetica ATCC 
39073,  Protein of unknown function  
Expect = 9e-05, Id = 23/61 (37%) 
BOTH  64aa  KSWNFQDAGIGMAAINAYHSHPEVALARGFTPCEENNWARTFHPYAPL
VAGKRVAIIGHFPFAGVQVD 
55  Acaryochloris marina acriflavin 
resistance protein, putative  
Clavibacter michiganensis 
tryptophan synthase beta subunit 
BOTH  15aa  PRTRFPPASTTRVSGVQVD FN Antibody Screening Results 
Expect =21, Id= 9/11 (81%)  Expect = 1.0, Id=14/14 (100%) 
56  No insert 
57  No similarity  Fusobacterium nucleatum subsp. nucleatum  
Protein translocase subunit secY 
Expect = 2e-112, Id = 181/189 (95%) 
BOTH  243aa  RKDTRGANRQEPPLVCQGC*CSYCSYKKAYSWIINKPNRL*PKTNSSSLN
NSKCYCQVSCPLSYSISSRFPFFLNFFKLRNNRYK*TYNY*CINVRDNP**
EYRYPCEGSSRKHIYITKYVTFRSHRSKSIHIYTRSRN*SSYSGN*EH**CE
NNSFSKFRNFYYTT*SRAKFLH*SHIYTYLRLILFITFCSFKTFNFNYFNCS
TFCFNSSLSLRLSGGSVDRLTN*LRDLSAAGTYARAQGVQVD 
 
58  No similarity  Propionibacterium acnes  preprotein 
translocase SecA subunit 
Expect = 2e-21, Id = 41/52 (78%) 
BOTH  54aa  WAWRTCTRLRTPRSSASSTTRSVRRSCSSGIATTSWTPVRSLSSTSTRVA
SCRGVQVD 
 
59  Chlamydomonas 
reinhardtii predicted 
protein  
Expect = 1.5, Id = 16/28 
(57%) 
Bordetella petrii enoyl-CoA hydratase 
Expect = 7.0, Id = 10/13 (76%) 
BOTH  18aa  LRGGRVPVAPHPALALPGVQVD 
 
60  Neisseria meningitidis 
putative fructose-1,6-
bisphosphate aldolase  
Expect = 1e-67, 
Id=124/129 (96%) 
Neisseria meningitidis  fructose-1,6-
bisphosphate aldolase 
Expect = 3e-60, Id = 117/117 (100%) 
BOTH  164aa  EFCFNFLESFVNAVGIAYICLDGEKFFGGFTAAVGDADVVAAVEEFPHIP
VVMHQDHGASPDVCQRSIQLGFSSVMMDGSLMEDGKTPSSYEYNVNAT
RTVVNFSHACGVSVEGEIGVLGNLETGEAGEEDGVGAVGKLSHDQMLT
SVEDAVRFVKDTGVDALGVQVD 
 
62  One match, not bacterial  Strep at LHS, human at end  cmyc  174aa  IFQHFCLFSI*KVLTNSCRGHLNNRKKP*FQGFFDVK*LFVANHYKGFPTL
SNLSFILNQLLAIFDKTNCFLQYRASL*LTKLY*FVPILHGLDLSETSLAHA
RAIADKAPPQWINLMPTKEGAPALRQ*GQTL*RSPYIIRFSIRCNREWNIY
RLIYITKGF*SFHHERWLKGVQVD 
 
63  No similarity  Anaeromyxobacter ABC transporter related 
Expect = 0.081, Id = 17/32 (53%) 
Cmyc  34aa  CVVLPSTVRVTLVASARWFTAETTWSRVMPATEGVQVD 
 
64  Pseudomonas entomophila  
P-type ATPase, Mg2+ 
ATPase transporter  
Expect = 0.48, Id= 25/79 
(31%) 
Homo sapiens PAC clone RP4-765G7 from 7, 
Expect = 2e-94, Id= 141/141 (100%) 
BOTH  142aa  LNRDFS*LCFYTANREAPET*WASVGEWQQFLKSCQCLSASTLVSAVRE
ESTPPKEKKSANKTSAARLFCGGWHRDGLLSANLCRAYSQPLRKPGFHS
SSPTPPTVFQPLAFCGVEGFFLPFFSLPQFFLVSLRP*PQGKGGVQVD 
 
65  One match - mammalian  Pelobacter propionicus PpiC-type peptidyl-
prolyl cis-trans isomerise 
Expect = 0.73, Id = 13/23 (56%) 
BOTH  40aa  PNGAPPSCMCSSSRDRRRPMP*TRTPLSPAGGSPLQPSVGVQVD 
 FN Antibody Screening Results 
66  No similarity  Streptococcus gordonii conserved 
hypothetical protein 
Expect = 0.001, Id = 12/24 (50%) 
BOTH  94aa  CLYYSRGNLHSLGE*RSNLHSPRFSFGSP*PILSRLNHQMNSPSD*LHHRIF
LKALCKRFLQHRSHYFQL*IHLQSCPQP*DFSQID*IQI*QGVQVD 
 
67  Rhodopseudomonas 
palustris hypothetical 
protein  
Expect = 0.15, Id = 18/29 
(62%) 
Kineococcus radiotolerans ribosomal protein 
S7/translation elongation factor G 
Expect = 2e-10, Id= 30/53 (56%) 
BOTH  63aa  LIKT*KQRSPTMFHSTHVFTGETICRRPAQSLVFTSPAVVRERAVGLSHLV
HVLTALHSGTEGVQVD 
 
68  Methylobacterium 
sodium/hydrogen 
exchanger  
Expect = 1.7, Id = 22/61 
(36%) 
Bacteroides vulgatus 4-hydroxythreonine-4-
phosphate dehydrogenase 
Expect = 3e-32, Id = 55/95 (57%) 
BOTH  277aa  FLRRYT*FNLNLVIEDREQVKPSILCF*CIFNNSEVCFNIECIAMIGGYFRR
TIDDGRAEFQHLWFSKGLKDKLITNAVRVSVCDCYTDSFILVHIIISCIVLF
YSVSFLSFTFLSSSFFINLLCR*EQTASHVKHVGFGFFTDHVHHFVNGDPA
DQLFVFIDNRRGDQVITFKRLRRFFHVVFGTEAHDIGGRPRCLPPSESMG
ALVSGKRRQSRTCGRYGLNGCFRRPPVCGNLLQHPREMNTPSPPPPPLH
RGFP*ALPEDLLRQLQSTPVSQGVQVD 
 
69  No similarity  Clostridium difficile chorismate synthase (5-
enolpyruvylshikimate-3-phosphate  
Expect = 2e-05, Id = 29/83 (34%) 
BOTH  84aa  *TVFDANKIWIA*SN**TCNYDFN*TTGGVADLF*LHYKFFYFNTFICIEH
NNWLCCDVTKCFHIWMNHIYRSILNHSHLF*MGVQVD 
 
70  FTCDC superfamily 
conserved domain - 
Porphyromonas gingivalis  
hypothetical protein  
Expect = 0.003, Id = 21/40 
(52%) 
Clostridium tetani 
formiminotetrahydrofolate cyclodeaminase 
Expect = 6e-06, Id= 23/34 (67%) 
BOTH  37aa  LTAATGAALAEMVANLTFGKKGYEEVQSEMEELQTKGVQVD 
 
71  Neisseria meningitidis 
hypothetical protein 
Expect = 1e-10, Id = 42/78 
(53%) 
Neisseria meningitidis conserved hypothetical 
protein 
Expect = 1e-14, Id = 41/74 (55%) 
BOTH  77aa  AEAGHIEAAFQLAGCLFENHENEQDLAIAVEYLKQAARAGHPYARYNL
LQLQENNGAEVETLISAYQELAEEGLVPGVQVD 
 
72  No similarity  Streptococcus sanguinis CbiG protein, 
putative 
Expect = 2e-27, Id = 58/85 (68%) 
Cmyc  148aa  SPLLLVSSWQQFSSLLAFTCWFTREFSGTAIGFFSRKAISPTTRKATRGTT
DPQH*STGSKPRLSVCHLF*GRTSSSS**VSSIGICEEDCRCRKCCTC*CGP
CK*RKCADPTVRTKRCNICTW*IR*QLLNIKFKEK*ICYTLLDLGVQVD 
 
73  No similarity  Streptococcus salivarius isolate 8 DNA 
polymerase III (dnaE)  
Expect = 2e-21, Id = 43/43 (100%) 
Cmyc  44aa  PLTRKRFVRWRVTSESSSDLHSQNNALYVKELQDNQTLCQHLLGVQVD 
 
74  1 match – not bacterial  Some matches human, some bacterial  polyH  85aa  *QTRSSIRRWARAWRSQFHRTSLRVMTRSAWSSISSVPSPAPRQQGIAHLFN Antibody Screening Results 
E value =1  SPDRPSRESRRA*ASRRVGHWETC*DG*PPENRTGVQVD 
 
75  No similarity  Chromohalobacter salexigens glucose-
methanol-choline oxidoreductase 
Expect = 0.021, Id= 17/33 (51%) 
polyH  272aa  LRS*LVTQIPPSLTLTCVTSIPRDMNAIAYRIADTSRTDMAGSRLDQVLRV
LRPFFMSFPQCRWHAASAGTGASSRGHTPANHMDNSITRSTDTCKVSSR
VNVLYGTIPPLRRIWRT*PHRLTPAHHLRYPSTTSPRPFCF*ELVKRKPKK
RGRQA*KVPLIFLFLESIALLWKRKRLIPENLQIKPPRSSWSRRSSLNAWA
VELPVRRSSSNPTKEYTREYASPLPLPFSP*DSLRRTKVYSDAPRDNSSVE
SPKDSVLTPLHGTPAVAPGVQVD 
 
76  Actinomyces 
odontolyticus hypothetical 
protein 
Expect = 9e-05, Id= 39/90 
(43%) 
Bacillus amyloliquefaciens  YqjI 
Expect = 2e-88, Id = 90/129 (69%) 
BOTH  241aa  *IKFAGNVSERYES*YANALENVGTGIPARTAVTTTSRTASW*DSVTYKK
YLSNNKFFN*GSRSNASVIFCKNCARMIHPARKILAISP*FKSQLNSSLAT
RI*ANPCA*LMILEKYNPLRTCSIKA*RSEFVNSGILVAANSLLAATRSSFN
VDTKRANTDSVINGSGTPKSNALCEAHLPVPLFPAVSMITSTIGRPVSGSF
FVKISAVISIR*PNSTGTALVPGLAAIAIVAGRRLVGVQVD 
 
78  hypothetical protein 
Bacteroides stercoris  
Expect =    21, Id = 9/11 
(81%) 
Homo sapiens genomic DNA, chromosome 11  
Expect = 2e-09, Id = 25/25 (100%) 
BOTH  25aa  PSS*YHHLGG*GSTV*RMQTSALAGVQVD 
 
79    Bacteroides vulgatus transcriptional regulator, 
involved in iron uptake 
Expect = 2e-09, Id = 18/33 (54%) 
BOTH    First 300bp 
80  hypothetical protein 
Actinomyces 
odontolyticus  
Expect = 4e-10, Id = 33/34 
(97%) 
Rhodococcus beta-glucosidase 
Expect = 5e-06, Id = 22/32 (68%) 
Cmyc  35aa  SSVPALVNGYLTGQGGAAAMLDVLTGVVNPSGRLGVQVD 
 
81  No insert 
82  Human zinc finger domain  Equal matches of mammalian and bacterial 
DNA – e values of ~0.5 
polyH  40aa  IVPSEIARAPEIFTHRGTFISPVIGSRILCVSP*PPASRGVQVD 
 
83  No similarity  Not bacterial  Cmyc  49aa  LC**ETPFSHYHGPHR*S*WSPHYIHNSYCIQCCSHYHSAQSLCHLC*GVQ
VD 
 
84  Human  Human chromosome 7  Cmyc  232aa  LINPVYCHLKFTNLMYEKWLLIVSLAFSIL*VGVSILSYD*R*LLKVCFAG
YLLT*LGENL**NFTKI*SFFVN*Y*SYIVKIFQNMM*RTKLICCVTYNYF*I
NLVI*DISDCIFFFGKSTMIFYLQSIEQK*SCTI*RQYILKYYLSVFLSILL*TFN Antibody Screening Results 
LFTYP*SLITQYIVDIIILNKPLNVRSTWSTW*NLVCTEKCKN*PGMVSHT
CNPSYSGG*SRRSLEPGRQRLQWVQVD 
 
85  multi-sensor signal 
transduction histidine 
kinase  
Methanoculleus  
marisnigri  
Expect = 0.51, Id = 22/66 
(33%) 
Not bacterial    145aa  LLVVHLDGDHQ*WPNPPQRGARRPRCPCRGSRRAGRRQEDLKGRPNRW
EPDHTPKRTFDSLPAPST*YLPDGRPMSVHDALPIYPLIRFLLFFFTSKLIS
DELLSDQWSFLDGKTLSLHFGGICSLSPLRPLAPSPRGPHLSFFRVQVD 
 
86  RNA binding protein 
Chlamydomonas 
reinhardtii 
Expect = 3.4, Id = 24/68 
(35%) 
1 match only 
Not bacterial    79aa  SMRSDCGRMLGVSGRVCAGSG*GSGSSWRDIGVSLCATFSLCAAVSLCG
AVVGAATSFAKVSLA*TADSLRGASAFCTGVQVD 
 
87  No similarity 
 
Haemophilus influenzae PittEE, 
phosphoribosylamine--glycine ligase 
Expect = 1e-56, Id= 79/81 (97%) 
  110aa  NNG*SNLFILSKFH*GRDICRRNIHVFHFVFQCGTCVARCDKNFIC*WRLC
CFPC*GVFTTAISYDEDVHVIVLAYA*FKKVRLFFPVIPPLL*RGG*GEI*TI
LNLV*GVQVD 
 
88  1 match, not bacterial  Streptococcus thermophiles calcium 
transporter P-type ATPase 
Expect = 6e-86, Id = 82/98 (83%) 
  277aa  QQSTYSYVCKLVDQCFKCSILLYGYFPFWLGHCWSSFGDGACPSGGRHP
LVAKGPATLCPPWLGIGS*ALELSTSSSRRAADDAGWRCGNHCDRGCF
WDRGSRRKCYRRDLDPV*LHACVWGGHSRRTSCHCNHRSLFGDDNPC
QTEFDRS*ITSG*NTWFNRNHRI**NRYFDHEPNDC*TSVYQR*IAKLSK*
NCC*QQYSSCHELCQ*YQGRPIW*N*LGIQQKLLWYSLVWTTTFDVREV
FEG*ASCG*IAI*L*S*ALVHGHLRGDGALTRGVQVD 
 
89  No insert 
90  2 short matches – not 
bacterial 
Lactobacillus acidophilus glycolate oxidase 
Expect = 8e-57, Id = 60/89 (67%) 
cmyc  159aa  RTKGFDTCYKR*GR*CERI**GVSGQHSRGDEGNRCSSSGPRL*NIWREV
LFADYDACFFASK*GRKGWQETDGSVCRGGFGAKCFKLGRHGTE*RICR
NSSCRC*DSEDNKAFHES**DSR*DKVC*RARGNRCRY*YRPCAWNRWQ
IRCCRRISSRGVQVD 
 
91  Bacteroides fragilis 
tyrosine type site-specific 
recombinase 
Matches for both mammalian and bacterial e-
values around 0.3 
  139aa  PPVPPGRPERKWVPGTREAHPQQEPPEQPAVRRGIRYAPPPKPAGRGG*P
AHRRALRNGQGQQKKYIRIDPFADYKAELPHRTRRYLTTEELQRLLQTPI
IDRQFERARQLPSSW*WGVVTVIGIDLGFRIAELCATWGVQVD FN Antibody Screening Results 
Expect = 0.010, Id = 21/59 
(35%) 
 
92  Mycobacterium sp DNA 
polymerase IV. Expect = 
2.2, Id = 15/37 (40%) 
Pseudomonas aeruginosa ammonium 
transporter AmtB 
Expect = 0.022, Id = 21/51 (41%) 
  62aa  LTGTARALRIGKEVIKAILPINPDDIRSLAKLGKNMVGKLSAHGLNTAAD
VADLANTAKHLGVQVD 
 
93  Leishmania major  
hypothetical protein,  
Expect = 52, Id = 8/9 
(88%) 
   
No similarity  BOTH  16aa  PAAPRP*RLPLICMAGVQVD 
 
94  1 match, not bacterial  Fusobacterium nucleatum Inorganic 
pyrophosphatase 
Expect = 8e-43, Id = 77/80 (96%) 
polyH  90aa  IISPAANPATIA*NIPISNPRYLIIPKEAIIVNNPAILVPISSFACTLLPSSVLTV
KVAIIEATIPKADINKGAAT*GVASSTGNKKAKVIVGVQVD 
 
95  No similarity  Candidatus Desulforudis UDP-N-
acetylenolpyruvoylglucosamine reductase 
Expect = 1e-18, Id = 42/102 (41%) 
  118aa  P*KKPY*RNYLVHVCENRSCFVIIRHLKLVVLLIYLLNLRRWMS*ALRYA
LFTNYKCL*LLLVAAPIFW*KTVVFAVLSYRFDI*HKSWIAMIMYYALVL
VIC*KMLLNLLGKTGYLGVQVD 
 
96  No similarity  Not bacterial    88aa  YYIIMLQETYFAQLFILALSIY*FKHIRIICFIKIILL**IDSKISSFVRSHKITL*
I*IYFLSC*ILLLISLCHR*KLHTTLLHRIGVQVD 
 
97  No insert 
98  No similarity  Frankia sp. ATP-dependent helicase HrpA 
Expect = 4e-04, Id = 19/31 (61%) 
BOTH  48aa  PVTPQNAGTTDIPTLMAFDEGGLDEQFAGCGGVYAGVLYGAVGVDGQ
GVQVD 
 
100  No similarity  Campylobacter concisus putative lipoprotein 
Expect = 6e-36, Id = 67/73 (91%) 
  73aa  RR*CNRQDRVRNLAFSLA*KVSALQVYLKIKFVG*TALNLVQLHHFCYQ
ASLLYCYNLARLFGYFFLNFQKEGVQVD 
 
 
 BSA Antibody Screening Results 
  Protein BLAST  tblastx  Tag(cmyc 
polyH or 
BOTH) 
ORF 
size 
(aa) 
Amino Acid Sequence 
1  Moorella thermoacetica  Amino acid 
permease-associated region 
Expect = 6.9, Id = 12/21 (57%) 
Matches to mammalian and bacterial , e-
values all over 1 
BOTH  28aa  PRPPHRPSPLHAPSPPHRPSPPHEASSGVQVD 
 
2  No similarity  Nostoc sp.  
NADH dehydrogenase subunit 4 
Expect = 0.081, Id = 13/26 (50%) 
BOTH  37aa  PRDVTPRDQVMPIWGIHRWDSYTWYDAGADQSKTEAGV
QVD 
 
3  Yarrowia lipolytica  hypothetical protein 
Expect = 12, Id = 11/15 (73%) 
No similarity  BOTH  15aa  PRAHGLNGFPWANAGVQVD 
 
4  Alkaliphilus metalliredigens 
phospholipase D/Transphosphatidylase 
Expect = 4.9, Id = 11/19 (57%) 
No similarity  BOTH  16aa  LMDWYFVPKLSEFPHGVQVD 
 
5  Rhodospirillum rubrum RNA 
methyltransferase TrmH,  
Expect =12, Id = 11/17 (64%) 
Magnetospirillum magneticum Flp pilus 
assembly protein, ATPase CpaF 
Expect = 7.0, Id = 11/13 (84%) 
BOTH  15aa  PRGAGATGRAPRPPGVQVD 
 
6  Most likely to be mammalian  Homo sapiens chromosome 8,  
Expect = 1e-08, Id = 22/22 (100%) 
BOTH  24aa  PQTFPCHSLPCLSSWWLDLSSSQGVQVD 
 
7  Only 3 matches - Geobacter uraniireducens 
acetyl-CoA acetyltransferase 
Expect = 9.0, Id = 17/57 (29%) 
Chlamydomonas reinhardtii  NAD malic 
enzyme  
Expect = 0.054, Id = 12/22 (54%) 
BOTH  59aa  LRELLQKIETAHAEFWYYLVYNRLPDGYTGVNGFTKEEE
DSFSVYEFLKKQEHAKLHEGVQVD 
 
8  Actinomyces odontolyticus hypothetical 
protein  
Expect = 1e-06, Id = 27/27 (100%) 
Clostridium tetani  excinuclease ABC 
subunit A 
Expect = 8e-07, Id = 24/27 (88%) 
BOTH  28aa  LIATLERLRDLGNTLIVVEHDEETMEAGVQVD 
 
9  No similarity  Azorhizobium caulinodans  putative 
glycogen debranching protein 
Expect = 1e-04, Id = 20/29 (68%) 
BOTH  32aa  PPCPT*RTWASPPSSCSPSTLSATSPSSPNEGVQVD 
 
10  Bacillus clausii  para-aminobenzoate synthase 
component I 
Expect =38, Id = 12/20 (60%) 
No similarity  BOTH  18aa  PRLSAYGVRQTRSLPKSGVQVD 
 
11  Heliobacterium modesticaldum conserved 
hypothetical protein  
Expect =    21, Id = 9/10 (90%) 
Pseudomonas putida uI gene, rsaL gene 
and uR gene 
Expect = 6.6, Id = 10/16 (62%) 
BOTH  18aa  PSWSWLTAPPSATEHSPGVQVD 
 
12  mammalian  Homo sapiens FOSMID clone from 
chromosome 10,  
BOTH  18aa  PREALSPRKWGQAQLLQGVQVD 
 BSA Antibody Screening Results 
Expect = 4e-04, Id = 17/17 (100%) 
13  No similarity  Akkermansia muciniphila  
Expect = 4e-06, Id = 22/33 (66%) 
BOTH  32aa  PGFGRVDRGVERAIRTDEDVLADDHRSDVEDGQGVQVD 
 
14  Salinispora arenicola  
Fibronectin type III domain protein 
Expect = 8.7, Id = 13/29 (44%) 
4 matches, all mammalian e-values over 2  BOTH  24aa  PSSWLWSLLPFPSSGSSEITRISGVQVD 
 
15  Heliobacterium modesticaldum conserved 
hypothetical protein  
Expect =    21, Id = 9/10 (90%) 
Pseudomonas putida uI gene, rsaL gene 
and uR gene 
Expect = 6.6, Id = 10/16 (62%) 
BOTH  18aa  PSWSWLTAPPSATEHSPGVQVD 
 
16  chitinase [uncultured bacterium] 
Expect = 21, Id = 9/9 (100%) 
Homo sapiens chromosome 19  
Expect = 4e-06, Id = 20/20 (100%) 
BOTH  21aa  PVRSLLGLGIP*LPSGADDKGVQVD 
 
17  No insert 
18  No similarity  Renibacterium salmoninarum ATCC 
hypothetical protein 
Expect = 3e-06, Id = 20/32 (62%) 
BOTH  36aa  LSPASQHARDRHRLFPAARTNQGADDAAEGFGVARGVQV
D 
 
19  mammalian  Homo sapiens chromosome 15,  
Expect = 4e-06, Id= 19/19 (100%) 
BOTH  20aa  PLRHRSGQLYQWAWAEKDPGVQVD 
 
20  No similarity  No similarity  BOTH  54aa  PFLSSLPIPAPAPAPPMKPPPAPAPPRPAAPAAPAAPLPPAP
VVPVTPEAPAPGVQVD 
 
21  No similarity  Porphyromonas gingivalis  
hypothetical protein 
Expect = 6e-15, Id = 34/55 (61%) 
BOTH  57aa  LRQKAGIGIDELHRTAGAEAEADDVSIAHRVIIAEARDVSL
KEVFGLAGGELIVPQGVQVD 
 
22  Trypanosoma cruzi hypothetical protein 
Expect = 1.1, Id= 19/50 (38%) 
No similarity  BOTH  26aa  LCSWGVSLSFCYLQRVLELVPESDVGVQVD 
 
23  No similarity  Kocuria rhizophila 
30S ribosomal protein S13 
Expect = 8e-10, Id = 28/31 (90%) 
BOTH  41aa  PSSCLQRCAWDPCGYARWSWCADRGPAGGVGAPTGKAG
TGGVQVD 
 
24  No similarity  No similarity  BOTH  26aa  PHRSYFDHIFTGTVGMFQSSEDIVEEVGVQVD 
 
25  Burkholderia phymatum                3-carboxy-
cis,cis-muconate cycloisomerase  
Expect =12, Id = 10/12 (83%) 
No similarity  BOTH  14aa  PIWSPRATLSQAMGVQVD 
 
26  Pseudomonas putida general secretion 
pathway protein L  
Expect =2.0, Id = 17/39 (43%) 
Human chromosome 9 100%id,  
Expect=2-06 
BOTH  20aa  PRLQSRWKAEGGEQPWGAAGVQVD 
 BSA Antibody Screening Results 
27  Actinomyces odontolyticus hypothetical 
protein  
Expect = 1e-10, Id = 20/20 (100%) 
No similarity  BOTH  21aa  LTTLMERLAAAPVQVESPRMGVQVD 
 
28  No similarity  Human chromosome 11, 100% id, 
 Expect= 5e-12 
BOTH  28aa  LLLFYCGFPMSAPLSRTCIPPDPTPDPGVQVD 
 
29  No similarity  Equal matches mammalian and bacterial. 
E values not less than 0.1 
BOTH  35aa  PKIHHAPRADETREPTMTDRLIAPENADVPRTREGVQVD 
 
30  Burkholderia phymatum molybdenum 
cofactor synthesis domain protein  
Expect = 39, Id = 10/12 (83%) 
No similarity  BOTH  15aa  LFGHTPQPAEGTAGGVQVD 
 
31  Mammalian  Homo sapiens chromosome 17,  
Expect = 0.003, Id = 14/14 (100%) 
BOTH  15aa  LPKWWDYRREPLHPGVQVD 
 
32  mammalian  3 matches only. All to - Medicago 
truncatula  
Expect = 5.1,  Id(64%) 
BOTH  23aa  PGVILPIDRHQHRHVLPAQDPGGEQVD 
 
33  Mammalian  No similarity  BOTH  24aa  PSSWLWSLLPSPSSGSSETTQTSGVQVD 
 
34  Burkholderia pseudomallei sulfate 
adenylyltransferase subunit 2  
Expect =0.018, Id = 14/18 (77%) 
Actinobacillus succinogenes sulfate 
adenylyltransferase, small subunit 
Expect = 7e-04, Id = 21/23 (91%) 
BOTH  25aa  PSIWKALTASASNTTESLPPENSKGVQVD 
 
35  Synechococcus sp glycosyl transferase, 
WecB/TagA/CpsF family 
Expect = 4.8, Id= 7/7 (100%) 
2 matches only - Verminephrobacter 
eiseniae transglutaminase domain protein 
Expect = 2.0, Id= 10/19 (52%) 
BOTH  22aa  PGRWWRDHHDYTHAAEAGPFGGVQVD 
 
37  No similarity  No similarity  BOTH  29aa  P*TRPSSPTSTTSRPATVSPSASTRATPGVQVD 
 
38  Arthrobacter aurescens ferric enterobactin 
transport system permease protein 
Expect = 0.83, Id = 13/17 (76%) 
No similarity  BOTH  22aa  PRGTLSNRLFEIFSTPVAPPPGVQVD 
 
39  Actinomyces odontolyticus hypothetical 
protein  
Expect = 1e-10, Id = 20/20 (100%) 
No similarity  BOTH  39aa  LTTLMERLAAAPVQVESPRMGVQVD 
 
40  No similarity  Anaeromyxobacter sp. CHRD domain 
containing protein 
Expect = 0.29, Id = 14/31 (45%) 
BOTH  49aa  PGTAVPHVNPLIGASAGMPTYGTEGLRAEQRVPRWHAKA
PSALDCDRQGVQVD 
 
41  mammalian  Human DNA, Expect=2e-08 id 100%  BOTH  25aa  PLGFWSKVLPSSADNDSPFERQPLGVQVD 
 BSA Antibody Screening Results 
42  Verminephrobacter eiseniae Tfp pilus 
assembly protein tip-associated adhesin 
Expect =16, Id = 13/21 (61%) 
Bifidobacterium longum LacZ 
Expect = 3.7, Id = 12/17 (70%) 
BOTH  19aa  PWSSPTKTPSSRSPDSSTGVQVD 
 
43  1 match - hypothetical protein Victivallis 
vadensis  
Expect = 6.7, Id = 15/34 (44%) 
No similarity  BOTH  37aa  PRVTGQRLCLHPSANAVDAVDAVDAVDPVDTAGAAEGV
QVD 
 
44  No similarity  Symbiobacterium thermophilum UDP-N-
acetylglucosamine pyrophosphorylase 
Expect = 0.11, Id = 15/25 (60%) 
BOTH  34aa  LLPWHYAH*VVPWGDGLDDFAGRPPDLDLMSPTGVQVD 
 
45  No similarity  Not bacterial  BOTH  28aa  PRVPFLSPHFSPPNEEMAEPMDITNDPGVQVD 
 
46  Thermofilum pendens Hrk 5 hypothetical 
protein  
Expect = 4.9, Id = 11/18 (61%) 
Sulfurimonas denitrificans ATP synthase 
F1, alpha subunit 
Expect = 0.69, Id = 14/15 (93%) 
BOTH  17aa  PPALWRVRASTSPSPPGVQVD 
 
47  Clostridium scindens 
 hypothetical protein 
 Expect = 7e-08, Id = 24/30 (80%) 
Carboxydothermus hydrogenoformans 
DNA polymerase III,  Gram-positive type 
Expect = 8e-08, Id = 23/27 (85%) 
BOTH  29aa  PRIPKSELQRYREGLIIGSACEAGELYQGVQVD 
 
48  Natronomonas pharaonis  
predicted transporter -predicted permease 
Expect =29, Id= 10/15 (66%) 
No similarity  BOTH  16aa  PITWLTPYRGLPSDEGVQVD 
 
49  Cryptococcus neoformans var. neoformans 
hypothetical protein 
Expect = 6.5, Id = 11/15 (73%) 
Homo sapiens chromosome 15,  
Expect = 4e-06, Id = 19/19 (100%) 
BOTH  20aa  PLRHRSGQLYQWAWAEKDPGVQVD 
 
50  Ralstonia eutropha  
Secretion protein HlyD 
Expect = 8.8, Id = 11/19 (57%) 
Mesorhizobium tianshanense  
Expect = 9.9, Id = 10/17 (58%) 
BOTH  19aa  PLGWYWYPYIGSGAGSPQGVQVD 
 
52  no similarity  Human DNA Expect=4e-21, 82% id  BOTH  70aa  LIALPLGTWIGHTGRGPREAAPIVWG*FF*VNLPIN*KNKG
DGTGWIRLLARHYMASAGDKASVVPVSLGVQVD 
 
54  3 short matches - Stenotrophomonas 
maltophilia  
hypothetical protein  
Expect = 0.26, Id = 21/50 (42%) 
Human chromosome 14 Expect=4e-30  BOTH  156aa  PAMTADIK*ADAASSSKAHITAPRQFLFF*S*LLHTSGFFMC
KTNCY*IIVKARLGKEQ*VSHGGDAFNDISANEIALHGFTY
**LSSNSHVLLSACH*RPSVTSNCQPRAGTSSSAIPTLRTAPT
GSRPPRWTPPLSSSVIRPQMAAAGS*SVVGVQVD 
55  not bacterial  No similarity  BOTH  18aa  PTWRCAPHASSSASPPRGVQVD 
 
56  hypothetical protein   Clavibacter michiganensis conserved  BOTH  23aa  LLEWACDASSQWSLPTRLSEEQGVQVD BSA Antibody Screening Results 
Actinomyces odontolyticus  
Expect = 3e-07, Id = 17/22 (77%) 
 
hypothetical protein 
Expect = 2.3, Id = 14/22 (63%) 
 
57  no similarity  Clostridium phytofermentans binding-
protein-dependent transport systems inner 
membrane 
Expect = 1e-21, Id = 43/60 (71%) 
BOTH  62aa  SIVTKMNTIITSERPEPRFQFEVVVNSCSIILPIKYILPPPSMF
EIAKVVSAGTNTMVMPLGVQVD 
 
58  no similarity  Pseudomonas putida protein of unknown 
function DUF535 
Expect = 6e-14, Id = 24/61 (39%) 
BOTH  201aa  LFSLI*FLATLSSNRMLILLS*NISQ*LF*VWL*IFMNLYHILI
K*FIAFSVLTTFL*FDFFNWLAIFFQWNFVKSRIL*KFATTFL
P*RIEFRHFSTMNTY*MCICIKTFIRYSIDCFYTAFFSNQSK*I
YNKVFWSITKHLFGSYFCII*TILIALNRTNPHGFFPIKTFTK
SEISMIYTF*F*C***C*QAFFTLPWGVQVD 
 
59  hypothetical protein  
Actinomyces odontolyticus  
Expect = 3e-06, Id = 25/38 (65%) 
 
Mycobacterium sp. aspartyl-tRNA 
synthetase 
Expect = 9e-16, Id = 34/36 (94%) 
BOTH  78aa  PDGSWMQCHQCQNSVVAVVIDSQDRIVFTHYASNEGDPV
AACSRLPTWAPW*CPVAHPSPAAPWTLGRNGLSSAALRG
VQVD 
 
60  no similarity  Thermobifida fusca carbamoyl-phosphate 
synthase large subunit 
Expect = 1e-21, Id = 44/72 (61%) 
BOTH  81aa  PR**GPRPWVLHPRRVPPRTCAPSAPGCRCDAAQKRYQRS
PGS*SPFLPYGRWAGRSLVYRCRRSR*TPCPMWAYPWTHP
GVQVD 
 
61  no similarity  Renibacterium salmoninarum Trk system 
potassium uptake protein 
Expect = 8e-21, Id = 40/45 (88%) 
 
BOTH  46aa  TSTPQESSNIHSFLGLFTRATVRGTPNSVLASREITRFTLSSP
VAGVQVD 
 
62  no similarity  Thiobacillus denitrificans ribonucleotide 
reductase 
Expect = 6e-11, Id = 28/50 (56%) 
 
BOTH  199aa  PSFAPSRLQ*L*YTACRRSSQEGER*CRSPS*ASVSNFLS*TD
QMPGLIDHI**SVKLILCELYYISIRLELFLIVKVKEFVKL*P
MEGALILLLFLGLCWLVVSVKSLVSLMALLLLQLFVENDI*
TIALPTMHCPHIVPVKKVQSLIRAPGPPEVLQDRSEEARAH
LEPEGDLALGAPVTLHQPDLLLDGPG*PVVGVQVD 
 
64  no similarity  Pseudomonas fluorescens  
Secretion protein HlyD 
Expect = 2.7, Id = 13/24 (54%) 
BOTH  30aa  LI*AR*FMRKPRWT*GSSAPEPVRPGAAAGVQVD 
 
65  hypothetical protein  
Actinomyces odontolyticus  
Rhodococcus sp. glucose-6-phosphate 1-
dehydrogenase 
BOTH  17aa  LWYTGNYKDPETGEREGVQVD 
 BSA Antibody Screening Results 
Expect = 3e-08, Id = 17/19 (89%) 
 
Expect = 7.0, Id = 10/14 (71%) 
 
66  hypothetical protein  
Actinomyces odontolyticus  
Expect = 2e-09, Id = 20/21 (95%) 
 
Anaeromyxobacter sp. cell surface 
receptor IPT/TIG domain protein 
Expect = 7.0, Id = 10/16 (62%) 
 
BOTH  22aa  FQKAGITSVTLPDSLRDIKDEGVQVD 
 
67  no similarity  Streptomyces avermitilis putative DNA 
processing Smf-family protein 
Expect = 0.43, Id = 14/26 (53%) 
 
BOTH  119aa  LLPVSPLRPGCALPCFSLCGCTWCAFLGAPRRTRVSENHYT
HLGSK*QLFAKQLPYEIEK*ERVS*TLRSRPNDGSPHTPPHS
SSPAASPPSAAPPNSFPPQHCSRSPALPPPCPPQQGVQVD 
 
68  no insert         
69  no similarity  Uncultured bacterium clone 
Expect = 1e-19, Id = 39/71 (54%) 
 
BOTH  78aa  RCTRIPSSDCTARMSSSVSRGFQKSNMVRSSVASNFTLPSM
R*GWMRSSGRKIP*RKEVMKRCSCANRKSSGVQVD 
 
70  hypothetical protein  
Actinomyces odontolyticus  
Expect = 0.012, Id = 19/29 (65%) 
Streptomyces coelicolor A3(2)  
putative ATP/GTP binding protein 
Expect = 0.12, Id = 16/48 (33%) 
BOTH  76aa  ERRRMAEYLASPQGYDHVMHVVRARFMAGNYYDLCAG
VCRDFANTVGNFNIDRGVADGHWTRPTRRRRHGIGLGLG
VQVD 
 
71  no similarity  Streptococcus sanguinis SK36 
Hypothetical protein 
Expect = 3e-06, Id = 19/29 (65%) 
BOTH  65aa  PIAILNKFGPRKIKMKSPQALPESAK*EINNTR*IMDK*KAT
ERRMEVNLIFVG*F*IDAELKPGVQVD 
 
72  no similarity  Acidothermus cellulolyticus 11B strain 
isochorismatase hydrolase 
Expect = 1e-12, Id = 28/37 (75%) 
BOTH  38aa  RLLGRAPRRVSADRHHAGLAY*SGRSLFGDPRFRGHVGV
QVD 
 
73  no simialrity  Bifidobacterium longum NCC2705,  
 LysR-type transcriptional regulator 
Expect = 1e-04, Id = 16/31 (51%) 
 
BOTH  64aa  PRRLAGCCALV*YSPRSSHLRGDVNLLM*G*MARTGRPSR
ASKPTSRLTSRTGTQQDAK*SSRGVQVD 
 
74  sulfate adenylyltransferase Burkholderia 
pseudomallei  
Expect = 0.018, Id = 14/18 (77%) 
Actinobacillus succinogenes 130Z, sulfate 
adenylyltransferase,  
Expect = 7e-04, Id = 21/23 (91%) 
BOTH  25aa  PSIWKALTASASNTTESLPPENSKGVQVD 
 
75  shikimate kinase  
Clostridium butyricum  
Expect = 2e-05, Id = 22/39 (56%) 
Clostridium beijerinckii  
Shikimate kinase 
Expect = 3e-06, Id = 21/36 (58%) 
BOTH  40aa  PVFLGSKKGVVIATGGGVIKRRENIDIYKENGFIIFLDRGVQ
VD 
 
76  no insert 
79  Neisseria gonorrhoeae   Neisseria gonorrhoeae FA 1090,   BOTH  148aa  EGLWVEEGVTFADLKAVFTDFIRRFFERDDLQVRFRPSFFPBSA Antibody Screening Results 
phenylalanyl-tRNA synthetase subunit alpha 
Expect= 6e-65, Id= 117/119 (98%) 
putative phenylalanine tRNA synthetase,  
Expect = 1e-65, Id = 120/123 (97%) 
 
FTEPSAEIDIMGENGKWLEVGGCGMVHPNVLKNVDIDPEK
YTGFAFGIGLDRFAMLRYNVNDLRLFFDNDLNFLKQFK*IS
DGLLIVRLKSE*ILLISSDKNLFQTGVQVD 
 
80  no similarity  Salinispora arenicola  
125 bp at 5' side: hypothetical protein 
84 bp at 3' side: FAD-dependent pyridine 
nucleotide-disulphide oxidoreductase 
Expect = 0.043, Id = 19/32 (59%) 
 
BOTH  38aa  PS*EPTSCASHEDRCESPSKRVPRQFRVTDVMPRCARGVQ
VD 
 
83  hypothetical protein  
Actinomyces odontolyticus  
Expect = 5e-06, Id = 29/42 (69%) 
 
Streptococcus thermophilus  
replication initiator protein 
Expect = 2e-50, Id = 49/65 (75%) 
 
BOTH  344aa  LILGTLFGSTVLVEEAFSCPARQLLADSITTRMCPSCRRCA
ARRGRHHCRDADR*RCRVRRRSASGGGRGEGSVMVVSLP
PRALERGRRVRVRILPWRCHSDRVPDDRARLAGGRRARG
G 
G*GAYPSRGRVRAFPRRLPRGRRQSARSSKFSQSLT*KLAF
LTASNPIHLRQRPK*RAIGKNQ**QRITQILSIERRRYIEKYH
SISTRISKSSRFIKTRKIYLYQH*QINSNL***GPIT*TNIS*ITK
ITR*YNSRI*YSRKSKRRLFYSL*NDKRR*YKSNFLSTIGLW
WLSSYTPRLQPKLTKRI*GVTSVEADYELRSIKSIRN*TVTI
RPCF*YL**GVQVD 
 
84  No insert 
87  no similarity  Frankia sp. Phosphate ABC transporter, 
permease protein PstC 
Expect = 0.017, Id = 14/22 (63%) 
 
BOTH  34aa  LQWLVQQWLGGAPIADLLTRGLGGENGTYLTKQGVQVD 
 
91  Haemophilus influenzae  
outer membrane protein, PittII 
Expect = 6e-53, Id = 98/110 (89%) 
 
Mannheimia succiniciproducens 
unknown 
Expect = 2e-87, Id = 89/115 (77%) 
 
BOTH  217aa  FAGGDRSVRGYGYKKISPKNKEGKLVGGSRLVTGSLEYQ
YQVYPNWWGAVFADTGLAADAYKANELRYGAGFGVRW
ASPVGAIKFDIATPIRDKDNSKNIQFYIGLGAEI*GMTMSEQ
EKQPDNQTTQPVKKKKTCRKILCVGSAVIFVPVLGLVTAL
SFDSGQRAIIQLADKMLDSLSIEQVSGGLQDGLVLENLRFQ
TTGVDVALPKTRLQLNLGVQVD 
96  no similarity  Clostridium difficile 630  
conserved hypothetical protein 
Expect = 2e-06, Id = 27/69 (39%) 
 
BOTH  156aa  PQ*RRTSYYNQGNL*TR*KGEGSINIL*VARN*QP*MLKRR
RLLF*NLNVLN*EINH*SINILNNIITKRRIIALLHCICGKKPM
AFVGLKKMAYCTSKVVVSAIHSYYLHLLVRMRSSSMVYC
VQKNGL*KINYHSFSKVLARL*KNGWRNYAQGVQVD BSA Antibody Screening Results 
 
98  similar to human phospholipid transfer 
proteins  
Bacteroides fragilis  
putative glycosyltransferase 
Expect = 8e-22, Id = 29/55 (52%) 
 
BOTH  118aa  L*LL*KRFRCRKTVASIHKDNLITSRLLQSFVHSKVKSSIRF
ALYLHDMPILSLIGLTLISLSYTDCIVCRGSINDEMFNMNIV
LHKDTV*RWL*NVLRIIGYCDYRKCDHRWKLLRGVQVD 
 
99  Outer membrane receptor proteins, mostly Fe 
transport  
Actinobacillus pleuropneumoniae  
Expect = 7e-21, Id = 45/85 (52%) 
Neisseria meningitidis  
conserved hypothetical protein 
Expect = 2e-26, Id = 49/102 (48%) 
 
BOTH  109aa  LIFLLGLDAPLTDIWKIGNNISTGFRNPTASEMYFSFEHPAG
NWIPNPDLKAEQALNQSIYIQAEHLLGSFGLTFYHTRYKN
LLTEQESTYKKRNPYYNAYSASYGQQGVQVD 
 
100  no similarity  not bacterial  BOTH  43aa  CHPPFALHPPPRPRIIFP*KKKGAALRATAFAFFAWGTSSA
RRVQVD 
 
 
 bacterium SRMC-53-10
uncultured bacterium; P1D1-517
uncultured bacterium; P1D1-727
uncultured bacterium; AYRV2-138
Neisseria perflava; U15
Neisseria mucosa; M5
Neisseria sp. J01
uncultured bacterium; P2D11-603
uncultured bacterium; FIU_KM_MD_004
23
22
70
uncultured bacterium; nbw788f12c1
uncultured bacterium; P2D1-502
Prevotella melaninogenica (T)
Prevotella histicola; T05-04
uncultured bacterium; rRNA247
Prevotella histicola; N19-30
uncultured Bergeyella sp.; 450a
137
uncultured Prevotellaceae bacterium; 301C01(oral)
uncultured bacterium; P3D1-597
Prevotellaceae bacterium P4P_62 P1
Bacteroides cf. forsythus oral clone BU063
47
Prevotella salivae (T); JCM 12084; EPSA11
233
296
uncultured bacterium; P1D1-514
Prevotella pallens; 8792
Prevotella pallens; 9423
Streptococcus infantis; CCUG 39817
uncultured bacterium; SJTU_C_03_56
uncultured bacterium; 014B-B9
uncultured bacterium; LY03
Streptococcus salivarius; RKA5
human oral bacterium C23
uncultured bacterium; 2-002-a11
uncultured bacterium; Ax3_690
Veillonella parvula; ATCC 10790
Veillonella sp. NVG 24cf
Veillonella sp. NVG 84cf
uncultured bacterium; SJTU_F_11_45
Veillonella dispar; ATCC 17748
uncultured bacterium; B2_052
uncultured Veillonella sp.; EHFS1_S01e
uncultured bacterium; FD03C07
uncultured bacterium; FIU_KM_MD_005
uncultured bacterium; FIU_KM_MD_012
uncultured bacterium; nbw777a11c1
uncultured bacterium; nbw790b10c1
uncultured bacterium; FIU_KM_MD_002
Veillonella atypica; ATCC 17744
uncultured bacterium; rRNA069
uncultured Veillonella sp.; 59-8-23
uncultured Veillonella sp.; KLONG06
327
uncultured bacterium; SJTU_F_05_25
Veillonella parvula (T); DSM 2008
uncultured bacterium; P4D1-570
uncultured bacterium; nbw827e08c1
uncultured Bacteroidetes bacterium; S15B-MN34
71
uncultured bacterium; Oh_3127A5C
uncultured bacterium; P2D1-728
uncultured bacterium; P2D1-760
uncultured bacterium; Ax3_475
uncultured bacterium; nbw791a05c1
uncultured bacterium; nbw825b01c1
uncultured bacterium; P3D1-469
45
Haemophilus sp. oral clone JM053
Haemophilus parainfluenzae; CCUG 12836
60
uncultured bacterium; Z775
uncultured bacterium; Y132
uncultured bacterium; P5D1-466
Abiotrophia para-adiacens; TKT1
uncultured Streptococcus sp.; 401B03(oral)
uncultured bacterium; FC01G09
uncultured Streptococcus sp.; GI5-006-B07
Streptococcus sp. S16-11
Streptococcus infantis; ATCC 700779
Streptococcus sp. F1
uncultured bacterium; FD02H05
uncultured Streptococcus sp.; 2P-4-1-G19
uncultured Streptococcus sp.; 2P-3-2-C13
189
uncultured bacterium; JSC7-29
uncultured bacterium; P5D1-660
Streptococcus infantis (T); GTC849
273
Streptococcus oralis; CIP 105158
307
uncultured bacterium; nbw740f01c1
Streptococcus oralis; CIP 104985
uncultured bacterium; BF0001D086
Streptococcus australis; ATCC 700641
uncultured bacterium; nbw824b11c1
Streptococcus parasanguinis; mother C3; 5C3
Streptococcus sp. EO2001-01
uncultured bacterium; P2D1-692
Streptococcus sp. oral clone AG008
uncultured bacterium; P2D1-735
uncultured bacterium; NS03
Streptococcus parasanguinis; 85-81
Gemella sanguinis (T); 2045-94
uncultured bacterium; JPL2-3
uncultured bacterium; LG25
Peptostreptococcus stomatis (T); W2278
Oribacterium sinus; F0268
uncultured bacterium; BF0002C015
Eubacterium sp. oral clone DO016
uncultured bacterium; nbw816h06c1
Eubacterium sp. ’Smarlab BioMol-2301231’; Smarlab BioMol 230
uncultured bacterium; A_S_01_63
284
Fusobacterium periodonticum; ChDC F314
Fusobacterium periodonticum; ChDC F312
uncultured Leptotrichia sp.; 303A12(oral)
uncultured bacterium; nbw828b02c1
uncultured bacterium; nbu189a11c1
uncultured bacterium; NH01
uncultured bacterium; A_S_01_77
uncultured bacterium; P4D1-488
Rothia mucilaginosa; J04
9
Chlamydia trachomatis; B/TW-5/OT
Scale:
0.1  214 
Appendix 7: pQR492 text sequence  
 
>ORF 5 
GGGGGGGGGGCTCGTCGCGCTCTGAGGATGCCGTTGAATGCGGTTGCGGGGGTGG
CGTTGACGGTGTTAAGCTGTCGATGCCATCTTCGATGGCGTCAGCGATGCTCTGGT
TTTCGAGTGCGCCTGCGGCGGCATCTTCGAGCAGGTCTGCGTCGGTGACGAGTTCG
GTGATTTCCCACCAGCTGAGCTTGGCTTCGAGTGCCTGTGCGGTGGTTTGGTCGAT
GGTGCGGAATCCGCTGTCGCTCATGCGGAGCTGTCCGAGGTCGATGGGTGCTACTG
CGTCGGCTTCTGCGGAGGTGTCCCAGGCGGCGGCGAGGAATTCTTCGTTGGTGGCG
ACGAGGTCTTCGGCGCGGGCGCGCACACGCTCGGGTTCGACGTTAATGATCATGGA
CCCAGCCGGCAACAGCTCGGTGAGGGTGTTCATGGATTCGATGAGTAGCGGGGTG
AGTGATTCCATGCCTTCGACGTAGATTCCGCCGGCAATCTTCTCAAGCATGGCTGC
GGCTGCCGGGTAGTCGGCTTTCAGTCGTGCGGCGCGGCTCATGACCTCGGGGGTGA
TGAGCAGTTCGCGGCAGGGCAGCAGGGTGAGTTCGGTGAGTTCTTCTCCCCCGCTG
AGGGTGCGCTGGTCGGCGACGGAGAAGTGGCGCATTTCGTCGAGTTCGTCGCCGA
AGAATTCGAGGCGTACGGGGGTGGTGGCGGTGGGCGGGAAGACGTCGATAATGCC
GCCGCGTACAGCGTATTCGCCGCGCTTGGCAACCAGGTCTACGCGGGAGTATGCGG
CGTCGTTGAGACCGCGCACCACATCCTTGAAGGGGTATTCTTCGCCGCGAACCAGG
TGCACGGGTTCAAGTTTTTCGATGCCGGTGACGATGGGCTGGATGACCGCGCGTAC
GGGTGCGATAACGACCTGGGGGCGTTTAGCAGCTTCCCCGGTCATGGCGCGCAGTA
CCTGCAGGCGGCGGCCTACGGTGTCGGAGCGCGGTGAGAGGCGTTCGTGGGGCAG
GGTTTCCCAGGCGGGGAAGAGCGCAATGTCGGCGGCGGGCAGGTAGGAGCGCAGG
GCTGCGGCGAGGTCTTCTGCTTGACGGTCGGTGGGGGCGATGATGAGGCTGAGCG
CTTCGGCGGTGGTATCGCGTACTGCGGTGGAGATGTCTGCAATGAGCGCGGCGTGG
GTTCCGGCGACGGCGCCGATGAGGGTGCGTGCGCTACGTTCGGTGGGCTGTGCGG
AGGCGGCGGTACGGATCGCGGCCCAGCTGCTGAGTTGGTTGAGGGTGTTCAGGAG
GGGGTGCAG 
>1290-1924 
GGGTGCTTCGAGGGGCTGTGCAGTAGCTTTTCGGGTGGTGCTCACGGGTTCTCCTG
AGTCTGGGGTCTTCGCTTGCGGCGGTTGAGCTGGTGGAGGGCTGCTATGGATGGTC
GGTATAGAGCGGTGCCGGTTTGGGGCGTCCGAGTGAATTTGCCTTTATTTCATGGT
GCTTTTTGTGCGTTTTGGGGTGTTTTTTGCGGCTTTTCCATTGTATGACTTGTCTGCT
TTTTCTGGCATTTTTCTCTTGTATTCTCTGTGATGGAATATATTCCTTTTTGCACTCG
GTTGTCGCTTTCGTGGGTGATATTTGAGTATGGTTTTCTTCCGTGTCCGTTCCTGTGC
CACAACGTTCATCACATGGGGTGCAAATCACACATCCACGGGCATCTTTGCACTTT
GTGCACCATTATTTTCACAGCTTAATCCTGTACCCTAATCATTAACACTTAGAGAAA
ACCAGACAGTATATCCCCTTCCGGATTCTGTTTACCTCTTCCAACCAACCTCAGGTT
TCAGTATTTACTGCGGTTTTTCTAGTGCGCTAAATTCACCGTATCTTTCGATGTTTCT
TCCGGAACGTCGCATCAGAAAGACGCATATGACACTACATACACGAACAATCCGC
TGAAAGC 
>ORF1 1925-3481 
GCATGCCCATCATGTCTGCTAGATGGGGTGCTTTCGCCTCGCTTGTACTGCTTTACT
GGCGACCTCTTACTCTTACTATCAACCCTCCGGTTTTCAGTATTTACTGCGGTTTTTC
TAGTGCGCTAAATTCACCGTATCTTTCGATGTTTCTTCCGGAACGTCGCATCAGAAA
GACGCATATGACAACCACATACACGAACAAACCCGCTGAAAAGCGCCATGCCCAT
TCATGGTCTGCTAAGAAGTGGGGTGCTTTCGCACTCGCTTTTGGTACTGCTTTTACT
GCGGCACCTCTTACTCCTACTACTCCCGCCTCGGCTGCGACCGGAACCCATGACGG
TTCCAGCAGCGATAAGGCGGCTGCTTCCTGTTACGAGGTCAAGCAGGTTAATCCTT
CCGCCTCCTCTGGCACTTACTGGCTGTACACCCCGCAGATGAGCGGCCCGGCGCAG
TTCTACTGCGATCAGGAAACTGATGGCGGCGGCTGGGTCATGATTGGTCGCGGTCG
TGAGGGTTGGACCGAGTCTTACAACGGCACCGGCGACCCGAACCAGCTGCATCAG
AACCCCACGGGCCCTTCTGCTTTTACCCCGGTCCAGCTTCCCGCAAACACTGTCGAT
GCTCTGCTGAACGGCATTAAGCCTCAGGACCTTCCCGATGGCATGCGCCTGCACCG
TGCCCACAATGCAAGGGGCACCCAGTGGCAGAACGTTTATGTTCAGCGTCCTCAGA
CTGAGCAGTGGACCTGGGCGATGAGCTACGGTCAGCGTTGGGGCACCGTGAAGTT
CACCGGTGCCGGCATTAACCGCACCGCTCATATGGGTCGTCATGCTTCGGAGATGG
CTCCGGGTATTACCACCAGTTCTGTTCGTTTCTTCGCGAACCCGAACCAGGGCTACC  215 
AGATTGGTTTTGCGTACGGTGCGCTGGTGAACTTCGGTAATGAGAATCCGGATTCA
TACATTTACCACAAGCGTGGTTCCGCTGGTTACTCCATCCCCTTTACTCAGGTGTTC
CTGCGTCCGAAGCTGACTCAGCGTGACTTGAACTTCTCGCAAATTGGTTCTAGCTCT
GCCGCTAGCAACCGTCGTGCTCTGCCGAATAGCTACACGATGCCCGTTCGTTGGCG
CACCAGTGAGCAGACTGGCACCGGCAAGAAGAACGAGATGAACACCTACGTTCAG
GCTATTACTCAGGTGGGCGACACCGTCTTCACCGGTGGCGACTTCAAGTACGTGGA
GTCGGCTGGTGGCGAGCGCGTGGACCAGTCGTACCTGGCGGGCTATAACGTGGATT
CGGGCGAACTGGTTCGCTCTTTCCGTCCGACTTTCAACGGTCAGATTAAGGCTCTG
AAGGCTCTGCCGAATAACCGTCTGGCGTTGGTGGCGAGTTCACCGAGGGTAATGGC
GAGAAGGTCAACCACTTCGTCATTCTGGACGCAACCACCGGCCAGATCGACCGCA
CGTGGGATCTTCAGTCAGCGCGTAATGCGATGCAGTTCAGGTGAAGACCTGCTGGT
TCAGGACGGTTACCTGTACATTGGCGTAACTTCACCCATG 
>3481 - 4010 
TAAAGGGCAATACGTCTAAGGCGTACGCTTACTCGCGTGTGCCGCTCGTTTTAAGC
TCTCGAACGGTGCGGTGGATTGGAACTGGCGCCCGAACTTTAACGGTACGGTCAAC
GGTATTACCGCTGCGTCCGATAACTCGACTGTTCACGCTGCGGGTTACTTCACTGA
GCTGAATAACCAGCGTGCTTTCCGCCTGGCTGCTCTGAACGGCTCGGATGCTTCGA
ACATTAGGTGGGAGTGGGAGCCTTCGCTGAAGCTGAACATTACTGACCGTATTGTG
TACGCGTTCCAGTTCGATGTTCAGGATGCTGGCTCGACCGTGTGGACTGCCGGTGC
TGACCACCTGATTGCTAACTACTCGAAGAACGGTTACGGCCGTATTTCCACTGCGA
TTTCTAAGTATGGTGGCGACTGGCAGGATCTGCACCTGAGCGGTAACACCATTTAC
GGCGCGTGCCACTGCGGTGACGTCCTCTTTGAGGGTTCTACCGGTTACCACACCTA
CTGGAAGGAATCGAAGGCGGTTCAC 
>ORF 2 4011 - 4460 
CGCATGCGCCTGGTCGCGGCGTTTGATAAGGACAGCGGCGAGGTTGTGGGCGAGT
TCAGCCCGGTTCTGAAGGGCGCTAGCGGCTACGGTGTCTGGGAGTCCTTCGTGGAT
TCTCGCGGCAACCTGTGGGTTGGTGGCGACATTAACCGTTCGCTGGGTGCTAATGG
TGAGCAGCGCACTGTCGGTTTTGCTCGTTTTGCTCCTCGCGATGTGACCGCCCCGTC
GACTCCGTCGAATCTGTCGGTTCAGCGTGATGGCTCGACCGATAAGCTGTCTTGGT
CTGGTGTTCGTGAGAGCGGTGCTCGCTACCAGGTGCTGCGTGATGACCGTGTGATT
GCTACGGTCTCGGGCACCAGCTACGAGGTTGAGCATACTGATGGCGCTCGCTACTA
TGTGCGTTCCATCGATGCGTCTGAGAACTTCTCGGCTTCCACGGGAGCTGCTCAGG
C 
>4461 - 4988 
TTAGGTCAGATTGTTGATCTAGTTTCTTTGAGCCGCCGCCTGGTTCGGGCTCTGCAG
GGTTTGCGGGGTCCGGGTCAGGCGGCGGTGCACCCGGGGTGTATGCCCTCTATAGT
TTTGGTTCGGTCCGGTTTTCCCAGTTTGCTATCTCTTCGCCCCTGTGGCGGCTATGA
TGGGTTGGGATTCATTGCGTCGGATGGGTTGCTTCCGTCCTTTCCGATGATGGGCTG
AATCTTGATCTGTGGTGTTTCTTCGCTGTTGGTACGACAGAGGAAACTTCACAGATT
TTTAGCGTTCCGCTTCGTACGGGTGCGTTGCCACTGTTGGCTTCGTGCGTGAGGGGT
GGGGCGTATTCATTCAATTTCCGATAACTACACTCACTGATTCCGGCTACAGACTC
GCTGTTAGCGCAGTTCATAACGCTTCCCCCTTACCCCGATGCCTGGTCACTATGCTG
TGCCTTGTGTGGGGTGGGTGTTGCTGTGTGAATTGCAGTTTTCTGCTGTGTGCCGGT
TGAGGTCTCTAGGAGA 
>ORF 3 4989 - 5504 
GACAAATGAATTTTCTTCCGTTCACGCGTGGAGGGCGCGCGCAGGGTGCTGCTTCC
TCCGCTTCTGAGGGCTCTCGCGTAGCTTCTCGCTCCGGGTCCCGTGCTTTGGGTGCG
GCGGCTGCTTCTTTTGCGATGGTTGCGGCTTCTTTGGGTCCGATTGCTTCGGGCGCG
CAGGCTGCTGATGCACGCTACTATGACGGTTCGTCGAGCGAGCGCGCGGCTGCGA
GCTGCTGGGAGGTTAAGCAGAATAATCCGCGTGGCAAGAGCGGCGCGTACTGGCT
GTACACCCCTGCGATGAGTGCTCCTGAGCAGTTCTATTGCGATCAGGAAACTGATG
GCGGCGGCTGGGTTATGATTGGCCGCGGTCGTGAGAGCTGGACTGAGAACTACTA
CGGTCGCGGTAATGCCGATCAGCTGTATAAGAACCCGACCGGCTTTGATGCGGTGC
AGCTCTCCGGCGTGACCGTGAACGCGCTACTGAACGGTACCCGTCCGCAGGATTCC
ATCGCGCGAGAA 
5504 - 5565   216 
CGTTGAGGGCACTACCTGGCAGGATTTTAAGGCTCACCGTGATTCCAGTACCGAAT
GGACT 
>ORF 4 
TGGACTTTGCGTTCGAAGATGTTCTGGTCAAATATTTCGGTCAAAAACACCTGGCA
GTACAGTAACCGTTATGACTACGCCAACCGTGGTCAGGTGGCTGGTAACATCTTCA
CCCATGATTCTGATGACTTCCGTTCCCTGAACTTCGAAGAGAAGGCATCGCAGGGC
TACAAGTTGGGCTTCACCTACGGTCGCAACGCCAAGATTACATGGTGGACCGAGAC
CTACCTGATGAACCGTCCTTCGGCGTATATTTACCGCCCGGCGGATGATTCGACCA
CTCCCCTGGTATTTACTCAGATGTTCTTGCGCCCGAAGGTGACTCAGAACGATTTG
GTGGCTAAGGGTCTGCATGATTATGGCCAGCAGGGCGCTGCGGCAAGTAACCGCC
GCGCGCTACCCAATAGCTACTCCGAGAAGTGGAAGTGGCGTACCAGCGCTGATAC
CGGAACCGGTAAGAACGGCGAGATGAACACCCAGGTTGAGGCGATCACCGAGGTC
GGTGGCGCTGTCTTTACCGGTGGCGATTTCGCGTATGTTGAGTCGGCAAGCGGCGA
GAAGGTTGAGCAGGCTTTCTTGGCTGGTTACGAGGTGGGTACCGGCGAGCTGCGCC
GTTCCTTCCGCCCGAAGATTAACGGTCAGGTGAAGTCGGTTGAGGCTCTGCCGAAC
GGCCTGCTTGCTGTGGGTGGTTCTTTCGACCAGGTGAACGGCGAGTACTACAACGG
TTTTGTAATTCTGGTCCCCGGACCGAGCTTGAAT 
 
 
  Appendix 8: InterProScan Analysis 
                                                                                     
Clone 1 
 
Frame +1/-3 
PLLVLLVDPIVSGGNASEADAGHEIAARVWRVGSDLTAGVDVPAPGTQVGLAPEIACG
HCAPCTSGRSNVCANMRLFGTGVDG 
 
SignalP analysis 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    24       0.711   0.52   YES 
  max. Y    24       0.430   0.32   YES 
  max. S    21       0.960   0.97   NO 
  mean S     1-23    0.495   0.51   NO 
       D     1-23    0.462   0.45   YES 
# Most likely cleavage site between pos. 23 and 24: AGA-CC 
Prediction: Non-secretory protein 
Signal peptide probability: 0.438 
Max cleavage site probability: 0.290 between pos. 23 and 24 
 
tBLASTx : Methylobacterium nodulans ORS 2060, Alcohol dehydrogenase GroES domain 
protein. Expect = 4e-07, Identities = 23/46 (50%). 
 
 
 
 
 
 
 
Clone 2 
 
frame +2 
> - 63 codons 
RSIAGNDKELYTYMDAYDGDQMARELGVEAKHEVEKLAAHKARTVMPAALPVIASA
PAGVQVD 
 218 
 
SignalP analysis 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    24       0.620   0.52   YES 
  max. Y    36       0.305   0.33   NO 
  max. S    38       0.992   0.92   YES 
  mean S     1-35    0.888   0.49   YES 
       D     1-35    0.596   0.44   YES 
# Most likely cleavage site between pos. 35 and 36: ATA-CC 
Prediction: Signal peptide 
Signal peptide probability: 0.989 
Max cleavage site probability: 0.904 between pos. 23 and 24 
 
No InterProScan hits for this protein 
 
tBLASTx : Porphyromonas gingivalis ATCC 33277, glycogen synthase 
Expect = 3e-12, Identities = 31/44 (70%). 
 
 
Clone 11 
 
frame +2 
> - 51 codons 
LNLLELKAVAKEFGMPAFTGGQMAKWLYIQHVTTIDEMTNISKNNREKLKA 
 
SignalP analysis 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    34       0.464   0.52   NO 
  max. Y    34       0.564   0.32   YES 
  max. S    29       0.981   0.97   YES 
  mean S     1-33    0.818   0.51   YES 
       D     1-33    0.691   0.45   YES 
# Most likely cleavage site between pos. 33 and 34: AAA-AG 
>Sequence 
Prediction: Signal peptide 
Signal peptide probability: 0.995 
Max cleavage site probability: 0.429 between pos. 31 and 32 
 
 
No InterProScan hits were found for this protein 
 
tBLASTx : Bacteroides fragilis NCTC 9343, conserved hypothetical protein 
Expect = 2e-10, Identities = 28/50 (56%). 
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Clone 16 
 
frame +2 
> - 57 codons 
QRHAIELEKARWIAKDLGVKQTLIDTSVIKSITHNALMDANADIEQKDGELPNTFVD 
 
SignalP analysis 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    19       0.676   0.52   YES 
  max. Y    19       0.394   0.33   YES 
  max. S    18       0.996   0.92   YES 
  mean S     1-18    0.954   0.49   YES 
       D     1-18    0.674   0.44   YES 
# Most likely cleavage site between pos. 18 and 19: AGA-AC 
 
Prediction: Signal peptide 
Signal peptide probability: 0.997 
Max cleavage site probability: 0.353 between pos. 24 and 25 
 
tBLASTx : Aggregatibacter aphrophilus NJ8700. WD-40 repeat, putative ExsB protein 
Expect = 7e-24, Identities = 48/57 (84%). 
 
 
 
 
 
Clone 17 
 
frame +2 
> - 65 codons 
YIISASLYVSLLSLIWALPLGIGTSVGLSLGVSPRIRQFCLSTIDMIAGIPSVIVGFIGLAVV
VP 
 
SignalP analysis 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    29       0.278   0.52   NO 
  max. Y    29       0.297   0.32   NO 
  max. S     1       0.973   0.97   YES 
  mean S     1-28    0.863   0.51   YES 
       D     1-28    0.580   0.45   YES 
# Most likely cleavage site between pos. 28 and 29: GTA-TC 
>Sequence 
Prediction: Signal peptide 
Signal peptide probability: 0.794 
Max cleavage site probability: 0.490 between pos. 31 and 32 
 
tBLASTx : Clostridium botulinum B1 str. Okra, phosphate uptake ABC transporter, PhoT 
family, permease, Expect = 1e-11, Identities = 33/62 (53%). 220 
 
 
 
 
 
 
 
 
Clone 19 
 
>Frame +3 
KSWNFQDAGIGMAAINAYHSHPEVALARGFTPCEENNWARTFHPYAPLVAGKRVAII
GHFPFAGVQVD 
 
SignalP analysis 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    22       0.521   0.52   YES 
  max. Y    22       0.372   0.32   YES 
  max. S     9       0.958   0.97   NO 
  mean S     1-21    0.602   0.51   YES 
       D     1-21    0.487   0.45   YES 
# Most likely cleavage site between pos. 21 and 22: AGG-AC 
Prediction: Signal peptide 
Signal peptide probability: 0.730 
Max cleavage site probability: 0.455 between pos. 24 and 25 
 
tBLASTx : Desulfitobacterium hafniense Y51,  hypothetical protein 
Expect = 1e-06, Identities = 17/29 (58%). 
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Clone 20 
 
frame +1. This sequence translates into frames +1 and +2 without stop codons, but a tBLASTx 
search picks out frame +1 as being A. adontolyticus. 
> - 53 codons 
LGVENLYEAANTPLIGFLNNAIRAKELFFRDRDYIVDAGEILIVDEHTGRVLP 
 
SignalP analysis 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    35       0.661   0.52   YES 
  max. Y    35       0.420   0.32   YES 
  max. S    30       0.848   0.97   NO 
  mean S     1-34    0.476   0.51   NO 
       D     1-34    0.448   0.45   NO 
# Most likely cleavage site between pos. 34 and 35: ACA-CC 
Prediction: Signal peptide 
Signal peptide probability: 0.786 
Max cleavage site probability: 0.504 between pos. 22 and 23 
 
tBLASTx : Bifidobacterium animalis subsp. lactis DSM 10140, preprotein translocase subunit 
SecA,  Expect = 2e-21, Identities = 40/53 (75%). 
 
 
 
 
 
Clone 22 
 
frame +3 
> - 76 codons 
AEAGHIEAAFQLAGCLFENHENEQDLAIAVEYLKQAARAGHPYARYNLLQLQENNGA
EVETLISAYQELAEEGLVP 
 
SignalP analysis 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    17       0.161   0.52   NO 
  max. Y    17       0.204   0.33   NO 
  max. S     2       0.965   0.92   YES 
  mean S     1-16    0.861   0.49   YES 
       D     1-16    0.533   0.44   YES 
# Most likely cleavage site between pos. 16 and 17: ACA-TA 
Prediction: Signal peptide 
Signal peptide probability: 0.530 222 
 
Max cleavage site probability: 0.282 between pos. 22 and 23 
 
tBLASTx : Neisseria meningitidis 053442, conserved hypothetical protein. 
Expect = 2e-14, Identities = 41/74 (55%). 
 
 
 
 
 
 
 
 
 
Clone 27 
 
Frames +1 and +3 have no frameshifts in them. According to tBLASTx the frame of all hits is 
+3. 
> - 57 codons 
EGTPPENRDGTCRVLVLPRVQPPAGRLHGRQWLHEGRRGFFLGVRVSEKARTRKATR 
 
SignalP analysis 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    65       0.498   0.52   NO 
  max. Y    65       0.197   0.33   NO 
  max. S    19       0.999   0.92   YES 
  mean S     1-64    0.568   0.49   YES 
       D     1-64    0.383   0.44   NO 
# Most likely cleavage site between pos. 64 and 65: ACA-AC 
Prediction: Signal peptide 
Signal peptide probability: 1.000 
Max cleavage site probability: 0.527 between pos. 21 and 22 
 
No InterProScan hits reported for this clone. 
 
tBLASTx: Chlamydomonas reinhardtii strain CC-503 cw92 mt+, NAD malic enzyme  
Expect = 0.065, Identities = 12/22 (54%). 
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Clone 30 
 
Frame +3 
ERRRMAEYLASPQGYDHVMHVVRARFMAGNYYDLCAGVCRDFANTVGNFNIDRGV
ADGHWTRPTRRRRHGIGLGLGVQVD 
 
SignalP analysis 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    23       0.540   0.52   YES 
  max. Y    36       0.261   0.32   NO 
  max. S    34       0.778   0.97   NO 
  mean S     1-35    0.352   0.51   NO 
       D     1-35    0.307   0.45   NO 
Sequence 
Prediction: Non-secretory protein 
Signal peptide probability: 0.259 
Max cleavage site probability: 0.228 between pos. 22 and 23 
 
No interProScan hits reported for this clone. 
 
tBLASTx : Ralstonia solanacearum strain IPO1609, transmembrane protein 
Expect = 0.044, Identities = 15/31 (48%). 
 
 
 
 
Clone 36 
 
Frame +1 
LIFLLGLDAPLTDIWKIGNNISTGFRNPTASEMYFSFEHPAGNWIPNPDLKAEQALNQSI
YIQAEHLLGSFGLTFYHTRYKNLLTEQESTYKKRNPYYNAYSASYGQQGVQVD 
 
SignalP analysis 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    24       0.588   0.52   YES 
  max. Y    47       0.258   0.32   NO 
  max. S     5       0.935   0.97   NO 
  mean S     1-46    0.664   0.51   YES 
       D     1-46    0.461   0.45   YES 
# Most likely cleavage site between pos. 46 and 47: GGA-AG 
Prediction: Signal peptide 
Signal peptide probability: 0.739 
Max cleavage site probability: 0.300 between pos. 23 and 24 
 
tBLASTx : Neisseria meningitidis hmbR pseudogene, strain 30931  
Expect = 3e-26, Identities = 49/102 (48%). 
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Clone 39 
 
frame +1, as dictated by tBLASTx. 
> - 82 codons 
VMAVHRMISLFPGEQQEEIRSQISQVLRAVICQRLLRWNKKFITIRDILLNTHAVANLIR
TRKEPQIISIQETQLPMKTLEM 
 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    45       0.470   0.52   NO 
  max. Y    45       0.521   0.32   YES 
  max. S    40       0.989   0.97   YES 
  mean S     1-44    0.622   0.51   YES 
       D     1-44    0.571   0.45   YES 
# Most likely cleavage site between pos. 44 and 45: ACA-AC 
Prediction: Signal peptide 
Signal peptide probability: 0.865 
Max cleavage site probability: 0.566 between pos. 27 and 28 
 
No InterProScan hits reported for this clone. No obvious structural similarity to the PilT 
protein. 
 
tBLASTx : G. kaustophilus PilT-like protein, pili biogenesis. E=0.0001, 17/27 (62%) id. 
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Clone 42 
 
frame +2 
> - 83 codons 
LYLMTAKSSKTQTKKRASTKPAAKPTTRKSAKTQTQADNKVSQRLKAAKELQKNEEK
KARPEHVVNLINDALWLFGLVITIYL 
 
SignalP analysis 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    22       0.673   0.52   YES 
  max. Y    22       0.184   0.33   NO 
  max. S    37       0.998   0.92   YES 
  mean S     1-21    0.943   0.49   YES 
       D     1-21    0.564   0.44   YES 
# Most likely cleavage site between pos. 21 and 22: AAA-AT 
Prediction: Signal peptide 
Signal peptide probability: 1.000 
Max cleavage site probability: 0.317 between pos. 21 and 22 
 
No InterProScan hits reported for this clone. 
 
tBLASTx : Neisseria meningitidis 053442, cell division protein FtsK 
Expect = 1e-14, Identities = 36/45 (80%) 
 
 
 
 
Clone 44 
 
frame +3 
> - 79 codons 
PHTVSASADNNALMTCWSRERIKSGDAWDNASPSRPPESDSGWRCASSVKSNDASIVR
VRCSSARLVESSTSSNTLSRK 
 
SignalP analysis 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    34       0.661   0.52   YES 
  max. Y    34       0.538   0.32   YES 
  max. S    30       0.983   0.97   YES 
  mean S     1-33    0.603   0.51   YES 
       D     1-33    0.570   0.45   YES 
# Most likely cleavage site between pos. 33 and 34: ACA-AC 
Prediction: Signal peptide 
Signal peptide probability: 0.960 
Max cleavage site probability: 0.679 between pos. 33 and 34 
 
No InterProScan hits reported for this clone. 
 
tBLASTx : Rothia sp. T40-1 Mef, asparate/ornithine binding domain, IS30 transposase family 
protein, and tet(W) genes. Expect = 1e-13, Identities = 32/39 (82%). 
 
 
 
 
 226 
 
Clone 52 
 
frame +3 
> - 79 codons 
IGIVKGGLAGFSTPSIDRWLSRLIDLVLGFPNMVIAIAFIGIMGPSITNVIISLCITKWAEY
ALITRGLVVVEKVFYRH 
 
>Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    18       0.277   0.52   NO 
  max. Y    18       0.318   0.33   NO 
  max. S    41       0.989   0.92   YES 
  mean S     1-17    0.943   0.49   YES 
       D     1-17    0.631   0.44   YES 
# Most likely cleavage site between pos. 17 and 18: AAA-GG 
Prediction: Signal peptide 
Signal peptide probability: 0.535 
Max cleavage site probability: 0.109 between pos. 31 and 32 
 
tBLASTx : Methylovorus sp. SIP3-4, binding-protein-dependent transport systems inner 
membrane. Expect = 6e-14, Identities = 32/67 (47%) 
 
 
 
 
 
Clone 58 
 
Frame +1 
STLMIGMETDTVESIRQIPDIIEEIGVDVPRYNILTPYPGTPFYEQLKAENRLLTRDWYY
YDTETVVFQPKNMSPATLQEEFYKLWQDTFTYKRIFK 
 
SignalP analysis 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    26       0.332   0.52   NO 
  max. Y    41       0.209   0.33   NO 
  max. S    12       0.984   0.92   YES 
  mean S     1-40    0.857   0.49   YES 
       D     1-40    0.533   0.44   YES 
# Most likely cleavage site between pos. 40 and 41: AAA-GC 
Prediction: Non-secretory protein 
Signal peptide probability: 0.451 
Max cleavage site probability: 0.128 between pos. 21 and 22 
 
No InterProScan hits reported for this clone. 
tBLASTx : Leptotrichia buccalis DSM 1135, Expect = 5e-51, Identities = 82/97 (84%),  227 
 
Clone 59 
 
Frame +1 
LILGRINYNNWFFELLAKFFAGVLGIGAGLSLGREGPSVQLGSYVGYGASKILKTDTVE
RNYLLTSGSSAGLSGAFGAPLAGVMFSIEEIHKYLSGKLLI 
 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    29       0.548   0.52   YES 
  max. Y    29       0.343   0.33   YES 
  max. S    19       0.994   0.92   YES 
  mean S     1-28    0.950   0.49   YES 
       D     1-28    0.646   0.44   YES 
# Most likely cleavage site between pos. 28 and 29: ACA-AC 
Prediction: Signal peptide 
Signal peptide probability: 0.991 
Max cleavage site probability: 0.411 between pos. 28 and 29 
 
tBLASTx : F. nucleatum chloride channel protein. E=2e-46, id= 99/100 (99%) 
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Clone 60 
 
Frame +1 
VILGLIFFLDTRLGQAYIATGDNSDMAKSFGINTDRMELMGLVISNGIIALSGALMAQQ
EGYADASRGIGVIV 
 
SignalP analysis 
Sequence              length = 70 
# Measure  Position  Value  Cutoff  signal peptide? 
  max. C    32       0.358   0.52   NO 
  max. Y    32       0.319   0.32   NO 
  max. S    29       0.952   0.97   NO 
  mean S     1-31    0.500   0.51   NO 
       D     1-31    0.410   0.45   NO 
Prediction: Non-secretory protein 
Signal peptide probability: 0.282 
Max cleavage site probability: 0.131 between pos. 28 and 29 
 
tBLASTx: Streptococcus gordonii str. Challis  ABC transporter, permease protein. Expect = 
6e-34, Identities = 63/73 (86%) 
 
 
 
 
 
 